Publications

  1. Bader, P., Potschger, U., Dalle, J. H., Moser, L. M., Balduzzi, A., Ansari, M., Buechner, J., Gungor, T., Ifversen, M., Krivan, G., Pichler, H., Renard, M., Staciuk, R., Sedlacek, P., Stein, J., Heusel, J. R., Truong, T., Wachowiak, J., Yesilipek, A., Locatelli, F., & Peters, C. (2024). Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study. Blood Adv, 8(2), 416-428, PMID: 37738088 https://doi.org/10.1182/bloodadvances.2023010591
  2. Buldini, B., Varotto, E., Maurer-Granofszky, M., Gaipa, G., Schumich, A., Bruggemann, M., Mejstrikova, E., Cazzaniga, G., Hrusak, O., Szczepanowski, M., Scarparo, P., Zimmermann, M., Strehl, S., Schinnerl, D., Zaliova, M., Karawajew, L., Bourquin, J. P., Feuerstein, T., Cario, G., Alten, J., Moricke, A., Biffi, A., Parasole, R., Fagioli, F., Valsecchi, M. G., Biondi, A., Locatelli, F., Attarbaschi, A., Schrappe, M., Conter, V., Basso, G., & Dworzak, M. N. (2024). CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment. Blood, PMID: 38215390 https://doi.org/10.1182/blood.2023021952
  3. Conter, V., Valsecchi, M. G., Cario, G., Zimmermann, M., Attarbaschi, A., Stary, J., Niggli, F., Dalla Pozza, L., Elitzur, S., Silvestri, D., Locatelli, F., Moricke, A., Engstler, G., Smisek, P., Bodmer, N., Barbaric, D., Izraeli, S., Rizzari, C., Boos, J., Buldini, B., Zucchetti, M., von Stackelberg, A., Matteo, C., Lehrnbecher, T., Lanvers-Kaminsky, C., Cazzaniga, G., Gruhn, B., Biondi, A., & Schrappe, M. (2024). Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study. J Clin Oncol, 42(8), 915-926, PMID: 38096462 https://doi.org/10.1200/JCO.23.01388
  4. Cseh, A., Galimard, J. E., de la Fuente, J., Isgro, A., Zecca, M., Garwer, B., Biffi, A., Aljurf, M., Sundin, M., Belendez, C., Locatelli, F., Balduzzi, A., Lawson, S., Sengeloev, H., Ifversen, M., Saccardi, R., Wynn, R., Lankester, A. C., Corbacioglu, S., & Peters, C. (2024). Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties. Br J Haematol, 204(1), e1-e5, PMID: 37795523 https://doi.org/10.1111/bjh.19122
  5. Dobersberger, M., Sumesgutner, D., Zajc, C. U., Salzer, B., Laurent, E., Emminger, D., Sylvander, E., Lehner, E., Teufl, M., Seigner, J., Bobbili, M. R., Kunert, R., Lehner, M., & Traxlmayr, M. W. (2024). An engineering strategy to target activated EGFR with CAR T cells. Cell Rep Methods, 100728, PMID: 38492569 https://doi.org/10.1016/j.crmeth.2024.100728
  6. Erlacher, M., Andresen, F., Sukova, M., Stary, J., De Moerloose, B., Bosch, J., Dworzak, M., Seidel, M. G., Polychronopoulou, S., Beier, R., Kratz, C. P., Nathrath, M., Fruhwald, M. C., Gohring, G., Bergmann, A. K., Mayerhofer, C., Lebrecht, D., Ramamoorthy, S., Yoshimi, A., Strahm, B., Wlodarski, M. W., & Niemeyer, C. M. (2024). Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome. Haematologica, 109(2), 422-430, PMID: 37584291 PMC10828767 https://doi.org/10.3324/haematol.2023.283591
  7. Erman, B., Bal, S. K., Aydogmus, C., Ersoy, G. Z., & Boztug, K. (2024). A Novel Homozygous Six Base Pair Deletion Found in the NFATC2 Gene in a Patient with EBV-Associated Lymphoproliferation. J Clin Immunol, 44(3), 74, PMID: 38427060 PMC10907409 https://doi.org/10.1007/s10875-024-01675-z
  8. Feuchtinger, T., Bader, P., Subklewe, M., Breidenbach, M., Willier, S., Metzler, M., Gokbuget, N., Hauer, J., Muller, F., Schlegel, P. G., Fruhwald, M., Schmid, C., Troeger, A., Baldus, C., Meisel, R., Kunkele, A., Topp, M., Bourquin, J. P., Cario, G., Von Stackelberg, A., & Peters, C. (2024). Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults. Haematologica, PMID: 38356450 https://doi.org/10.3324/haematol.2023.283780
  9. Filbert, A. L., Kremer, L., Ladenstein, R., Chronaki, C., Degelsegger-Marquez, A., van der Pal, H., Bardi, E., Uyttebroeck, A., Langer, T., Muraca, M., Nieto, A. C., Rascon, J., Bagnasco, F., Beyer, S., Te Dorsthorst, J., Essiaf, S., Galan, A. O., Kienesberger, A., O’Brien, K., Palau, M. C., Pluijm, S. M. F., di Profio, S., Saraceno, D., Schneider, C., Schreier, G., Trinkunas, J., Zamberlan, I., Grabow, D., Haupt, R., & PanCareSurPass, c. (2024). Scaling up and implementing the digital Survivorship Passport tool in routine clinical care – The European multidisciplinary PanCareSurPass project. Eur J Cancer, 202, 114029, PMID: 38513384 https://doi.org/10.1016/j.ejca.2024.114029
  10. Gargano, M. A., Matentzoglu, N., Coleman, B., Addo-Lartey, E. B., Anagnostopoulos, A. V., Anderton, J., Avillach, P., Bagley, A. M., Bakstein, E., Balhoff, J. P., Baynam, G., Bello, S. M., Berk, M., Bertram, H., Bishop, S., Blau, H., Bodenstein, D. F., Botas, P., Boztug, K., Cady, J., Callahan, T. J., Cameron, R., Carbon, S. J., Castellanos, F., Caufield, J. H., Chan, L. E., Chute, C. G., Cruz-Rojo, J., Dahan-Oliel, N., Davids, J. R., de Dieuleveult, M., de Souza, V., de Vries, B. B. A., de Vries, E., DePaulo, J. R., Derfalvi, B., Dhombres, F., Diaz-Byrd, C., Dingemans, A. J. M., Donadille, B., Duyzend, M., Elfeky, R., Essaid, S., Fabrizzi, C., Fico, G., Firth, H. V., Freudenberg-Hua, Y., Fullerton, J. M., Gabriel, D. L., Gilmour, K., Giordano, J., Goes, F. S., Moses, R. G., Green, I., Griese, M., Groza, T., Gu, W., Guthrie, J., Gyori, B., Hamosh, A., Hanauer, M., Hanusova, K., He, Y. O., Hegde, H., Helbig, I., Holasova, K., Hoyt, C. T., Huang, S., Hurwitz, E., Jacobsen, J. O. B., Jiang, X., Joseph, L., Keramatian, K., King, B., Knoflach, K., Koolen, D. A., Kraus, M. L., Kroll, C., Kusters, M., Ladewig, M. S., Lagorce, D., Lai, M. C., Lapunzina, P., Laraway, B., Lewis-Smith, D., Li, X., Lucano, C., Majd, M., Marazita, M. L., Martinez-Glez, V., McHenry, T. H., McInnis, M. G., McMurry, J. A., Mihulova, M., Millett, C. E., Mitchell, P. B., Moslerova, V., Narutomi, K., Nematollahi, S., Nevado, J., Nierenberg, A. A., Cajbikova, N. N., Nurnberger, J. I., Jr., Ogishima, S., Olson, D., Ortiz, A., Pachajoa, H., Perez de Nanclares, G., Peters, A., Putman, T., Rapp, C. K., Rath, A., Reese, J., Rekerle, L., Roberts, A. M., Roy, S., Sanders, S. J., Schuetz, C., Schulte, E. C., Schulze, T. G., Schwarz, M., Scott, K., Seelow, D., Seitz, B., Shen, Y., Similuk, M. N., Simon, E. S., Singh, B., Smedley, D., Smith, C. L., Smolinsky, J. T., Sperry, S., Stafford, E., Stefancsik, R., Steinhaus, R., Strawbridge, R., Sundaramurthi, J. C., Talapova, P., Tenorio Castano, J. A., Tesner, P., Thomas, R. H., Thurm, A., Turnovec, M., van Gijn, M. E., Vasilevsky, N. A., Vlckova, M., Walden, A., Wang, K., Wapner, R., Ware, J. S., Wiafe, A. A., Wiafe, S. A., Wiggins, L. D., Williams, A. E., Wu, C., Wyrwoll, M. J., Xiong, H., Yalin, N., Yamamoto, Y., Yatham, L. N., Yocum, A. K., Young, A. H., Yuksel, Z., Zandi, P. P., Zankl, A., Zarante, I., Zvolsky, M., Toro, S., Carmody, L. C., Harris, N. L., Munoz-Torres, M. C., Danis, D., Mungall, C. J., Kohler, S., Haendel, M. A., & Robinson, P. N. (2024). The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Res, 52(D1), D1333-D1346, PMID: 37953324 PMC10767975 https://doi.org/10.1093/nar/gkad1005
  11. Hagele, P., Staus, P., Scheible, R., Uhlmann, A., Heeg, M., Klemann, C., Maccari, M. E., Ritterbusch, H., Armstrong, M., Cutcutache, I., Elliott, K. S., von Bernuth, H., Leahy, T. R., Leyh, J., Holzinger, D., Lehmberg, K., Svec, P., Masjosthusmann, K., Hambleton, S., Jakob, M., Sparber-Sauer, M., Kager, L., Puzik, A., Wolkewitz, M., Lorenz, M. R., Schwarz, K., Speckmann, C., Rensing-Ehl, A., Ehl, S., & group, A. s. (2024). Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study. Lancet Haematol, 11(2), e114-e126, PMID: 38302222 https://doi.org/10.1016/S2352-3026(23)00362-9
  12. Huibers, M. H. W., Abla, O., Andres, M., Balague, O., Beishuizen, A., Carraro, E., Chiang, A. K. S. D., Csoka, M., David, B. A., de Ville de Goyet, M., Gilad, G., Hori, D., Kotecha, R. S., Kabickova, E., Klapper, W., Miakova, N., Minard-Colin, V., Nakazawa, A., Pillon, M., Rigaud, C., Salaverria, I., Tolle, I., Verdu-Amoros, J., von Mersi, H., Woessmann, W., Burkhardt, B., & Attarbaschi, A. (2024). Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm? Blood Adv, PMID: 38290136 https://doi.org/10.1182/bloodadvances.2023012109
  13. Kager, L., Jimenez-Heredia, R., Zeitlhofer, P., Novak, W., Eder, S. K., Segarra-Roca, A., Frohne, A., Nebral, K., Haimel, M., Geyeregger, R., Roetzer-Londgin, K., Haas, O. A., & Boztug, K. (2024). A single-center cohort study of patients with hereditary spherocytosis in Central Europe reveals a high frequency of novel disease-causing genotypes. Hemasphere, 8(1), e31, PMID: 38434532 PMC10878193 https://doi.org/10.1002/hem3.31
  14. Kameneva, P., & Taschner-Mandl, S. (2024). In preprints: recapitulation of development and wound healing shapes the spatial organization of glioblastoma. Development, 151(1), PMID: 38180240 https://doi.org/10.1242/dev.202618
  15. Kamnev, A., Mehta, T., Wielscher, M., Chaves, B., Lacouture, C., Mautner, A. K., Shaw, L. E., Caldera, M., Menche, J., Weninger, W. P., Farlik, M., Boztug, K., & Dupre, L. (2024). Coordinated ARP2/3 and glycolytic activities regulate the morphological and functional fitness of human CD8(+) T cells. Cell Rep, 43(3), 113853, PMID: 38421875 https://doi.org/10.1016/j.celrep.2024.113853
  16. Karaatmaca, B., Cagdas, D., Esenboga, S., Erman, B., Tan, C., Turul Ozgur, T., Boztug, K., van der Burg, M., Sanal, O., & Tezcan, I. (2024). Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre. Clin Exp Immunol, 215(2), 160-176, PMID: 37724703 PMC10847812 https://doi.org/10.1093/cei/uxad110
  17. Karakus, I. S., Catak, M. C., Frohne, A., Bayram Catak, F., Yorgun Altunbas, M., Babayeva, R., Bal, S. K., Eltan, S. B., Yalcin Gungoren, E., Esen, F., Zemheri, I. E., Karakoc-Aydiner, E., Ozen, A., Caki-Kilic, S., Kraakman, M. J., Boztug, K., & Baris, S. (2024). Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion. J Clin Immunol, 44(4), 94, PMID: 38578569 PMC10997552 https://doi.org/10.1007/s10875-024-01682-0
  18. Karwacki-Neisius, V., Jang, A., Cukuroglu, E., Tai, A., Jiao, A., Predes, D., Yoon, J., Brookes, E., Chen, J., Iberg, A., Halbritter, F., Ounap, K., Gecz, J., Schlaeger, T. M., Ho Sui, S., Goke, J., He, X., Lehtinen, M. K., Pomeroy, S. L., & Shi, Y. (2024). WNT signalling control by KDM5C during development affects cognition. Nature, PMID: 38383780 https://doi.org/10.1038/s41586-024-07067-y
  19. Kirchberger, S., Shoeb, M. R., Lazic, D., Wenninger-Weinzierl, A., Fischer, K., Shaw, L. E., Nogueira, F., Rifatbegovic, F., Bozsaky, E., Ladenstein, R., Bodenmiller, B., Lion, T., Traver, D., Farlik, M., Schofer, C., Taschner-Mandl, S., Halbritter, F., & Distel, M. (2024). Comparative transcriptomics coupled to developmental grading via transgenic zebrafish reporter strains identifies conserved features in neutrophil maturation. Nat Commun, 15(1), 1792, PMID: 38413586 https://doi.org/10.1038/s41467-024-45802-1
  20. Koehrer, S., & Burger, J. A. (2024). Chronic Lymphocytic Leukemia: Disease Biology. Acta Haematol, 147(1), 8-21, PMID: 37717577 https://doi.org/10.1159/000533610
  21. Kowarsch, F., Maurer-Granofszky, M., Weijler, L., Wodlinger, M., Reiter, M., Schumich, A., Feuerstein, T., Sala, S., Novakova, M., Faggin, G., Gaipa, G., Hrusak, O., Buldini, B., & Dworzak, M. N. (2024). FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report. Cytometry A, 105(1), 24-35, PMID: 37776305 https://doi.org/10.1002/cyto.a.24805
  22. Luedersen, J., Stadt, U. Z., Richter, J., Oschlies, I., Klapper, W., Rosenwald, A., Kalinova, M., Simonitsch-Klupp, I., Siebert, R., Zimmermann, M., Qi, M., Nakel, J., Scheinemann, K., Knorr, F., Attarbaschi, A., Kabickova, E., Woessmann, W., & Damm-Welk, C. (2024). Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group. Br J Haematol, PMID: 38279625 https://doi.org/10.1111/bjh.19308
  23. Mark, C., Meshinchi, S., Joyce, B., Gibson, B., Harrison, C., Bergmann, A. K., Goemans, B. F., Pronk, C. J. H., Lapillonne, H., Leverger, G., Antoniou, E., Schneider, M., Attarbaschi, A., Dworzak, M., Stary, J., Tomizawa, D., Ebert, S., Lejman, M., Kolb, E. A., Schmiegelow, K., Hasle, H., & Abla, O. (2024). Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias. Br J Haematol, 204(2), 576-584, PMID: 37743097 https://doi.org/10.1111/bjh.19067
  24. Maurer-Granofszky, M., Kohrer, S., Fischer, S., Schumich, A., Nebral, K., Larghero, P., Meyer, C., Mecklenbrauker, A., Muhlegger, N., Marschalek, R., Haas, O. A., Panzer-Grumayer, R., & Dworzak, M. N. (2024). Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia. Haematologica, 109(3), 740-750, PMID: 37345487 PMC10910191 https://doi.org/10.3324/haematol.2022.282424
  25. Mettmann, V. L., Blattmann, C., Friedel, G., Harrabi, S., von Kalle, T., Kager, L., Kevric, M., Kuhne, T., Nathrath, M., Sorg, B., Werner, M., Bielack, S. S., & Hecker-Nolting, S. (2024). Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study Group. Cancers (Basel), 16(2), PMID: 38254767 PMC10813782 https://doi.org/10.3390/cancers16020275
  26. Moser, O., Ngoya, M., Galimard, J. E., Dalissier, A., Dalle, J. H., Kalwak, K., Wossmann, W., Burkhardt, B., Bierings, M., Gonzalez-Vicent, M., Lopez Corral, L., Mellgren, K., Attarbaschi, A., Bourhis, J. H., Carlson, K., Corbacioglu, S., Drabko, K., Sundin, M., Toporski, J., Cario, G., & Kontny, U. (2024). Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study. Bone Marrow Transplant, PMID: 38331982 https://doi.org/10.1038/s41409-024-02226-1
  27. Papadakis, V., Astigarraga, I., van den Bos, C., Donadieu, J., Henter, J. I., Jacobs, S., Lehrnbecher, T., Munthe-Kaas, M. C., Naeije, L., Nanduri, V., Nguyen, T., Nysom, K., Pears, J., Raciborska, A., Sieni, E., Svojgr, K., Tzotzola, V., Minkov, M., & European Consortium for, H. (2024). The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis. Pediatr Blood Cancer, 71(3), e30850, PMID: 38185727 https://doi.org/10.1002/pbc.30850
  28. Park, A. Y., Leney-Greene, M., Lynberg, M., Gabrielski, J. Q., Xu, X., Schwarz, B., Zheng, L., Balasubramaniyam, A., Ham, H., Chao, B., Zhang, Y., Matthews, H. F., Cui, J., Yao, Y., Kubo, S., Chanchu, J. M., Morawski, A. R., Cook, S. A., Jiang, P., Ravell, J. C., Cheng, Y. H., George, A., Faruqi, A., Pagalilauan, A. M., Bergerson, J. R. E., Ganesan, S., Chauvin, S. D., Aluri, J., Edwards-Hicks, J., Bohrnsen, E., Tippett, C., Omar, H., Xu, L., Butcher, G. W., Pascall, J., Karakoc-Aydiner, E., Kiykim, A., Maecker, H., Tezcan, I., Esenboga, S., Heredia, R. J., Akata, D., Tekin, S., Kara, A., Kuloglu, Z., Unal, E., Kendirli, T., Dogu, F., Karabiber, E., Atkinson, T. P., Cochet, C., Filhol, O., Bosio, C. M., Davis, M. M., Lifton, R. P., Pearce, E. L., Daumke, O., Aytekin, C., Sahin, G. E., Aksu, A. U., Uzel, G., Koneti Rao, V., Sari, S., Boztug, K., Cagdas, D., Haskologlu, S., Ikinciogullari, A., Schwefel, D., Vilarinho, S., Baris, S., Ozen, A., Su, H. C., & Lenardo, M. J. (2024). GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway. Nat Immunol, PMID: 38172257 https://doi.org/10.1038/s41590-023-01691-y
  29. Peters, C. (2024). Haematopoietic stem cell transplantation in children with sickle cell disease: Still to do? Br J Haematol, 204(1), 22-23, PMID: 37957026 https://doi.org/10.1111/bjh.19175
  30. Pucci, P., Lee, L. C., Han, M., Matthews, J. D., Jahangiri, L., Schlederer, M., Manners, E., Sorby-Adams, A., Kaggie, J., Trigg, R. M., Steel, C., Hare, L., James, E. R., Prokoph, N., Ducray, S. P., Merkel, O., Rifatbegovic, F., Luo, J., Taschner-Mandl, S., Kenner, L., Burke, G. A. A., & Turner, S. D. (2024). Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma. Nat Commun, 15(1), 3422, PMID: 38653965 PMC11039739 https://doi.org/10.1038/s41467-024-47771-x
  31. Ramamoorthy, S., Lebrecht, D., Schanze, D., Schanze, I., Wieland, I., Andrieux, G., Metzger, P., Hess, M., Albert, M. H., Borkhardt, A., Bresters, D., Buechner, J., Catala, A., De Haas, V., Dworzak, M., Erlacher, M., Hasle, H., Jahnukainen, K., Locatelli, F., Masetti, R., Stary, J., Turkiewicz, D., Vinci, L., Wlodarski, M. W., Yoshimi, A., Boerries, M., Niemeyer, C. M., Zenker, M., & Flotho, C. (2024). Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup. Br J Haematol, 204(2), 595-605, PMID: 37945316 https://doi.org/10.1111/bjh.19190
  32. Rascon, J., Blackute, R., Cerkauskiene, A., Taschner-Mandl, S., Andrade, N., Planinic, A., Rutkowski, S., Schuller, U., Nysom, K., Tuckuviene, R., Brok, J., Schmiegelow, K., van den Heuvel-Eibrink, M. M., van der Perk, M. E. M., Haupt, R., Muraca, M., Saraceno, D., Geoerger, B., Manuzi, G., & R., L. (2024). Twinning to reduce research and innovation inequalities in paediatric solid tumours across Europe. EJC Paediatric Oncology, 3,DOI: https://doi.org/https://doi.org/10.1016/j.ejcped.2024.100153
  33. Schelch, K., Eder, S., Zitta, B., Phimmachanh, M., Johnson, T. G., Emminger, D., Wenninger-Weinzierl, A., Sturtzel, C., Poplimont, H., Ries, A., Hoetzenecker, K., Hoda, M. A., Berger, W., Distel, M., Dome, B., Reid, G., & Grusch, M. (2024). YB-1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2. Mol Oncol, 18(4), 815-831, PMID: 36550787 PMC10994239 https://doi.org/10.1002/1878-0261.13367
  34. Schofer, S., Laffer, S., Kirchberger, S., Kothmayer, M., Lohnert, R., Ebner, E. E., Weipoltshammer, K., Distel, M., Pusch, O., & Schofer, C. (2024). Senescence-associated ss-galactosidase staining over the lifespan differs in a short- and a long-lived fish species. Eur J Histochem, 68(1), PMID: 38568207 PMC11017726 https://doi.org/10.4081/ejh.2024.3977
  35. Sponseiler, I., Bandian, A. M., Pusic, P., & Lion, T. (2024). Combinatorial treatment options for highly resistant compound mutations in the kinase domain of the BCR::ABL1 fusion gene in Ph-positive leukemias. Am J Hematol, 99(1), E9-E11, PMID: 38085116 https://doi.org/10.1002/ajh.27095
  36. Stoevesandt, D., Ludwig, C., Mauz-Korholz, C., Korholz, D., Hasenclever, D., McCarten, K., Flerlage, J. E., Kurch, L., Wohlgemuth, W. A., Landman-Parker, J., Wallace, W. H., Fossa, A., Vordermark, D., Karlen, J., Cepelova, M., Klekawka, T., Attarbaschi, A., Hraskova, A., Uyttebroeck, A., Beishuizen, A., Dieckmann, K., Leblanc, T., Daw, S., & Steglich, J. (2024). Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging. Pediatr Radiol, PMID: 38296856 https://doi.org/10.1007/s00247-024-05859-y
  37. Suske, T., Sorger, H., Manhart, G., Ruge, F., Prutsch, N., Zimmerman, M. W., Eder, T., Abdallah, D. I., Maurer, B., Wagner, C., Schonefeldt, S., Spirk, K., Pichler, A., Pemovska, T., Schweicker, C., Poloske, D., Hubanic, E., Jungherz, D., Muller, T. A., Aung, M. M. K., Orlova, A., Pham, H. T. T., Zimmel, K., Krausgruber, T., Bock, C., Muller, M., Dahlhoff, M., Boersma, A., Rulicke, T., Fleck, R., de Araujo, E. D., Gunning, P. T., Aittokallio, T., Mustjoki, S., Sanda, T., Hartmann, S., Grebien, F., Hoermann, G., Haferlach, T., Staber, P. B., Neubauer, H. A., Look, A. T., Herling, M., & Moriggl, R. (2024). Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia. J Clin Invest, 134(8), PMID: 38618957 PMC11014662 https://doi.org/10.1172/JCI168536
  38. Tuna Kirsaclioglu, C., Frohne, A., Kuloglu, Z., Kristofersdottir, I., Demir, E., Altuntas, C., Haskologlu, Z. S., Cobanoglu, F. N., Kendirli, T., Ozdemir, H., Ozcakar, Z. B., Savas, B., Dogu, F., Ikinciogullari, A., Boztug, K., & Kansu, A. (2024). Very-early-onset Inflammatory Bowel Disease in an Infant with a Partial RIPK1 Deletion. J Clin Immunol, 44(5), 108, PMID: 38676845 PMC11055784 https://doi.org/10.1007/s10875-024-01707-8
  39. van Weelderen, R. E., Harrison, C. J., Klein, K., Jiang, Y., Abrahamsson, J., Alonzo, T., Aplenc, R., Arad-Cohen, N., Bart-Delabesse, E., Buldini, B., De Moerloose, B., Dworzak, M. N., Elitzur, S., Fernandez Navarro, J. M., Gamis, A. S., Gerbing, R. B., Goemans, B. F., de Groot-Kruseman, H. A., Guest, E. M., Ha, S. Y., Hasle, H., Kelaidi, C., Lapillonne, H., Leverger, G., Locatelli, F., Miyamura, T., Noren-Nystrom, U., Polychronopoulou, S., Rasche, M., Rubnitz, J. E., Stary, J., Tierens, A., Tomizawa, D., Zwaan, M. C., & Kaspers, G. J. L. (2024). Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia. Blood Adv, PMID: 38621200 https://doi.org/10.1182/bloodadvances.2023011771
  40. Welter, N., Metternich, G., Furtwangler, R., Bayoumi, A., Mergen, M., Kager, L., Vokuhl, C., Warmann, S. W., Fuchs, J., Meier, C. M., Melchior, P., Gessler, M., Wagenpfeil, S., Schenk, J. P., & Graf, N. (2024). How to improve initial diagnostic accuracy of kidney tumours in childhood?-A non-invasive approach. Int J Cancer, PMID: 38319190 https://doi.org/10.1002/ijc.34870
  41. Werren, E. A., LaForce, G. R., Srivastava, A., Perillo, D. R., Li, S., Johnson, K., Baris, S., Berger, B., Regan, S. L., Pfennig, C. D., de Munnik, S., Pfundt, R., Hebbar, M., Jimenez-Heredia, R., Karakoc-Aydiner, E., Ozen, A., Dmytrus, J., Krolo, A., Corning, K., Prijoles, E. J., Louie, R. J., Lebel, R. R., Le, T. L., Amiel, J., Gordon, C. T., Boztug, K., Girisha, K. M., Shukla, A., Bielas, S. L., & Schaffer, A. E. (2024). TREX tetramer disruption alters RNA processing necessary for corticogenesis in THOC6 Intellectual Disability Syndrome. Nat Commun, 15(1), 1640, PMID: 38388531 PMC10884030 https://doi.org/10.1038/s41467-024-45948-y
  42. Yoshimi, A., Noellke, P., Stary, J., Kallay, K., Smith, O., Locatelli, F., Buechner, J., Bodova, I., Sevilla, J., Schmugge, M., Bierings, M., Masmas, T., Dworzak, M., Labarque, V., Pawelec, K., Jahnukainen, K., Polychronopoulou, S., Kjollerstrom, P., Kavcic, M., Erlacher, M., Niemeyer, C. M., & Strahm, B. (2024). Comparison of outcomes of immunosuppressive therapy with rabbit versus horse antithymocyte globulin and cyclosporine a in children with acquired severe aplastic anemia. Am J Hematol, PMID: 38622880 https://doi.org/10.1002/ajh.27334

  1. A, V. S., Jaschke, K., Jousseaume, E., Templin, C., Jeratsch, U., Kosmides, D., Steffen, I., Gokbuget, N., & Peters, C. (2023). Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia. Leukemia, PMID: 37880478 https://doi.org/10.1038/s41375-023-02042-4
  2. Aigner-Radakovics, K., De Sousa Linhares, A., Salzer, B., Lehner, M., Izadi, S., Castilho, A., Pickl, W. F., Leitner, J., & Steinberger, P. (2023). The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif. Sci Signal, 16(805), eadg2610, PMID: 37788323 https://doi.org/10.1126/scisignal.adg2610
  3. Attarbaschi, A., Moricke, A., Harrison, C. J., Mann, G., Baruchel, A., De Moerloose, B., Conter, V., Devidas, M., Elitzur, S., Escherich, G., Hunger, S. P., Horibe, K., Manabe, A., Loh, M. L., Pieters, R., Schmiegelow, K., Silverman, L. B., Stary, J., Vora, A., Pui, C. H., Schrappe, M., Zimmermann, M., & Ponte-di-Legno Childhood Acute Lymphoblastic Leukemia Working, G. (2023). Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. J Clin Oncol, 41(7), 1404-1422, PMID: 36256911 https://doi.org/10.1200/JCO.22.01297
  4. Barnbrock, A. E., Hutter, C., Bochennek, K., Minkov, M., & Lehrnbecher, T. (2023). [Therapeutic Strategies In Children And Adolescents With Langerhans Cell Histiocytosis]. Klin Padiatr, PMID: 37673093 https://doi.org/10.1055/a-2146-1395
  5. Bauer, K., Machherndl-Spandl, S., Kazianka, L., Sadovnik, I., Gultekin, S., Suessner, S., Proell, J., Lauf, J., Hoermann, G., Eisenwort, G., Hafner, N., Fodermayr-Mayrleitner, M., Schmolke, A. S., van der Kouwe, E., Platzbecker, U., Lion, T., Weltermann, A., Zach, O., Webersinke, G., Germing, U., Gabriel, C., Sperr, W. R., Bene, M. C., Staber, P. B., Bettelheim, P., & Valent, P. (2023). CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS. Leukemia, PMID: 37673973 https://doi.org/10.1038/s41375-023-02015-7
  6. Berner, J., van de Wetering, C., Jimenez Heredia, R., Rashkova, C., Ferdinandusse, S., Koster, J., Weiss, J. G., Frohne, A., Giuliani, S., Waterham, H. R., Castanon, I., Brunner, J., & Boztug, K. (2023). Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases. J Allergy Clin Immunol, PMID: 37364720 https://doi.org/10.1016/j.jaci.2023.06.013
  7. Bernkopf, M.*, Abdullah, U. B.*, Bush, S. J., Wood, K. A., Ghaffari, S., Giannoulatou, E., Koelling, N., Maher, G. J., Thibaut, L. M., Williams, J., Blair, E. M., Kelly, F. B., Bloss, A., Burkitt-Wright, E., Canham, N., Deng, A. T., Dixit, A., Eason, J., Elmslie, F., Gardham, A., Hay, E., Holder, M., Homfray, T., Hurst, J. A., Johnson, D., Jones, W. D., Kini, U., Kivuva, E., Kumar, A., Lees, M. M., Leitch, H. G., Morton, J. E. V., Nemeth, A. H., Ramachandrappa, S., Saunders, K., Shears, D. J., Side, L., Splitt, M., Stewart, A., Stewart, H., Suri, M., Clouston, P., Davies, R. W., Wilkie, A. O. M., & Goriely, A. (2023). Personalized recurrence risk assessment following the birth of a child with a pathogenic de novo mutation. Nat Commun, 14(1), 853, PMID: 36792598 PMC9932158 https://doi.org/10.1038/s41467-023-36606-w  *Shared first authorship
  8. Bertrums, E. J. M., Smith, J. L., Harmon, L., Ries, R. E., Wang, Y. J., Alonzo, T. A., Menssen, A. J., Chisholm, K. M., Leonti, A. R., Tarlock, K., Ostronoff, F., Pogosova-Agadjanyan, E. L., Kaspers, G. J. L., Hasle, H., Dworzak, M., Walter, C., Muhlegger, N., Morerio, C., Pardo, L., Hirsch, B., Raimondi, S., Cooper, T. M., Aplenc, R., Gamis, A. S., Kolb, E. A., Farrar, J. E., Stirewalt, D., Ma, X., Shaw, T. I., Furlan, S. N., Brodersen, L. E., Loken, M. R., Van den Heuvel-Eibrink, M. M., Zwaan, C. M., Triche, T. J., Goemans, B. F., & Meshinchi, S. (2023). Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. Haematologica, PMID: 36815378 https://doi.org/10.3324/haematol.2022.281653
  9. Bielack, S. S., Blattmann, C., Hassenpflug, W., Kager, L., Kuhne, T., Kevric, M., Schlegel, P. G., Mettmann, V., Sorg, B., & Hecker-Nolting, S. (2023). Osteosarcoma Arising After Ewing Sarcoma or Vice Versa: A Report of 20 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS). Anticancer Res, 43(11), 4975-4981, PMID: 37909999 https://doi.org/10.21873/anticanres.16696 
  10. Bielack, S. S., Kager, L., Kuhne, T., Langer, T., Reichardt, P., Blattmann, C., Kevric, M., Mettmann, V., Sorg, B., & Hecker-Nolting, S. (2023). Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS). Cancers (Basel), 15(5), PMID: 36900310 PMC10000534 https://doi.org/10.3390/cancers15051520  
  11. Bielack, S. S., Lindner, L. H., Egerer, G., Benzler, K., Blattmann, C., Grube, M., Hahn, D., Kager, L., Kuhne, T., Mettmann, V., Reichardt, P., & Hecker-Nolting, S. (2023). Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group. J Geriatr Oncol, 14(3), 101445, PMID: 36842425 https://doi.org/10.1016/j.jgo.2023.101445
  12. Block, J., Rashkova, C., Castanon, I., Zoghi, S., Platon, J., Ardy, R. C., Fujiwara, M., Chaves, B., Schoppmeyer, R., van der Made, C. I., Jimenez Heredia, R., Harms, F. L., Alavi, S., Alsina, L., Sanchez Moreno, P., Avila Polo, R., Cabrera-Perez, R., Kostel Bal, S., Pfajfer, L., Ransmayr, B., Mautner, A. K., Kondo, R., Tinnacher, A., Caldera, M., Schuster, M., Dominguez Conde, C., Platzer, R., Salzer, E., Boyer, T., Brunner, H. G., Nooitgedagt-Frons, J. E., Iglesias, E., Deya-Martinez, A., Camacho-Lovillo, M., Menche, J., Bock, C., Huppa, J. B., Pickl, W. F., Distel, M., Yoder, J. A., Traver, D., Engelhardt, K. R., Linden, T., Kager, L., Hannich, J. T., Hoischen, A., Hambleton, S., Illsinger, S., Da Costa, L., Kutsche, K., Chavoshzadeh, Z., van Buul, J. D., Anton, J., Calzada-Hernandez, J., Neth, O., Viaud, J., Nishikimi, A., Dupre, L., & Boztug, K. (2023). Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency. N Engl J Med, PMID: 37342957 https://doi.org/10.1056/NEJMoa2210054
  13. Bodmer, N., Hecker-Nolting, S., Friedel, G., Blattmann, C., Kager, L., Kessler, T., Kevric, M., Kuhne, T., Mettmann, V., Muller-Abt, P., Sorg, B., Theobald, M., & Bielack, S. S. (2023). Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group. Cancer, PMID: 36928868 https://doi.org/10.1002/cncr.34744
  14. Bomken, S., Enshaei, A., Schwalbe, E. C., Mikulasova, A., Dai, Y., Zaka, M., Fung, K. T. M., Bashton, M., Lim, H., Jones, L., Karataraki, N., Winterman, E., Ashby, C., Attarbaschi, A., Bertrand, Y., Bradtke, J., Buldini, B., Burke, G. A. A., Cazzaniga, G., Gohring, G., De Groot-Kruseman, H. A., Haferlach, C., Nigro, L. L., Parihar, M., Plesa, A., Seaford, E., Sonneveld, E., Strehl, S., Van der Velden, V. H. J., Rand, V., Hunger, S. P., Harrison, C. J., Bacon, C. M., Van Delft, F. W., Loh, M. L., Moppett, J., Vormoor, J., Walker, B. A., Moorman, A. V., & Russell, L. J. (2023). Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement. Haematologica, 108(3), 717-731, PMID: 35484682 PMC9973471 https://doi.org/10.3324/haematol.2021.280557
  15. Brandes, D., Yasin, L., Nebral, K., Ebler, J., Schinnerl, D., Picard, D., Bergmann, A. K., Alam, J., Kohrer, S., Haas, O. A., Attarbaschi, A., Marschall, T., Stanulla, M., Borkhardt, A., Brozou, T., Fischer, U., & Wagener, R. (2023). Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia. Hemasphere, 7(8), e925, PMID: 37469802 PMC10353714 https://doi.org/10.1097/HS9.0000000000000925
  16. Campbell, M., Kiss, C., Zimmermann, M., Riccheri, C., Kowalczyk, J., Felice, M. S., Kuzmanovic, M., Kovacs, G., Kosmidis, H., Gonzalez, A., Bilic, E., Castillo, L., Kolenova, A., Jazbec, J., Popa, A., Konstantinov, D., Kappelmayer, J., Szczepanski, T., Dworzak, M., Buldini, B., Gaipa, G., Marinov, N., Rossi, J., Nagy, A., Gaspar, I., Stary, J., & Schrappe, M. (2023). Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Munster 2009 Trial. J Clin Oncol, JCO2201760, PMID: 37141547 https://doi.org/10.1200/JCO.22.01760
  17. Cekic, S., Aydin, F., Karali, Y., Sevinir, B. B., Canoz, O., Boztug, K., Unal, E., & Kilic, S. S. (2023). T-cell/histiocyte-rich large B-cell lymphoma in a patient with a novel frameshift MSH6 mutation. Pediatr Blood Cancer, 70(3), e30008, PMID: 36151955 https://doi.org/10.1002/pbc.30008
  18. Corallo, D., Dalla Vecchia, M., Lazic, D., Taschner-Mandl, S., Biffi, A., & Aveic, S. (2023). The molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma. Biochem Pharmacol, 215, 115696, PMID: 37481138 https://doi.org/10.1016/j.bcp.2023.115696
  19. de Beijer, I. A. E., Hardijzer, E. C., Haupt, R., Grabow, D., Balaguer, J., Bardi, E., Canete Nieto, A., Ciesiuniene, A., Duster, V., Filbert, A. L., Gsell, H., Kapitancuke, M., Ladenstein, R., Langer, T., Muraca, M., van den Oever, S. R., Prikken, S., Rascon, J., Tormo, M. T., Uyttebroeck, A., Vercruysse, G., van der Pal, H. J. H., Kremer, L. C. M., Pluijm, S. M. F., & PanCareSurPass, c. (2023). Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study. J Cancer Surviv, PMID: 38015382 https://doi.org/10.1007/s11764-023-01498-8 Online ahead of print
  20. Delehaye, F., Rouger, J., Brossier, D., Suttorp, M., Gunes, A. M., Sedlacek, P., Versluys, B., Li, C. K., Kalwak, K., Lausen, B., Srdjana, C., Dworzak, M., Hraskova, A., De Moerloose, B., Roula, F., Briant, A., Parienti, J. J., & Millot, F. (2023). Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course. Ann Hematol, 102(3), 563-570, PMID: 36370190 https://doi.org/10.1007/s00277-022-05024-1
  21. Ebner, J., Schmoellerl, J., Piontek, M., Manhart, G., Troester, S., Carter, B. Z., Neubauer, H., Moriggl, R., Szakacs, G., Zuber, J., Kocher, T., Andreeff, M., Sperr, W. R., Valent, P., & Grebien, F. (2023). ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia. Nat Commun, 14(1), 5709, PMID: 37726279 PMC10509209 https://doi.org/10.1038/s41467-023-41229-2
  22. Eichhoff, O. M., Stoffel, C. I., Kasler, J., Briker, L., Turko, P., Karsai, G., Zila, N., Paulitschke, V., Cheng, P. F., Leitner, A., Bileck, A., Zamboni, N., Irmisch, A., Balazs, Z., Tastanova, A., Pascoal, S., Johansen, P., Wegmann, R., Mena, J., Othman, A., Viswanathan, V. S., Wenzina, J., Aloia, A., Saltari, A., Dzung, A., TuPro, C., Krauthammer, M., Schreiber, S. L., Hornemann, T., Distel, M., Snijder, B., Dummer, R., & Levesque, M. P. (2023). ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Cancer Res, OF1-OF19, PMID: 36946761 https://doi.org/10.1158/0008-5472.CAN-22-1826
  23. Erlacher, M., Andresen, F., Sukova, M., Stary, J., De Moerloose, B., Bosch, J., Dworzak, M., Seidel, M. G., Polychronopoulou, S., Beier, R., Kratz, C. P., Nathrath, M., Fruhwald, M. C., Gohring, G., Bergmann, A. K., Mayerhofer, C., Lebrecht, D., Ramamoorthy, S., Yoshimi, A., Strahm, B., Wlodarski, M. W., & Niemeyer, C. M. (2023). Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome. Haematologica, PMID: 37584291 https://doi.org/10.3324/haematol.2023.283591 Online ahead of print
  24. Fetahu, I. S., Esser-Skala, W., Dnyansagar, R., Sindelar, S., Rifatbegovic, F., Bileck, A., Skos, L., Bozsaky, E., Lazic, D., Shaw, L., Totzl, M., Tarlungeanu, D., Bernkopf, M., Rados, M., Weninger, W., Tomazou, E. M., Bock, C., Gerner, C., Ladenstein, R., Farlik, M., Fortelny, N., & Taschner-Mandl, S. (2023). Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis. Nat Commun, 14(1), 3620, PMID: 37365178 PMC10293285 https://doi.org/10.1038/s41467-023-39210-0
  25. Flaadt, T.*, Ladenstein, R. L.*, Ebinger, M., Lode, H. N., Arnardottir, H. B., Poetschger, U., Schwinger, W., Meisel, R., Schuster, F. R., Doring, M., Ambros, P. F., Queudeville, M., Fuchs, J., Warmann, S. W., Schafer, J., Seitz, C., Schlegel, P., Brecht, I. B., Holzer, U., Feuchtinger, T., Simon, T., Schulte, J. H., Eggert, A., Teltschik, H. M., Illhardt, T., Handgretinger, R., & Lang, P. (2023). Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial. J Clin Oncol, JCO2201630, PMID: 36854071 https://doi.org/10.1200/JCO.22.01630  *Shared first authorship
  26. Flaadt, T., Ebinger, M., Schreiber, M., Ladenstein, R. L., Simon, T., Lode, H. N., Hero, B., Schuhmann, M. U., Schafer, J., Paulsen, F., Timmermann, B., Eggert, A., & Lang, P. (2023). Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse. J Clin Med, 12(19), PMID: 37834840 PMC10573405 https://doi.org/10.3390/jcm12196196
  27. Funk, M. A., Leitner, J., Gerner, M. C., Hammerler, J. M., Salzer, B., Lehner, M., Battin, C., Gumpelmair, S., Stiasny, K., Grabmeier-Pfistershammer, K., & Steinberger, P. (2023). Interrogating ligand-receptor interactions using highly sensitive cellular biosensors. Nat Commun, 14(1), 7804, PMID: 38016944 PMC10684770 https://doi.org/10.1038/s41467-023-43589-1
  28. Gidl, A., Fureder, A., Benesch, M., Dworzak, M., Engstler, G., Jones, N., Kropshofer, G., Potschger, U., Poyer, F., Tamesberger, M., Witt, V., Mann, G., Attarbaschi, A., & Austrian Berlin-Frankfurt-Munster Study, G. (2023). Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia – a Population-Based Analysis of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group. Pediatr Hematol Oncol, 40(2), 181-191, PMID: 35848787 https://doi.org/10.1080/08880018.2022.2089791  
  29. Grissenberger, S., Sturtzel, C., Wenninger-Weinzierl, A., Radic-Sarikas, B., Scheuringer, E., Bierbaumer, L., Etienne, V., Nemati, F., Pascoal, S., Totzl, M., Tomazou, E. M., Metzelder, M., Putz, E. M., Decaudin, D., Delattre, O., Surdez, D., Kovar, H., Halbritter, F., & Distel, M. (2023). High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X(L) inhibition against Ewing sarcoma. Cancer Lett, 554, 216028, PMID: 36462556 https://doi.org/10.1016/j.canlet.2022.216028
  30. Guthrie, J., Bal, S., Lombardo, S., Müller, F., Sin, C., Hütter, C., Menche, J., & Boztug, K. (2023). AutoCore: A network-based definition of the core module of human autoimmunity and autoinflammation. Sci Adv, 9 (35), eadg6375, PMID: 37656781 https://doi.org/10.1126/sciadv.adg6375
  31. Haas, M., Furhacker, P., Hodek, J., Stangl, P., Alon, I., Kainz, K., Fajgelj, V., Madel, C., Dotzler, S., Gotzinger, F., Ulrychova, L., Preuner, S., Fortschegger, M., Schinnerl, D., Walter, C., Obrova, K., Weber, J., Zacharasiewicz, A., & Lion, T. (2023). Detection of viable SARS-CoV-2 on the hands of hospitalised children with COVID-19. Clin Microbiol Infect, PMID: 37321398 PMC10263223 https://doi.org/10.1016/j.cmi.2023.06.012
  32. Hackl, B., Zabrodska, E., Gewessler, S., Lilliu, E., Putz, E. M., Kiss, A., Podesser, B., Todt, H., Ristl, R., Hilber, K., & Koenig, X. (2023). The type of suture material affects transverse aortic constriction-induced heart failure development in mice: a repeated measures correlation analysis. Front Cardiovasc Med, 10, 1242763, PMID: 37795481 PMC10546326 https://doi.org/10.3389/fcvm.2023.1242763
  33. Hecker-Nolting, S., Baumhoer, D., Blattmann, C., Kager, L., Kuhne, T., Kevric, M., Lang, S., Mettmann, V., Sorg, B., Werner, M., & Bielack, S. S. (2023). Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS). J Cancer Res Clin Oncol, 149(5), 1961-1967, PMID: 35980483 https://doi.org/10.1007/s00432-022-04156-1  
  34. Hecker-Nolting, S., Kager, L., Kuhne, T., Baumhoer, D., Blattmann, C., Friedel, G., von Kalle, T., Kevric, M., Mayer-Steinacker, R., Schwarz, R., Sorg, B., Wirth, T., & Bielack, S. S. (2023). Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis. J Adolesc Young Adult Oncol, 12(1), 76-82, PMID: 36454220 https://doi.org/10.1089/jayao.2021.0221
  35. Heilmann, J., Vieth, S., Moricke, A., Attarbaschi, A., Barbaric, D., Bodmer, N., Colombini, A., Dalla-Pozza, L., Elitzur, S., Izraeli, S., Mann, G., Niggli, F., Silvestri, D., Stary, J., Rizzari, C., Valsecchi, M. G., Zapotocka, E., Zimmermann, M., Cario, G., Schrappe, M., & Conter, V. (2023). Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia. Haematologica, PMID: 37021527 https://doi.org/10.3324/haematol.2022.281788
  36. Heipertz, A. E., Pajtler, K. W., Pfaff, E., Schramm, K., Blattner-Johnson, M., Milde, T., Jones, B. C., Zuliani, C., Hutter, C., Lohi, O., Kattamis, A., Dachowska-Kalwak, I., Nilsson, A., Gerber, N. U., Langenberg, K. P. S., Goemans, B., Zwaan, C. M., Molenaar, J. J., Jager, N., Dirksen, U., Witt, R., Pfister, S. M., Jones, D. T. W., Kopp-Schneider, A., Witt, O., & van Tilburg, C. M. (2023). Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. JCO Precis Oncol, 7, e2300015, PMID: 37364231 https://doi.org/10.1200/PO.23.00015
  37. Heyes, E., Wilhelmson, A. S., Wenzel, A., Manhart, G., Eder, T., Schuster, M. B., Rzepa, E., Pundhir, S., D’Altri, T., Frank, A. K., Gentil, C., Woessmann, J., Schoof, E. M., Meggendorfer, M., Schwaller, J., Haferlach, T., Grebien, F., & Porse, B. T. (2023). TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression. Nat Commun, 14(1), 6185, PMID: 37794021 PMC10550934 https://doi.org/10.1038/s41467-023-41927-x
  38. Hollenstein, D. M., Maurer-Granofszky, M., Reiter, W., Anrather, D., Gossenreiter, T., Babic, R., Hartl, N., Kraft, C., & Hartl, M. (2023). Chemical Acetylation of Ligands and Two-Step Digestion Protocol for Reducing Codigestion in Affinity Purification-Mass Spectrometry. J Proteome Res, PMID: 37712406 https://doi.org/10.1021/acs.jproteome.3c00424
  39. Italia, M., Wertheim, K. Y., Taschner-Mandl, S., Walker, D., & Dercole, F. (2023). Mathematical Model of Clonal Evolution Proposes a Personalised Multi-Modal Therapy for High-Risk Neuroblastoma. Cancers (Basel), 15(7), PMID: 37046647 PMC10093626 https://doi.org/10.3390/cancers15071986
  40. Jevtic, Z., Allram, M., Grebien, F., & Schwaller, J. (2023). Biomolecular Condensates in Myeloid Leukemia: What Do They Tell Us? Hemasphere, 7(7), e923, PMID: 37388925 PMC10306439 https://doi.org/10.1097/HS9.0000000000000923
  41. Kelly, S. M., Turcas, A., Corning, C., Bailey, S., Canete, A., Clementel, E., di Cataldo, A., Dieckmann, K., Gaze, M. N., Horan, G., Jenney, M., Ladenstein, R., Padovani, L., Valteau-Couanet, D., Boterberg, T., & Mandeville, H. (2023). Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials. Radiother Oncol, 109549, PMID: 36828140 https://doi.org/10.1016/j.radonc.2023.109549
  42. Kemps, P. G., Zondag, T. C. E., Arnardottir, H. B., Solleveld-Westerink, N., Borst, J., Steenwijk, E. C., van Egmond, D., Swennenhuis, J. F., Stelloo, E., Trambusti, I., Verdijk, R. M., van Noesel, C. J. M., Cleven, A. H. G., Scheijde-Vermeulen, M. A., Koudijs, M. J., Krskova, L., Hawkins, C., Egeler, R. M., Brok, J., von Bahr Greenwood, T., Svojgr, K., Beishuizen, A., van Laar, J. A. M., Potschger, U., Hutter, C., Sieni, E., Minkov, M., Abla, O., van Wezel, T., van den Bos, C., & van Halteren, A. G. S. (2023). Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study. Blood Adv, 7(4), 664-679, PMID: 36083130 https://doi.org/10.1182/bloodadvances.2022007947
  43. Kirkiz, E., Meers, O., Grebien, F., & Buschbeck, M. (2023). Histone Variants and Their Chaperones in Hematological Malignancies. Hemasphere, 7(8), e927, PMID: 37449197 PMC10337764 https://doi.org/10.1097/HS9.0000000000000927
  44. Klughammer, J., Romanovskaia, D., Nemc, A., Posautz, A., Seid, C. A., Schuster, L. C., Keinath, M. C., Lugo Ramos, J. S., Kosack, L., Evankow, A., Printz, D., Kirchberger, S., Erguner, B., Datlinger, P., Fortelny, N., Schmidl, C., Farlik, M., Skjaerven, K., Bergthaler, A., Liedvogel, M., Thaller, D., Burger, P. A., Hermann, M., Distel, M., Distel, D. L., Kubber-Heiss, A., & Bock, C. (2023). Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal species. Nat Commun, 14(1), 232, PMID: 36646694 PMC9842680 https://doi.org/10.1038/s41467-022-34828-y
  45. Koch, R.*, Haveman, L.*, Ladenstein, R.*, Brichard, B., Juergens, H., Cyprova, S., van den Berg, H., Hassenpflug, W., Raciborska, A., Ek, T., Baumhoer, D., Egerer, G., Kager, L., Renard, M., Hauser, P., Burdach, S., Bovee, J., Hong, A. M., Reichardt, P., Kruseova, J., Streitburger, A., Kuhne, T., Kessler, T., Bernkopf, M., Butterfass-Bahloul, T., Dhooge, C., Bauer, S., Kiss, J., Paulussen, M., Bonar, F., Ranft, A., Timmermann, B., Rascon, J., Vieth, V., Kanerva, J., Faldum, A., Hartmann, W., Hjorth, L., Bhadri, V. A., Metzler, M., Gelderblom, H., & Dirksen, U. (2023). Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial. Clin Cancer Res, PMID: 37843857 https://doi.org/10.1158/1078-0432.CCR-23-1966 *Shared first authorship
  46. Kostel Bal, S., Giuliani, S., Block, J., Repiscak, P., Hafemeister, C., Shahin, T., Kasap, N., Ransmayr, B., Miao, Y., van de Wetering, C., Frohne, A., Jimenez-Heredia, R., Schuster, M. K., Zoghi, S., Hertlein, V., Thian, M., Bykov, A., Babayeva, R., Bilgic Eltan, S., Karakoc-Aydiner, E., Shaw, L. E., Chowdury, I., Varjosalo, M., Arguello, R. J., Farlik, M., Ozen, A., Serfling, E. A. E., Dupre, L., Bock, C., Halbritter, F., Hannich, J. T., Castanon, I., Kraakman, M. J., Baris, S., & Boztug, K. (2023). Biallelic NFATC1 mutations cause an inborn error of immunity with impaired CD8+ T-cell function and perturbed glycolysis. Blood, PMID: 37249233 https://doi.org/10.1182/blood.2022018303
  47. Kroeze, E., Padilla, L. A., Burkhardt, B., Attarbaschi, A., von Mersi, H., Kebudi, R., Nievelstein, R. A. J., Tolboom, N., Hagleitner, M. M., Kuiper, R. P., Beishuizen, A., & Loeffen, J. L. C. (2023). (18) F-FDG-PET/CT imaging in diagnostic workup of pediatric precursor B-cell lymphoblastic lymphoma. Pediatr Blood Cancer, e30642, PMID: 37638834 https://doi.org/10.1002/pbc.30642
  48. Lazic, J., Haas, O. A., Ozbek, U., Ripperger, T., Byrjalsen, A., Te Kronnie, G., & members, L.-C. W. g. (2023). Perception and management of cancer predisposition in pediatric cancer centers: A European-wide questionnaire-based survey. Pediatr Blood Cancer, 70(5), e30229, PMID: 36860090 https://doi.org/10.1002/pbc.30229
  49. Le Voyer, T., Parent, A. V., Liu, X., Cederholm, A., Gervais, A., Rosain, J., Nguyen, T., Perez Lorenzo, M., Rackaityte, E., Rinchai, D., Zhang, P., Bizien, L., Hancioglu, G., Ghillani-Dalbin, P., Charuel, J. L., Philippot, Q., Gueye, M. S., Maglorius Renkilaraj, M. R. L., Ogishi, M., Soudee, C., Migaud, M., Rozenberg, F., Momenilandi, M., Riller, Q., Imberti, L., Delmonte, O. M., Muller, G., Keller, B., Orrego, J., Franco Gallego, W. A., Rubin, T., Emiroglu, M., Parvaneh, N., Eriksson, D., Aranda-Guillen, M., Berrios, D. I., Vong, L., Katelaris, C. H., Mustillo, P., Raedler, J., Bohlen, J., Bengi Celik, J., Astudillo, C., Winter, S., Consortium, N. F.-k., Effort, C. H. G., McLean, C., Guffroy, A., DeRisi, J. L., Yu, D., Miller, C., Feng, Y., Guichard, A., Beziat, V., Bustamante, J., Pan-Hammarstrom, Q., Zhang, Y., Rosen, L. B., Holland, S. M., Bosticardo, M., Kenney, H., Castagnoli, R., Slade, C. A., Boztug, K., Mahlaoui, N., Latour, S., Abraham, R. S., Lougaris, V., Hauck, F., Sediva, A., Atschekzei, F., Sogkas, G., Poli, M. C., Slatter, M. A., Palterer, B., Keller, M. D., Pinzon-Charry, A., Sullivan, A., Droney, L., Suan, D., Wong, M., Kane, A., Hu, H., Ma, C., Grombirikova, H., Ciznar, P., Dalal, I., Aladjidi, N., Hie, M., Lazaro, E., Franco, J., Keles, S., Malphettes, M., Pasquet, M., Maccari, M. E., Meinhardt, A., Ikinciogullari, A., Shahrooei, M., Celmeli, F., Frosk, P., Goodnow, C. C., Gray, P. E., Belot, A., Kuehn, H. S., Rosenzweig, S. D., Miyara, M., Licciardi, F., Servettaz, A., Barlogis, V., Le Guenno, G., Herrmann, V. M., Kuijpers, T., Ducoux, G., Sarrot-Reynauld, F., Schuetz, C., Cunningham-Rundles, C., Rieux-Laucat, F., Tangye, S. G., Sobacchi, C., Doffinger, R., Warnatz, K., Grimbacher, B., Fieschi, C., Berteloot, L., Bryant, V. L., Trouillet Assant, S., Su, H., Neven, B., Abel, L., Zhang, Q., Boisson, B., Cobat, A., Jouanguy, E., Kampe, O., Bastard, P., Roifman, C. M., Landegren, N., Notarangelo, L. D., Anderson, M. S., Casanova, J. L., & Puel, A. (2023). Autoantibodies against type I IFNs in humans with alternative NF-kappaB pathway deficiency. Nature, 623(7988), 803-813, PMID: 37938781 PMC10665196 https://doi.org/10.1038/s41586-023-06717-x
  50. Lehrnbecher, T., Ahlmann, M., Albert, M., Barnbrock, A. E., Beutel, K., Bochennek, K., Classen, C. F., Holzhauer, S., Hutter, C., Lakatos, K., Meisel, R., Porto, L., Vokuhl, C., Vraetz, T., & Minkov, M. (2023). [Updated AWMF Guideline on the Diagnosis and Treatment of Langerhans cell Histiocytosis in Children and Adolescents]. Klin Padiatr, PMID: 37666270 https://doi.org/10.1055/a-2135-3175
  51. Lehrnbecher, T., Groll, A. H., Cesaro, S., Alten, J., Attarbaschi, A., Barbaric, D., Bodmer, N., Conter, V., Izraeli, S., Mann, G., Moricke, A., Niggli, F., Schrappe, M., Stary, J., Zapotocka, E., Zimmermann, M., & Elitzur, S. (2023). Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009. Leukemia, 37(1), 72-78, PMID: 36509893 PMC9883161 https://doi.org/10.1038/s41375-022-01768-x
  52. Li, B. E., Li, G. Y., Cai, W., Zhu, Q., Seruggia, D., Fujiwara, Y., Vakoc, C. R., & Orkin, S. (2023). In vivo CRISPR/Cas9 Screening Identifies Pbrm1 as a Regulator of Mouse Myeloid Leukemia Development. Blood Adv, PMID: 37428871 https://doi.org/10.1182/bloodadvances.2022009455
  53. Locatelli, F., Zugmaier, G., Rizzari, C., Morris, J. D., Gruhn, B., Klingebiel, T., Parasole, R., Linderkamp, C., Flotho, C., Petit, A., Micalizzi, C., Zeng, Y., Desai, R., Kormany, W. N., Eckert, C., Moricke, A., Sartor, M., Hrusak, O., Peters, C., Saha, V., Vinti, L., & von Stackelberg, A. (2023). Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL. Leukemia, 37(1), 222-225, PMID: 36482128 PMC9883152 https://doi.org/10.1038/s41375-022-01770-3
  54. Lode, H. N., Ehlert, K., Huber, S., Troschke-Meurer, S., Siebert, N., Zumpe, M., Loibner, H., & Ladenstein, R. (2023). Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study. Br J Cancer, PMID: 37813959 https://doi.org/10.1038/s41416-023-02457-x
  55. Lode, H. N., Ladenstein, R., Troschke-Meurer, S., Struppe, L., Siebert, N., Zumpe, M., Ehlert, K., Huber, S., Glogova, E., Hundsdoerfer, P., Eggert, A., Zaniewska-Tekieli, A., Balwierz, W., & Wieczorek, A. (2023). Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy. Cancers (Basel), 15(13), PMID: 37444475 PMC10341209 https://doi.org/10.3390/cancers15133364
  56. Machkova, A., Vankova, E., Obrova, K., Furhacker, P., Kosutova, T., Lion, T., Hanus, J., & Scholtz, V. (2023). Silver nanoparticles with plasma-polymerized hexamethyldisiloxane coating on 3D printed substrates are non-cytotoxic and effective against respiratory pathogens. Front Microbiol, 14, 1217617, PMID: 37637122 PMC10450633 https://doi.org/10.3389/fmicb.2023.1217617
  57. Manieri, E., Tie, G., Malagola, E., Seruggia, D., Madha, S., Maglieri, A., Huang, K., Fujiwara, Y., Zhang, K., Orkin, S. H., Wang, T. C., He, R., McCarthy, N., & Shivdasani, R. A. (2023). Role of PDGFRA(+) cells and a CD55(+) PDGFRA(Lo) fraction in the gastric mesenchymal niche. Nat Commun, 14(1), 7978, PMID: 38042929 PMC10693581 https://doi.org/10.1038/s41467-023-43619-y
  58. Meier, C. M., Furtwangler, R., Mergen, M., Welter, N., Melchior, P., Schenk, J. P., Vokuhl, C., Kager, L., Kroiss-Benninger, S., Wagenpfeil, S., & Graf, N. (2023). Impact of Time to Surgery on Outcome in Wilms Tumor Treated with Preoperative Chemotherapy. Cancers (Basel), 15(5), PMID: 36900286 PMC10001069 https://doi.org/10.3390/cancers15051494
  59. Mettmann, V. L., Baumhoer, D., Bielack, S. S., Blattmann, C., Friedel, G., von Kalle, T., Kager, L., Kevric, M., Nathrath, M., Sorg, B., Durken, M., & Hecker-Nolting, S. (2023). Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group. Cancer Med, PMID: 37548393 https://doi.org/10.1002/cam4.6409
  60. Meyer, C., Larghero, P., Almeida Lopes, B., Burmeister, T., Groger, D., Sutton, R., Venn, N. C., Cazzaniga, G., Corral Abascal, L., Tsaur, G., Fechina, L., Emerenciano, M., Pombo-de-Oliveira, M. S., Lund-Aho, T., Lundan, T., Montonen, M., Juvonen, V., Zuna, J., Trka, J., Ballerini, P., Lapillonne, H., Van der Velden, V. H. J., Sonneveld, E., Delabesse, E., de Matos, R. R. C., Silva, M. L. M., Bomken, S., Katsibardi, K., Keernik, M., Grardel, N., Mason, J., Price, R., Kim, J., Eckert, C., Lo Nigro, L., Bueno, C., Menendez, P., Zur Stadt, U., Gameiro, P., Sedek, L., Szczepanski, T., Bidet, A., Marcu, V., Shichrur, K., Izraeli, S., Madsen, H. O., Schafer, B. W., Kubetzko, S., Kim, R., Clappier, E., Trautmann, H., Bruggemann, M., Archer, P., Hancock, J., Alten, J., Moricke, A., Stanulla, M., Lentes, J., Bergmann, A. K., Strehl, S., Kohrer, S., Nebral, K., Dworzak, M. N., Haas, O. A., Arfeuille, C., Caye-Eude, A., Cave, H., & Marschalek, R. (2023). The KMT2A recombinome of acute leukemias in 2023. Leukemia, PMID: 37019990 https://doi.org/10.1038/s41375-023-01877-1
  61. Moradian, N., Zoghi, S., Rayzan, E., Seyedpour, S., Jimenez Heredia, R., Boztug, K., & Rezaei, N. (2023). Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype of a patient. Allergy Asthma Clin Immunol, 19(1), 51, PMID: 37296469 PMC10257254 https://doi.org/10.1186/s13223-023-00804-4
  62. Moricke, A., Rizzari, C., Alten, J., Attarbaschi, A., Beier, R., Biondi, A., Burkhardt, B., Bodmer, N., Boos, J., Cario, G., Conter, V., Flotho, C., Kulozik, A., Lanvers-Kaminsky, C., Mann, G., Niggli, F., Silvestri, D., von Stackelberg, A., Stanulla, M., Valsecchi, M. G., Schrappe, M., & Zimmermann, M. (2023). Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction. Hemasphere, 7(6), e888, PMID: 37275738 PMC10238044 https://doi.org/10.1097/HS9.0000000000000888
  63. Novak, W., Berner, J., Svaton, M., Jimenez-Heredia, R., Segarra-Roca, A., Frohne, A., Guiliani, S., Rouhani, D., Eder, S. K., Rottal, A., Trapin, D., Scheuchenstuhl, A., Pickl, W. F., Simonitsch-Klupp, I., Kager, L., & Boztug, K. (2023). Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3. Br J Haematol, PMID: 37646304 https://doi.org/10.1111/bjh.19061
  64. Novak, W., Sunder-Plassmann, R., Berner, J., Kohrer, S., Zeitlhofer, P., Haas, O. A., Riedl, J., Kager, L., & Sillaber, C. (2023). Dominant inherited beta-thalassemia intermedia in a Polish family due to a novel frameshift mutation in HBB. Pediatr Blood Cancer, e30511, PMID: 37353956 https://doi.org/10.1002/pbc.30511
  65. Ohki, K., Butler, E. R., Kiyokawa, N., Hirabayashi, S., Bergmann, A. K., Moricke, A., Boer, J. M., Cave, H., Cazzaniga, G., Yeoh, A. E. J., Sanada, M., Imamura, T., Inaba, H., Mullighan, C. G., Loh, M. L., Noren-Nystrom, U., Shih, L. Y., Zaliova, M., Pui, C. H., Haas, O. A., Harrison, C. J., Moorman, A. V., & Manabe, A. (2023). Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. Leukemia, 37(1), 212-216, PMID: 36309560 PMC9883149 https://doi.org/10.1038/s41375-022-01737-4  
  66. Olofsson Bagge, R., Berndtsson, J., Urzi, O., Lotvall, J., Micaroni, M., & Crescitelli, R. (2023). Three-dimensional reconstruction of interstitial extracellular vesicles in human liver as determined by electron tomography. J Extracell Vesicles, 12(12), e12380, PMID: 38010190 PMC10680575 https://doi.org/10.1002/jev2.12380
  67. Perrone, A., Lakatos, K., Pegoraro, F., Trambusti, I., Fotzi, I., Selvi, V., Prosch, H., Sertorio, F., Potschger, U., Favre, C., Conte, M., Minkov, M., & Sieni, E. (2023). Whole-body magnetic resonance imaging for staging Langerhans cell histiocytosis in children and young adults. Pediatr Blood Cancer, 70(2), e30064, PMID: 36317710 https://doi.org/10.1002/pbc.30064
  68. Radauer-Plank, A. C., Diesch-Furlanetto, T., Schneider, M., Sommerhauser, G., Friedrich, L. A., Salow, V., Dulberg, J., Diepold, M., Rovo, A., Njue, L. M., Drexler, B., Infanti, L., Kroiss, S., Merki, R., Scheinemann, K., Eisenreich, B., Hegemann, I., Mandic, L., Kager, L., Borgmann-Staudt, A., Schilling, R., Roll, S., & Balcerek, M. (2023). Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies. Pediatr Blood Cancer, e30359, PMID: 37057367 https://doi.org/10.1002/pbc.30359
  69. Raetz, E. A., Rebora, P., Conter, V., Schrappe, M., Devidas, M., Escherich, G., Imai, C., De Moerloose, B., Schmiegelow, K., Burns, M. A., Elitzur, S., Pieters, R., Attarbaschi, A., Yeoh, A., Pui, C. H., Stary, J., Cario, G., Bodmer, N., Moorman, A. V., Buldini, B., Vora, A., & Valsecchi, M. G. (2023). Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. J Clin Oncol, JCO2300088, PMID: 37487146 https://doi.org/10.1200/JCO.23.00088
  70. Ramamoorthy, S., Lebrecht, D., Schanze, D., Schanze, I., Wieland, I., Andrieux, G., Metzger, P., Hess, M., Albert, M. H., Borkhardt, A., Bresters, D., Buechner, J., Catala, A., De Haas, V., Dworzak, M., Erlacher, M., Hasle, H., Jahnukainen, K., Locatelli, F., Masetti, R., Stary, J., Turkiewicz, D., Vinci, L., Wlodarski, M. W., Yoshimi, A., Boerries, M., Niemeyer, C. M., Zenker, M., & Flotho, C. (2023). Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup. Br J Haematol, PMID: 37945316 https://doi.org/10.1111/bjh.19190 Online ahead of print
  71. Riestra, M. R., Pillay, B. A., Willemsen, M., Kienapfel, V., Ehlers, L., Delafontaine, S., Pinton, A., Wouters, M., Hombrouck, A., Sauer, K., Bossuyt, X., Voet, A., Soenen, S. J., Conde, C. D., Bucciol, G., Boztug, K., Humblet-Baron, S., Touzart, A., Rieux-Laucat, F., Notarangelo, L. D., Moens, L., & Meyts, I. (2023). Human Autosomal Recessive DNA Polymerase Delta 3 Deficiency Presenting as Omenn Syndrome. J Clin Immunol, 44(1), 2, PMID: 38099988 https://doi.org/10.1007/s10875-023-01627-z
  72. Rizzari, C., Moricke, A., Valsecchi, M. G., Conter, V., Zimmermann, M., Silvestri, D., Attarbaschi, A., Niggli, F., Barbaric, D., Stary, J., Elitzur, S., Cario, G., Vinti, L., Boos, J., Zucchetti, M., Lanvers-Kaminsky, C., von Stackelberg, A., Biondi, A., & Schrappe, M. (2023). Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol. Hemasphere, 7(6), e893, PMID: 37275740 PMC10237686 https://doi.org/10.1097/HS9.0000000000000893
  73. Ronceray, L., Dworzak, M., Dieckmann, K., Ebetsberger-Dachs, G., Glogova, E., Haas, O. A., Jones, N., Nebral, K., Moser, R., Lion, T., Meister, B., Panzer-Grumayer, R., Strehl, S., Peters, C., Potschger, U., Urban, C., Mann, G., Attarbaschi, A., & Austrian Berlin-Frankfurt-Munster Study, G. (2023). Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria. Wien Klin Wochenschr, PMID: 37535134 https://doi.org/10.1007/s00508-023-02249-6 Online ahead of print
  74. Rubio-San-Simon, A., van Eijkelenburg, N. K. A., Hoogendijk, R., Hasle, H., Niemeyer, C. M., Dworzak, M. N., Zecca, M., Lopez-Yurda, M., Janssen, J. M., Huitema, A. D. R., van den Heuvel-Eibrink, M. M., Laille, E. J., van Tinteren, H., & Zwaan, C. M. (2023). Azacitidine (Vidaza((R))) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015). Paediatr Drugs, PMID: 37695474 https://doi.org/10.1007/s40272-023-00588-5
  75. Scheer, M., Hallmen, E., Vokuhl, C., Fuchs, J., Tunn, P. U., Munter, M., Timmermann, B., Bauer, S., Henssen, A. G., Kazanowska, B., Niggli, F., Ladenstein, R., Ljungman, G., Eggert, A., Klingebiel, T., Koscielniak, E., & Cooperative Weichteilsarkom, S. (2023). Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma. J Cancer Res Clin Oncol, 149(5), 1717-1731, PMID: 35687182 PMC10097790 https://doi.org/10.1007/s00432-022-04051-9
  76. Scholtz, V., Jiresova, J., Fiser, L., Obrova, K., Slama, M., Klenivskyi, M., Khun, J., & Vankova, E. (2023). Non-thermal plasma disinfecting procedure is harmless to delicate items of everyday use. Sci Rep, 13(1), 15479, PMID: 37726338 PMC10509187 https://doi.org/10.1038/s41598-023-42405-6
  77. Seidel, M. G., Brcic, L., Hoefler, G., Hutter, C., Minkov, M., Steffen, L. S., Zebisch, A., & Benesch, M. (2023). Concurrence of a kinase-dead BRAF and an oncogenic KRAS gain-of-function mutation in juvenile xanthogranuloma. Pediatr Blood Cancer, 70(4), e30060, PMID: 36317675 https://doi.org/10.1002/pbc.30060
  78. Seigner, J., Zajc, C. U., Dotsch, S., Eigner, C., Laurent, E., Busch, D. H., Lehner, M., & Traxlmayr, M. W. (2023). Solving the mystery of the FMC63-CD19 affinity. Sci Rep, 13(1), 23024, PMID: 38155191 https://doi.org/10.1038/s41598-023-48528-0
  79. Silao, F. G. S., Jiang, T., Bereczky-Veress, B., Kuhbacher, A., Ryman, K., Uwamohoro, N., Jenull, S., Nogueira, F., Ward, M., Lion, T., Urban, C. F., Rupp, S., Kuchler, K., Chen, C., Peuckert, C., & Ljungdahl, P. O. (2023). Proline catabolism is a key factor facilitating Candida albicans pathogenicity. PLoS Pathog, 19(11), e1011677, PMID: 37917600 PMC10621835 https://doi.org/10.1371/journal.ppat.1011677
  80. Staudacher, O., Klein, J., Thee, S., Ullrich, J., Wahn, V., Unterwalder, N., Kolsch, U., Lankes, E., Stittrich, A., Dedieu, C., Dinges, S., Voller, M., Schuetz, C., Schulte, J., Boztug, K., Meisel, C., Kuehl, J. S., Kruger, R., Blankenstein, O., & von Bernuth, H. (2023). Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome. J Allergy Clin Immunol Pract, PMID: 37302792 https://doi.org/10.1016/j.jaip.2023.06.006
  81. Strobl, J., Huber, B., Heredia, R. J., Kirnbauer, R., Boztug, K. #, & Stary, G. # (2023). Polymerase-delta-deficiency as a novel cause of inborn cancer predisposition associated with human papillomavirus infection. Br J Dermatol, PMID: 36787285 https://doi.org/10.1093/bjd/ljad021  # Shared senior authorship
  82. Sturtzel, C., Grissenberger, S., Bozatzi, P., Scheuringer, E., Wenninger-Weinzierl, A., Zajec, Z., Dernovsek, J., Pascoal, S., Gehl, V., Kutsch, A., Granig, A., Rifatbegovic, F., Carre, M., Lang, A., Valtingojer, I., Moll, J., Lotsch, D., Erhart, F., Widhalm, G., Surdez, D., Delattre, O., Andre, N., Stampfl, J., Tomasic, T., Taschner-Mandl, S., & Distel, M. (2023). Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts. NPJ Precis Oncol, 7(1), 44, PMID: 37202469 PMC10195872 https://doi.org/10.1038/s41698-023-00386-9
  83. Tallgren, A., Kager, L., O’Grady, G., Tuominen, H., Korkko, J., Kuismin, O., Feucht, M., Wilson, C., Behunova, J., England, E., Kurki, M. I., Palotie, A., Hallman, M., Kaarteenaho, R., Laccone, F., Boztug, K., Hinttala, R., & Uusimaa, J. (2023). Novel patients with NHLRC2 variants expand the phenotypic spectrum of FINCA disease. Front Neurosci, 17, 1123327, PMID: 37179546 PMC10173879 https://doi.org/10.3389/fnins.2023.1123327   
  84. Tischer-Zimmermann, S., Salzer, E., Bitencourt, T., Frank, N., Hoffmann-Freimuller, C., Stemberger, J., Maecker-Kolhoff, B., Blasczyk, R., Witt, V., Fritsch, G., Paster, W., Lion, T., Eiz-Vesper, B., & Geyeregger, R. (2023). Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure. Front Immunol, 14, 988947, PMID: 37090716 PMC10114046 https://doi.org/10.3389/fimmu.2023.988947  
  85. Tosato, V., Rossi, B., Sims, J., & Bruschi, C. V. (2023). Timing of Chromosome DNA Integration throughout the Yeast Cell Cycle. Biomolecules, 13(4), PMID: 37189362 PMC10135612 https://doi.org/10.3390/biom13040614
  86. Tramsen, L., Bochennek, K., Sparber-Sauer, M., Salzmann-Manrique, E., Scheer, M., Dantonello, T., Borkhardt, A., Dirksen, U., Thorwarth, A., Greiner, J., Ebinger, M., Weclawek-Tompol, J., Ladenstein, R., Ljungman, G., Hallmen, E., Lehrnbecher, T., Koscielniak, E., & Klingebiel, T. (2023). Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers (Basel), 15(7), PMID: 37046711 PMC10093505 https://doi.org/10.3390/cancers15072050
  87. Valent, P., Sadovnik, I., Peter, B., Ivanov, D., Schulenburg, A., Hadzijusufovic, E., Willmann, M., Rulicke, T., Herrmann, H., Rabitsch, W., Karlic, H., Gleixner, K. V., Sperr, W. R., Hoermann, G., Dahlhoff, M., Pfeilstocker, M., Keil, F., Lion, T., & Grunt, T. W. (2023). Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives. Expert Rev Hematol, 1-12, PMID: 37493441 https://doi.org/10.1080/17474086.2023.2232545
  88. van den Oever, S. R., de Beijer, I. A. E., Kremer, L. C. M., Alfes, M., Balaguer, J., Bardi, E., Nieto, A. C., Cangioli, G., Charalambous, E., Chronaki, C., Costa, T., Degelsegger, A., Duster, V., Filbert, A. L., Grabow, D., Gredinger, G., Gsell, H., Haupt, R., van Helvoirt, M., Ladenstein, R., Langer, T., Laschkolnig, A., Muraca, M., Rascon, J., Schreier, G., Tomasikova, Z., Tormo, M. T., Trinkunas, J., Trollip, J., Trunner, K., Uyttebroeck, A., van der Pal, H. J. H., Pluijm, S. M. F., & PanCareSurPass, c. (2023). Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study. J Cancer Surviv, PMID: 36808389 https://doi.org/10.1007/s11764-023-01335-y  Online ahead of print
  89. van der Sluis, I. M., de Lorenzo, P., Kotecha, R. S., Attarbaschi, A., Escherich, G., Nysom, K., Stary, J., Ferster, A., Brethon, B., Locatelli, F., Schrappe, M., Scholte-van Houtem, P. E., Valsecchi, M. G., & Pieters, R. (2023). Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia. N Engl J Med, 388(17), 1572-1581, PMID: 37099340 https://doi.org/10.1056/NEJMoa2214171
  90.  van Ewijk, R., Cleirec, M., Herold, N., le Deley, M. C., van Eijkelenburg, N., Boudou-Rouquette, P., Risbourg, S., Strauss, S. J., Palmerini, E., Boye, K., Kager, L., Hecker-Nolting, S., Marchais, A., Gaspar, N., & Foster Consortium, w. p. o. r. r. o. t. (2023). A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design? Cancer Treat Rev, 120, 102625, PMID: 37738712 https://doi.org/10.1016/j.ctrv.2023.102625
  91. van Weelderen, R. E., Klein, K., Harrison, C. J., Jiang, Y., Abrahamsson, J., Arad-Cohen, N., Bart-Delabesse, E., Buldini, B., De Moerloose, B., Dworzak, M. N., Elitzur, S., Fernandez Navarro, J. M., Gerbing, R. B., Goemans, B. F., de Groot-Kruseman, H. A., Guest, E., Ha, S. Y., Hasle, H., Kelaidi, C., Lapillonne, H., Leverger, G., Locatelli, F., Masetti, R., Miyamura, T., Noren-Nystrom, U., Polychronopoulou, S., Rasche, M., Rubnitz, J. E., Stary, J., Tierens, A., Tomizawa, D., Zwaan, C. M., & Kaspers, G. J. L. (2023). Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Munster Study Group. J Clin Oncol, JCO2202120, PMID: 36996387 https://doi.org/10.1200/JCO.22.02120
  92. Veiga-Canuto, D., Cerda-Alberich, L., Jimenez-Pastor, A., Carot Sierra, J. M., Gomis-Maya, A., Sanguesa-Nebot, C., Fernandez-Paton, M., Martinez de Las Heras, B., Taschner-Mandl, S., Duster, V., Potschger, U., Simon, T., Neri, E., Alberich-Bayarri, A., Canete, A., Hero, B., Ladenstein, R., & Marti-Bonmati, L. (2023). Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images. Cancers (Basel), 15(5), PMID: 36900410 PMC10000775 https://doi.org/10.3390/cancers15051622  
  93. Worel, N., Grabmeier-Pfistershammer, K., Kratzer, B., Schlager, M., Tanzmann, A., Rottal, A., Kormoczi, U., Porpaczy, E., Staber, P. B., Skrabs, C., Herkner, H., Gudipati, V., Huppa, J. B., Salzer, B., Lehner, M., Saxenhuber, N., Friedberg, E., Wohlfarth, P., Hopfinger, G., Rabitsch, W., Simonitsch-Klupp, I., Jager, U., & Pickl, W. F. (2023). The frequency of differentiated CD3(+)CD27(-)CD28(-) T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma. Front Immunol, 13, 1004703, PMID: 36700229 PMC9868136 https://doi.org/10.3389/fimmu.2022.1004703  
  94. Xavier, A. C., Suzuki, R., & Attarbaschi, A. (2023). Diagnosis and management of rare paediatric Non-Hodgkin lymphoma. Best Pract Res Clin Haematol, 36(1), 101440, PMID: 36907633 https://doi.org/10.1016/j.beha.2023.101440  
  95. Yaldiz, B., Kucuk, E., Hampstead, J., Hofste, T., Pfundt, R., Corominas Galbany, J., Rinne, T., Yntema, H. G., Hoischen, A., Nelen, M., Gilissen, C., & Solve, R. D. c. (2023). Twist exome capture allows for lower average sequence coverage in clinical exome sequencing. Hum Genomics, 17(1), 39, PMID: 37138343 PMC10155375 https://doi.org/10.1186/s40246-023-00485-5  Boztug, K. part of the Solve-RD consortium
  96. Yuan, D., Hu, J., Ju, X., Putz, E. M., Zheng, S., Koda, S., Sun, G., Deng, X., Xu, Z., Nie, W., Zhao, Y., Li, X., Dougall, W. C., Shao, S., Chen, Y., Tang, R., Zheng, K., & Yan, J. (2023). NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages. Proc Natl Acad Sci U S A, 120(47), e2302126120, PMID: 37967215 PMC10666127 https://doi.org/10.1073/pnas.2302126120 
  97. Zajec, Z., Dernovsek, J., Distel, M., Gobec, M., & Tomasic, T. (2023). Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma. Bioorg Chem, 131, 106311, PMID: 36495678 https://doi.org/10.1016/j.bioorg.2022.106311

  1. Aryee, D. N. T., Fock, V., Kapoor, U., Radic-Sarikas, B., & Kovar, H. (2022). Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis. Cells, 11(8), PMID: 35455947 PMC9032025 https://doi.org/10.3390/cells11081267  
  2. Berner, J., Weiss, T., Sorger, H., Rifatbegovic, F., Kauer, M., Windhager, R., Dohnal, A., Ambros, P. F., Ambros, I. M., Boztug, K., Steinberger, P., & Taschner-Mandl, S. (2022). Human repair-related Schwann cells adopt functions of antigen-presenting cells in vitro. Glia, PMID: 36054432 https://doi.org/10.1002/glia.24257  
  3. Bertrums, E. J. M., Zwaan, C. M., Hasegawa, D., De Haas, V., Reinhardt, D. N., Locatelli, F., De Moerloose, B., Dworzak, M., Buijs, A., Smisek, P., Kolenova, A., Pronk, C. J., Klusmann, J. H., Carbone, A., Ferster, A., Antoniou, E., Meshinchi, S., Raimondi, S. C., Niemeyer, C. M., Hasle, H., Van den Heuvel-Eibrink, M. M., & Goemans, B. F. (2022). Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS. Haematologica, 107(3), 759-764, PMID: 34854279 PMC8883540 https://doi.org/10.3324/haematol.2021.279507  
  4. Bielack, S. S., Blattmann, C., Borkhardt, A., Csoka, M., Hassenpflug, W., Kabickova, E., Kager, L., Kessler, T., Kratz, C., Kuhne, T., Kevric, M., Lehrnbecher, T., Mayer-Steinacker, R., Mettmann, V., Metzler, M., Reichardt, P., Rossig, C., Sorg, B., von Luettichau, I., Windhager, R., & Hecker-Nolting, S. (2022). Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS). Eur J Cancer, 176, 50-57, PMID: 36191386 https://doi.org/10.1016/j.ejca.2022.09.007  
  5. Borkhardt, A., & Haas, O. A. (2022). Chromosomal risk classification in high hyperdiploid acute lymphocytic leukaemia: the beginning of a new chapter. Lancet Haematol, 9(1), e9, PMID: 34971585 https://doi.org/10.1016/S2352-3026(21)00348-3  
  6. Buechner, J., Caruana, I., Kunkele, A., Rives, S., Vettenranta, K., Bader, P., Peters, C., Baruchel, A., & Calkoen, F. G. (2021). Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant? Front Pediatr, 9, 784024, PMID: 35145941 PMC8823293 https://doi.org/10.3389/fped.2021.784024  
  7. Burghart, L., Halilbasic, E., Schwabl, P., Simbrunner, B., Stattermayer, A. F., Petrenko, O., Scheiner, B., Bauer, D., Pinter, M., Boztug, K., Mandorfer, M., Trauner, M., & Reiberger, T. (2022). Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. J Gastroenterol,57(2), 99-110, PMID: 34893924 PMC8831368 https://doi.org/10.1007/s00535-021-01839-3  
  8. Burke, M. J., Ziegler, D. S., Bautista, F., Attarbaschi, A., Gore, L., Locatelli, F., M, M. O. B., Pauly, M., Kormany, W. N., Tian, S., Morris, C. L., & Baruchel, A. (2022). Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia. Pediatr Blood Cancer, 69(12), e29999, PMID: 36215217 https://doi.org/10.1002/pbc.29999  
  9. Chronaki, C., Charalambous, E., Cangioli, G., Schreier, G., van den Oever, S., van der Pal, H., Kremer, L., Uyttebroeck, A., Van den Bosch, B., Trinkunas, J., Rascon, J., Ladenstein, R., Duster, V., Bardi, E., Walz, D., Filberd, A. L., Grabow, D., Langer, T., Nieto, A. C., Galan, A. J. O., Correcher Palau, M., Cavalca, G., & Haupt, R. (2022). Factors Influencing Implementation of the Survivorship Passport: The IT Perspective. Stud Health Technol Inform, 293, 161-168, PMID: 35592976 https://doi.org/10.3233/SHTI220363  
  10. Danandeh, K., Jabbari, P., Rayzan, E., Zoghi, S., Shahkaramic, S., Heredia, R. J., Krolo, A., Shamsian, B. S., Boztug, K., & Rezaei, N. (2022). Novel NFkB mutation in a case of lymphoproliferative disorder case report. Endocr Metab Immune Disord Drug Targets, PMID: 35392793 https://doi.org/10.2174/1871530322666220407091356  
  11. Drago, E., Garbarino, F., Signa, S., Grossi, A., Schena, F., Penco, F., Santori, E., Candotti, F., Boztug, K., Volpi, S., Gattorno, M., & Caorsi, R. (2022). Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency. Front Immunol, 13, 937108, PMID: 36159847 PMC9503826 https://doi.org/10.3389/fimmu.2022.937108  
  12. Eder, S. K., Schwentner, R., Ben Soussia, P., Abagnale, G., Attarbaschi, A., Minkov, M., Halbritter, F., & Hutter, C. (2022). Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis. Blood Adv, 6(3), 970-975, PMID: 34619771 PMC8945316 https://doi.org/10.1182/bloodadvances.2021005442  
  13. Eichinger, A., Poetschger, U., Glogova, E., Bader, P., Basu, O., Beier, R., Burkhardt, B., Classen, C. F., Claviez, A., Corbacioglu, S., Deubzer, H. E., Greil, J., Gruhn, B., Gungor, T., Kafa, K., Kuhl, J. S., Lang, P., Lange, B. S., Meisel, R., Muller, I., Sauer, M. G., Schlegel, P. G., Schulz, A., Stachel, D., Strahm, B., Wawer, A., Peters, C.#, & Albert, M. H. # (2022). Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial. Leukemia, 36(11), 2567-2576, PMID: 36097283 PMC9613465 https://doi.org/10.1038/s41375-022-01693-z Shared senior authorship  
  14. Fallahi, M., Jamee, M., Enayat, J., Abdollahimajd, F., Mesdaghi, M., Khoddami, M., Segarra-Roca, A., Frohne, A., Dmytrus, J., Keramatipour, M., Mansouri, M., Eslamian, G., Fallah, S., Boztug, K., & Chavoshzadeh, Z. (2022). Novel PGM3 mutation in two siblings with combined immunodeficiency and childhood bullous pemphigoid: a case report and review of the literature. Allergy Asthma Clin Immunol, 18(1), 111, PMID: 36566211 PMC9789581 https://doi.org/10.1186/s13223-022-00749-0  
  15. Fishman, H., Madiwale, S., Geron, I., Bari, V., Van Loocke, W., Kirschenbaum, Y., Ganmore, I., Kugler, E., Rein-Gil, A., Friedlander, G., Schiby, G., Birger, Y., Strehl, S., Soulier, J., Knoechel, B., Ferrando, A., Noy-Lotan, S., Nagler, A., Mulloy, J. C., Van Vlierberghe, P., & Izraeli, S. (2022). ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells. Blood, 139(3), 399-412, PMID: 34624096 https://doi.org/10.1182/blood.2020010405  
  16. Fuereder, T., Minichsdorfer, C., Mittlboeck, M., Wagner, C., Heller, G., Putz, E. M., Oberndorfer, F., Mullauer, L., Aretin, M. B., Czerny, C., & Schwarz-Nemec, U. (2022). Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study. Oral Oncol, 124, 105634, PMID: 34844042 https://doi.org/10.1016/j.oraloncology.2021.105634  
  17. Gabler, L., Jaunecker, C. N., Katz, S., van Schoonhoven, S., Englinger, B., Pirker, C., Mohr, T., Vician, P., Stojanovic, M., Woitzuck, V., Laemmerer, A., Kirchhofer, D., Mayr, L., LaFranca, M., Erhart, F., Grissenberger, S., Wenninger-Weinzierl, A., Sturtzel, C., Kiesel, B., Lang, A., Marian, B., Grasl-Kraupp, B., Distel, M., Schuler, J., Gojo, J., Grusch, M., Spiegl-Kreinecker, S., Donoghue, D. J., Lotsch, D., & Berger, W. (2022). Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness. Acta Neuropathol Commun, 10(1), 65, PMID: 35484633 https://doi.org/10.1186/s40478-022-01363-2  
  18. Gao, L., Meiring, J. C. M., Varady, A., Ruider, I. E., Heise, C., Wranik, M., Velasco, C. D., Taylor, J. A., Terni, B., Weinert, T., Standfuss, J., Cabernard, C. C., Llobet, A., Steinmetz, M. O., Bausch, A. R., Distel, M., Thorn-Seshold, J., Akhmanova, A., & Thorn-Seshold, O. (2022). In Vivo Photocontrol of Microtubule Dynamics and Integrity, Migration and Mitosis, by the Potent GFP-Imaging-Compatible Photoswitchable Reagents SBTubA4P and SBTub2M. J Am Chem Soc, PMID: 35290733 https://doi.org/10.1021/jacs.2c01020  
  19. Gogolou, A., Souilhol, C., Granata, I., Wymeersch, F. J., Manipur, I., Wind, M., Frith, T. J. R., Guarini, M., Bertero, A., Bock, C., Halbritter, F., Takasato, M., Guarracino, M. R., & Tsakiridis, A. (2022). Early anteroposterior regionalisation of human neural crest is shaped by a pro-mesodermal factor. Elife, 11, PMID: 36154671 https://doi.org/10.7554/eLife.74263  
  20. Grissenberger, S., Salzer, B., Pascoal, S., Wenninger-Weinzierl, A., Lehner, M., & Distel, M. (2022). Preclinical testing of CAR T cells in zebrafish xenografts. Methods Cell Biol, 167, 133-147, PMID: 35152991 https://doi.org/10.1016/bs.mcb.2021.07.002  
  21. Haas, O. A., & Borkhardt, A. (2022). Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children. Leukemia, 36(12), 2769-2783, PMID: 36266323 PMC9712104 https://doi.org/10.1038/s41375-022-01720-z  
  22. Haimel, M.*, Pazmandi, J.*, Heredia, R. J., Dmytrus, J., Bal, S. K., Zoghi, S., van Daele, P., Briggs, T. A., Wouters, C., Bader-Meunier, B., Aeschlimann, F. A., Caorsi, R., Eleftheriou, D., Hoppenreijs, E., Salzer, E., Bakhtiar, S., Derfalvi, B., Saettini, F., Kusters, M. A. A., Elfeky, R., Truck, J., Riviere, J. G., van der Burg, M., Gattorno, M., Seidel, M. G., Burns, S., Warnatz, K., Hauck, F., Brogan, P., Gilmour, K. C., Schuetz, C., Simon, A., Bock, C., Hambleton, S., de Vries, E., Robinson, P. N., van Gijn, M.#, & Boztug, K. # (2022). Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity. J Allergy Clin Immunol, 149(1), 369-378, PMID: 33991581 PMC9346194 https://doi.org/10.1016/j.jaci.2021.04.033 * Shared first authorship, # Shared senior authorship
  23. Heitzeneder, S., Bosse, K. R., Zhu, Z., Zhelev, D., Majzner, R. G., Radosevich, M. T., Dhingra, S., Sotillo, E., Buongervino, S., Pascual-Pasto, G., Garrigan, E., Xu, P., Huang, J., Salzer, B., Delaidelli, A., Raman, S., Cui, H., Martinez, B., Bornheimer, S. J., Sahaf, B., Alag, A., Fetahu, I. S., Hasselblatt, M., Parker, K. R., Anbunathan, H., Hwang, J., Huang, M., Sakamoto, K., Lacayo, N. J., Klysz, D. D., Theruvath, J., Vilches-Moure, J. G., Satpathy, A. T., Chang, H. Y., Lehner, M., Taschner-Mandl, S., Julien, J. P., Sorensen, P. H., Dimitrov, D. S., Maris, J. M., & Mackall, C. L. (2022). GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity. Cancer Cell, 40(1), 53-69 e59, PMID: 34971569 PMC9092726 https://doi.org/10.1016/j.ccell.2021.12.005  
  24. Hetzer, B., Meryk, A., Kropshofer, G., Bargehr, C., Jimenez-Heredia, R., Boztug, K., Muhlegger, B. E., Dworzak, M., Gruber, T., & Crazzolara, R. (2022). A R307H substitution in GATA1 that prevents S310 phosphorylation causes severe fetal anemia. Blood Adv, PMID: 35580337 https://doi.org/10.1182/bloodadvances.2021006347  
  25. Hutt, D., Arjona, E. T., Mekelenkamp, H., Galimard, J. E., Kozijn, A., Schroder, T., Gjergji, M., Dalissier, A., Liptrott, S. J., Murray, J., Kenyon, M., van Gestel, J. P. J., Corbacioglu, S., Bader, P., Nurses Group of the European Society for, B., Marrow, T., Pediatric Diseases Working Party of the European Society for, B., & Marrow, T. (2022). Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians. Bone Marrow Transplant, 57(5), 734-741, PMID: 35190674 https://doi.org/10.1038/s41409-021-01559-5
  26. Jurado, S., Fedl, A. S., Jaritz, M., Kostanova-Poliakova, D., Malin, S. G., Mullighan, C. G., Strehl, S., Fischer, M., & Busslinger, M. (2022). The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation. EMBO J, e108397, PMID: 35156727 https://doi.org/10.15252/embj.2021108397 
  27. Kitko, C. L., Abdel-Azim, H., Carpenter, P. A., Dalle, J. H., Diaz-de-Heredia, C., Gaspari, S., Gennery, A. R., Handgretinger, R., & Lawitschka, A. (2022). A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease. Transplant Cell Ther,28(5), 261 e261-261 e267, PMID: 35124293 https://doi.org/10.1016/j.jtct.2022.01.025  
  28. Klein, K., Beverloo, H. B., Zimmermann, M., Raimondi, S. C., von Neuhoff, C., de Haas, V., van Weelderen, R., Cloos, J., Abrahamsson, J., Bertrand, Y., Dworzak, M., Fynn, A., Gibson, B., Ha, S. Y., Harrison, C. J., Hasle, H., Elitzur, S., Leverger, G., Maschan, A., Razzouk, B., Reinhardt, D., Rizzari, C., Smisek, P., Creutzig, U., & Kaspers, G. J. L. (2022). Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study. Pediatr Blood Cancer, 69(1), e29341, PMID: 34532968 https://doi.org/10.1002/pbc.29341  
  29. Kolukisa, B., Baser, D., Akcam, B., Danielson, J., Bilgic Eltan, S., Haliloglu, Y., Sefer, A. P., Babayeva, R., Akgun, G., Charbonnier, L. M., Schmitz-Abe, K., Kendir Demirkol, Y., Zhang, Y., Gonzaga-Jauregui, C., Jimenez Heredia, R., Kasap, N., Kiykim, A., Ozek Yucel, E., Gok, V., Unal, E., Pac Kisaarslan, A., Nepesov, S., Baysoy, G., Onal, Z., Yesil, G., Celkan, T. T., Cokugras, H., Camcioglu, Y., Eken, A., Boztug, K., Lo, B., Karakoc-Aydiner, E., Su, H. C., Ozen, A., Chatila, T. A., & Baris, S. (2022). Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency. Allergy, 77(3), 1004-1019, PMID: 34287962 https://doi.org/10.1111/all.15010  
  30. Koscielniak, E., Blank, B., Vokuhl, C., Kazanowska, B., Ladenstein, R., Niggli, F., Ljungman, G., Handgretinger, R., Seitz, G., Fuchs, J., Frohlich, B., Scheer, M., Wessalowski, R., Schmid, I., Sparber-Sauer, M., & Klingebiel, T. (2022). Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol. Cancers (Basel), 14(4), PMID: 35205646 PMC8870315 https://doi.org/10.3390/cancers14040899  
  31. Lange, J. T., Rose, J. C., Chen, C. Y., Pichugin, Y., Xie, L., Tang, J., Hung, K. L., Yost, K. E., Shi, Q., Erb, M. L., Rajkumar, U., Wu, S., Taschner-Mandl, S., Bernkopf, M., Swanton, C., Liu, Z., Huang, W., Chang, H. Y., Bafna, V., Henssen, A. G., Werner, B., & Mischel, P. S. (2022). The evolutionary dynamics of extrachromosomal DNA in human cancers. Nat Genet, PMID: 36123406 https://doi.org/10.1038/s41588-022-01177-x  
  32. Lichtenegger, A., Mukherjee, P., Zhu, L., Morishita, R., Tomita, K., Oida, D., Leskovar, K., Abd El-Sadek, I., Makita, S., Kirchberger, S., Distel, M., Baumann, B., & Yasuno, Y. (2022). Non-destructive characterization of adult zebrafish models using Jones matrix optical coherence tomography. Biomed Opt Express, 13(4), 2202-2223, PMID: 35519284 PMC9045912 https://doi.org/10.1364/BOE.455876  
  33. Liu, I., Jiang, L., Samuelsson, E. R., Marco Salas, S., Beck, A., Hack, O. A., Jeong, D., Shaw, M. L., Englinger, B., LaBelle, J., Mire, H. M., Madlener, S., Mayr, L., Quezada, M. A., Trissal, M., Panditharatna, E., Ernst, K. J., Vogelzang, J., Gatesman, T. A., Halbert, M. E., Palova, H., Pokorna, P., Sterba, J., Slaby, O., Geyeregger, R., Diaz, A., Findlay, I. J., Dun, M. D., Resnick, A., Suva, M. L., Jones, D. T. W., Agnihotri, S., Svedlund, J., Koschmann, C., Haberler, C., Czech, T., Slavc, I., Cotter, J. A., Ligon, K. L., Alexandrescu, S., Yung, W. K. A., Arrillaga-Romany, I., Gojo, J., Monje, M., Nilsson, M., & Filbin, M. G. (2022). The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet, 54(12), 1881-1894, PMID: 36471067 PMC9729116 https://doi.org/10.1038/s41588-022-01236-3  
  34. Martinez-Monleon, A., Kryh Oberg, H., Gaarder, J., Berbegall, A. P., Javanmardi, N., Djos, A., Ussowicz, M., Taschner-Mandl, S., Ambros, I. M., Ora, I., Sandstedt, B., Beiske, K., Ladenstein, R., Noguera, R., Ambros, P. F., Gordon Murkes, L., Ljungman, G., Kogner, P., Fransson, S., & Martinsson, T. (2022). Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup. Sci Rep, 12(1), 12420, PMID: 35859155 PMC9300649 https://doi.org/10.1038/s41598-022-16455-1
  35. Mehta, S., Buyanbat, A., Kai, Y., Karayel, O., Goldman, S. R., Seruggia, D., Zhang, K., Fujiwara, Y., Donovan, K. A., Zhu, Q., Yang, H., Nabet, B., Gray, N. S., Mann, M., Fischer, E. S., Adelman, K., & Orkin, S. H. (2022). Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells. Cell Chem Biol, PMID: 35839780 https://doi.org/10.1016/j.chembiol.2022.06.007  
  36. Meier, C. M., Furtwangler, R., von Schweinitz, D., Stein, R., Welter, N., Wagenpfeil, S., Kager, L., Schenk, J. P., Vokuhl, C., Melchior, P., Fuchs, J., & Graf, N. (2022). Vena Cava Thrombus in Patients with Wilms Tumor. Cancers (Basel), 14(16), PMID: 36010917 PMC9405781 https://doi.org/10.3390/cancers14163924  
  37. Mittlbock, M.*, Potschger, U.*, & Heinzl, H. (2022). Weighted pseudo-values for partly unobserved group membership in paediatric stem cell transplantation studies. Stat Methods Med Res, 31(1), 76-86, PMID: 34812663 PMC8721556 https://doi.org/10.1177/09622802211041756 * Shared first authorship
  38. Nogueira, F., Obrova, K., Haas, M., Tucek, E., Kosulin, K., Fortschegger, M., Furhacker, P., Walter, C., Grosslinger, L., Peter, S., Hassan, J. O., Probst, M., Salzer, H., & Lion, T. (2022). Intestinal Shedding of SARS-CoV-2 in Children: No Evidence for Infectious Potential. Microorganisms, 11(1), PMID: 36677323 PMC9864026 https://doi.org/10.3390/microorganisms11010033
  39. Obrova, K., Vankova, E., Slama, M., Hodek, J., Khun, J., Ulrychova, L., Nogueira, F., Laos, T., Sponseiler, I., Kasparova, P., Machkova, A., Weber, J., Scholtz, V., & Lion, T. (2022). Decontamination of High-Efficiency Mask Filters From Respiratory Pathogens Including SARS-CoV-2 by Non-thermal Plasma. Front Bioeng Biotechnol, 10, 815393, PMID: 35237577 PMC8883054 https://doi.org/10.3389/fbioe.2022.815393
  40. Papadakis, V., Segura, V., Conte, M., Plantaz, D., Di Cataldo, A., Schleiermacher, G., Wheeler, K., Bermudez, J. D., Ash, S., Brichard, B., Ladenstein, R., Combaret, V., Sarnacki, S., Fagnani, A. M., Granata, C., & Canete, A. (2022). Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results. Cancers (Basel), 14(16), PMID: 36011005 PMC9406882 https://doi.org/10.3390/cancers14164007  
  41. Park, J. R., Villablanca, J. G., Hero, B., Kushner, B. H., Wheatley, K., Beiske, K. H., Ladenstein, R. L., Baruchel, S., Macy, M. E., Moreno, L., Seibel, N. L., Pearson, A. D., Matthay, K. K., & Valteau-Couanet, D. (2022). Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer, PMID: 36101004 https://doi.org/10.1002/cncr.34445  
  42. Pearson, A. D., Allen, C., Fangusaro, J., Hutter, C., Witt, O., Weiner, S., Reaman, G., Russo, M., Bandopadhayay, P., Ahsan, S., Barone, A., Barry, E., de Rojas, T., Fisher, M., Fox, E., Bender, J. G., Gore, L., Hargrave, D., Hawkins, D., Kreider, B., Langseth, A. J., Lesa, G., Ligas, F., Marotti, M., Marshall, L. V., Nasri, K., Norga, K., Nysom, K., Pappo, A., Rossato, G., Scobie, N., Smith, M., Stieglitz, E., Weigel, B., Weinstein, A., Viana, R., Karres, D., & Vassal, G. (2022). Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer, 177, 120-142, PMID: 36335782 https://doi.org/10.1016/j.ejca.2022.09.036  
  43. Peters, C., Balduzzi, A., & Bader, P. (2022). Editorial: Allogeneic haematopoietic stem cell transplantation for children with acute lymphoblastic leukaemia in the era of immunotherapy. Front Pediatr, 10, 959471, PMID: 36052358 PMC9426657 https://doi.org/10.3389/fped.2022.959471  
  44. Peterziel, H., Jamaladdin, N., ElHarouni, D., Gerloff, X. F., Herter, S., Fiesel, P., Berker, Y., Blattner-Johnson, M., Schramm, K., Jones, B. C., Reuss, D., Turunen, L., Friedenauer, A., Holland-Letz, T., Sill, M., Weiser, L., Previti, C., Balasubramanian, G., Gerber, N. U., Gojo, J., Hutter, C., Ora, I., Lohi, O., Kattamis, A., de Wilde, B., Westermann, F., Tippelt, S., Graf, N., Nathrath, M., Sparber-Sauer, M., Sehested, A., Kramm, C. M., Dirksen, U., Kallioniemi, O., Pfister, S. M., van Tilburg, C. M., Jones, D. T. W., Saarela, J., Pietiainen, V., Jager, N., Schlesner, M., Kopp-Schneider, A., Oppermann, S., Milde, T., Witt, O., & Oehme, I. (2022). Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. NPJ Precis Oncol,6(1), 94, PMID: 36575299 PMC9794727 https://doi.org/10.1038/s41698-022-00335-y  
  45. Poyer, F., Dieckmann, K., Dworzak, M., Tamesberger, M., Haas, O., Jones, N., Nebral, K., Kohrer, S., Moser, R., Kropshofer, G., Peters, C., Urban, C., Mann, G., Potschger, U.#, Attarbaschi, A.#, & Austrian Berlin-Frankfurt-Munster Study, G. (2022). Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia-A population-based analysis of the Austrian ALL-BFM Study Group. EJHaem, 3(3), 940-948, PMID: 36051012 PMC9421960 https://doi.org/10.1002/jha2.488 Shared senior authorship 
  46. Poyer, F., Fureder, A., Holter, W., Peters, C., Boztug, H., Dworzak, M., Engstler, G., Friesenbichler, W., Kohrer, S., Luftinger, R., Ronceray, L., Witt, V., Pichler, H., & Attarbaschi, A. (2022). Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports). Ther Adv Hematol, 13, 20406207221099468, PMID: 35646299 PMC9134426 https://doi.org/10.1177/20406207221099468  
  47. Poyer, F., Jimenez Heredia, R., Novak, W., Zeitlhofer, P., Nebral, K., Dworzak, M. N., Haas, O. A.#, Boztug, K.#, & Kager, L#. (2022). Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor. Front Immunol, 13, 869047, PMID: 35812385 PMC9263211 https://doi.org/10.3389/fimmu.2022.869047 Shared senior authorship
  48. Rieder, D., Fotakis, G., Ausserhofer, M., Rene, G., Paster, W., Trajanoski, Z., & Finotello, F. (2021). nextNEOpi: a comprehensive pipeline for computational neoantigen prediction. Bioinformatics, 38(4), 1131-1132, PMID: 34788790 PMC8796378 https://doi.org/10.1093/bioinformatics/btab759  
  49. Salmon, M., White, H. E., Zizkova, H., Gottschalk, A., Motlova, E., Cerveira, N., Colomer, D., Coriu, D., Franke, G. N., Gottardi, E., Izzo, B., Jurcek, T., Lion, T., Schafer, V., Venturi, C., Vigneri, P., Zawada, M., Zuna, J., Hovorkova, L., Koblihova, J., Klamova, H., Markova, M. S., Srbova, D., Benesova, A., Polivkova, V., Zackova, D., Mayer, J., Roeder, I., Glauche, I., Ernst, T., Hochhaus, A., Polakova, K. M., & Cross, N. C. P. (2022). Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. Leukemia, PMID: 35676453 https://doi.org/10.1038/s41375-022-01612-2  
  50. Schober, S. J., Hallmen, E., Ressle, F., Gassmann, H., Prexler, C., Wawer, A., von Luettichau, I., Ladenstein, R., Kazanowska, B., Ljungman, G., Niggli, F., Lohi, O., Hauer, J., Gruhn, B., Klingebiel, T., Bader, P., Burdach, S., Lang, P., Sparber-Sauer, M., Koscielniak, E., & Thiel, U. (2022). No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy. Front Oncol, 12, 878367, PMID: 35619911 PMC9127413 https://doi.org/10.3389/fonc.2022.878367  
  51. Schriegel, F., Taschner-Mandl, S., Bernkopf, M., Grunwald, U., Siebert, N., Ambros, P. F., Ambros, I., Lode, H. N., Henze, G., & Ehlert, K. (2022). Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma. J Cancer Res Clin Oncol, 148(10), 2581-2588, PMID: 34623519 PMC9470647 https://doi.org/10.1007/s00432-021-03780-7  
  52. Shahin, T.*, Mayr, D.*, Shoeb, M. R., Kuehn, H. S., Hoeger, B., Giuliani, S., Gawriyski, L. M., Petronczki, O. Y., Hadjadj, J., Bal, S. K., Zoghi, S., Haimel, M., Jimenez Heredia, R., Boutboul, D., Triebwasser, M. P., Rialland-Battisti, F., Costedoat Chalumeau, N., Quartier, P., Tangye, S. G., Fleisher, T. A., Rezaei, N., Romberg, N., Latour, S., Varjosalo, M., Halbritter, F., Rieux-Laucat, F., Castanon, I., Rosenzweig, S. D. #, & Boztug, K. #(2022). Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation. Blood Adv, 6(7), 2444-2451, PMID: 34920454 PMC9006292 https://doi.org/10.1182/bloodadvances.2021006367 * Shared first authorship, Shared senior authorship
  53. Shulman, D. S., Whittle, S. B., Surdez, D., Bailey, K. M., de Alava, E., Yustein, J. T., Shlien, A., Hayashi, M., Bishop, A. J. R., Crompton, B. D., DuBois, S. G., Shukla, N., Leavey, P. J., Lessnick, S. L., Kovar, H., Delattre, O., Grunewald, T. G. P., Antonescu, C. R., Roberts, R. D., Toretsky, J. A., Tirode, F., Gorlick, R., Janeway, K. A., Reed, D., Lawlor, E. R., & Grohar, P. J. (2022). An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. NPJ Precis Oncol, 6(1), 65, PMID: 36115869 PMC9482616 https://doi.org/10.1038/s41698-022-00307-2  
  54. Sobkowiak-Sobierajska, A., Lindemans, C., Sykora, T., Wachowiak, J., Dalle, J. H., Bonig, H., Gennery, A., & Lawitschka, A. (2022). Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan. Front Pediatr, 10, 808103, PMID: 35252060 PMC8894895 https://doi.org/10.3389/fped.2022.808103  
  55. Sparber-Sauer, M., Ferrari, A., Kosztyla, D., Ladenstein, R., Cecchetto, G., Kazanowska, B., Scarzello, G., Ljungman, G., Milano, G. M., Niggli, F., Alaggio, R., Vokuhl, C., Casanova, M., Klingebiel, T., Zin, A., Koscielniak, E., & Bisogno, G. (2022). Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults. Pediatr Blood Cancer, e29691, PMID: 35441463 https://doi.org/10.1002/pbc.29691  
  56. Sparber-Sauer, M., Vokuhl, C., Seitz, G., Sorg, B., Tobias, M., von Kalle, T., Munter, M., Bielack, S. S., Ladenstein, R., Ljungman, G., Niggli, F., Fruhwald, M., Loff, S., Klingebiel, T., & Koscielniak, E. (2022). Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Pediatr Blood Cancer, 69(3), e29403, PMID: 34636137 https://doi.org/10.1002/pbc.29403  
  57. Surucu Yilmaz, N., Bilgic Eltan, S., Kayaoglu, B., Geckin, B., Heredia, R. J., Sefer, A. P., Kiykim, A., Nain, E., Kasap, N., Dogru, O., Yucelten, A. D., Cinel, L., Karasu, G., Yesilipek, A., Sozeri, B., Kaya, G. G., Yilmaz, I. C., Baydemir, I., Aydin, Y., Cansen Kahraman, D., Haimel, M., Boztug, K., Karakoc-Aydiner, E., Gursel, I., Ozen, A., Baris, S., & Gursel, M. (2022). Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency. J Clin Immunol, PMID: 35028801 https://doi.org/10.1007/s10875-021-01176-3  
  58. Tirtakusuma, R., Szoltysek, K., Milne, P., Grinev, V., Ptasinska, A., Chin, P. S., Meyer, C., Nakjang, S., Hehir-Kwa, J. Y., Williamson, D., Cauchy, P., Keane, P., Assi, S. A., Ashtiani, M., Kellaway, S. G., Imperato, M. R., Vogiatzi, F., Schweighart-James, E. K., Lin, S., Wunderlich, M., Stutterheim, J., Komkov, A., Zerkalenkova, E., Evans, P., McNeill, H. V., Elder, A., Martinez-Soria, N., Fordham, S. E., Shi, Y., Russell, L. J., Pal, D., Smith, A. G., Kingsbury, Z., Becq, J., Eckert, C., Haas, O. A., Carey, P., Bailey, S., Skinner, R., Miakova, N., Collin, M., Bigley, V., Haniffa, M., Marschalek, R., Harrison, C. J., Cargo, C. A., Schewe, D. M., Olshanskaya, Y., Thirman, M. J., Cockerill, P. N., Mulloy, J. C., Blair, H. J., Vormoor, H. J., Allan, J. M., Bonifer, C., Heidenreich, O., & Bomken, S. (2022). Epigenetic regulator genes direct lineage switching in MLL/AF4 leukaemia. Blood, PMID: 35839448 https://doi.org/10.1182/blood.2021015036  
  59. van Gerven, M. R., Bozsaky, E., Matser, Y. A. H., Vosseberg, J., Taschner-Mandl, S., Koster, J., Tytgat, G. A. M., Molenaar, J. J., & van den Boogaard, M. (2022). Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics. Cancer Sci, PMID: 35384159 https://doi.org/10.1111/cas.15363  
  60. Varlet, P., Bouffet, E., Casanova, M., Giangaspero, F., Antonelli, M., Hargrave, D., Ladenstein, R., Pearson, A., Hawkins, C., Konig, F. B., Ruschoff, J., Schmauch, C., Buhnemann, C., Garin-Chesa, P., Schweifer, N., Uttenreuther-Fischer, M., Gibson, N., Ittrich, C., Kramer, N., Solca, F., Stolze, B., & Geoerger, B. (2022). Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma. Pediatr Blood Cancer, 69(1), e29316, PMID: 34546642 https://doi.org/10.1002/pbc.29316 
  61. Vassal, G., Lazarov, D., Rizzari, C., Szczepanski, T., Ladenstein, R., & Kearns, P. R. (2022). The impact of the EU General Data Protection Regulation on childhood cancer research in Europe. Lancet Oncol, 23(8), 974-975, PMID: 35901818 https://doi.org/10.1016/S1470-2045(22)00287-X  
  62. Veiga-Canuto, D. C.-A., L.; Sangüesa Nebot, C.; Martínez de las Heras, B.; Pötschger, U.; Gabelloni, M.; Carot Sierra, J.M.; Taschner-Mandl, S.; Düster, V.; Cañete, A.; Ladenstein, R.; Neri, E.; Martí-Bonmatí, L. . (2022). Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images. . Cancers (Basel), 14, PMID: https://doi.org/https://doi.org/10.3390/cancers14153648  
  63. Velez-Tirado, N., Yamazaki-Nakashimada, M. A., Lopez Valentin, E., Partida-Gaytan, A., Scheffler-Mendoza, S. C., Chaia Semerena, G. M., Alvarez-Cardona, A., Suarez Gutierrez, M. A., Medina Torres, E. A., Baeza Capetillo, P., Hirschmugl, T., Garncarz, W., Espinosa-Padilla, S. E., Aguirre Hernandez, J., Klein, C., Boztug, K., & Lugo Reyes, S. O. (2022). Severe congenital neutropenia due to G6PC3 deficiency: Case series of five patients and literature review. Scand J Immunol, 95(4), e13136, PMID: 34964150 https://doi.org/10.1111/sji.13136  
  64. Weber, K., Zeissig, Y., Haag, C., Schmelz, R., Pazmandi, J., Kalinichenko, A., Boztug, K., Zeissig, S., Aust, D., Laass, M. W., & Schuetz, C. (2022). [Chronic or severe enteropathy and immunodeficiency: be prepared for a rara avis]. Z Gastroenterol, PMID: 35297030 https://doi.org/10.1055/a-1709-5024  
  65. Weijler, L., Kowarsch, F., Wodlinger, M., Reiter, M., Maurer-Granofszky, M., Schumich, A., & Dworzak, M. N. (2022). UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia. Cancers (Basel), 14(4), PMID: 35205645 PMC8870142 https://doi.org/10.3390/cancers14040898  
  66. White, H. E., Salmon, M., Albano, F., Andersen, C. S. A., Balabanov, S., Balatzenko, G., Barbany, G., Cayuela, J. M., Cerveira, N., Cochaux, P., Colomer, D., Coriu, D., Diamond, J., Dietz, C., Dulucq, S., Engvall, M., Franke, G. N., Gineikiene-Valentine, E., Gniot, M., Gomez-Casares, M. T., Gottardi, E., Hayden, C., Hayette, S., Hedblom, A., Ilea, A., Izzo, B., Jimenez-Velasco, A., Jurcek, T., Kairisto, V., Langabeer, S. E., Lion, T., Meggyesi, N., Mesanovic, S., Mihok, L., Mitterbauer-Hohendanner, G., Moeckel, S., Naumann, N., Nibourel, O., Oppliger Leibundgut, E., Panayiotidis, P., Podgornik, H., Pott, C., Rapado, I., Rose, S. J., Schafer, V., Touloumenidou, T., Veigaard, C., Venniker-Punt, B., Venturi, C., Vigneri, P., Vorkinn, I., Wilkinson, E., Zadro, R., Zawada, M., Zizkova, H., Muller, M. C., Saussele, S., Ernst, T., Machova Polakova, K., Hochhaus, A., & Cross, N. C. P. (2022). Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia, PMID: 35614319 https://doi.org/10.1038/s41375-022-01607-z  
  67. Wieczorek, A., Manzitti, C., Garaventa, A., Gray, J., Papadakis, V., Valteau-Couanet, D., Zachwieja, K., Poetschger, U., Pribill, I., Fiedler, S., Ladenstein, R. #, & Lode, H. N. # (2022). Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials. Cancers (Basel), 14(8), PMID: 35454826 PMC9026788 https://doi.org/10.3390/cancers14081919 # Shared senior authorship
  68. Wodlinger, M., Reiter, M., Weijler, L., Maurer-Granofszky, M., Schumich, A., Sajaroff, E. O., Groeneveld-Krentz, S., Rossi, J. G., Karawajew, L., Ratei, R., & Dworzak, M. N. (2022). Automated identification of cell populations in flow cytometry data with transformers. Comput Biol Med, 144, 105314, PMID: 35247762 https://doi.org/10.1016/j.compbiomed.2022.105314  
  69. Wolfl, M., Qayed, M., Benitez Carabante, M. I., Sykora, T., Bonig, H., Lawitschka, A., & Diaz-de-Heredia, C. (2021). Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia. Front Pediatr, 9, 784377, PMID: 35071133 PMC8771910 https://doi.org/10.3389/fped.2021.784377  
  70. Yanir, A., Schulz, A., Lawitschka, A., Nierkens, S., & Eyrich, M. (2021). Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions. Front Pediatr, 9, 786017, PMID: 35087775 PMC8789272 https://doi.org/10.3389/fped.2021.786017  
  71. Zhang, W., Scerbo, P., Delagrange, M., Candat, V., Mayr, V., Vriz, S., Distel, M., Ducos, B., & Bensimon, D. (2022). Fgf8 dynamics and critical slowing down may account for the temperature independence of somitogenesis. Commun Biol, 5(1), 113, PMID: 35132142 PMC8821593 https://doi.org/10.1038/s42003-022-03053-0  
  72. Zhu, L., Makita, S., Oida, D., Miyazawa, A., Oikawa, K., Mukherjee, P., Lichtenegger, A., Distel, M., & Yasuno, Y. (2022). Computational refocusing of Jones matrix polarization-sensitive optical coherence tomography and investigation of defocus-induced polarization artifacts. Biomed Opt Express, 13(5), 2975-2994, PMID: 35774308 PMC9203103 https://doi.org/10.1364/BOE.454975  
  73. Zollner, S. K., Kauertz, K. L., Kaiser, I., Kerkhoff, M., Schaefer, C., Tassius, M., Jabar, S., Jurgens, H., Ladenstein, R., Kuhne, T., Haveman, L. M., Paulussen, M., Ranft, A., & Dirksen, U. (2022). Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry. Cancers (Basel), 14(23), PMID: 36497417 PMC9735743 https://doi.org/10.3390/cancers14235935  
  74. Zubarovskaya, N., Bauer, D., Ronceray, L., Poetschger, U., Kurzmann, P., Lender, C., Kuzmina, Z., & Lawitschka, A. (2021). To Lighten the Burden of Cure: Thyroid Disease in Long-Term Survivors After TBI Conditioning for Paediatric ALL. Front Pediatr, 9, 798974, PMID: 35127596 PMC8809136 https://doi.org/10.3389/fped.2021.798974  
  75. Zubarovskaya, N., Hofer-Popow, I., Idzko, M., Haas, O. A., & Lawitschka, A. (2021). SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report. Front Pediatr, 9, 775318, PMID: 35096703 PMC8795895 https://doi.org/10.3389/fped.2021.775318  

  1. Abbasi, M. R. *, Nebral, K. *, Haslinger, S., Inthal, A., Zeitlhofer, P., Konig, M., Schinnerl, D., Kohrer, S., Strehl, S., Panzer-Grumayer, R., Mann, G., Attarbaschi, A., & Haas, O. A. (2021). Copy Number Changes and Allele Distribution Patterns of Chromosome 21 in B Cell Precursor Acute Lymphoblastic Leukemia. Cancers (Basel), 13(18). https://doi.org/10.3390/cancers13184597 *shared first authorship
  2. Agerer, B., Koblischke, M., Gudipati, V., Montano-Gutierrez, L. F., Smyth, M., Popa, A., Genger, J. W., Endler, L., Florian, D. M., Muhlgrabner, V., Graninger, M., Aberle, S. W., Husa, A. M., Shaw, L. E., Lercher, A., Gattinger, P., Torralba-Gombau, R., Trapin, D., Penz, T., Barreca, D., Fae, I., Wenda, S., Traungott, M., Walder, G., Pickl, W. F., Thiel, V., Allerberger, F., Stockinger, H., Puchhammer-Stöckl, E., Weninger, W., Fischer, G., Hoepler, W., Pawelka, E., Zoufaly, A., Valenta, R., Bock, C., Paster, W.,Geyeregger, R., Farlik, M., Halbritter, F.,  Huppa, J. B., Aberle, J. H., Bergthaler, A. (2021). SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses. Sci Immunol, 6(57). https://doi.org/10.1126/sciimmunol.abg6461 
  3. Al-Kershi, S., Golnik, R., Flasinski, M., Waack, K., Rasche, M., Creutzig, U., Dworzak, M., Reinhardt, D., & Klusmann, J. H. (2021). Recommendations for Diagnosis and Treatment of Children with Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia in Down Syndrome (ML-DS). Klin Padiatr. https://doi.org/10.1055/a-1532-2016 (Empfehlungen fur die Diagnose und Behandlung von Kindern mit transienter abnormer Myelopoese (TAM) und myeloischer Leukamie bei Down Syndrom (ML-DS).) https://doi.org/10.1055/a-1532-2016
  4. Andreana, M. S., C.; Yang, M.; Latham, R.; Leitgeb, R.; Member, IEEE, Drexler, W.; Zimmer, M.; Le, T.; Distel, M.; and Unterhuber, A. (2021). Molecular Multicolor Multiphoton in Vivo Bioimaging Based on a Direct Diode Pumped Ti:sapphire Oscillator. IEEE Journal of Selected Topics in Quantum Electronics, 27https://doi.org/10.1109/JSTQE.2021.3060289
  5. Andreana, M., Sturtzel, C., Spielvogel, C. P., Papp, L., Leitgeb, R., Drexler, W., Distel, M., & Unterhuber, A. (2021). Toward Quantitative in vivo Label-Free Tracking of Lipid Distribution in a Zebrafish Cancer Model. Front Cell Dev Biol, 9, 675636. https://doi.org/10.3389/fcell.2021.675636 
  6. Ban, J. *, Fock, V. *, Aryee, D. N. T., & Kovar, H. (2021). Mechanisms, Diagnosis and Treatment of Bone Metastases. Cells, 10(11). https://doi.org/10.3390/cells10112944 *shared first authorship
  7. Baumgartner, A., Stepien, N., Mayr, L., Madlener, S., Dorfer, C., Schmook, M. T., Traub-Weidinger, T., Lotsch-Gojo, D., Kirchhofer, D., Reisinger, D., Hedrich, C., Arshad, S., Irschik, S., Boztug, H., Engstler, G., Bernkopf, M., Rifatbegovic, F., Holler, C., Slavc, I., Berger, W., Müllauer, L., Haberler, C., Azizi, A. A., Peyrl, A., Gojo, J. (2021). Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis. J Pers Med, 11(4). https://doi.org/10.3390/jpm11040292 
  8. Bayram, O., Haskologlu, S., Bayrakoglu, D., Bal, S. K., Islamoglu, C., Cipe, F. E., Kendirli, T., Kursun, N., Guner, S. N., Yildiran, A., Bozdogan, G., Yuksek, M., Reisli, I., Dalva, K., Aytekin, C., Boztug, K., Dogu, F., & Ikinciogullari, A. (2021). Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes. J Clin Immunolhttps://doi.org/10.1007/s10875-021-01062-y 
  9. Bellini, A.*, Potschger, U.*, Bernard, V., Lapouble, E., Baulande, S., Ambros, P. F., Auger, N., Beiske, K., Bernkopf, M., Betts, D. R., Bhalshankar, J., Bown, N., de Preter, K., Clement, N., Combaret, V., Font de Mora, J., George, S. L., Jimenez, I., Jeison, M., Marques, B., Martinsson, T., Mazzocco, K., Morini, M., Mühlethaler-Mottet, A., Noguera, R., Pierron, G., Rossing, M., Taschner-Mandl, S., Van Roy, N., Vicha, A., Chesler, L., Balwierz, W., Castel, V., Elliott, M., Kogner, P., Laureys, G., Luksch, R., Malis, J., Popovic-Beck, M., Ash, S., Delattre, O., Valteau-Couanet, D., Tweddle, D.A.#, Ladenstein, R.#, Schleiermacher, G.# (2021). Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). J Clin Oncol, JCO2100086. https://doi.org/10.1200/JCO.21.00086 *shared first authorship # shared senior authorship
  10. Berlanga, P., Pasqualini, C., Potschger, U., Sanguesa, C., Castellani, M. R., Canete, A., Luksch, R., Elliot, M., Schreier, G., Kropf, M., Morgenstern, D., Papadakis, V., Ash, S., Ruud, E., Brock, P., Wieczorek, A., Kogner, P., Trahair, T., Ambros, P., Boterberg, T., Castel, V., Valteau-Couanet, D., & Ladenstein, R. (2021). Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience. Eur J Cancer, 144, 1-8, PMID: 33316634 https://doi.org/10.1016/j.ejca.2020.10.020  
  11. Bierbaumer, L., Katschnig, A. M., Radic-Sarikas, B., Kauer, M. O., Petro, J. A., Hogler, S., Gurnhofer, E., Pedot, G., Schafer, B. W., Schwentner, R., Muhlbacher, K., Kromp, F., Aryee, D. N. T., Kenner, L., Uren, A., & Kovar, H. (2021). YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells. Oncogenesis, 10(1), 2. https://doi.org/10.1038/s41389-020-00294-8
  12. Boer, J. M., Valsecchi, M. G., Hormann, F. M., Antic, Z., Zaliova, M., Schwab, C., Cazzaniga, G., Arfeuille, C., Cave, H., Attarbaschi, A., Strehl, S., Escherich, G., Imamura, T., Ohki, K., Gruber, T. A., Sutton, R., Pastorczak, A., Lammens, T., Lambert, F., Kong Li, C., Carrillo de Santa Pau, E., Hoffmann, S., Möricke, A., Harrison, C. J., Den Boer, M. L., De Lorenzo, P., Stam, R. W., Bergmann, A. K, Pieters, R. (2021). Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study. Leukemiahttps://doi.org/10.1038/s41375-021-01333-y 
  13. Cagdas, D. *, Mayr, D. *, Baris, S. *, Worley, L., Langley, D. B., Metin, A., Aytekin, E. S., Atan, R., Kasap, N., Bal, S. K., Dmytrus, J., Heredia, R. J., Karasu, G., Torun, S. H., Toyran, M., Karakoc-Aydiner, E., Christ, D., Kuskonmaz, B., Uckan-Cetinkaya, D., Uner, A., Oberndorfer, F., Schiefer, A-I., Uzel, G., Deenick, E. K., Keller, B., Warnatz, K., Neven, B., Durandy, A., Sanal, O., Ma, C. S., Özen, A., Stepensky, P., Tezcan, I., Boztug, K. #, Tangye, S. G. # (2021). Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor Deficiency. J Clin Immunolhttps://doi.org/10.1007/s10875-021-01031-5 *shared first authorship # shared senior authorship
  14. Casteels, T., Zhang, Y., Frogne, T., Sturtzel, C., Lardeau, C. H., Sen, I., Liu, X., Hong, S., Pauler, F. M., Penz, T., Brandstetter, M., Barbieux, C., Berishvili, E., Heuser, T., Bock, C., Riedel, C. G., Meyer, D., Distel, M., Hecksher-Sorensen, J., Li, J., Kubicek, S. (2021). An inhibitor-mediated beta cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturation. Mol Metab, 101329. https://doi.org/10.1016/j.molmet.2021.101329 
  15. Cicconi, L., Testi, A. M., Montesinos, P., Rego, E., Zhu, H. H., Takahashi, H., Dworzak, M., Estey, E., Schwarer, A., Esteve, J., Annibali, O., Castelli, R., Mirabile, M., Angelini, M., Lazarevic, V., Kumar, J., Avvisati, G., Gurnari, C., Locatelli, F., Voso, M. T., Sanz, M. A., Lo-Coco, F., Abla, O. (2021). Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants. Blood Cancer J, 11(10), 167. https://doi.org/10.1038/s41408-021-00561-w 
  16. Coronado, E., Yanez, Y., Vidal, E., Rubio, L., Vera-Sempere, F., Canada-Martinez, A. J., Panadero, J., Canete, A., Ladenstein, R., Castel, V., & Font de Mora, J. (2021). Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets. Mol Oncol, 15(2), 364-380. https://doi.org/10.1002/1878-0261.12868 
  17. Creasey, T., Enshaei, A., Nebral, K., Schwab, C., Watts, K., Cuthbert, G., Vora, A., Moppett, J., Harrison, C. J., Fielding, A. K., Haas, O. A., & Moorman, A. V. (2021). Single nucleotide polymorphism (SNP) array-based signature of low hypodiploidy in acute lymphoblastic leukemia. Genes Chromosomes Cancerhttps://doi.org/10.1002/gcc.22956 
  18. de Winter, D. T. C., Langerak, A. W., Te Marvelde, J., Dworzak, M. N., De Moerloose, B., Stary, J., Locatelli, F., Hasle, H., de Vries, A. C. H., Schmugge, M., Niemeyer, C. M., van den Heuvel-Eibrink, M. M., & van der Velden, V. H. J. (2021). The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study. Leuk Res, 106652. https://doi.org/10.1016/j.leukres.2021.106652
  19. Deng, S. H., R.; Zhang, E.; Beard, P.; Scheuringer, E.; Sturtzel, C.; Li, Q.; Deloria, A.; Sattmann, H.; Leitgeb, R.; Yuan, Y.; Schmetterer, L.; Pramanik, M.; Distel, M.; Drexler, W and Liu, M. (2021). An optical coherence photoacoustic microscopy system using a fiber optic senso. APL Photonics, 6(9). https://doi.org/https://doi.org/10.1063/5.0059351 
  20. Dupre, L., Boztug, K., & Pfajfer, L. (2021). Actin Dynamics at the T Cell Synapse as Revealed by Immune-Related Actinopathies. Front Cell Dev Biol, 9, 665519. https://doi.org/10.3389/fcell.2021.665519
  21. Fernandez, A., Straw, A., Distel, M., Leitgeb, R., Baltuska, A., & Verhoef, A. J. (2021). Dynamic real-time subtraction of stray-light and background for multiphoton imaging. Biomed Opt Express, 12(1), 288-302. https://doi.org/10.1364/BOE.403255 
  22. Fetahu, I. S., & Taschner-Mandl, S. (2021). Neuroblastoma and the epigenome. Cancer Metastasis Revhttps://doi.org/10.1007/s10555-020-09946-y
  23. Fiedler, S., Ambros, I. M., Glogova, E., Benesch, M., Urban, C., Mayer, M., Ebetsberger-Dachs, G., Bardi, E., Jones, N., Gamper, A., Meister, B., Crazzolara, R., Amann, G., Dieckmann, K., Horcher, E., Kerbl, R., Brunner-Herglotz, B., Ziegler, A., Ambros, P. F., & Ladenstein, R. L. (2021). Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94. Cancers (Basel), 13(3). https://doi.org/10.3390/cancers13030572
  24. Fortschegger, K., Husa, A. M., Schinnerl, D., Nebral, K., & Strehl, S. (2021). Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways. Int J Mol Sci, 22(14). https://doi.org/10.3390/ijms22147576
  25. Friesenbichler, W., Luftinger, R., Kropshofer, G., Henkel, M., Amann, G., Furtwangler, R., Graf, N., & Kager, L.(2021). Clear cell sarcoma of the kidney in Austrian children: Long-term survival after relapse. Pediatr Blood Cancer, e28860. https://doi.org/10.1002/pbc.28860 
  26. Fruhwald, M. C., Nemes, K., Boztug, H., Cornips, M. C. A., Evans, D. G., Farah, R., Glentis, S., Jorgensen, M., Katsibardi, K., Hirsch, S., Jahnukainen, K., Kventsel, I., Kerl, K., Kratz, C. P., Pajtler, K. W., Kordes, U., Ridola, V., Stutz, E., & Bourdeaut, F. (2021). Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group. Fam Cancerhttps://doi.org/10.1007/s10689-021-00229-1 
  27. Garaventa, A., Poetschger, U., Valteau-Couanet, D., Luksch, R., Castel, V., Elliott, M., Ash, S., Chan, G. C. F., Laureys, G., Beck-Popovic, M., Vettenranta, K., Balwierz, W., Schroeder, H., Owens, C., Cesen, M., Papadakis, V., Trahair, T., Schleiermacher, G., Ambros, P., Sorrentino, S., Pearson, A.D.J, Ladenstein, R. L. (2021). Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. J Clin Oncol, JCO2003144. https://doi.org/10.1200/JCO.20.03144
  28. German, Y. , Vulliard, L. , Kamnev, A., Pfajfer, L., Huemer, J., Mautner, A. K., Rubio, A., Kalinichenko, A., Boztug, K., Ferrand, A., Menche, J., & Dupre, L. (2021). Morphological profiling of human T and NK lymphocytes by high-content cell imaging. Cell Rep, 36(1), 109318. https://doi.org/10.1016/j.celrep.2021.109318 
  29. Gleixner, K. V., Filik, Y., Berger, D., Schewzik, C., Stefanzl, G., Sadovnik, I., Degenfeld-Schonburg, L., Eisenwort, G., Schneeweiss-Gleixner, M., Byrgazov, K., Sperr, W. R., Mayer, J., Lion, T., & Valent, P. (2021). Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 (T315I)-compound mutations. Am J Cancer Res, 11(9), 4470-4484. https://www.ncbi.nlm.nih.gov/pubmed/34659899
  30. Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., Bonvalot, S., Boukovinas, I., Bovee, J., Boye, K., Brennan, B., Brodowicz, T., Buonadonna, A., De Alava, E., Del Muro, X. G., Dufresne, A., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Frezza, A. M., Gasperoni, S., Gelderblom, H., Gouin, F., Grignani, G., Haas, R., Hassan, A. B., Hecker-Nolting, S., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R. L., Jungels, C., Jutte, P., Kager, L., Kasper, B., Kawai, A., Kopeckova, K., Krákorová, D. A., Le Cesne A., Le Grange, F., Legius, E., Leithner, A., Lopez-Pousa, A., Martin-Broto, J., Merimsky, O., Messiou, C., Mir, O., Montemurro, M., Morland, B., Morosi, C., Palmerini, E., Pantaleo, M. A., Piana, R., Piperno-Neumann, S., Reichardt, P., Rutkowski, P., Safwat, A. A., Sangalli, C., Sbaraglia, M., Scheipl, S., Schöffski, P., Sleijfer S., Strauss, D., Strauss, S., Sundby Hall, K., Trama, A., Unk, M., van de Sande, M. A. J., van der Graaf, W. T. A., van Houdt, W. J., Frebourg T., Casali, P. G., Stacchiotti, S. clinicalguidelines@esmo.org, G. E. a. (2021). Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(). Ann Oncol, 32(11), 1348-1365. https://doi.org/10.1016/j.annonc.2021.07.006 
  31. Haas, O. A. (2021). Somatic Sex: On the Origin of Neoplasms With Chromosome Counts in Uneven Ploidy Ranges. Front Cell Dev Biol, 9, 631946. https://doi.org/10.3389/fcell.2021.631946
  32. Hartlieb, S. A., Sieverling, L., Nadler-Holly, M., Ziehm, M., Toprak, U. H., Herrmann, C., Ishaque, N., Okonechnikov, K., Gartlgruber, M., Park, Y. G., Wecht, E. M., Savelyeva, L., Henrich, K. O., Rosswog, C., Fischer, M., Hero, B., Jones, D. T. W., Pfaff, E., Witt, O., Pfister, S. M., Volckmann, R., Koster, J., Kiesel, K., Rippe, K., Taschner-Mandl, S., Ambros, P., Brors, B., Selbach, M., Feuerbach, L., & Westermann, F. (2021). Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome. Nat Commun, 12(1), 1269. https://doi.org/10.1038/s41467-021-21247-8 
  33. Hirabayashi, S., Butler, E. R., Ohki, K., Kiyokawa, N., Bergmann, A. K., Moricke, A., Boer, J. M., Cave, H., Cazzaniga, G., Yeoh, A. E. J., Sanada, M., Imamura, T., Inaba, H., Mullighan, C., Loh, M. L., Noren-Nystrom, U., Pastorczak, A., Shih, L. Y., Zaliova, M., Pui, C.-H., Haas, O. A., Harrison, C. J., Moorman, A. V., Manabe, A. (2021). Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group. Leukemiahttps://doi.org/10.1038/s41375-021-01199-0 
  34. Kalinichenko, A., Perinetti Casoni, G., Dupre, L., Trotta, L. C., Huemer, J., Galgano, D., German, Y., Haladik, B., Pazmandi, J., Thian, M., Yuce Petronczki, O., Chiang, S. C. C., Taskinen, M. H., Hekkala, A., Kauppila, S., Lindgren, O., Tapiainen, T., Kraakman, M. J., Vettenranta, K., Lomakin, A. J., Saarela, J. #, Seppänen, M. R. J. #, Bryceson, J. T. #, Boztug, K. # (2021). RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis. Bloodhttps://doi.org/10.1182/blood.2020008738 # Shared senior authorship
  35. Kogler, H., Novak, W., Vecsei, A., Zachbauer, C., Huber, W. D., Lakatos, K., Woeran, K., Stift, J., Boztug, K., & Kager, L. (2021). Occurrence of autoimmune pancreatitis after chronic immune thrombocytopenia in a Caucasian adolescent. Clin J Gastroenterolhttps://doi.org/10.1007/s12328-021-01383-w 
  36. Kollmann, S., Grausenburger, R., Klampfl, T., Prchal-Murphy, M., Bastl, K., Pisa, H., Knab, V. M., Brandstoetter, T., Doma, E., Sperr, W. R., Lagger, S., Farlik, M., Moriggl, R. H., Valent, P., Halbritter, F., Kollmann, K., Heller, G., Maurer, B., & Sexl, V. (2021). A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells. Bloodhttps://doi.org/10.1182/blood.2021010980 
  37. Koscielniak, E., Sparber-Sauer, M., Scheer, M., Vokuhl, C., Kazanowska, B., Ladenstein, R., Niggli, F., Ljungman, G., Paulussen, M., Bielack, S. S., Seitz, G., Fuchs, J., Hallmen, E., Klingebiel, T., & On Behalf Of The Cws Study, G. (2021). Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS). Pediatr Blood Cancer, 68(10), e29145. https://doi.org/10.1002/pbc.29145
  38. Kozyra, E. J., Gohring, G., Hickstein, D. D., Calvo, K. R., DiNardo, C. D., Dworzak, M., de Haas, V., Stary, J., Hasle, H., Shimamura, A., Fleming, M. D., Inaba, H., Lewis, S., Hsu, A. P., Holland, S. M., Arnold, D. E., Mecucci, C., Keel, S. B., Bertuch, A. A., Tawana, K., Barzilai, S., Hirabayashi, S., Onozawa, M., Lei, S., Alaiz, H., Andrikovics, H., Betts, D., Beverloo, B. H., Buechner, J., Čermák, M., Cervera, J., Haus, O., Jahnukainen, K., Manola, K.N., Nebral, K., Pasquali, F., Tchinda, J., Turkiewicz, D., Van Roy, N., Zemanova, Z., Pastor, V. B., Strahm, B., Noellke, P., Niemeyer, C. M., Schlegelberger, B., Yoshimi, A., Wlodarski, M. W. (2021). Association of Unbalanced Translocation der(1;7) with Germline GATA2 Mutations. Bloodhttps://doi.org/10.1182/blood.2021012781 
  39. Kromp, F., Fischer, L., Bozsaky, E., Ambros, I. M., Dorr, W., Beiske, K., Ambros, P. F., Hanbury, A.#, & Taschner-Mandl, S. #(2021). Evaluation of Deep Learning architectures for complex immunofluorescence nuclear image segmentation. IEEE Trans Med Imaging, PPhttps://doi.org/10.1109/TMI.2021.3069558 # Shared senior authorship
  40. Krumbholz, M., Eiblwieser, J., Ranft, A., Zierk, J., Schmidkonz, C., Stutz, A. M., Peneder, P., Tomazou, E. M., Agaimy, A., Bauerle, T., Hartmann, W., Dirksen, U., & Metzler, M. (2021). Quantification of translocation-specific ctDNA provides an integrating parameter for early assessment of treatment response and risk stratification in Ewing sarcoma. Clin Cancer Reshttps://doi.org/10.1158/1078-0432.CCR-21-1324 
  41. Kuehn, H. S., Niemela, J. E., Stoddard, J., Mannurita, S. C., Shahin, T., Goel, S., Hintermeyer, M., Heredia, R. J., Garofalo, M., Lucas, L., Singh, S., Tondo, A., Jacobs, Z., Gahl, W. A., Latour, S., Verbsky, J., Routes, J., Cunningham-Rundles, C., Boztug, K., Gambineri, E., Fleisher, T. A., Chandrakasan, S., Rosenzweig, S. D. (2021). Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies. Blood, 137(3), 349-363. https://doi.org/10.1182/blood.2020007292 
  42. Lakatos, K., Sterlich, K., Potschger, U., Thiem, E., Hutter, C., Prosch, H., & Minkov, M. (2021). Langerhans Cell Histiocytosis of the Orbit: Spectrum of Clinical and Imaging Findings. J Pediatr, 230, 174-181 e171, PMID: 33157073 https://doi.org/10.1016/j.jpeds.2020.10.056  
  43. Lammle, C. A., Varady, A., Muller, T. G., Sturtzel, C., Riepl, M., Mathes, B., Eichhorst, J., Sporbert, A., Lehmann, M., Krausslich, H. G., Distel, M., & Broichhagen, J. (2021). Photocaged Hoechst Enables Subnuclear Visualization and Cell Selective Staining of DNA in vivo. Chembiochem, 22(3), 548-556, PMID: 32974998 PMC7894298 https://doi.org/10.1002/cbic.202000465  
  44. Laurent, E., Sieber, A., Salzer, B., Wachernig, A., Seigner, J., Lehner, M., Geyeregger, R., Kratzer, B., Jager, U., Kunert, R., Pickl, W. F., & Traxlmayr, M. W. (2021). Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biolhttps://doi.org/10.1021/acssynbio.1c00010 
  45. Lawitschka, A., Brunmair, M., Bauer, D., Zubarovskaya, N., Felder-Puig, R., Strahm, B., Bader, P., Strauss, G., Albert, M., von Luettichau, I., Greinix, H., Wolff, D., & Peters, C. (2021). Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium. Wien Klin Wochenschr, 133(1-2), 41-51, PMID: 32246210 PMC7840624 https://doi.org/10.1007/s00508-020-01641-w  
  46. Lawitschka, A., Ronceray, L., Bauer, D., Rittenschober, M., Zubarovskaya, N., Geyeregger, R., Pickl, W. F., & Kuzmina, Z. (2021). Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation. Front Pediatr, 9, 788360. https://doi.org/10.3389/fped.2021.788360
  47. Lazic, D., Kromp, F., Rifatbegovic, F., Repiscak, P., Kirr, M., Mivalt, F., Halbritter, F., Bernkopf, M., Bileck, A., Ussowicz, M., Ambros, I. M., Ambros, P. F., Gerner, C., Ladenstein, R., Ostalecki, C., & Taschner-Mandl, S. (2021). Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging. Cancers (Basel), 13(17). https://doi.org/10.3390/cancers13174311
  48. Maurer-Granofszky, M., Schumich, A., Buldini, B., Gaipa, G., Kappelmayer, J., Mejstrikova, E., Karawajew, L., Rossi, J., Suzan, A. C., Agriello, E., Anastasiou-Grenzelia, T., Barcala, V., Barna, G., Batinic, D., Bourquin, J. P., Bruggemann, M., Bukowska-Strakova, K., Burnusuzov, H., Carelli, D., Deniz, G., Dubravčić, K., Feuerstein, T., Gaillard, M. I., Galeano, G., Giordano, H., Gonzalez, A., Groeneveld-Krentz, S., Hevessy, Z., Hrusak, O., Belen Iarossi, M., Jáksó, P., Kloboves Prevodnik, V., Kohlscheen, S., Kreminska, E., Maglia, O., Malusardi, C., Marinov, N., Martin, B. M., Möller, C., Nikulshin, S., Palazzi, J., Paterakis, G., Popov, A., Ratei, R., Rodríguez, C., Sajaroff, E. O., Sala, S., Samardzija, G., Sartor, M., Scarparo, P., Sędek, Ł., Slavkovic, B., Solari, L., Svec, P., Szczepanski, T., Taparkou, A., Torrebadell, M., Tzanoudaki, M., Varotto, E., Vernitsky, H., Attarbaschi, A., Schrappe, M., Conter, V., Biondi, A., Felice, M., Campbell, M., Kiss, C., Basso, G., Dworzak, M.N., On Behalf Of, I. B.-F.-N. (2021). An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report. Cancers (Basel), 13(23). https://doi.org/10.3390/cancers13236148
  49. Melika, S., Hossein, E., Mona, S., Elham, R., Samaneh, Z., Sepideh, S., Raul Jimenez, H., Ana, K., Kaan, B., & Nima, R. (2021). A novel homozygous RAG1 mutation is associated with severe combined immunodeficiency and neurological presentations. Allergol Immunopathol (Madr), 49(4), 91-97. https://doi.org/10.15586/aei.v49i4.194 
  50. Meral Gunes, A., Millot, F., Kalwak, K., Lausen, B., Sedlacek, P., Versluys, A. B., Dworzak, M., De Moerloose, B., & Suttorp, M. (2021). Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry. Pediatr Blood Cancer, 68(1), e28706, PMID: 33034135 https://doi.org/10.1002/pbc.28706 
  51. Minkov, M.*, Potschger, U.*, Thacker, N., Astigarraga, I., Braier, J., Donadieu, J., Henter, J. I., Lehrnbecher, T., Rodriguez-Galindo, C., Sieni, E., Nanduri, V., van den Bos, C., Abla, O., & Society, L. C. H. S. G. o. t. H. (2021). Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis. J Pediatrhttps://doi.org/10.1016/j.jpeds.2021.06.016 * Shared first authorship
  52. Moreno, L., Guo, D., Irwin, M. S., Berthold, F., Hogarty, M., Kamijo, T., Morgenstern, D., Pasqualini, C., Ash, S., Potschger, U., Ladenstein, R., Valteau-Couanet, D., Cohn, S. L., Pearson, A. D. J., & London, W. B. (2020). A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project. Pediatr Blood Cancer, e28794, PMID: 33205902 https://doi.org/10.1002/pbc.28794  
  53. Neehus, A. L., Moriya, K., Nieto-Patlan, A., Le Voyer, T., Levy, R., Ozen, A., Karakoc-Aydiner, E., Baris, S., Yildiran, A., Altundag, E., Roynard, M., Haake, K., Migaud, M., Dorgham, K., Gorochov, G., Abel, L., Lachmann, N., Dogu, F., Haskologlu, S., Boztug, K., Roderick, M. R., Shahrooei, M., Brogan, P. A., Abolhassani, H., Hancioglu, G., Parvaneh , N., Belot, A., Ikinciogullari, A., Casanova, J.-L., Puel, A., Bustamante, J. (2021). Impaired respiratory burst contributes to infections in PKCdelta-deficient patients. J Exp Med, 218(9). https://doi.org/10.1084/jem.20210501
  54. Oberbauer R, E. M., Berlakovich G, Kalhs P, Worel N, Heinze G, Wolzt M, Lion T, Wekerle T. . (2021). Ponatinib and palbociclib combination in TKI-resistant CML—A case report. memo – Magazine of European Medical Oncologyhttps://doi.org/https://doi.org/10.1007/s12254-021-00742-0
  55. Oberbauer, R., Edinger, M., Berlakovich, G., Kalhs, P., Worel, N., Heinze, G., Wolzt, M., Lion, T., & Wekerle, T. (2021). A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001). Front Med (Lausanne), 7, 634260. https://doi.org/10.3389/fmed.2020.634260
  56. Obrova, K., Grumaz, S., Remely, M., Czurda, S., Krickl, I., Herndlhofer, S., Gleixner, K. V., Sperr, W. R., Grosslinger, L., Frank, T., Andrade, N., Egger-Matiqi, T., Peters, C., Engstler, G., Dworzak, M., Attarbaschi, A., van Grotel, M., van den Heuvel-Eibrink, M. M., Moiseev, I. S., Rogacheva, Y., Zubarovskaya, L., Zubarovskaya, N., Pichler, H., Lawitschka, A., Koller, E., Keil, F., Valent, P., Sohn, K., Lion, T. (2021). Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms. Am J Hematolhttps://doi.org/10.1002/ajh.26177
  57. Okuda, K. S., Keyser, M. S., Gurevich, D. B., Sturtzel, C., Mason, E. A., Paterson, S., Chen, H., Scott, M., Condon, N. D., Martin, P., Distel, M., & Hogan, B. M. (2021). Live-imaging of endothelial Erk activity reveals dynamic and sequential signalling events during regenerative angiogenesis. Elife, 10https://doi.org/10.7554/eLife.62196 
  58. Orbach, D., Ferrari, A., Schneider, D. T., Reguerre, Y., Godzinski, J., Bien, E., Stachowicz-Stencel, T., Surun, A., Almaraz, R. L., Dragomir, M., Jani, D., Ami, T. B., Roganovic, J., Brecht, I. B., Ladenstein, R., & Bisogno, G. (2021). The European Paediatric Rare Tumours Network – European Registry (PARTNER) project for very rare tumors in children. Pediatr Blood Cancer, e29072. https://doi.org/10.1002/pbc.29072 
  59. Palmisani, F., Kovar, H., Kager, L., Amann, G., Metzelder, M., & Bergmann, M. (2021). Systematic review of the immunological landscape of Wilms tumors. Mol Ther Oncolytics, 22, 454-467. https://doi.org/10.1016/j.omto.2021.06.016 
  60. Pascoal, S., Grissenberger, S., Scheuringer, E., Fior, R., Ferreira, M. G., & Distel, M. (2021). Using Zebrafish Larvae as a Xenotransplantation Model to Study Ewing Sarcoma. Methods Mol Biol, 2226, 243-255. https://doi.org/10.1007/978-1-0716-1020-6_19
  61. Peneder, P.*, Stutz, A. M.*, Surdez, D., Krumbholz, M., Semper, S., Chicard, M., Sheffield, N. C., Pierron, G., Lapouble, E., Totzl, M., Erguner, B., Barreca, D., Rendeiro, A. F., Agaimy, A., Boztug, H., Engstler, G., Dworzak, M., Bernkopf, M., Taschner-Mandl, S., Ambros, I. M., Myklebost, O., Marec-Bérard, P., Burchill, S. A., Brennan, B., Strauss, S. J., Whelan, J., Schleiermacher, G., Schaefer, C., Dirksen, U., Hutter, C., Boye, K., Ambros, P .F., Delattre, O., Metzler, M., Bock, C.#, Tomazou, E. M.# (2021). Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. Nat Commun, 12(1), 3230. https://doi.org/10.1038/s41467-021-23445-w * Shared first authorship # Shared senior authorship
  62. Peters, C., Dalle, J. H., Locatelli, F., Poetschger, U., Sedlacek, P., Buechner, J., Shaw, P. J., Staciuk, R., Ifversen, M., Pichler, H., Vettenranta, K., Svec, P., Aleinikova, O., Stein, J., Gungor, T., Toporski, J., Truong, T. H., Diaz-de-Heredia, C., Bierings, M., Ariffin, H., Essa, M., Burkhardt, B., Schultz, K., Meisel, R., Lankester, A., Ansari, M., Schrappe, M., IBFM Study Group; von Stackelberg, A., IntReALL Study Group; Balduzzi, A., I-BFM SCT Study Group; Corbacioglu, S., EBMT Paediatric Diseases Working Party; Bader, P. (2021). Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study. J Clin Oncol, 39(4), 295-307. https://doi.org/10.1200/JCO.20.02529
  63. Pidala, J., Kitko, C., Lee, S. J., Carpenter, P., Cuvelier, G. D. E., Holtan, S., Flowers, M. E., Cutler, C., Jagasia, M., Gooley, T., Palmer, J., Randolph, T., Levine, J. E., Ayuk, F., Dignan, F., Schoemans, H., Tkaczyk, E., Farhadfar, N., Lawitschka, A., Schultz, K. R., Martin, P. J., Sarantopoulos, S., Inamoto, Y., Socie, G., Wolff, D., Blazar, B., Greinix, H., Paczesny, S., Pavletic, S., Hill, G. (2021). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report. Transplant Cell Ther, 27(8), 632-641. https://doi.org/10.1016/j.jtct.2021.03.029 
  64. Pirch, S., Muller, F., Iofinova, E., Pazmandi, J., Hutter, C. V. R., Chiettini, M., Sin, C., Boztug, K., Podkosova, I., Kaufmann, H., & Menche, J. (2021). The VRNetzer platform enables interactive network analysis in Virtual Reality. Nat Commun, 12(1), 2432. https://doi.org/10.1038/s41467-021-22570-w
  65. Popitsch, N., Preuner, S., & Lion, T. (2021). Nanopanel2 calls phased low-frequency variants in Nanopore panel sequencing data. Bioinformaticshttps://doi.org/10.1093/bioinformatics/btab526 
  66. Rasche, M., Steidel, E., Zimmermann, M., Bourquin, J. P., Boztug, H., Janotova, I., Kolb, E. A., Lehrnbecher, T., von Neuhoff, N., Niktoreh, N., Muhlegger, N., Sramkova, L., Stary, J., Walter, C., Creutzig, U., Dworzak, M., & Reinhardt, D. (2021). Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group. Cancers (Basel), 13(4). https://doi.org/10.3390/cancers13040789
  67. Rasche, M., Zimmermann, M., Steidel, E., Alonzo, T., Aplenc, R., Bourquin, J. P., Boztug, H., Cooper, T., Gamis, A. S., Gerbing, R. B., Janotova, I., Klusmann, J. H., Lehrnbecher, T., Muhlegger, N., Neuhoff, N. V., Niktoreh, N., Sramkova, L., Stary, J., Waack, K., Walter, C., Creutzig, U., Dworzak, M., Kaspers, G., Anders Kolb, E., Reinhardt, D. (2021). Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG. Cancers (Basel), 13(10). https://doi.org/10.3390/cancers13102336 
  68. Rindler, K., Jonak, C., Alkon, N., Thaler, F. M., Kurz, H., Shaw, L. E., Stingl, G., Weninger, W., Halbritter, F., Bauer, W. M., Farlik, M., & Brunner, P. M. (2021). Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma. Mol Cancer, 20(1), 124. https://doi.org/10.1186/s12943-021-01419-2 
  69. Sagi, J. C., Gezsi, A., Egyed, B., Jakab, Z., Benedek, N., Attarbaschi, A., Kohrer, S., Sipek, J., Winkowska, L., Zaliova, M., Anastasopoulou, S., Wolthers, B. O., Ranta, S., Szalai, C., Kovacs, G. T., Semsei, A. F., & Erdelyi, D. J. (2021). Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia. Cancers (Basel), 13(10). https://doi.org/10.3390/cancers13102333 
  70. Sahoo, S. S., Pastor, V. B., Goodings, C., Voss, R. K., Kozyra, E. J., Szvetnik, A., Noellke, P., Dworzak, M., Stary, J., Locatelli, F., Masetti, R., Schmugge, M., De Moerloose, B., Catala, A., Kallay, K., Turkiewicz, D., Hasle, H., Buechner, J., Jahnukainen, K., Ussowicz, M., Polychronopoulou, S., Smith, O. P., Fabri, O., Barzilai, S., de Haas, V., Baumann, I., Schwarz-Furlan, S., European Working Group of MDS in Children (EWOG-MDS); Niewisch; M. R., Sauer, M. G., Burkhardt, B., Lang, P., Bader, P., Beier, R., Müller, I., Albert, M. H., Meisel, R., Schulz, A., Cario, G., Panda, P. K., Wehrle, J., Hirabayashi, S., Derecka, M., Durruthy-Durruthy, R., Göhring, G., Yoshimi-Noellke, A., Ku, M., Lebrecht, D., Erlacher, M., Flotho, C., Strahm, B., Niemeyer, C. M., Wlodarski, M. W. (2021). Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nat Med, 27(10), 1806-1817. https://doi.org/10.1038/s41591-021-01511-6 
  71. Santini, L.*, Halbritter, F.*, Titz-Teixeira, F., Suzuki, T., Asami, M., Ma, X., Ramesmayer, J., Lackner, A., Warr, N., Pauler, F., Hippenmeyer, S., Laue, E., Farlik, M., Bock, C., Beyer, A., Perry, A. C. F., & Leeb, M. (2021). Genomic imprinting in mouse blastocysts is predominantly associated with H3K27me3. Nat Commun, 12(1), 3804. https://doi.org/10.1038/s41467-021-23510-4 * Shared first authorship
  72. Scheer, M., Vokuhl, C., Bauer, S., Fuchs, J., Loff, S., Timmermann, B., Munter, M., Henssen, A. G., Kazanowska, B., Niggli, F., Ladenstein, R., Ljungman, G., Koscielniak, E., Klingebiel, T., & European Cooperative Weichteilsarkom, S. (2021). The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents. J Cancer Res Clin Oncolhttps://doi.org/10.1007/s00432-021-03614-6 
  73. Shahin, T., Kuehn, H. S., Shoeb, M. R., Gawriyski, L., Giuliani, S., Repiscak, P., Hoeger, B., Yuce Petronczki, O., Bal, S. K., Zoghi, S., Dmytrus, J., Seruggia, D., Castanon, I., Rezaei, N., Varjosalo, M., Halbritter, F., Rosenzweig, S. D., & Boztug, K. (2021). Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity. Sci Immunol, 6(65), eabe3981. https://doi.org/10.1126/sciimmunol.abe3981
  74. Shaka, Z., Mojtabavi, H., Rayzan, E., Zoghi, S., Shahkarami, S., Raul, J. H., Sedighi, I., Boztug, K., & Rezaei, N. (2021). Novel BTK mutation in X-linked agammaglobulinemia: Report of a 17-year-old male. Allergol Immunopathol (Madr), 49(2), 80-83. https://doi.org/10.15586/aei.v49i2.62 
  75. Strauss, S. J., Frezza, A. M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., Bonvalot, S., Boukovinas, I., Bovee, J., Boye, K., Brennan, B., Brodowicz, T., Buonadonna, A., de Alava, E., Dei Tos, A. P., Garcia Del Muro, X., Dufresne, A., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Gaspar, N., Gasperoni, S., Gelderblom, H., Gouin, F., Grignani, G., Gronchi, A., Haas, R., Hassan, A. B., Hecker-Nolting, S., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R. L., Jungels, C., Jutte, P., Kager, L, Kasper, B., Kawai, A., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Le Grange, F., Legius, E., Leithner, A., López Pousa, A., Martin-Broto, J., Merimsky, O., Messiou, C., Miah, A. B., Mir O., Montemurro, M., Morland, B., Morosi, C., Palmerini, E., Pantaleo, M. A., Piana, R., Piperno-Neumann, S., Reichardt, P., Rutkowski, P., Safwat, A. A., Sangalli, C., Sbaraglia, M., Scheipl, S., Schöffski, P., Sleijfer, S., Strauss, D., Sundby Hall, K., Trama, A., Unk, M., van de Sande, M. A. J., van der Graaf, W. T. A., van Houdt W. J., Frebourg, T., Ladenstein, R.#, Casali, P. G.#, Stacchiotti, S.# clinicalguidelines@esmo.org, E. R. N. P. E. a. (2021). Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncolhttps://doi.org/10.1016/j.annonc.2021.08.1995 # Shared senior authorship
  76. Sturtzel, C., Hocking, J., Kirchberger, S., & Distel, M. (2021). Studying the Tumor Microenvironment in Zebrafish. Adv Exp Med Biol, 1329, 69-92. https://doi.org/10.1007/978-3-030-73119-9_4
  77. Terlecki-Zaniewicz, S., Humer, T., Eder, T., Schmoellerl, J., Heyes, E., Manhart, G., Kuchynka, N., Parapatics, K., Liberante, F. G., Muller, A. C., Tomazou, E. M., & Grebien, F. (2021). Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression. Nat Struct Mol Biol, 28(2), 190-201. https://doi.org/10.1038/s41594-020-00550-w 
  78. Thalhammer, J., Kindle, G., Nieters, A., Rusch, S., Seppanen, M. R. J., Fischer, A., Grimbacher, B., Edgar, D., Buckland, M., Mahlaoui, N., Ehl, S., & European Society for Immunodeficiencies Registry Working Party (Boztug, K. et al.). (2021). Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol, 148(5), 1332-1341 e1335. https://doi.org/10.1016/j.jaci.2021.04.015 
  79. Thomas, H. F., Kotova, E., Jayaram, S., Pilz, A., Romeike, M., Lackner, A., Penz, T., Bock, C., Leeb, M., Halbritter, F., Wysocka, J., & Buecker, C. (2021). Temporal dissection of an enhancer cluster reveals distinct temporal and functional contributions of individual elements. Mol Cellhttps://doi.org/10.1016/j.molcel.2020.12.047 
  80. Truong, T. H., Jinca, C., Mann, G., Arghirescu, S., Buechner, J., Merli, P., & Whitlock, J. A. (2021). Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy. Front Pediatr, 9, 782785. https://doi.org/10.3389/fped.2021.782785
  81. Untersmayr, E., Forster-Waldl, E., Bonelli, M., Boztug, K., Brunner, P. M., Eiwegger, T., Eller, K., Goschl, L., Grabmeier-Pfistershammer, K., Hotzenecker, W., Jordakieva, G., Moschen, A. R., Pfaller, B., Pickl, W., Reinisch, W., Wiedermann, U., Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Novak, N., Merk, N., Rabe, U., Schlenter, W., Ring, J., Wehrmann, W., Mülleneisen, N., Wrede, H., Fuchs, T., Jensen-Jarolim, E. (2021). Immunologically relevant aspects of the new COVID-19 vaccines-an OGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper. Allergo J Int, 1-14. https://doi.org/10.1007/s40629-021-00178-2 
  82. Valent, P., Orfao, A., Kubicek, S., Staber, P., Haferlach, T., Deininger, M., Kollmann, K., Lion, T., Virgolini, I., Winter, G., Hantschel, O., Kenner, L., Zuber, J., Grebien, F., Moriggl, R., Hoermann, G., Hermine, O., Andreeff, M., Bock, C., Mughal, T., Constantinescu, S. N., Kralovics, R., Sexl, V., Skoda, R., Superti-Furga, G., Jager, U. (2021). Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions. Hemasphere, 5(3), e536. https://doi.org/10.1097/HS9.0000000000000536 
  83. van Tilburg, C. M., Pfaff, E., Pajtler, K. W., Langenberg, K. P. S., Fiesel, P., Jones, B. C., Balasubramanian, G. P., Stark, S., Johann, P. D., Blattner-Johnson, M., Schramm, K., Dikow, N., Hirsch, S., Sutter, C., Grund, K., von Stackelberg, A., Kulozik, A. E., Lissat, A., Borkhardt, A., Meisel, R., Reinhardt, D., Klusmann, J-H., Fleischhack, G., Tippelt, S., von Schweinitz, D., Schmid, I., Kramm, C. M., von Bueren, A. O., Calaminus, G., Vorwerk, P., Graf, N., Westermann, F., Fischer, M., Eggert, A., Burkhardt, B., Wößmann, W., Nathrath, M., Hecker-Nolting, S., Frühwald, M. C., Schneider, D. T., Brecht, I. B., Ketteler, P., Fulda, S., Koscielniak, E., Meister, M. T., Scheer, M., Hettmer, S., Schwab, M., Tremmel, R., Øra, I., Hutter, C., Gerber, N. U., Lohi, O., Kazanowska, B., Kattamis, A., Filippidou, M., Goemans, B., Zwaan, C. M., Milde, T., Jäger, N., Wolf, S., Reuss, D., Sahm, F., von Deimling, A., Dirksen, U., Freitag, A., Witt, R., Lichter, P., Kopp-Schneider A., Jones, D. T. W., Molenaar, J. J., Capper, D., Pfister, S. M., Witt O. (2021). The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets. Cancer Discovhttps://doi.org/10.1158/2159-8290.CD-21-0094 
  84. Wagner, A., Teufl, M., Gold, L., Lehner, M., Obinger, C., Sykacek, P., & Traxlmayr, M. W. (2021). PhosphoFlowSeq – A High-throughput Kinase Activity Assay for Screening Drug Resistance Mutations in EGFR. J Mol Biol, 433(22), 167210. https://doi.org/10.1016/j.jmb.2021.167210 
  85. Wang, L. *, Aschenbrenner, D. *, Zeng, Z. *, Cao, X., Mayr, D., Mehta, M., Capitani, M., Warner, N., Pan, J., Wang, L., Li, Q., Zuo, T., Cohen-Kedar, S., Lu, J., Ardy, R. C., Mulder, D. J., Dissanayake, D., Peng, K., Huang, Z., Li, X., Wang, Y., Wang, X., Li, S., Bullers, S., Gammage, A. N., Warnatz, K., Schiefer, A. I., Krivan, G., Goda, V., Kahr, W. H. A., Lemaire, M.; Genomics England Research Consortium, Lu, C. Y., Siddiqui, I., Surette, M.G., Kotlarz, D., Engelhardt, K.R., Griffin, H. R., Rottapel, R., Decaluwe, H., Laxer, R. M., Proietti, M., Hambleton, S., Elcombe, S., Guo, C. H., Grimbacher, B., Dotan, I., Ng, S. C., Freeman, S. A., Snapper, S. B., Klein, C., Boztug, K. #, Huang, Y. #, Li, D. #, Uhlig, H. H. #, Muise, A. M. # (2021). Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice. Nat Genet, 53(4), 500-510. https://doi.org/10.1038/s41588-021-00803-4 * Shared first authorship # Shared senior authorship
  86. Weiss, T.*, Taschner-Mandl, S.*, Janker, L., Bileck, A., Rifatbegovic, F., Kromp, F., Sorger, H., Kauer, M. O., Frech, C., Windhager, R., Gerner, C., Ambros, P. F., & Ambros, I. M. (2021). Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8. Nat Commun, 12(1), 1624. https://doi.org/10.1038/s41467-021-21859-0 * Shared first authorship
  87. Yucel, E., Karakus, I. S., Krolo, A., Kiykim, A., Heredia, R. J., Tamay, Z., Cipe, F. E., Karakoc-Aydiner, E., Ozen, A., Karaman, S., Boztug, K., & Baris, S. (2021). Novel Frameshift Autosomal Recessive Loss-of-Function Mutation in SMARCD2 Encoding a Chromatin Remodeling Factor Mediates Granulopoiesis. J Clin Immunol, 41(1), 59-65, PMID: 33025377 https://doi.org/10.1007/s10875-020-00878-4
  88. Zajc, C. U., Salzer, B., Taft, J. M., Reddy, S. T., Lehner, M., & Traxlmayr, M. W. (2021). Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds. FEBS J, 288(7), 2103-2118, PMID: 32794303 PMC8048499 https://doi.org/10.1111/febs.15523  
  89. Zollner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Alava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., Shulman, D. S., Streitburger, A., Timmermann, B., Toretsky, J. A., Uhlenbruch, Y., Vieth, V., Grunewald, T. G. P., & Dirksen, U. (2021). Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives. J Clin Med, 10(8). https://doi.org/10.3390/jcm10081685

  1. Ambros, I. M., Tonini, G. P., Potschger, U., Gross, N., Mosseri, V., Beiske, K., Berbegall, A. P., Benard, J., Bown, N., Caron, H., Combaret, V., Couturier, J., Defferrari, R., Delattre, O., Jeison, M., Kogner, P., Lunec, J., Marques, B., Martinsson, T., Mazzocco, K., Noguera, R., Schleiermacher, G., Valent, A., Van Roy, N., Villamon, E., Janousek, D., Pribill, I., Glogova, E., Attiyeh, E. F., Hogarty, M. D., Monclair, T. F., Holmes, K., Valteau-Couanet, D., Castel, V., Tweddle, D. A., Park, J. R., Cohn, S., Ladenstein, R., Beck-Popovic, M., De Bernardi, B., Michon, J., Pearson, A. D. J., & Ambros, P. F. (2020). Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group. J Clin Oncol, 38(31), 3685-3697, PMID: 32903140 PMC7605396 https://doi.org/10.1200/JCO.18.02132  
  2. Andreou, D., Ranft, A., Gosheger, G., Timmermann, B., Ladenstein, R., Hartmann, W., Bauer, S., Baumhoer, D., van den Berg, H., Dijkstra, P. D. S., Durr, H. R., Gelderblom, H., Hardes, J., Hjorth, L., Kreyer, J., Kruseova, J., Leithner, A., Scobioala, S., Streitburger, A., Tunn, P. U., Wardelmann, E., Windhager, R., Jurgens, H., Dirksen, U., & consortium, G. P.-E.-E. (2020). Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing’s Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial. Clin Orthop Relat Res, 478(2), 290-302, PMID: 31580267 PMC7438129 https://doi.org/10.1097/CORR.0000000000000962  
  3. Baccarani, M., Iacobucci, I., Chiaretti, S., Foa, R., Balasubramanian, P., Paietta, E., Foroni, L., Jeromin, S., Izzo, B., Spinelli, O., Varma, N., Menif, S., Terragna, C., Seth, T., Bidet, A., Coriu, D., Lunghi, F., Mayer, J., Scappini, B., Langabeer, S., Maier, J., Burt, E., Candoni, A., Albano, F., Luppi, M., Zupan, I., Lion, T., Zadro, R., di Raimondo, F., Poopak, B., Rege-Cambrin, G., Annunziata, M., Ayala, A., Salinas-Viedma, V., Ines Prado, A., Milner, B., Galimberti, S., Janssen, J., Polli, V., Comba, L., Borsellino, B., Annibali, O., Crugnola, M., & Passamonti, F. (2020). In Ph+BCR-ABL1(P210+) acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent. Leukemia, 34(3), 929-931, PMID: 31595038 https://doi.org/10.1038/s41375-019-0591-9  
  4. Bornhauser, B., Cario, G., Rinaldi, A., Risch, T., Rodriguez Martinez, V., Schutte, M., Warnatz, H. J., Scheidegger, N., Mirkowska, P., Temperli, M., Moller, C., Schumich, A., Dworzak, M., Attarbaschi, A., Bruggemann, M., Ritgen, M., Mejstrikova, E., Hofmann, A., Buldini, B., Scarparo, P., Basso, G., Maglia, O., Gaipa, G., Skoblyn, T. L., Te Kronnie, G., Vendramini, E., Panzer-Grumayer, R., Barz, M. J., Marovca, B., Hauri-Hohl, M., Niggli, F., Eckert, C., Schrappe, M., Stanulla, M., Zimmermann, M., Wollscheid, B., Yaspo, M. L., & Bourquin, J. P. (2020). The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL. Blood Adv, 4(17), 4052-4064, PMID: 32853382 PMC7479947 https://doi.org/10.1182/bloodadvances.2019000938  
  5. Byrgazov, K., Anderson, C., Salzer, B., Bozsaky, E., Larsson, R., Gullbo, J., Lehner, M., Lehmann, F., Slipicevic, A., Kager, L., Fryknas, M., & Taschner-Mandl, S. (2020). Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide. Ther Adv Med Oncol, 12, 1758835920937891, PMID: 32774473 PMC7391428 https://doi.org/10.1177/1758835920937891  
  6. Calaminus, G., Schneider, D. T., von Schweinitz, D., Jurgens, H., Infed, N., Schonberger, S., Olson, T. A., Albers, P., Vokuhl, C., Stein, R., Looijenga, L., Sehouli, J., Metzelder, M., Claviez, A., Dworzak, M., Eggert, A., Frohlich, B., Gerber, N. U., Kratz, C. P., Faber, J., Klingebiel, T., Harms, D., & Gobel, U. (2020). Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology. Cancers (Basel), 12(3), PMID: 32155835 PMC7139559 https://doi.org/10.3390/cancers12030611
  7. Cario, G., Leoni, V., Conter, V., Attarbaschi, A., Zaliova, M., Sramkova, L., Cazzaniga, G., Fazio, G., Sutton, R., Elitzur, S., Izraeli, S., Lauten, M., Locatelli, F., Basso, G., Buldini, B., Bergmann, A. K., Lentes, J., Steinemann, D., Gohring, G., Schlegelberger, B., Haas, O. A., Schewe, D., Buchmann, S., Moericke, A., White, D., Revesz, T., Stanulla, M., Mann, G., Bodmer, N., Arad-Cohen, N., Zuna, J., Valsecchi, M. G., Zimmermann, M., Schrappe, M., & Biondi, A. (2020). Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols. Haematologica, 105(7), 1887-1894, PMID: 31601692 PMC7327633 https://doi.org/10.3324/haematol.2019.231720  
  8. Cinquina, V., Calvigioni, D., Farlik, M., Halbritter, F., Fife-Gernedl, V., Shirran, S. L., Fuszard, M. A., Botting, C. H., Poullet, P., Piscitelli, F., Mate, Z., Szabo, G., Yanagawa, Y., Kasper, S., Di Marzo, V., Mackie, K., McBain, C. J., Bock, C., Keimpema, E., & Harkany, T. (2020). Life-long epigenetic programming of cortical architecture by maternal ‘Western’ diet during pregnancy. Mol Psychiatry, 25(1), 22-36, PMID: 31735910 https://doi.org/10.1038/s41380-019-0580-4  
  9. Corallo, D., Donadon, M., Pantile, M., Sidarovich, V., Cocchi, S., Ori, M., De Sarlo, M., Candiani, S., Frasson, C., Distel, M., Quattrone, A., Zanon, C., Basso, G., Tonini, G. P., & Aveic, S. (2020). LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors. Cell Death Differ, 27(4), 1225-1242, PMID: 31601998 PMC7206034 https://doi.org/10.1038/s41418-019-0425-3  
  10. Debiasi, M., Pichler, H., Klinglmuller, F., Boztug, H., Schmidthaler, K., Rech, J., Scherer, D., Lupinek, C., Valenta, R., Kacinska-Pfaller, E., Geyeregger, R., Fritsch, G., Haas, O. A., Peters, C., Lion, T., Akdis, M., Matthes, S., Akdis, C. A., Szepfalusi, Z., & Eiwegger, T. (2020). Transfer and loss of allergen-specific responses via stem cell transplantation: A prospective observational study. Allergy, 75(9), 2243-2253, PMID: 32181893 https://doi.org/10.1111/all.14278
  11. Erhart, F., Hackl, M., Hahne, H., Buchroithner, J., Meng, C., Klingenbrunner, S., Reitermaier, R., Fischhuber, K., Skalicky, S., Berger, W., Spiegl-Kreinecker, S., Lotsch, D., Ricken, G., Kuster, B., Wohrer, A., Widhalm, G., Hainfellner, J., Felzmann, T., Dohnal, A. M., Marosi, C., & Visus, C. (2020). Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors. NPJ Vaccines, 5(1), 5, PMID: 31969991 PMC6965118 https://doi.org/10.1038/s41541-019-0149-x   
  12. Fortschegger, M., Preuner, S., Printz, D., Poetsch, A. R., Geyeregger, R., Pichler, H., Lawitschka, A., & Lion, T. (2020). Detection and Monitoring of Lineage-Specific Chimerism by Digital Droplet PCR-Based Testing of Deletion/Insertion Polymorphisms. Biol Blood Marrow Transplant, 26(6), 1218-1224, PMID: 32092354 https://doi.org/10.1016/j.bbmt.2020.02.016  
  13. Gasteiger, L. M., Robinson, P. N., Pazmandi, J., Boztug, K., Seppanen, M. R. J., Seidel, M. G., & Registry Working Party of the European Society for, I. (2020). Supplementation of the ESID registry working definitions for the clinical diagnosis of inborn errors of immunity with encoded human phenotype ontology (HPO) terms. J Allergy Clin Immunol Pract, 8(5), 1778, PMID: 32389282 PMC9393911 https://doi.org/10.1016/j.jaip.2020.02.019  
  14. Gerber, T., Taschner-Mandl, S., Saloberger-Sindhoringer, L., Popitsch, N., Heitzer, E., Witt, V., Geyeregger, R., Hutter, C., Schwentner, R., Ambros, I. M., & Ambros, P. F. (2020). Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy Analysis. J Mol Diagn, 22(8), 1070-1086, PMID: 32497717 https://doi.org/10.1016/j.jmoldx.2020.05.006
  15. Ghosh, S., Kostel Bal, S., Edwards, E. S. J., Pillay, B., Jimenez Heredia, R., Erol Cipe, F., Rao, G., Salzer, E., Zoghi, S., Abolhassani, H., Momen, T., Gostick, E., Price, D. A., Zhang, Y., Oler, A. J., Gonzaga-Jauregui, C., Erman, B., Metin, A., Ilhan, I., Haskologlu, S., Islamoglu, C., Baskin, K., Ceylaner, S., Yilmaz, E., Unal, E., Karakukcu, M., Berghuis, D., Cole, T., Gupta, A. K., Hauck, F., Kogler, H., Hoepelman, A. I. M., Baris, S., Karakoc-Aydiner, E., Ozen, A., Kager, L., Holzinger, D., Paulussen, M., Kruger, R., Meisel, R., Oommen, P. T., Morris, E., Neven, B., Worth, A., van Montfrans, J., Fraaij, P. L. A., Choo, S., Dogu, F., Davies, E. G., Burns, S., Duckers, G., Becker, R. P., von Bernuth, H., Latour, S., Faraci, M., Gattorno, M., Su, H. C., Pan-Hammarstrom, Q., Hammarstrom, L., Lenardo, M. J., Ma, C. S., Niehues, T., Aghamohammadi, A., Rezaei, N.#, Ikinciogullari, A. #, Tangye, S. G. #, Lankester, A. C. #, & Boztug, K. # (2020). Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood, 136(23), 2638-2655, PMID: 32603431 PMC7735164 https://doi.org/10.1182/blood.2020006738 # Shared senior authorship
  16. Gojo, J., Englinger, B., Jiang, L., Hubner, J. M., Shaw, M. L., Hack, O. A., Madlener, S., Kirchhofer, D., Liu, I., Pyrdol, J., Hovestadt, V., Mazzola, E., Mathewson, N. D., Trissal, M., Lotsch, D., Dorfer, C., Haberler, C., Halfmann, A., Mayr, L., Peyrl, A., Geyeregger, R., Schwalm, B., Mauermann, M., Pajtler, K. W., Milde, T., Shore, M. E., Geduldig, J. E., Pelton, K., Czech, T., Ashenberg, O., Wucherpfennig, K. W., Rozenblatt-Rosen, O., Alexandrescu, S., Ligon, K. L., Pfister, S. M., Regev, A., Slavc, I., Berger, W., Suva, M. L., Kool, M., & Filbin, M. G. (2020). Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma. Cancer Cell, 38(1), 44-59 e49, PMID: 32663469 PMC7479515 https://doi.org/10.1016/j.ccell.2020.06.004  
  17. Goschl, L., Winkler, S., Dmytrus, J., Heredia, R. J., Lagler, H., Ramharter, M., Scheinecker, C., Bonelli, M., Schmetterer, K., Pickl, W. F., Grabmeier-Pfistershammer, K., Hershfield, M. S., Boztug, K., Forster-Waldl, E., & Gualdoni, G. A. (2020). Unreported Missense Mutation in the Dimerization Domain of ADA2 Leads to ADA2 Deficiency Associated with Severe Oral Ulcers and Neutropenia in a Female Somalian Patient-Addendum to the Genotype-Phenotype Puzzle. J Clin Immunol, 40(1), 223-226, PMID: 31686313 https://doi.org/10.1007/s10875-019-00700-w  
  18. Grissenberger, S., Riedl, S., Rinner, B., Leber, R., & Zweytick, D. (2020). Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. Biochim Biophys Acta Biomembr, 1862(8), 183264, PMID: 32151609 https://doi.org/10.1016/j.bbamem.2020.183264  
  19. Grunewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre-Aranaz, F., Di Pompo, G., Distel, M., Dorado-Garcia, H., Garcia-Castro, J., Gonzalez-Gonzalez, L., Grigoriadis, A. E., Kasan, M., Koelsche, C., Krumbholz, M., Lecanda, F., Lemma, S., Longo, D. L., Madrigal-Esquivel, C., Morales-Molina, A., Musa, J., Ohmura, S., Ory, B., Pereira-Silva, M., Perut, F., Rodriguez, R., Seeling, C., Al Shaaili, N., Shaabani, S., Shiavone, K., Sinha, S., Tomazou, E. M., Trautmann, M., Vela, M., Versleijen-Jonkers, Y. M., Visgauss, J., Zalacain, M., Schober, S. J., Lissat, A., English, W. R., Baldini, N., & Heymann, D. (2020). Sarcoma treatment in the era of molecular medicine. EMBO Mol Med, 12(11), e11131, PMID: 33047515 PMC7645378 https://doi.org/10.15252/emmm.201911131  
  20. Haindl, R., Deloria, A. J., Sturtzel, C., Sattmann, H., Rohringer, W., Fischer, B., Andreana, M., Unterhuber, A., Schwerte, T., Distel, M., Drexler, W., Leitgeb, R., & Liu, M. (2020). Functional optical coherence tomography and photoacoustic microscopy imaging for zebrafish larvae. Biomed Opt Express, 11(4), 2137-2151, PMID: 32341872 PMC7173920 https://doi.org/10.1364/BOE.390410  
  21. Haindl, R., Duelk, M., Gloor, S., Dahdah, J., Ojeda, J., Sturtzel, C., Deng, S., Joyce Deloria, A., Li, Q., Liu, M., Distel, M., Drexler, W., & Leitgeb, R. (2020). Ultra-high-resolution SD-OCM imaging with a compact polarization-aligned 840 nm broadband combined-SLED source. Biomed Opt Express, 11(6), 3395-3406, PMID: 32637262 PMC7316001 https://doi.org/10.1364/BOE.394229
  22. Hanitsch, L., Baumann, U., Boztug, K., Burkhard-Meier, U., Fasshauer, M., Habermehl, P., Hauck, F., Klock, G., Liese, J., Meyer, O., Muller, R., Pachlopnik-Schmid, J., Pfeiffer-Kascha, D., Warnatz, K., Wehr, C., Wittke, K., Niehues, T., & von Bernuth, H. (2020). Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline. Eur J Immunol, 50(10), 1432-1446, PMID: 32845010 https://doi.org/10.1002/eji.202048713  
  23. Haveman, L. M., Ranft, A., Berg, H. V. D., Klco-Brosius, S., Ladenstein, R., Paulussen, M., Juergens, H., Dirksen, U., & Merks, J. H. M. (2020). Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review. Cancers (Basel), 12(6), PMID: 32599807 PMC7352789 https://doi.org/10.3390/cancers12061675  
  24. Heibl, S., Buxhofer-Ausch, V., Schmidt, S., Webersinke, G., Lion, T., Piringer, G., Kuehr, T., Wolf, D., Melchardt, T., Greil, R., & Thaler, J. (2020). A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1. Hematol Oncol, 38(5), 792-798, PMID: 32757230 https://doi.org/10.1002/hon.2786  
  25. Holmes, K., Potschger, U., Pearson, A. D. J., Sarnacki, S., Cecchetto, G., Gomez-Chacon, J., Squire, R., Freud, E., Bysiek, A., Matthyssens, L. E., Metzelder, M., Monclair, T., Stenman, J., Rygl, M., Rasmussen, L., Joseph, J. M., Irtan, S., Avanzini, S., Godzinski, J., Bjornland, K., Elliott, M., Luksch, R., Castel, V., Ash, S., Balwierz, W., Laureys, G., Ruud, E., Papadakis, V., Malis, J., Owens, C., Schroeder, H., Beck-Popovic, M., Trahair, T., Forjaz de Lacerda, A., Ambros, P. F., Gaze, M. N., McHugh, K., Valteau-Couanet, D., Ladenstein, R. L., & International Society of Paediatric Oncology Europe Neuroblastoma, G. (2020). Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study. J Clin Oncol, 38(25), 2902-2915, PMID: 32639845 https://doi.org/10.1200/JCO.19.03117  
  26. Karai, B., Gyurina, K., Ujfalusi, A., Sedek, L., Barna, G., Jakso, P., Svec, P., Szantho, E., Nagy, A. C., Muller, J., Simon, R., Vojczek, A., Szegedi, I., Tiszlavicz, L. G., Kowalczyk, J. R., Kolenova, A., Kovacs, G. T., Szczepanski, T., Dworzak, M., Schumich, A., Attarbaschi, A., Nebral, K., Haas, O. A., Kappelmayer, J., Hevessy, Z., & Kiss, C. (2020). Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia. Cancers (Basel), 12(8), PMID: 32823516 PMC7463512 https://doi.org/10.3390/cancers12082264  
  27. Karastaneva, A., Nebral, K., Schlagenhauf, A., Baschin, M., Palankar, R., Juch, H., Heitzer, E., Speicher, M. R., Hofler, G., Grigorow, I., Urban, C., Benesch, M., Greinacher, A., Haas, O. A., & Seidel, M. G. (2020). Novel phenotypes observed in patients with ETV6-linked leukaemia/familial thrombocytopenia syndrome and a biallelic ARID5B risk allele as leukaemogenic cofactor. J Med Genet, 57(6), 427-433, PMID: 31704777 https://doi.org/10.1136/jmedgenet-2019-106339  
  28. Khunweeraphong, N., & Kuchler, K. (2020). The first intracellular loop is essential for the catalytic cycle of the human ABCG2 multidrug resistance transporter. FEBS Lett, 594(23), 4059-4075, PMID: 33169382 PMC7756363 https://doi.org/10.1002/1873-3468.13994  
  29. Khunweeraphong, N., Mitchell-White, J., Szollosi, D., Hussein, T., Kuchler, K., Kerr, I. D., Stockner, T., & Lee, J. Y. (2020). Picky ABCG5/G8 and promiscuous ABCG2 – a tale of fatty diets and drug toxicity. FEBS Lett, 594(23), 4035-4058, PMID: 32978801 PMC7756502 https://doi.org/10.1002/1873-3468.13938  
  30. Kostel Bal, S., Pazmandi, J., Boztug, K. #, & Ozen, S. # (2020). Rheumatological manifestations in inborn errors of immunity. Pediatr Res, 87(2), 293-299, PMID: 31581173 https://doi.org/10.1038/s41390-019-0600-8  # Shared senior authorship
  31. Kovar, H., Bierbaumer, L., & Radic-Sarikas, B. (2020). The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. Cells, 9(4), PMID: 32326412 PMC7227004 https://doi.org/10.3390/cells9040972
  32. Kozyra, E. J., Pastor, V. B., Lefkopoulos, S., Sahoo, S. S., Busch, H., Voss, R. K., Erlacher, M., Lebrecht, D., Szvetnik, E. A., Hirabayashi, S., Pasauliene, R., Pedace, L., Tartaglia, M., Klemann, C., Metzger, P., Boerries, M., Catala, A., Hasle, H., de Haas, V., Kallay, K., Masetti, R., De Moerloose, B., Dworzak, M., Schmugge, M., Smith, O., Stary, J., Mejstrikova, E., Ussowicz, M., Morris, E., Singh, P., Collin, M., Derecka, M., Gohring, G., Flotho, C., Strahm, B., Locatelli, F., Niemeyer, C. M., Trompouki, E., Wlodarski, M. W., & European Working Group of, M. D. S. i. C. (2020). Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia, 34(10), 2673-2687, PMID: 32555368 PMC7515837 https://doi.org/10.1038/s41375-020-0899-5  
  33. Kromp, F., Bozsaky, E., Rifatbegovic, F., Fischer, L., Ambros, M., Berneder, M., Weiss, T., Lazic, D., Dorr, W., Hanbury, A., Beiske, K., Ambros, P. F., Ambros, I. M., & Taschner-Mandl, S. (2020). An annotated fluorescence image dataset for training nuclear segmentation methods. Sci Data, 7(1), 262, PMID: 32782410 PMC7419523 https://doi.org/10.1038/s41597-020-00608-w  
  34. Kruger, R., Martin, E., Dmytrus, J., Feiterna-Sperling, C., Meisel, C., Unterwalder, N., Kolsch, U., Wahn, V., Hofmann, J., Korn, P., Latour, S., Boztug, K., & von Bernuth, H. (2020). CD70 Deficiency Associated With Chronic Epstein-Barr Virus Infection, Recurrent Airway Infections and Severe Gingivitis in a 24-Year-Old Woman. Front Immunol, 11, 1593, PMID: 32849540 PMC7417345 https://doi.org/10.3389/fimmu.2020.01593   
  35. Ladenstein, R., Potschger, U., Valteau-Couanet, D., Luksch, R., Castel, V., Ash, S., Laureys, G., Brock, P., Michon, J. M., Owens, C., Trahair, T., Chi Fung Chan, G., Ruud, E., Schroeder, H., Beck-Popovic, M., Schreier, G., Loibner, H., Ambros, P., Holmes, K., Castellani, M. R., Gaze, M. N., Garaventa, A., Pearson, A. D. J., & Lode, H. N. (2020). Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1). Cancers (Basel), 12(2), PMID: 32013055 PMC7072500 https://doi.org/10.3390/cancers12020309  
  36. Lau, A., Avery, D. T., Jackson, K., Lenthall, H., Volpi, S., Brigden, H., Russell, A. J., Bier, J., Reed, J. H., Smart, J. M., Cole, T., Choo, S., Gray, P. E., Berglund, L. J., Hsu, P., Wong, M., O’Sullivan, M., Boztug, K., Meyts, I., Uzel, G., Notarangelo, L. D., Brink, R., Goodnow, C. C., Tangye, S. G., & Deenick, E. K. (2020). Activated PI3Kdelta breaches multiple B cell tolerance checkpoints and causes autoantibody production. J Exp Med, 217(2), PMID: 31841125 PMC7041712 https://doi.org/10.1084/jem.20191336  
  37. Lawitschka, A., Buehrer, S., Bauer, D., Peters, K., Silbernagl, M., Zubarovskaya, N., Brunmair, B., Kayali, F., Hlavacs, H., Mateus-Berr, R., Riedl, D., Rumpold, G., & Peters, C. (2020). A Web-Based Mobile App (INTERACCT App) for Adolescents Undergoing Cancer and Hematopoietic Stem Cell Transplantation Aftercare to Improve the Quality of Medical Information for Clinicians: Observational Study. JMIR Mhealth Uhealth, 8(6), e18781, PMID: 32602847 PMC7367529 https://doi.org/10.2196/18781   
  38. Lin, S. H., Sampson, J. N., Grunewald, T. G. P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E., Rubio, R. A., Zaidi, S., Grossetete-Lalami, S., Ballet, S., Lapouble, E., Laurence, V., Michon, J., Pierron, G., Kovar, H., Kontny, U., Gonzalez-Neira, A., Alonso, J., Patino-Garcia, A., Corradini, N., Berard, P. M., Miller, J., Freedman, N. D., Rothman, N., Carter, B. D., Dagnall, C. L., Burdett, L., Jones, K., Manning, M., Wyatt, K., Zhou, W., Yeager, M., Cox, D. G., Hoover, R. N., Khan, J., Armstrong, G. T., Leisenring, W. M., Bhatia, S., Robison, L. L., Kulozik, A. E., Kriebel, J., Meitinger, T., Metzler, M., Krumbholz, M., Hartmann, W., Strauch, K., Kirchner, T., Dirksen, U., Mirabello, L., Tucker, M. A., Tirode, F., Morton, L. M., Chanock, S. J., Delattre, O., & Machiela, M. J. (2020). Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma. PLoS One, 15(9), e0237792, PMID: 32881892 PMC7470401 https://doi.org/10.1371/journal.pone.0237792  
  39. Lobner, E., Wachernig, A., Gudipati, V., Mayrhofer, P., Salzer, B., Lehner, M., Huppa, J. B., & Kunert, R. (2020). Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells. Front Bioeng Biotechnol, 8, 49, PMID: 32117929 PMC7020774 https://doi.org/10.3389/fbioe.2020.00049
  40. Lomakin, A. J., Cattin, C. J., Cuvelier, D., Alraies, Z., Molina, M., Nader, G. P. F., Srivastava, N., Saez, P. J., Garcia-Arcos, J. M., Zhitnyak, I. Y., Bhargava, A., Driscoll, M. K., Welf, E. S., Fiolka, R., Petrie, R. J., De Silva, N. S., Gonzalez-Granado, J. M., Manel, N., Lennon-Dumenil, A. M., Muller, D. J., & Piel, M. (2020). The nucleus acts as a ruler tailoring cell responses to spatial constraints. Science, 370(6514), PMID: 33060332 PMC8059074 https://doi.org/10.1126/science.aba2894  
  41. Lorenzini, T., Fliegauf, M., Klammer, N., Frede, N., Proietti, M., Bulashevska, A., Camacho-Ordonez, N., Varjosalo, M., Kinnunen, M., de Vries, E., van der Meer, J. W. M., Ameratunga, R., Roifman, C. M., Schejter, Y. D., Kobbe, R., Hautala, T., Atschekzei, F., Schmidt, R. E., Schroder, C., Stepensky, P., Shadur, B., Pedroza, L. A., van der Flier, M., Martinez-Gallo, M., Gonzalez-Granado, L. I., Allende, L. M., Shcherbina, A., Kuzmenko, N., Zakharova, V., Neves, J. F., Svec, P., Fischer, U., Ip, W., Bartsch, O., Baris, S., Klein, C., Geha, R., Chou, J., Alosaimi, M., Weintraub, L., Boztug, K., Hirschmugl, T., Dos Santos Vilela, M. M., Holzinger, D., Seidl, M., Lougaris, V., Plebani, A., Alsina, L., Piquer-Gibert, M., Deya-Martinez, A., Slade, C. A., Aghamohammadi, A., Abolhassani, H., Hammarstrom, L., Kuismin, O., Helminen, M., Allen, H. L., Thaventhiran, J. E., Freeman, A. F., Cook, M., Bakhtiar, S., Christiansen, M., Cunningham-Rundles, C., Patel, N. C., Rae, W., Niehues, T., Brauer, N., Syrjanen, J., Seppanen, M. R. J., Burns, S. O., Tuijnenburg, P., Kuijpers, T. W., BioResource, N., Warnatz, K., Grimbacher, B., & BioResource, N. (2020). Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol, 146(4), 901-911, PMID: 32278790 PMC8246418 https://doi.org/10.1016/j.jaci.2019.11.051  
  42. Marti-Bonmati, L., Alberich-Bayarri, A., Ladenstein, R., Blanquer, I., Segrelles, J. D., Cerda-Alberich, L., Gkontra, P., Hero, B., Garcia-Aznar, J. M., Keim, D., Jentner, W., Seymour, K., Jimenez-Pastor, A., Gonzalez-Valverde, I., Martinez de Las Heras, B., Essiaf, S., Walker, D., Rochette, M., Bubak, M., Mestres, J., Viceconti, M., Marti-Besa, G., Canete, A., Richmond, P., Wertheim, K. Y., Gubala, T., Kasztelnik, M., Meizner, J., Nowakowski, P., Gilperez, S., Suarez, A., Aznar, M., Restante, G., & Neri, E. (2020). PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers. Eur Radiol Exp, 4(1), 22, PMID: 32246291 PMC7125275 https://doi.org/10.1186/s41747-020-00150-9  
  43. Meister, M. T., Scheer, M., Hallmen, E., Stegmaier, S., Vokuhl, C., von Kalle, T., Fuchs, J., Munter, M., Niggli, F., Ladenstein, R., Kazanowska, B., Ljungman, G., Bielack, S., Koscielniak, E., Klingebiel, T., & Cooperative Weichteilsarkom, S. (2020). Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. J Surg Oncol, 122(7), 1337-1347, PMID: 32812260 https://doi.org/10.1002/jso.26153  
  44. Mughal, T. I., Pemmaraju, N., Psaila, B., Radich, J., Bose, P., Lion, T., Kiladjian, J. J., Rampal, R., Jain, T., Verstovsek, S., Yacoub, A., Cortes, J. E., Mesa, R., Saglio, G., & van Etten, R. A. (2020). Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies. Hematol Oncol, 38(5), 654-664, PMID: 32592408 PMC8895354 https://doi.org/10.1002/hon.2771  
  45. Pascoal, S., Salzer, B., Scheuringer, E., Wenninger-Weinzierl, A., Sturtzel, C., Holter, W., Taschner-Mandl, S., Lehner, M., & Distel, M. (2020). A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo. Cancers (Basel), 12(3), PMID: 32121414 PMC7139560 https://doi.org/10.3390/cancers12030567  
  46. Perwein, T., Lackner, H., Ebetsberger-Dachs, G., Beham-Schmid, C., Zach, K., Tamesberger, M., Simonitsch-Klupp, I., Luftinger, R., Dworzak, M., Mann, G., Benesch, M., Attarbaschi, A., Austrian Society of Pediatric, H., Oncology, & the Austrian Berlin-Frankfurt-Munster Study, G. (2020). Management of children and adolescents with gray zone lymphoma: A case series. Pediatr Blood Cancer, 67(5), e28206, PMID: 32037692 https://doi.org/10.1002/pbc.28206  
  47. Poetsch, A. R. (2020). AP-Seq: A Method to Measure Apurinic Sites and Small Base Adducts Genome-Wide. Methods Mol Biol, 2175, 95-108, PMID: 32681486 https://doi.org/10.1007/978-1-0716-0763-3_8
  48. Poetsch, A. R. (2020). The genomics of oxidative DNA damage, repair, and resulting mutagenesis. Comput Struct Biotechnol J, 18, 207-219, PMID: 31993111 PMC6974700 https://doi.org/10.1016/j.csbj.2019.12.013  
  49. Prinz, D., Klein, K., List, J., Knab, V. M., Menzl, I., Leidenfrost, N., Heller, G., Polic, B., Putz, E. M., Witalisz-Siepracka, A., Sexl, V., & Gotthardt, D. (2020). Loss of NKG2D in murine NK cells leads to increased perforin production upon long-term stimulation with IL-2. Eur J Immunol, 50(6), 880-890, PMID: 32052406 PMC7318224 https://doi.org/10.1002/eji.201948222  
  50. Salzer, B., Schueller, C. M., Zajc, C. U., Peters, T., Schoeber, M. A., Kovacic, B., Buri, M. C., Lobner, E., Dushek, O., Huppa, J. B., Obinger, C., Putz, E. M., Holter, W., Traxlmayr, M. W., & Lehner, M. (2020). Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function. Nat Commun, 11(1), 4166, PMID: 32820173 PMC7441178 https://doi.org/10.1038/s41467-020-17970-3  
  51. Salzer, E., Zoghi, S., Kiss, M. G., Kage, F., Rashkova, C., Stahnke, S., Haimel, M., Platzer, R., Caldera, M., Ardy, R. C., Hoeger, B., Block, J., Medgyesi, D., Sin, C., Shahkarami, S., Kain, R., Ziaee, V., Hammerl, P., Bock, C., Menche, J., Dupre, L., Huppa, J. B., Sixt, M., Lomakin, A., Rottner, K., Binder, C. J., Stradal, T. E. B., Rezaei, N., & Boztug, K. (2020). The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity. Sci Immunol, 5(49), PMID: 32646852 PMC7116756 https://doi.org/10.1126/sciimmunol.abc3979  
  52. Scheer, M., Blank, B., Bauer, S., Vokuhl, C., Stegmaier, S., Feuchtgruber, S., Henssen, A., Sparber-Sauer, M., Eggert, A., Handgretinger, R., Pekrun, A., Rossig, C., Rutkowski, S., Schlegel, P. G., Schrappe, M., Simon, T., Kazanowska, B., Niggli, F., Ladenstein, R., Ljungman, G., Jahnukainen, K., Fuchs, J., Bielack, S. S., Koscielniak, E., Klingebiel, T., & Cooperative Weichteilsarkom, S. (2020). Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS). J Cancer Res Clin Oncol, 146(4), 953-960, PMID: 31932909 https://doi.org/10.1007/s00432-019-03121-9  
  53. Scheer, M., Vokuhl, C., Veit-Friedrich, I., Munter, M., von Kalle, T., Greulich, M., Loff, S., Stegmaier, S., Sparber-Sauer, M., Niggli, F., Ladenstein, R., Kazanowska, B., Ljungman, G., Jahnukainen, K., Fuchs, J., Bielack, S. S., Koscielniak, E., Klingebiel, T., & Cooperative Weichteilsarkom, S. (2020). Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr Blood Cancer, 67(2), e28009, PMID: 31736251 https://doi.org/10.1002/pbc.28009  
  54. Schumich, A., Prchal-Murphy, M., Maurer-Granofszky, M., Hoelbl-Kovacic, A., Muhlegger, N., Potschger, U., Fajmann, S., Haas, O. A., Nebral, K., von Neuhoff, N., Zimmermann, M., Boztug, H., Rasche, M., Dolezal, M., Walter, C., Reinhardt, D., Sexl, V., & Dworzak, M. N. (2020). Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia. Hemasphere, 4(1), e312, PMID: 32072137 PMC7000467 https://doi.org/10.1097/HS9.0000000000000312 
  55. Shivarathri, R., Jenull, S., Stoiber, A., Chauhan, M., Mazumdar, R., Singh, A., Nogueira, F., Kuchler, K., Chowdhary, A., & Chauhan, N. (2020). The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris. mSphere, 5(5), PMID: 33055262 PMC7565899 https://doi.org/10.1128/mSphere.00973-20  
  56. Thian, M., Hoeger, B., Kamnev, A., Poyer, F., Kostel Bal, S., Caldera, M., Jimenez-Heredia, R., Huemer, J., Pickl, W. F., Gross, M., Ehl, S., Lucas, C. L., Menche, J., Hutter, C., Attarbaschi, A., Dupre, L., & Boztug, K. (2020). Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation. Haematologica, 105(10), e488, PMID: 33054089 PMC7556668 https://doi.org/10.3324/haematol.2019.231399
  57. Vankova, E., Kasparova, P., Khun, J., Machkova, A., Julak, J., Slama, M., Hodek, J., Ulrychova, L., Weber, J., Obrova, K., Kosulin, K., Lion, T., & Scholtz, V. (2020). Polylactic acid as a suitable material for 3D printing of protective masks in times of COVID-19 pandemic. PeerJ, 8, e10259, PMID: 33194427 PMC7603793 https://doi.org/10.7717/peerj.10259  
  58. Varady, A., & Distel, M. (2020). Non-neuromodulatory Optogenetic Tools in Zebrafish. Front Cell Dev Biol, 8, 418, PMID: 32582702 PMC7283495 https://doi.org/10.3389/fcell.2020.00418  
  59. Wolff, D., Bardak, J., Edinger, M., Klinger-Schindler, U., Holler, E., Lawitschka, A., Schoemans, H., Herr, W., Kroger, N., & Ayuk Ayuketang, F. (2020). Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation-An Analysis of 2 German Transplantation Centers. Front Public Health, 8, 572470, PMID: 33072711 PMC7544947 https://doi.org/10.3389/fpubh.2020.572470  
  60. Wrobel, J. K., Najafi, S., Ayhan, S., Gatzweiler, C., Krunic, D., Ridinger, J., Milde, T., Westermann, F., Peterziel, H., Meder, B., Distel, M., Witt, O., & Oehme, I. (2020). Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts. Pharmaceuticals (Basel), 13(11), PMID: 33121173 PMC7692187 https://doi.org/10.3390/ph13110345
  61. Zajc, C. U., Dobersberger, M., Schaffner, I., Mlynek, G., Puhringer, D., Salzer, B., Djinovic-Carugo, K., Steinberger, P., De Sousa Linhares, A., Yang, N. J., Obinger, C., Holter, W., Traxlmayr, M. W., & Lehner, M. (2020). A conformation-specific ON-switch for controlling CAR T cells with an orally available drug. Proc Natl Acad Sci U S A, 117(26), 14926-14935, PMID: 32554495 PMC7334647 https://doi.org/10.1073/pnas.1911154117
  1. Bier, J., Rao, G., Payne, K., Brigden, H., French, E., Pelham, S. J., Lau, A., Lenthall, H., Edwards, E. S. J., Smart, J. M., Cole, T. S., Choo, S., Joshi, A. Y., Abraham, R. S., O’Sullivan, M., Boztug, K., Meyts, I., Gray, P. E., Berglund, L. J., Hsu, P., Wong, M., Holland, S. M., Notarangelo, L. D., Uzel, G., Ma, C. S., Brink, R., Tangye, S. G., & Deenick, E. K. (2019). Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells. J Allergy Clin Immunol, 144(1), 236-253, PMID: 30738173 PMC6612302 https://doi.org/10.1016/j.jaci.2019.01.033   
  2. Buldini, B., Maurer-Granofszky, M., Varotto, E., & Dworzak, M. N. (2019). Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies. Front Pediatr, 7, 412, PMID: 31681710 PMC6798174 https://doi.org/10.3389/fped.2019.00412   
  3. Calzoni, E., Platt, C. D., Keles, S., Kuehn, H. S., Beaussant-Cohen, S., Zhang, Y., Pazmandi, J., Lanzi, G., Pala, F., Tahiat, A., Artac, H., Heredia, R. J., Dmytrus, J., Reisli, I., Uygun, V., Uygun, D., Bingol, A., Basaran, E., Djenouhat, K., Benhalla, N., Bendahmane, C., Emiroglu, M., Kirchhausen, T., Pasham, M., Jones, J., Wallace, J. G., Zheng, L., Boisson, B., Porta, F., Rosenzweig, S. D., Su, H., Giliani, S., Lenardo, M., Geha, R. S., Boztug, K., Chou, J., & Notarangelo, L. D. (2019). F-BAR domain only protein 1 (FCHO1) deficiency is a novel cause of combined immune deficiency in human subjects. J Allergy Clin Immunol, 143(6), 2317-2321 e2312, PMID: 30822429 PMC6701838 https://doi.org/10.1016/j.jaci.2019.02.014  
  4. Conde, C. D., Petronczki, O. Y., Baris, S., Willmann, K. L., Girardi, E., Salzer, E., Weitzer, S., Ardy, R. C., Krolo, A., Ijspeert, H., Kiykim, A., Karakoc-Aydiner, E., Forster-Waldl, E., Kager, L., Pickl, W. F., Superti-Furga, G., Martinez, J., Loizou, J. I., Ozen, A., van der Burg, M., & Boztug, K. (2019). Polymerase delta deficiency causes syndromic immunodeficiency with replicative stress. J Clin Invest, 129(10), 4194-4206, PMID: 31449058 PMC6763221 https://doi.org/10.1172/JCI128903  
  5. Csillag, B., Ilencikova, D., Meissl, M., Webersinke, G., Laccone, F., Narumi, S., Haas, O., & Duba, H. C. (2019). Somatic mosaic monosomy 7 and UPD7q in a child with MIRAGE syndrome caused by a novel SAMD9 mutation. Pediatr Blood Cancer, 66(4), e27589, PMID: 30565860 https://doi.org/10.1002/pbc.27589  
  6. Dauber, E. M., Mayr, W. R., Hustinx, H., Schonbacher, M., Budde, H., Legler, T. J., Konig, M., Haas, O. A., Fritsch, G., & Kormoczi, G. F. (2019). Somatic mosaicisms of chromosome 1 at two different stages of ontogenetic development detected by Rh blood group discrepancies. Haematologica, 104(3), 632-638, PMID: 30237270 PMC6395338 https://doi.org/10.3324/haematol.2018.201293  
  7. Doz, F., Locatelli, F., Baruchel, A., Blin, N., De Moerloose, B., Frappaz, D., Dworzak, M., Fischer, M., Stary, J., Fuertig, R., Riemann, K., Taube, T., & Reinhardt, D. (2019). Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors. Pediatr Blood Cancer, 66(10), e27900, PMID: 31276318 https://doi.org/10.1002/pbc.27900  
  8. Duong, J. K., Veal, G. J., Nath, C. E., Shaw, P. J., Errington, J., Ladenstein, R., & Boddy, A. V. (2019). Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function. Br J Clin Pharmacol, 85(1), 136-146, PMID: 30261554 PMC6303207 https://doi.org/10.1111/bcp.13774  
  9. Edwards, E. S. J., Bier, J., Cole, T. S., Wong, M., Hsu, P., Berglund, L. J., Boztug, K., Lau, A., Gostick, E., Price, D. A., O’Sullivan, M., Meyts, I., Choo, S., Gray, P., Holland, S. M., Deenick, E. K., Uzel, G., & Tangye, S. G. (2019). Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. J Allergy Clin Immunol, 143(1), 276-291 e276, PMID: 29800648 https://doi.org/10.1016/j.jaci.2018.04.030
  10. Eghbal-Zadeh, H., Fischer, L., Popitsch, N., Kromp, F., Taschner-Mandl, S., Gerber, T., Bozsaky, E., Ambros, P. F., Ambros, I. M., Widmer, G., & Moser, B. A. (2019). DeepSNP: An End-to-End Deep Neural Network with Attention-Based Localization for Breakpoint Detection in Single-Nucleotide Polymorphism Array Genomic Data. J Comput Biol, 26(6), 572-596, PMID: 30585743 https://doi.org/10.1089/cmb.2018.0172  
  11. Erhart, F., Blauensteiner, B., Zirkovits, G., Printz, D., Soukup, K., Klingenbrunner, S., Fischhuber, K., Reitermaier, R., Halfmann, A., Lotsch, D., Spiegl-Kreinecker, S., Berger, W., Visus, C., & Dohnal, A. (2019). Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature. J Cell Mol Med, 23(1), 281-292, PMID: 30467961 PMC6307809 https://doi.org/10.1111/jcmm.13927  
  12. Erhart, F., Weiss, T., Klingenbrunner, S., Fischhuber, K., Reitermaier, R., Halfmann, A., Blauensteiner, B., Lotsch, D., Spiegl-Kreinecker, S., Berger, W., Sialana, F. J., Lubec, G., Felzmann, T., Dohnal, A., & Visus, C. (2019). Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon gamma production. Cytotherapy, 21(6), 643-658, PMID: 30975602 https://doi.org/10.1016/j.jcyt.2019.03.002  
  13. Farmer, J. R., Foldvari, Z., Ujhazi, B., De Ravin, S. S., Chen, K., Bleesing, J. J. H., Schuetz, C., Al-Herz, W., Abraham, R. S., Joshi, A. Y., Costa-Carvalho, B. T., Buchbinder, D., Booth, C., Reiff, A., Ferguson, P. J., Aghamohammadi, A., Abolhassani, H., Puck, J. M., Adeli, M., Cancrini, C., Palma, P., Bertaina, A., Locatelli, F., Di Matteo, G., Geha, R. S., Kanariou, M. G., Lycopoulou, L., Tzanoudaki, M., Sleasman, J. W., Parikh, S., Pinero, G., Fischer, B. M., Dbaibo, G., Unal, E., Patiroglu, T., Karakukcu, M., Al-Saad, K. K., Dilley, M. A., Pai, S. Y., Dutmer, C. M., Gelfand, E. W., Geier, C. B., Eibl, M. M., Wolf, H. M., Henderson, L. A., Hazen, M. M., Bonfim, C., Wolska-Kusnierz, B., Butte, M. J., Hernandez, J. D., Nicholas, S. K., Stepensky, P., Chandrakasan, S., Miano, M., Westermann-Clark, E., Goda, V., Krivan, G., Holland, S. M., Fadugba, O., Henrickson, S. E., Ozen, A., Karakoc-Aydiner, E., Baris, S., Kiykim, A., Bredius, R., Hoeger, B., Boztug, K., Pashchenko, O., Neven, B., Moshous, D., Villartay, J. P., Bousfiha, A. A., Hill, H. R., Notarangelo, L. D., & Walter, J. E. (2019). Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. J Allergy Clin Immunol Pract, 7(6), 1970-1985 e1974, PMID: 30877075 PMC6612449 https://doi.org/10.1016/j.jaip.2019.02.038  
  14. Fauster, A., Rebsamen, M., Willmann, K. L., Cesar-Razquin, A., Girardi, E., Bigenzahn, J. W., Schischlik, F., Scorzoni, S., Bruckner, M., Konecka, J., Hormann, K., Heinz, L. X., Boztug, K., & Superti-Furga, G. (2019). Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ, 26(6), 1138-1155, PMID: 30237509 PMC6748104 https://doi.org/10.1038/s41418-018-0192-6  
  15. Gleixner, K. V., Sadovnik, I., Schneeweiss, M., Eisenwort, G., Byrgazov, K., Stefanzl, G., Berger, D., Herrmann, H., Hadzijusufovic, E., Lion, T., & Valent, P. (2019). A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1(T315I) in Ph+ CML. Leuk Res, 78, 36-44, PMID: 30711891 PMC6834439 https://doi.org/10.1016/j.leukres.2018.12.013  
  16. Gotthardt, D., Trifinopoulos, J., Sexl, V., & Putz, E. M. (2019). JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation. Front Immunol, 10, 2590, PMID: 31781102 PMC6861185 https://doi.org/10.3389/fimmu.2019.02590  
  17. Groeneveld-Krentz, S., Schroeder, M. P., Reiter, M., Pogodzinski, M. J., Pimentel-Gutierrez, H. J., Vagkopoulou, R., Hof, J., Chen-Santel, C., Nebral, K., Bradtke, J., Turkmen, S., Baldus, C. D., Gattenlohner, S., Haas, O. A., von Stackelberg, A., Karawajew, L., Eckert, C., & Kirschner-Schwabe, R. (2019). Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse. Br J Haematol, 185(2), 266-283, PMID: 30714092 https://doi.org/10.1111/bjh.15770
  18. Haas, O. A. (2018). Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. Front Immunol, 9, 3136, PMID: 30809233 PMC6379258 https://doi.org/10.3389/fimmu.2018.03136  
  19. Halbritter, F., Farlik, M., Schwentner, R., Jug, G., Fortelny, N., Schnoller, T., Pisa, H., Schuster, L. C., Reinprecht, A., Czech, T., Gojo, J., Holter, W., Minkov, M., Bauer, W. M., Simonitsch-Klupp, I., Bock, C., & Hutter, C. (2019). Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis. Cancer Discov, 9(10), 1406-1421, PMID: 31345789 PMC6795548 https://doi.org/10.1158/2159-8290.CD-19-0138  
  20. Hamadeh, L., Enshaei, A., Schwab, C., Alonso, C. N., Attarbaschi, A., Barbany, G., den Boer, M. L., Boer, J. M., Braun, M., Dalla Pozza, L., Elitzur, S., Emerenciano, M., Fechina, L., Felice, M. S., Fronkova, E., Haltrich, I., Heyman, M. M., Horibe, K., Imamura, T., Jeison, M., Kovacs, G., Kuiper, R. P., Mlynarski, W., Nebral, K., Ivanov Ofverholm, I., Pastorczak, A., Pieters, R., Piko, H., Pombo-de-Oliveira, M. S., Rubio, P., Strehl, S., Stary, J., Sutton, R., Trka, J., Tsaur, G., Venn, N., Vora, A., Yano, M., Harrison, C. J., Moorman, A. V., & International, B. F. M. S. G. (2019). Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL. Blood Adv, 3(2), 148-157, PMID: 30651283 PMC6341196 https://doi.org/10.1182/bloodadvances.2018025718  
  21. Haveman, L. M., Ranft, A., Vd Berg, H., Smets, A., Kruseova, J., Ladenstein, R., Brichard, B., Paulussen, M., Kuehne, T., Juergens, H., Klco-Brosius, S., Dirksen, U., & Merks, J. H. M. (2019). The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma. Cancer Med, 8(3), 1086-1094, PMID: 30790456 PMC6434194 https://doi.org/10.1002/cam4.2002  
  22. Hovestadt, V., Smith, K. S., Bihannic, L., Filbin, M. G., Shaw, M. L., Baumgartner, A., DeWitt, J. C., Groves, A., Mayr, L., Weisman, H. R., Richman, A. R., Shore, M. E., Goumnerova, L., Rosencrance, C., Carter, R. A., Phoenix, T. N., Hadley, J. L., Tong, Y., Houston, J., Ashmun, R. A., DeCuypere, M., Sharma, T., Flasch, D., Silkov, A., Ligon, K. L., Pomeroy, S. L., Rivera, M. N., Rozenblatt-Rosen, O., Rusert, J. M., Wechsler-Reya, R. J., Li, X. N., Peyrl, A., Gojo, J., Kirchhofer, D., Lotsch, D., Czech, T., Dorfer, C., Haberler, C., Geyeregger, R., Halfmann, A., Gawad, C., Easton, J., Pfister, S. M., Regev, A., Gajjar, A., Orr, B. A., Slavc, I., Robinson, G. W., Bernstein, B. E., Suva, M. L., & Northcott, P. A. (2019). Resolving medulloblastoma cellular architecture by single-cell genomics. Nature, 572(7767), 74-79, PMID: 31341285 PMC6754173 https://doi.org/10.1038/s41586-019-1434-6  
  23. Kearns, P. R., Vassal, G., Ladenstein, R., Schrappe, M., Biondi, A., Blanc, P., Eggert, A., Kienesberger, A., Kozhaeva, O., Pieters, R., & Schmiegelow, K. (2019). A European paediatric cancer mission: aspiration or reality? Lancet Oncol, 20(9), 1200-1202, PMID: 31486360 https://doi.org/10.1016/S1470-2045(19)30487-5  
  24. Kosulin, K., Pichler, H., Lawitschka, A., Geyeregger, R., & Lion, T. (2019). Diagnostic Parameters of Adenoviremia in Pediatric Stem Cell Transplant Recipients. Front Microbiol, 10, 414, PMID: 30853954 PMC6396503 https://doi.org/10.3389/fmicb.2019.00414  
  25. Lawitschka, A., Gueclue, E. D., Januszko, A., Kormoczi, U., Rottal, A., Fritsch, G., Bauer, D., Peters, C., Greinix, H. T., Pickl, W. F., & Kuzmina, Z. (2019). National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution. Front Immunol, 10, 1879, PMID: 31507582 PMC6718560 https://doi.org/10.3389/fimmu.2019.01879  
  26. Lin, M., Nebral, K., Gertzen, C. G. W., Ganmore, I., Haas, O. A., Bhatia, S., Fischer, U., Kuhlen, M., Gohlke, H., Izraeli, S., Trka, J., Hu, J., Borkhardt, A., Hauer, J., & Auer, F. (2019). JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility. Leukemia, 33(9), 2331-2335, PMID: 30967616 PMC6756027 https://doi.org/10.1038/s41375-019-0459-z
  27. Lion, T. (2019). Adenovirus persistence, reactivation, and clinical management. FEBS Lett, 593(24), 3571-3582, PMID: 31411731 https://doi.org/10.1002/1873-3468.13576  
  28. Moll, H. P., Mohrherr, J., Blaas, L., Musteanu, M., Stiedl, P., Grabner, B., Zboray, K., Konig, M., Stoiber, D., Rulicke, T., Strehl, S., Eferl, R., & Casanova, E. (2019). A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. Cancers (Basel), 11(9), PMID: 31443474 PMC6770775 https://doi.org/10.3390/cancers11091226  
  29. Morini, M., Cangelosi, D., Segalerba, D., Marimpietri, D., Raggi, F., Castellano, A., Fruci, D., de Mora, J. F., Canete, A., Yanez, Y., Viprey, V., Corrias, M. V., Carlini, B., Pezzolo, A., Schleiermacher, G., Mazzocco, K., Ladenstein, R., Sementa, A. R., Conte, M., Garaventa, A., Burchill, S., Luksch, R., Bosco, M. C., Eva, A., & Varesio, L. (2019). Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study. Cancers (Basel), 11(10), PMID: 31575060 PMC6826693 https://doi.org/10.3390/cancers11101476  
  30. Neftel, C., Laffy, J., Filbin, M. G., Hara, T., Shore, M. E., Rahme, G. J., Richman, A. R., Silverbush, D., Shaw, M. L., Hebert, C. M., Dewitt, J., Gritsch, S., Perez, E. M., Gonzalez Castro, L. N., Lan, X., Druck, N., Rodman, C., Dionne, D., Kaplan, A., Bertalan, M. S., Small, J., Pelton, K., Becker, S., Bonal, D., Nguyen, Q. D., Servis, R. L., Fung, J. M., Mylvaganam, R., Mayr, L., Gojo, J., Haberler, C., Geyeregger, R., Czech, T., Slavc, I., Nahed, B. V., Curry, W. T., Carter, B. S., Wakimoto, H., Brastianos, P. K., Batchelor, T. T., Stemmer-Rachamimov, A., Martinez-Lage, M., Frosch, M. P., Stamenkovic, I., Riggi, N., Rheinbay, E., Monje, M., Rozenblatt-Rosen, O., Cahill, D. P., Patel, A. P., Hunter, T., Verma, I. M., Ligon, K. L., Louis, D. N., Regev, A., Bernstein, B. E., Tirosh, I., & Suva, M. L. (2019). An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell, 178(4), 835-849 e821, PMID: 31327527 PMC6703186 https://doi.org/10.1016/j.cell.2019.06.024  
  31. Niktoreh, N., Lerius, B., Zimmermann, M., Gruhn, B., Escherich, G., Bourquin, J. P., Dworzak, M., Sramkova, L., Rossig, C., Creutzig, U., Reinhardt, D., & Rasche, M. (2019). Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Munster study group. Haematologica, 104(1), 120-127, PMID: 30093401 PMC6312035 https://doi.org/10.3324/haematol.2018.191841  
  32. Nogueira, F., Sharghi, S., Kuchler, K., & Lion, T. (2019). Pathogenetic Impact of Bacterial-Fungal Interactions. Microorganisms, 7(10), PMID: 31623187 PMC6843596 https://doi.org/10.3390/microorganisms7100459  
  33. Nogueira, M. F., Pereira, L., Jenull, S., Kuchler, K., & Lion, T. (2019). Klebsiella pneumoniae prevents spore germination and hyphal development of Aspergillus species. Sci Rep, 9(1), 218, PMID: 30659217 PMC6338788 https://doi.org/10.1038/s41598-018-36524-8  
  34. Pazmandi, J., Kalinichenko, A., Ardy, R. C., & Boztug, K. (2019). Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms. Immunol Rev, 287(1), 162-185, PMID: 30565237 PMC7379380 https://doi.org/10.1111/imr.12726  
  35. Pfeifer, H., Cazzaniga, G., van der Velden, V. H. J., Cayuela, J. M., Schafer, B., Spinelli, O., Akiki, S., Avigad, S., Bendit, I., Borg, K., Cave, H., Elia, L., Reshmi, S. C., Gerrard, G., Hayette, S., Hermanson, M., Juh, A., Jurcek, T., Chillon, M. C., Homburg, C., Martinelli, G., Kairisto, V., Lange, T., Lion, T., Mueller, M. C., Pane, F., Rai, L., Damm-Welk, C., Sacha, T., Schnittger, S., Touloumenidou, T., Valerhaugen, H., Vandenberghe, P., Zuna, J., Serve, H., Herrmann, E., Markovic, S., Dongen, J., & Ottmann, O. G. (2019). Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia, 33(8), 1910-1922, PMID: 30858550 https://doi.org/10.1038/s41375-019-0413-0
  36. Pichler, H., Lawitschka, A., Glogova, E., Willasch, A. M., von Luettichau, I., Lehrnbecher, T., Matthes-Martin, S., Lang, P., Bader, P., Sykora, K. W., Schrum, J., Kremens, B., Ehlert, K., Albert, M. H., Kuhlen, M., Meisel, R., Guengoer, T., Strahm, B., Gruhn, B., Schulz, A., Woessmann, W., Poetschger, U., & Peters, C. (2019). Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP. Am J Hematol, 94(8), 880-890, PMID: 31095771 PMC6772138 https://doi.org/10.1002/ajh.25511  
  37. Popitsch, N. (2019). VARAN-GIE: curation of genomic interval sets. Bioinformatics, 35(5), 868-870, PMID: 30137307 https://doi.org/10.1093/bioinformatics/bty723
  38. Potter, N., Jones, L., Blair, H., Strehl, S., Harrison, C. J., Greaves, M., Kearney, L., & Russell, L. J. (2019). Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia. Leukemia, 33(4), 893-904, PMID: 30487598 PMC6398588 https://doi.org/10.1038/s41375-018-0297-4  
  39. Poyer, F., Friesenbichler, W., Hutter, C., Pichler, H., Dworzak, M., Peters, C., Mann, G., Indra, A., & Attarbaschi, A. (2019). Rothia mucilaginosa bacteremia: A 10-year experience of a pediatric tertiary care cancer center. Pediatr Blood Cancer, 66(7), e27691, PMID: 30825249 https://doi.org/10.1002/pbc.27691
  40. Reiter, M., Diem, M., Schumich, A., Maurer-Granofszky, M., Karawajew, L., Rossi, J. G., Ratei, R., Groeneveld-Krentz, S., Sajaroff, E. O., Suhendra, S., Kampel, M., Dworzak, M. N., International Berlin-Frankfurt-Munster, F.-n., & the Auto, F. c. (2019). Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning. Cytometry A, 95(9), 966-975, PMID: 31282025 https://doi.org/10.1002/cyto.a.23852  
  41. Scheer, M., Vokuhl, C., Blank, B., Hallmen, E., von Kalle, T., Munter, M., Wessalowski, R., Hartwig, M., Sparber-Sauer, M., Schlegel, P. G., Kramm, C. M., Kontny, U., Spriewald, B., Kegel, T., Bauer, S., Kazanowska, B., Niggli, F., Ladenstein, R., Ljungman, G., Jahnukainen, K., Fuchs, J., Bielack, S. S., Klingebiel, T., Koscielniak, E., & Cooperative Weichteilsarkom, S. (2019). Desmoplastic small round cell tumors: Multimodality treatment and new risk factors. Cancer Med, 8(2), 527-542, PMID: 30652419 PMC6382921 https://doi.org/10.1002/cam4.1940  
  42. Schinnerl, D., Mejstrikova, E., Schumich, A., Zaliova, M., Fortschegger, K., Nebral, K., Attarbaschi, A., Fiser, K., Kauer, M. O., Popitsch, N., Haslinger, S., Inthal, A., Buldini, B., Basso, G., Bourquin, J. P., Gaipa, G., Bruggemann, M., Feuerstein, T., Maurer-Granofszky, M., Panzer-Grumayer, R., Trka, J., Mann, G., Haas, O. A., Hrusak, O., Dworzak, M. N., & Strehl, S. (2019). CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia. Haematologica, 104(8), e352-e355, PMID: 30705095 PMC6669149 https://doi.org/10.3324/haematol.2018.214353  
  43. Schneeweiss-Gleixner, M., Byrgazov, K., Stefanzl, G., Berger, D., Eisenwort, G., Lucini, C. B., Herndlhofer, S., Preuner, S., Obrova, K., Pusic, P., Witzeneder, N., Greiner, G., Hoermann, G., Sperr, W. R., Lion, T., Deininger, M., Valent, P., & Gleixner, K. V. (2019). CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1(T315I)+ clones in TKI-resistant CML. EBioMedicine, 50, 111-121, PMID: 31761618 PMC6921367 https://doi.org/10.1016/j.ebiom.2019.11.004  
  44. Schumich, A., Maurer-Granofszky, M., Attarbaschi, A., Potschger, U., Buldini, B., Gaipa, G., Karawajew, L., Printz, D., Ratei, R., Conter, V., Schrappe, M., Mann, G., Basso, G., Dworzak, M. N., & Group, A. I.-B.-A.-F.-S. (2019). Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000. Pediatr Blood Cancer, 66(5), e27590, PMID: 30561169 https://doi.org/10.1002/pbc.27590
  45. Schwentner, R., Jug, G., Kauer, M. O., Schnoller, T., Waidhofer-Sollner, P., Holter, W., & Hutter, C. (2019). JAG2 signaling induces differentiation of CD14(+) monocytes into Langerhans cell histiocytosis-like cells. J Leukoc Biol, 105(1), 101-111, PMID: 30296338 https://doi.org/10.1002/JLB.1A0318-098R  
  46. Schwentner, R., Kolenova, A., Jug, G., Schnoller, T., Ahlmann, M., Meister, B., Lehrnbecher, T., Minkov, M., & Hutter, C. (2019). Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis. Pediatr Res, 85(6), 856-864, PMID: 30474648 https://doi.org/10.1038/s41390-018-0238-y    
  47. Selvanathan, S. P., Graham, G. T., Grego, A. R., Baker, T. M., Hogg, J. R., Simpson, M., Batish, M., Crompton, B., Stegmaier, K., Tomazou, E. M., Kovar, H., Uren, A., & Toretsky, J. A. (2019). EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex. Nucleic Acids Res, 47(18), 9619-9636, PMID: 31392992 PMC6765149 https://doi.org/10.1093/nar/gkz699  
  48. Serwas, N. K., Hoeger, B., Ardy, R. C., Stulz, S. V., Sui, Z., Memaran, N., Meeths, M., Krolo, A., Yuce Petronczki, O., Pfajfer, L., Hou, T. Z., Halliday, N., Santos-Valente, E., Kalinichenko, A., Kennedy, A., Mace, E. M., Mukherjee, M., Tesi, B., Schrempf, A., Pickl, W. F., Loizou, J. I., Kain, R., Bidmon-Fliegenschnee, B., Schickel, J. N., Glauzy, S., Huemer, J., Garncarz, W., Salzer, E., Pierides, I., Bilic, I., Thiel, J., Priftakis, P., Banerjee, P. P., Forster-Waldl, E., Medgyesi, D., Huber, W. D., Orange, J. S., Meffre, E., Sansom, D. M., Bryceson, Y. T., Altman, A., & Boztug, K. (2019). Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis. Nat Commun, 10(1), 3106, PMID: 31308374 PMC6629652 https://doi.org/10.1038/s41467-019-10812-x  
  49. Shahin, T., Aschenbrenner, D., Cagdas, D., Bal, S. K., Conde, C. D., Garncarz, W., Medgyesi, D., Schwerd, T., Karaatmaca, B., Cetinkaya, P. G., Esenboga, S., Twigg, S. R. F., Cant, A., Wilkie, A. O. M., Tezcan, I., Uhlig, H. H., & Boztug, K. (2019). Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function. Haematologica, 104(3), 609-621, PMID: 30309848 PMC6395342 https://doi.org/10.3324/haematol.2018.194233  
  50. Somekh, I., Thian, M., Medgyesi, D., Gulez, N., Magg, T., Gallon Duque, A., Stauber, T., Lev, A., Genel, F., Unal, E., Simon, A. J., Lee, Y. N., Kalinichenko, A., Dmytrus, J., Kraakman, M. J., Schiby, G., Rohlfs, M., Jacobson, J. M., Ozer, E., Akcal, O., Conca, R., Patiroglu, T., Karakukcu, M., Ozcan, A., Shahin, T., Appella, E., Tatematsu, M., Martinez-Jaramillo, C., Chinn, I. K., Orange, J. S., Trujillo-Vargas, C. M., Franco, J. L., Hauck, F., Somech, R., Klein, C., & Boztug, K. (2019). CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis. Blood, 134(18), 1510-1516, PMID: 31501153 PMC6839947 https://doi.org/10.1182/blood.2019000644  
  51. Soverini, S., Bassan, R., & Lion, T. (2019). Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges. J Hematol Oncol, 12(1), 39, PMID: 31014376 PMC6480772 https://doi.org/10.1186/s13045-019-0729-2  
  52. Sparber-Sauer, M., Koscielniak, E., Vokuhl, C., Seitz, G., Hallmen, E., von Kalle, T., Scheer, M., Munter, M., Bielack, S. S., Ladenstein, R., Fuchs, J., Klingebiel, T., & Group, C. W. S. S. (2019). Epithelioid sarcoma in children, adolescents, and young adults: Localized, primary metastatic and relapsed disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Pediatr Blood Cancer, 66(9), e27879, PMID: 31215116 https://doi.org/10.1002/pbc.27879  
  53. Sparber-Sauer, M., Stegmaier, S., Vokuhl, C., Seitz, G., von Kalle, T., Scheer, M., Munter, M., Bielack, S. S., Weclawek-Tompol, J., Ladenstein, R., Niggli, F., Ljungman, G., Fuchs, J., Hettmer, S., Koscielniak, E., Klingebiel, T., & Group, C. W. S. S. (2019). Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr Blood Cancer, 66(6), e27652, PMID: 30762282 https://doi.org/10.1002/pbc.27652
  54. Spencer, S., Kostel Bal, S., Egner, W., Lango Allen, H., Raza, S. I., Ma, C. A., Gurel, M., Zhang, Y., Sun, G., Sabroe, R. A., Greene, D., Rae, W., Shahin, T., Kania, K., Ardy, R. C., Thian, M., Staples, E., Pecchia-Bekkum, A., Worrall, W. P. M., Stephens, J., Brown, M., Tuna, S., York, M., Shackley, F., Kerrin, D., Sargur, R., Condliffe, A., Tipu, H. N., Kuehn, H. S., Rosenzweig, S. D., Turro, E., Tavare, S., Thrasher, A. J., Jodrell, D. I., Smith, K. G. C., Boztug, K.#, Milner, J. D.#, & Thaventhiran, J. E. D.# (2019). Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses. J Exp Med, 216(9), 1986-1998, PMID: 31235509 PMC6719421 https://doi.org/10.1084/jem.20190344  # Shared senior authorship
  55. Srivastava, S., Nataraj, N. B., Sekar, A., Ghosh, S., Bornstein, C., Drago-Garcia, D., Roth, L., Romaniello, D., Marrocco, I., David, E., Gilad, Y., Lauriola, M., Rotkopf, R., Kimchi, A., Haga, Y., Tsutsumi, Y., Mirabeau, O., Surdez, D., Zinovyev, A., Delattre, O., Kovar, H., Amit, I., & Yarden, Y. (2019). ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma. Cell Rep, 29(1), 104-117 e104, PMID: 31577941 PMC6899513 https://doi.org/10.1016/j.celrep.2019.08.088  
  56. Troschke-Meurer, S., Siebert, N., Marx, M., Zumpe, M., Ehlert, K., Mutschlechner, O., Loibner, H., Ladenstein, R., & Lode, H. N. (2019). Low CD4(+)/CD25(+)/CD127(-) regulatory T cell- and high INF-gamma levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2. Oncoimmunology, 8(12), 1661194, PMID: 31741754 PMC6844328 https://doi.org/10.1080/2162402X.2019.1661194  
  57. Valent, P., Orazi, A., Savona, M. R., Patnaik, M. M., Onida, F., van de Loosdrecht, A. A., Haase, D., Haferlach, T., Elena, C., Pleyer, L., Kern, W., Pemovska, T., Vladimer, G. I., Schanz, J., Keller, A., Lubbert, M., Lion, T., Sotlar, K., Reiter, A., De Witte, T., Pfeilstocker, M., Geissler, K., Padron, E., Deininger, M., Orfao, A., Horny, H. P., Greenberg, P. L., Arber, D. A., Malcovati, L., & Bennett, J. M. (2019). Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions. Haematologica, 104(10), 1935-1949, PMID: 31048353 PMC6886439 https://doi.org/10.3324/haematol.2019.222059  
  58. Witalisz-Siepracka, A., Klein, K., Prinz, D., Leidenfrost, N., Schabbauer, G., Dohnal, A., & Sexl, V. (2019). Loss of JAK1 Drives Innate Immune Deficiency. Front Immunol, 9, 3108, PMID: 30671064 PMC6331462 https://doi.org/10.3389/fimmu.2018.03108  
  59. Zhang, W., Mayr, V., Ducos, B., Distel, M., Bensimon, D. (2019). A Model of Somitogenesis. J Stat Phys, 175, 729–742, PMID: https://doi.org/https://doi.org/10.1007/s10955-019-02265-9
  1. Avery, D.T., Kane, A., Nguyen, T., Lau, A., Nguyen, A., Lenthall, H., Payne, K., Shi, W., Brigden, H., French, E., Bier, J., Hermes, J.R., Zahra, D., Sewell, W.A., Butt, D., Elliott, M., Boztug, K., Meyts, I., Choo, S., Hsu, P., Wong, M., Berglund, L.J., Gray, P., O’Sullivan, M., Cole, T., Holland, S.M., Ma, C.S., Burkhart, C., Corcoran, L.M., Phan, T.G., Brink, R., Uzel, G., Deenick, E.K., and Tangye, S.G. (2018). Germline-activating mutations in PIK3CD compromise B cell development and function. J Exp Med 215, 2073-2095.  
  2. Berbegall, A.P., Bogen, D., Potschger, U., Beiske, K., Bown, N., Combaret, V., Defferrari, R., Jeison, M., Mazzocco, K., Varesio, L., Vicha, A., Ash, S., Castel, V., Coze, C., Ladenstein, R., Owens, C., Papadakis, V., Ruud, E., Amann, G., Sementa, A.R., Navarro, S., Ambros, P.F., Noguera, R., and Ambros, I.M. (2018). Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study. Br J Cancer 118, 1502-1512.  
  3. Bigenzahn, S., Juergens, B., Mahr, B., Pratschke, J., Koenigsrainer, A., Becker, T., Fuchs, D., Brandacher, G., Kainz, A., Muehlbacher, F., and Wekerle, T. (2018). No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients. Clin Exp Immunol 192, 233-241.  
  4. Brey, C.U., Proff, J., Teufert, N., Salzer, B., Brozy, J., Munz, M., Pendzialek, J., Ensser, A., Holter, W., and Lehner, M. (2018). A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells. Sci Rep 8, 17453.  
  5. Byrne, J., Alessi, D., Allodji, R.S., Bagnasco, F., Bardi, E., Bautz, A., Bright, C.J., Brown, M., Diallo, I., Feijen, E., Fidler, M.M., Frey, E., Garwicz, S., Grabow, D., Gudmundsdottir, T., Hagberg, O., Harila-Saari, A., Hau, E.M., Haupt, R., Hawkins, M.M., Jakab, Z., Jankovic, M., Kaatsch, P., Kaiser, M., Kremer, L.C.M., Kuehni, C.E., Kuonen, R., Ladenstein, R., Lahteenmaki, P.M., Levitt, G., Linge, H., D, L.L., Michel, G., Morsellino, V., Mulder, R.L., Reulen, R.C., Ronckers, C.M., Sacerdote, C., Skinner, R., Steliarova-Foucher, E., van der Pal, H.J., de Vathaire, F., Vu Bezin, G., Wesenberg, F., Wiebe, T., Winter, D.L., Falck Winther, J., Witthoff, E., Zadravec Zaletel, L., and Hjorth, L. (2018). The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer. Eur J Cancer 103, 238-248.  
  6. Casali, P.G., Bielack, S., Abecassis, N., Aro, H.T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J., Brennan, B., Brodowicz, T., Broto, J.M., Brugieres, L., Buonadonna, A., De Alava, E., Dei Tos, A.P., Del Muro, X.G., Dileo, P., Dhooge, C., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A.M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R.L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R.L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krakorova, D.A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Morland, B., Pantaleo, M.A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A.L., Reichardt, P., Robinson, M.H., Rutkowski, P., Safwat, A.A., Schoffski, P., Sleijfer, S., Stacchiotti, S., Strauss, S.J., Sundby Hall, K., Unk, M., Van Coevorden, F., van der Graaf, W.T.A., Whelan, J., Wardelmann, E., Zaikova, O., Blay, J.Y., Esmo Guidelines Committee, P., and Ern, E. (2018). Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29, iv79-iv95.  
  7. Corrias, M.V., Parodi, S., Tchirkov, A., Lammens, T., Vicha, A., Pasqualini, C., Trager, C., Yanez, Y., Dallorso, S., Varesio, L., Luksch, R., Laureys, G., Valteau-Couanet, D., Canete, A., Poetschger, U., Ladenstein, R., and Burchill, S.A. (2018). Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. Pediatr Blood Cancer 65, e27052.  
  8. Creutzig, U., Dworzak, M., von Neuhoff, N., Rasche, M., and Reinhardt, D. (2018). [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO – AML-BFM-Recommendations]. Klin Padiatr 230, 299-304.  
  9. Csillag, B., Ilencikova, D., Meissl, M., Webersinke, G., Laccone, F., Narumi, S., Haas, O., and Duba, H.C. (2018). Somatic mosaic monosomy 7 and UPD7q in a child with MIRAGE syndrome caused by a novel SAMD9 mutation. Pediatr Blood Cancer, e27589.  
  10. Dauber, E.M., Mayr, W.R., Hustinx, H., Schonbacher, M., Budde, H., Legler, T.J., Konig, M., Haas, O.A., Fritsch, G., and Kormoczi, G.F. (2018). Somatic mosaicisms of chromosome 1 at two different stages of ontogenetic development detected by Rh blood group discrepancies. Haematologica.   Depuydt, P., Boeva, V., Hocking, T.D., Cannoodt, R., Ambros, I.M., Ambros, P.F., Asgharzadeh, S., Attiyeh, E.F., Combaret, V., Defferrari, R., Fischer, M., Hero, B., Hogarty, M.D., Irwin, M.S., Koster, J., Kreissman, S., Ladenstein, R., Lapouble, E., Laureys, G., London, W.B., Mazzocco, K., Nakagawara, A., Noguera, R., Ohira, M., Park, J.R., Potschger, U., Theissen, J., Tonini, G.P., Valteau-Couanet, D., Varesio, L., Versteeg, R., Speleman, F., Maris, J.M., Schleiermacher, G., and De Preter, K. (2018). Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients. J Natl Cancer Inst 110, 1084-1093.  
  11. Dillinger, B., Ahmadi-Erber, S., Lau, M., Hoelzl, M.A., Erhart, F., Juergens, B., Fuchs, D., Heitger, A., Ladisch, S., and Dohnal, A.M. (2018). IFN-gamma and tumor gangliosides: Implications for the tumor microenvironment. Cell Immunol 325, 33-40.  
  12. Duong, J.K., Veal, G.J., Nath, C.E., Shaw, P.J., Errington, J., Ladenstein, R., and Boddy, A.V. (2019). Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function. Br J Clin Pharmacol 85, 136-146.   Edwards, E.S.J., Bier, J., Cole, T.S., Wong, M., Hsu, P., Berglund, L.J., Boztug, K., Lau, A., Gostick, E., Price, D.A., O’Sullivan, M., Meyts, I., Choo, S., Gray, P., Holland, S.M., Deenick, E.K., Uzel, G., and Tangye, S.G. (2019). Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. J Allergy Clin Immunol 143, 276-291 e276.  
  13. Eghbal-Zadeh, H., Fischer, L., Popitsch, N., Kromp, F., Taschner-Mandl, S., Gerber, T., Bozsaky, E., Ambros, P.F., Ambros, I.M., Widmer, G., and Moser, B.A. (2018). DeepSNP: An End-to-End Deep Neural Network with Attention-Based Localization for Breakpoint Detection in Single-Nucleotide Polymorphism Array Genomic Data. J Comput Biol.  
  14. Erhart, F., Blauensteiner, B., Zirkovits, G., Printz, D., Soukup, K., Klingenbrunner, S., Fischhuber, K., Reitermaier, R., Halfmann, A., Lotsch, D., Spiegl-Kreinecker, S., Berger, W., Visus, C., and Dohnal, A. (2019). Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature. J Cell Mol Med 23, 281-292.  
  15. Erhart, F., Buchroithner, J., Reitermaier, R., Fischhuber, K., Klingenbrunner, S., Sloma, I., Hibsh, D., Kozol, R., Efroni, S., Ricken, G., Wohrer, A., Haberler, C., Hainfellner, J., Krumpl, G., Felzmann, T., Dohnal, A.M., Marosi, C., and Visus, C. (2018). Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. Acta Neuropathol Commun 6, 135.
  16. Fauster, A., Rebsamen, M., Willmann, K.L., Cesar-Razquin, A., Girardi, E., Bigenzahn, J.W., Schischlik, F., Scorzoni, S., Bruckner, M., Konecka, J., Hormann, K., Heinz, L.X., Boztug, K., and Superti-Furga, G. (2018). Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ.  
  17. Filbin, M.G., Tirosh, I., Hovestadt, V., Shaw, M.L., Escalante, L.E., Mathewson, N.D., Neftel, C., Frank, N., Pelton, K., Hebert, C.M., Haberler, C., Yizhak, K., Gojo, J., Egervari, K., Mount, C., van Galen, P., Bonal, D.M., Nguyen, Q.D., Beck, A., Sinai, C., Czech, T., Dorfer, C., Goumnerova, L., Lavarino, C., Carcaboso, A.M., Mora, J., Mylvaganam, R., Luo, C.C., Peyrl, A., Popovic, M., Azizi, A., Batchelor, T.T., Frosch, M.P., Martinez-Lage, M., Kieran, M.W., Bandopadhayay, P., Beroukhim, R., Fritsch, G., Getz, G., Rozenblatt-Rosen, O., Wucherpfennig, K.W., Louis, D.N., Monje, M., Slavc, I., Ligon, K.L., Golub, T.R., Regev, A., Bernstein, B.E., and Suva, M.L. (2018). Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360, 331-335.  
  18. Friesenbichler, W., Krizmanich, W., Lakatos, K., Attarbaschi, A., Dworzak, M., Amann, G., Furtwangler, R., Graf, N., and Kager, L. (2018). Outcome of two patients with bilateral nephroblastomatosis/Wilms tumour treated with an add-on 13-cis retinoic acid therapy – Case report. Pediatr Hematol Oncol, 1-7.  
  19. Friesenbichler, W., Schumich, A., Simonitsch-Klupp, I., Panzer-Grumayer, R., Haas, O., Mann, G., and Dworzak, M. (2018). Concurrent Acute Myelofibrosis and Acute Lymphoblastic Leukemia in Childhood: Case Report and Review of the Literature. J Pediatr Hematol Oncol 40, 235-237.  
  20. Garcia-Ramirez, I., Bhatia, S., Rodriguez-Hernandez, G., Gonzalez-Herrero, I., Walter, C., Gonzalez de Tena-Davila, S., Parvin, S., Haas, O., Woessmann, W., Stanulla, M., Schrappe, M., Dugas, M., Natkunam, Y., Orfao, A., Dominguez, V., Pintado, B., Blanco, O., Alonso-Lopez, D., De Las Rivas, J., Martin-Lorenzo, A., Jimenez, R., Garcia Criado, F.J., Garcia Cenador, M.B., Lossos, I.S., Vicente-Duenas, C., Borkhardt, A., Hauer, J., and Sanchez-Garcia, I. (2018). Lmo2 expression defines tumor cell identity during T-cell leukemogenesis. EMBO J 37.  
  21. Grunewald, T.G.P., Cidre-Aranaz, F., Surdez, D., Tomazou, E.M., de Alava, E., Kovar, H., Sorensen, P.H., Delattre, O., and Dirksen, U. (2018). Ewing sarcoma. Nat Rev Dis Primers 4, 5.   Haupt, R., Essiaf, S., Dellacasa, C., Ronckers, C.M., Caruso, S., Sugden, E., Zadravec Zaletel, L., Muraca, M., Morsellino, V., Kienesberger, A., Blondeel, A., Saraceno, D., Ortali, M., Kremer, L.C.M., Skinner, R., Roganovic, J., Bagnasco, F., Levitt, G.A., De Rosa, M., Schrappe, M., Hjorth, L., Ladenstein, R., PanCareSurFup, E.W.G., and ExPo-r-Net Working, G. (2018). The ‘Survivorship Passport’ for childhood cancer survivors. Eur J Cancer 102, 69-81.  
  22. Hiwarkar, P., Kosulin, K., Cesaro, S., Mikulska, M., Styczynski, J., Wynn, R., and Lion, T. (2018). Management of adenovirus infection in patients after haematopoietic stem cell transplantation: State-of-the-art and real-life current approach: A position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation. Rev Med Virol 28, e1980.  
  23. Hrusak, O., de Haas, V., Stancikova, J., Vakrmanova, B., Janotova, I., Mejstrikova, E., Capek, V., Trka, J., Zaliova, M., Luks, A., Bleckmann, K., Moricke, A., Irving, J., Konatkowska, B., Alexander, T.B., Inaba, H., Schmiegelow, K., Stokley, S., Zemanova, Z., Moorman, A.V., Rossi, J.G., Felice, M.S., Dalla-Pozza, L., Morales, J., Dworzak, M., Buldini, B., Basso, G., Campbell, M., Cabrera, M.E., Marinov, N., Elitzur, S., Izraeli, S., Luria, D., Feuerstein, T., Kolenova, A., Svec, P., Kreminska, O., Rabin, K.R., Polychronopoulou, S., da Costa, E., Marquart, H.V., Kattamis, A., Ratei, R., Reinhardt, D., Choi, J.K., Schrappe, M., and Stary, J. (2018). International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood 132, 264-276.  
  24. Husa, A.M., Strobl, M.R., Strajeriu, A., Wieser, M., Strehl, S., and Fortschegger, K. (2018). Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation. Stem Cells Dev 27, 1376-1384.  
  25. Juan Ribelles, A., Berlanga, P., Schreier, G., Nitzlnader, M., Brunmair, B., Castel, V., Essiaf, S., Canete, A., and Ladenstein, R. (2018). Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project. Clin Transl Oncol 20, 1046-1052.  
  26. Kager, L., Jimenez Heredia, R., Hirschmugl, T., Dmytrus, J., Krolo, A., Muller, H., Bock, C., Zeitlhofer, P., Dworzak, M., Mann, G., Holter, W., Haas, O., and Boztug, K. (2018). Targeted mutation screening of 292 candidate genes in 38 children with inborn haematological cytopenias efficiently identifies novel disease-causing mutations. Br J Haematol 182, 251-258.  
  27. Kosulin, K., Berkowitsch, B., Matthes, S., Pichler, H., Lawitschka, A., Potschger, U., Fritsch, G., and Lion, T. (2018). Intestinal Adenovirus Shedding Before Allogeneic Stem Cell Transplantation Is a Risk Factor for Invasive Infection Post-transplant. EBioMedicine 28, 114-119.  
  28. Kosulin K, Lam E, Heim A, Dobner T, Rodríguez E. Broad-spectrum antiviral activity of the deubiquitinase inhibitor HBX against human adenoviruses. Antivir Ther. 2018;23(6):475-483. doi: 10.3851/IMP3230. PMID: 29557344.
  29. Hoeger B, Serwas NK, Boztug K. Human NF-κB1 Haploinsufficiency and Epstein-Barr Virus-Induced Disease-Molecular Mechanisms and Consequences. Front Immunol. 2018 Jan 18;8:1978. doi: 10.3389/fimmu.2017.01978. PMID: 29403474; PMCID: PMC5778108.
  30. Krenn M, Salzer E, Simonitsch-Klupp I, Rath J, Wagner M, Haack TB, Strom TM, Schänzer A, Kilimann MW, Schmidt RLJ, Schmetterer KG, Zimprich A, Boztug K, Hahn A, Zimprich F. Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum. J Neurol. 2018 Feb;265(2):394-401. doi: 10.1007/s00415-017-8710-x. Epub 2017 Dec 19. PMID: 29260357; PMCID: PMC5808061.
  31. Kovar, H. (2018). Selective enhancer changes in osteosarcoma lung metastasis. Nat Med 24, 126-127.  
  32. Kuhlen, M., Bader, P., Sauer, M., Albert, M.H., Gruhn, B., Gungor, T., Kropshofer, G., Lang, P., Lawitschka, A., Metzler, M., Pentek, F., Rossig, C., Schlegel, P.G., Schrappe, M., Schrum, J., Schulz, A., Schwinger, W., von Stackelberg, A., Strahm, B., Suttorp, M., Luettichau, I.T., Wossmann, W., Borkhardt, A., Meisel, R., Poetschger, U., Glogova, E., and Peters, C. (2018). Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL – results of the ALL-SCT 2003 trial. Br J Haematol 183, 104-109.  
  33. Ladenstein, R., Potschger, U., Valteau-Couanet, D., Luksch, R., Castel, V., Yaniv, I., Laureys, G., Brock, P., Michon, J.M., Owens, C., Trahair, T., Chan, G.C.F., Ruud, E., Schroeder, H., Beck Popovic, M., Schreier, G., Loibner, H., Ambros, P., Holmes, K., Castellani, M.R., Gaze, M.N., Garaventa, A., Pearson, A.D.J., and Lode, H.N. (2018). Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. Lancet Oncol 19, 1617-1629.  
  34. Lawson, J.T., Tomazou, E.M., Bock, C., and Sheffield, N.C. (2018). MIRA: an R package for DNA methylation-based inference of regulatory activity. Bioinformatics 34, 2649-2650.   Maas, C., Luftinger, R., Krois, W., Matthes-Martin, S., Bayer, G., Boztug, K., and Metzelder, M. (2018). EBV-positive B-cell lymphoma manifestation of the liver in an infant with RAG1 severe combined immunodeficiency disease. Pediatr Blood Cancer 65, e27258.  
  35. Machiela, M.J., Grunewald, T.G.P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E., Rubio, R.A., Zaidi, S., Grossetete-Lalami, S., Ballet, S., Lapouble, E., Laurence, V., Michon, J., Pierron, G., Kovar, H., Gaspar, N., Kontny, U., Gonzalez-Neira, A., Picci, P., Alonso, J., Patino-Garcia, A., Corradini, N., Berard, P.M., Freedman, N.D., Rothman, N., Dagnall, C.L., Burdett, L., Jones, K., Manning, M., Wyatt, K., Zhou, W., Yeager, M., Cox, D.G., Hoover, R.N., Khan, J., Armstrong, G.T., Leisenring, W.M., Bhatia, S., Robison, L.L., Kulozik, A.E., Kriebel, J., Meitinger, T., Metzler, M., Hartmann, W., Strauch, K., Kirchner, T., Dirksen, U., Morton, L.M., Mirabello, L., Tucker, M.A., Tirode, F., Chanock, S.J., and Delattre, O. (2018). Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nat Commun 9, 3184.  
  36. Mayr, V., Sturtzel, C., Stadler, M., Grissenberger, S., and Distel, M. (2018). Fast Dynamic in vivo Monitoring of Erk Activity at Single Cell Resolution in DREKA Zebrafish. Front Cell Dev Biol 6, 111.  
  37. Meyer, C., Burmeister, T., Groger, D., Tsaur, G., Fechina, L., Renneville, A., Sutton, R., Venn, N.C., Emerenciano, M., Pombo-de-Oliveira, M.S., Barbieri Blunck, C., Almeida Lopes, B., Zuna, J., Trka, J., Ballerini, P., Lapillonne, H., De Braekeleer, M., Cazzaniga, G., Corral Abascal, L., van der Velden, V.H.J., Delabesse, E., Park, T.S., Oh, S.H., Silva, M.L.M., Lund-Aho, T., Juvonen, V., Moore, A.S., Heidenreich, O., Vormoor, J., Zerkalenkova, E., Olshanskaya, Y., Bueno, C., Menendez, P., Teigler-Schlegel, A., Zur Stadt, U., Lentes, J., Gohring, G., Kustanovich, A., Aleinikova, O., Schafer, B.W., Kubetzko, S., Madsen, H.O., Gruhn, B., Duarte, X., Gameiro, P., Lippert, E., Bidet, A., Cayuela, J.M., Clappier, E., Alonso, C.N., Zwaan, C.M., van den Heuvel-Eibrink, M.M., Izraeli, S., Trakhtenbrot, L., Archer, P., Hancock, J., Moricke, A., Alten, J., Schrappe, M., Stanulla, M., Strehl, S., Attarbaschi, A., Dworzak, M., Haas, O.A., Panzer-Grumayer, R., Sedek, L., Szczepanski, T., Caye, A., Suarez, L., Cave, H., and Marschalek, R. (2018). The MLL recombinome of acute leukemias in 2017. Leukemia 32, 273-284.  
  38. Minkov, M. (2018). An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy. Expert Opin Pharmacother 19, 233-242.
  39. Morgenstern, D.A., Potschger, U., Moreno, L., Papadakis, V., Owens, C., Ash, S., Pasqualini, C., Luksch, R., Garaventa, A., Canete, A., Elliot, M., Wieczorek, A., Laureys, G., Kogner, P., Malis, J., Ruud, E., Beck-Popovic, M., Schleiermacher, G., Valteau-Couanet, D., and Ladenstein, R. (2018). Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study. Pediatr Blood Cancer 65, e27363.  
  40. Mughal, T.I., Lion, T., Abdel-Wahab, O., Mesa, R., Scherber, R.M., Perrotti, D., Mauro, M., Verstovsek, S., Saglio, G., Van Etten, R.A., and Kralovics, R. (2018). Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms. Hematol Oncol 36, 740-748.
  41. Niktoreh, N., Lerius, B., Zimmermann, M., Gruhn, B., Escherich, G., Bourquin, J.P., Dworzak, M., Sramkova, L., Rossig, C., Creutzig, U., Reinhardt, D., and Rasche, M. (2019). Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Munster study group. Haematologica 104, 120-127.  
  42. Noort, S., Zimmermann, M., Reinhardt, D., Cuccuini, W., Pigazzi, M., Smith, J., Ries, R.E., Alonzo, T.A., Hirsch, B., Tomizawa, D., Locatelli, F., Gruber, T.A., Raimondi, S., Sonneveld, E., Cheuk, D.K., Dworzak, M., Stary, J., Abrahamsson, J., Arad-Cohen, N., Czogala, M., De Moerloose, B., Hasle, H., Meshinchi, S., van den Heuvel-Eibrink, M., and Zwaan, C.M. (2018). Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. Blood 132, 1584-1592.  
  43. Olesnicky, E.C., Antonacci, S., Popitsch, N., Lybecker, M.C., Titus, M.B., Valadez, R., Derkach, P.G., Marean, A., Miller, K., Mathai, S.K., and Killian, D.J. (2018). Shep interacts with posttranscriptional regulators to control dendrite morphogenesis in sensory neurons. Dev Biol 444, 116-128.  
  44. Pastorczak, A., Sedek, L., Braun, M., Madzio, J., Sonsala, A., Twardoch, M., Fendler, W., Nebral, K., Taha, J., Bielska, M., Gorniak, P., Romiszewska, M., Matysiak, M., Derwich, K., Lejman, M., Kowalczyk, J., Badowska, W., Niedzwiecki, M., Kazanowska, B., Muszynska-Roslan, K., Sobol-Milejska, G., Karolczyk, G., Koltan, A., Ociepa, T., Szczepanski, T., and Mlynarski, W. (2018). Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions. Oncotarget 9, 25971-25982.  
  45. Pazmandi, J., Kalinichenko, A., Ardy, R.C., and Boztug, K. (2019). Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms. Immunol Rev 287, 162-185.  
  46. Pfajfer, L., Mair, N.K., Jimenez-Heredia, R., Genel, F., Gulez, N., Ardeniz, O., Hoeger, B., Bal, S.K., Madritsch, C., Kalinichenko, A., Chandra Ardy, R., Gerceker, B., Rey-Barroso, J., Ijspeert, H., Tangye, S.G., Simonitsch-Klupp, I., Huppa, J.B., van der Burg, M., Dupre, L., and Boztug, K. (2018). Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity. J Allergy Clin Immunol 142, 1589-1604 e1511.  
  47. Popitsch, N. (2018). VARAN-GIE: Curation of Genomic Interval Sets. Bioinformatics.   Potschger, U., Heinzl, H., Valsecchi, M.G., and Mittlbock, M. (2018). Assessing the effect of a partly unobserved, exogenous, binary time-dependent covariate on survival probabilities using generalised pseudo-values. BMC Med Res Methodol 18, 14.  
  48. Proff, J., Brey, C.U., Ensser, A., Holter, W., and Lehner, M. (2018). Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2-CH3 IgG spacer domains. J Transl Med 16, 26.  
  49. Rasche, M., Zimmermann, M., Borschel, L., Bourquin, J.P., Dworzak, M., Klingebiel, T., Lehrnbecher, T., Creutzig, U., Klusmann, J.H., and Reinhardt, D. (2018). Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia 32, 2167-2177.  
  50. Schuh, A., Dreau, H., Knight, S.J.L., Ridout, K., Mizani, T., Vavoulis, D., Colling, R., Antoniou, P., Kvikstad, E.M., Pentony, M.M., Hamblin, A., Protheroe, A., Parton, M., Shah, K.A., Orosz, Z., Athanasou, N., Hassan, B., Flanagan, A.M., Ahmed, A., Winter, S., Harris, A., Tomlinson, I., Popitsch, N., Church, D., and Taylor, J.C. (2018). Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing. Cold Spring Harb Mol Case Stud 4.  
  51. Schumich, A., Maurer-Granofszky, M., Attarbaschi, A., Potschger, U., Buldini, B., Gaipa, G., Karawajew, L., Printz, D., Ratei, R., Conter, V., Schrappe, M., Mann, G., Basso, G., Dworzak, M.N., and Group, A.I.-B.-A.-F.-S. (2018). Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000. Pediatr Blood Cancer, e27590.  
  52. Schuster, A.J., Kager, L., Reichardt, P., Baumhoer, D., Csoka, M., Hecker-Nolting, S., Lang, S., Lorenzen, S., Mayer-Steinacker, R., von Kalle, T., Kevric, M., Werner, M., Windhager, R., Wirth, T., and Bielack, S.S. (2018). High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients. Sarcoma 2018, 1632978.  
  53. Schwentner, R., Jug, G., Kauer, M.O., Schnoller, T., Waidhofer-Sollner, P., Holter, W., and Hutter, C. (2019). JAG2 signaling induces differentiation of CD14(+) monocytes into Langerhans cell histiocytosis-like cells. J Leukoc Biol 105, 101-111.  
  54. Schwentner, R., Kolenova, A., Jug, G., Schnoller, T., Ahlmann, M., Meister, B., Lehrnbecher, T., Minkov, M., and Hutter, C. (2018). Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis. Pediatr Res.   Schwinger, W., Urban, C., Ulreich, R., Sperl, D., Karastaneva, A., Strenger, V., Lackner, H., Boztug, K., Albert, M.H., Benesch, M., and Seidel, M.G. (2018). The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV. Front Immunol 9, 2554.  
  55. Serwas, N.K., Huemer, J., Dieckmann, R., Mejstrikova, E., Garncarz, W., Litzman, J., Hoeger, B., Zapletal, O., Janda, A., Bennett, K.L., Kain, R., Kerjaschky, D., and Boztug, K. (2018). CEBPE-Mutant Specific Granule Deficiency Correlates With Aberrant Granule Organization and Substantial Proteome Alterations in Neutrophils. Front Immunol 9, 588.  
  56. Shen, J., Najafi, S., Stable, S., Fabian, J., Koeneke, E., Kolbinger, F.R., Wrobel, J.K., Meder, B., Distel, M., Heimburg, T., Sippl, W., Jung, M., Peterziel, H., Kranz, D., Boutros, M., Westermann, F., Witt, O., and Oehme, I. (2018). A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment. Cell Death Differ 25, 2053-2070.  
  57. Siebert, N., Troschke-Meurer, S., Marx, M., Zumpe, M., Ehlert, K., Gray, J., Garaventa, A., Manzitti, C., Ash, S., Klingebiel, T., Beck, J., Castel, V., Valteau-Couanet, D., Loibner, H., Ladenstein, R., and Lode, H.N. (2018). Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial. Cancers (Basel) 10.  
  58. Stanulla, M., Dagdan, E., Zaliova, M., Moricke, A., Palmi, C., Cazzaniga, G., Eckert, C., Te Kronnie, G., Bourquin, J.P., Bornhauser, B., Koehler, R., Bartram, C.R., Ludwig, W.D., Bleckmann, K., Groeneveld-Krentz, S., Schewe, D., Junk, S.V., Hinze, L., Klein, N., Kratz, C.P., Biondi, A., Borkhardt, A., Kulozik, A., Muckenthaler, M.U., Basso, G., Valsecchi, M.G., Izraeli, S., Petersen, B.S., Franke, A., Dorge, P., Steinemann, D., Haas, O.A., Panzer-Grumayer, R., Cave, H., Houlston, R.S., Cario, G., Schrappe, M., Zimmermann, M., Consortium, T., and International, B.F.M.S.G. (2018). IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. J Clin Oncol 36, 1240-1249.  
  59. Troll, J.V., Hamilton, M.K., Abel, M.L., Ganz, J., Bates, J.M., Stephens, W.Z., Melancon, E., van der Vaart, M., Meijer, A.H., Distel, M., Eisen, J.S., and Guillemin, K. (2018). Microbiota promote secretory cell determination in the intestinal epithelium by modulating host Notch signaling. Development 145.  
  60. Tsafou, K., Katschnig, A.M., Radic-Sarikas, B., Mutz, C.N., Iljin, K., Schwentner, R., Kauer, M.O., Muhlbacher, K., Aryee, D.N.T., Westergaard, D., Haapa-Paananen, S., Fey, V., Superti-Furga, G., Toretsky, J., Brunak, S., and Kovar, H. (2018). Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers. Oncotarget 9, 31018-31031.  
  61. van Eijkelenburg, N.K.A., Rasche, M., Ghazaly, E., Dworzak, M.N., Klingebiel, T., Rossig, C., Leverger, G., Stary, J., De Bont, E., Chitu, D.A., Bertrand, Y., Brethon, B., Strahm, B., van der Sluis, I.M., Kaspers, G.J.L., Reinhardt, D., and Zwaan, C.M. (2018). Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study. Haematologica 103, 1484-1492.  
  62. van Rijn, J.M., Ardy, R.C., Kuloglu, Z., Harter, B., van Haaften-Visser, D.Y., van der Doef, H.P.J., van Hoesel, M., Kansu, A., van Vugt, A.H.M., Thian, M., Kokke, F.T.M., Krolo, A., Basaran, M.K., Kaya, N.G., Aksu, A.U., Dalgic, B., Ozcay, F., Baris, Z., Kain, R., Stigter, E.C.A., Lichtenbelt, K.D., Massink, M.P.G., Duran, K.J., Verheij, J., Lugtenberg, D., Nikkels, P.G.J., Brouwer, H.G.F., Verkade, H.J., Scheenstra, R., Spee, B., Nieuwenhuis, E.E.S., Coffer, P.J., Janecke, A.R., van Haaften, G., Houwen, R.H.J., Muller, T., Middendorp, S., and Boztug, K. (2018). Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency. Gastroenterology 155, 130-143 e115.  
  63. Velicky, P., Meinhardt, G., Plessl, K., Vondra, S., Weiss, T., Haslinger, P., Lendl, T., Aumayr, K., Mairhofer, M., Zhu, X., Schutz, B., Hannibal, R.L., Lindau, R., Weil, B., Ernerudh, J., Neesen, J., Egger, G., Mikula, M., Rohrl, C., Urban, A.E., Baker, J., Knofler, M., and Pollheimer, J. (2018). Genome amplification and cellular senescence are hallmarks of human placenta development. PLoS Genet 14, e1007698.  
  64. Weinhofer, I., Zierfuss, B., Hametner, S., Wagner, M., Popitsch, N., Machacek, C., Bartolini, B., Zlabinger, G., Ohradanova-Repic, A., Stockinger, H., Kohler, W., Hoftberger, R., Regelsberger, G., Forss-Petter, S., Lassmann, H., and Berger, J. (2018). Impaired plasticity of macrophages in X-linked adrenoleukodystrophy. Brain.  
  65. Weiss, T., Taschner-Mandl, S., Ambros, P.F., and Ambros, I.M. (2018). Detailed Protocols for the Isolation, Culture, Enrichment and Immunostaining of Primary Human Schwann Cells. Methods Mol Biol 1739, 67-86.  
  66. Whelan, J., Le Deley, M.C., Dirksen, U., Le Teuff, G., Brennan, B., Gaspar, N., Hawkins, D.S., Amler, S., Bauer, S., Bielack, S., Blay, J.Y., Burdach, S., Castex, M.P., Dilloo, D., Eggert, A., Gelderblom, H., Gentet, J.C., Hartmann, W., Hassenpflug, W.A., Hjorth, L., Jimenez, M., Klingebiel, T., Kontny, U., Kruseova, J., Ladenstein, R., Laurence, V., Lervat, C., Marec-Berard, P., Marreaud, S., Michon, J., Morland, B., Paulussen, M., Ranft, A., Reichardt, P., van den Berg, H., Wheatley, K., Judson, I., Lewis, I., Craft, A., Juergens, H., Oberlin, O., Euro, E.W.I.N.G., and Investigators, E.-. (2018). High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. J Clin Oncol, JCO2018782516.  
  67. Zoghi, S., Ziaee, V., Hirschmugl, T., Jimenez-Heredia, R., Krolo, A., Boztug, K., and Rezaei, N. (2018). Exome sequencing revealed C1Q homozygous mutation in Pediatric Systemic Lupus Erythematosus. Allergol Immunopathol (Madr) 46, 594-598.
  1. Abbasi MR, Rifatbegovic F, Brunner C, Mann G, Ziegler A, Potschger U, Crazzolara R, Ussowicz M, Benesch M, Ebetsberger-Dachs G, Chan GCF, Jones N, Ladenstein R, Ambros IM ,Ambros PF (2017). Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone. Clin Cancer Res 23, 4224-4232.  
  2. Aichhorn S, Linhardt A, Halfmann A, Nadlinger M, Kirchberger S, Stadler M, Dillinger B, Distel M, Dohnal A, Teasdale I ,Schoefberger W (2017). A pH-sensitive macromolecular prodrug as TLR7/8 targeting immune response modifier. Chemistry.  
  3. Amoroso L, Erminio G, Makin G, Pearson AD, Brock P, Valteau-Couanet D, Castel V, Pasquet M, Laureys G, Thomas C, Luksch R, Ladenstein R, Haupt R, Garaventa A ,Group S (2017). Topotecan-Vincristine-Doxorubicin in Stage 4 High Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC – a SIOPEN Study. Cancer Res Treat.  
  4. Balendran S, Liebmann-Reindl S, Berghoff AS, Reischer T, Popitsch N, Geier CB, Kenner L, Birner P, Streubel B ,Preusser M (2017). Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations. J Neurooncol 133, 469-476.  
  5. Bileck A, Mayer RL, Kreutz D, Weiss T, Taschner-Mandl S, Meier SM, Slany A, Gerner C (2017). Evaluation of inflammation-related signaling events covering phosphorylation and nuclear translocation of proteins based on mass spectrometry data. J Proteomics 152, 161-171.  
  6. Colomer-Lahiguera S, Pisecker M, Konig M, Nebral K, Pickl WF, Kauer MO, Haas OA, Ullmann R, Attarbaschi A, Dworzak MN ,Strehl S (2017). MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy. Leuk Lymphoma 58, 2895-2904.  
  7. Pfajfer L, Seidel MG, Houmadi R, Rey-Barroso J, Hirschmugl T, Salzer E, Antón IM, Urban C, Schwinger W, Boztug K*, Dupré L*. WIP deficiency severely affects human lymphocyte architecture during migration and synapse assembly. Blood. 2017 Oct 26;130(17):1949-1953. doi: 10.1182/blood-2017-04-777383. Epub 2017 Sep 13. PMID: 28903942. *Shared senior authorship
  8. Creutzig U, Dworzak MN, Bochennek K, Faber J, Flotho C, Graf N, Kontny U, Rossig C, Schmid I, von Stackelberg A, Mueller JE, von Neuhoff C, Reinhardt D, von Neuhoff N (2017). First experience of the AML-Berlin-Frankfurt-Munster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid. Pediatr Blood Cancer 64.  
  9. Creutzig U, Dworzak MN, Zimmermann M, Reinhardt D, Sramkova L, Bourquin JP, Hasle H, Abrahamsson J, Kaspers G, van den Heuvel MM, Reedijk AMJ, De Moerloose B, Locatelli F, Masetti R (2017). Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups. Pediatr Blood Cancer.  
  10. Dillinger B, Ahmadi-Erber S, Soukup K, Halfmann A, Schrom S, Vanhove B, Steinberger P, Geyeregger R, Ladisch S ,Dohnal AM (2017). CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity. Front Immunol 8, 1152.  
  11. Dixon ZA, Nicholson L, Zeppetzauer M, Matheson E, Sinclair P, Harrison CJ, Irving JA (2017). CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response. Haematologica 102, 736-745.  
  12. Dworzak MN, Buldini B, Gaipa G, Ratei R, Hrusak O, Luria D, Rosenthal E, Bourquin JP, Sartor M, Schumich A, Karawajew L, Mejstrikova E, Maglia O, Mann G, Ludwig WD, Biondi A, Schrappe M, Basso G, International BFMFn (2017). AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom.  
  13. Farrokhi S, Shabani M, Aryan Z, Zoghi S, Krolo A, Boztug K ,Rezaei N (2017). MHC class II deficiency: Report of a novel mutation and special review. Allergol Immunopathol (Madr).  
  14. Fernandez A, Gruner-Nielsen L, Andreana M, Stadler M, Kirchberger S, Sturtzel C, Distel M, Zhu L, Kautek W, Leitgeb R, Baltuska A, Jespersen K ,Verhoef A (2017). Optimizing pulse compressibility in completely all-fibered Ytterbium chirped pulse amplifiers for in vivo two photon laser scanning microscopy. Biomed Opt Express 8, 3526-3537.  
  15. Gardiner JD, Abegglen LM, Huang X, Carter BE, Schackmann EA, Stucki M, Paxton CN, Lor Randall R, Amatruda JF, Putnam AR, Kovar H, Lessnick SL, Schiffman JD (2017). C/EBPbeta-1 promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget 8, 26013-26026.  
  16. Gleixner KV, Schneeweiss M, Eisenwort G, Berger D, Herrmann H, Blatt K, Greiner G, Byrgazov K, Hoermann G, Konopleva M, Waliul I, Cumaraswamy AA, Gunning PT, Maeda H, Moriggl R, Deininger M, Lion T, Andreeff M ,Valent P (2017). Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia. Haematologica 102, 1519-1529.  
  17. He T, Surdez D, Rantala JK, Haapa-Paananen S, Ban J, Kauer M, Tomazou E, Fey V, Alonso J, Kovar H, Delattre O ,Iljin K (2017). High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability. Gene 596, 137-146.
  18. Husak Z ,Dworzak MN (2017). Chronic stress induces CD99, suppresses autophagy, and affects spontaneous adipogenesis in human bone marrow stromal cells. Stem Cell Res Ther 8, 83.  
  19. Kainrath S, Stadler M, Reichhart E, Distel M ,Janovjak H (2017). Green-Light-Induced Inactivation of Receptor Signaling Using Cobalamin-Binding Domains. Angew Chem Int Ed Engl 56, 4608-4611.  
  20. Katschnig AM, Kauer MO, Schwentner R, Tomazou EM, Mutz CN, Linder M, Sibilia M, Alonso J, Aryee DNT ,Kovar H (2017). EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma. Oncogene.  
  21. Kirchberger S, Sturtzel C, Pascoal S ,Distel M (2017). Quo natas, Danio?-Recent Progress in Modeling Cancer in Zebrafish. Front Oncol 7, 186.   Kolenová A, Schwentner R, Jug G, Simonitsch-Klupp I, Kornauth C, Plank L, Horáková J, Bodová I, Sýkora T, Geczová L, Holter W, Minkov M ,Hutter C (2017). Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH. Blood Advances 1, 352-356.  
  22. Kostel Bal S, Haskologlu S, Serwas NK, Islamoglu C, Aytekin C, Kendirli T, Kuloglu Z, Yavuz G, Dalgic B, Siklar Z, Kansu A, Ensari A, Boztug K, Dogu F, Ikinciogullari A (2017). Multiple Presentations of LRBA Deficiency: a Single-Center Experience. J Clin Immunol.  
  23. Ladenstein R, Lambert B, Potschger U, Castellani MR, Lewington V, Bar-Sever Z, Oudoux A, Sliwinska A, Taborska K, Biassoni L, Yanik GA, Naranjo A, Parisi MT, Shulkin BL, Nadel H, Gelfand MJ, Matthay KK, Park JR, Kreissman SG, Valteau-Couanet D ,Boubaker A (2017). Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials. Eur J Nucl Med Mol Imaging.  
  24. Ladenstein R, Pötschger U, Pearson ADJ, Brock P, Luksch R, Castel V, Yaniv I, Papadakis V, Laureys G, Malis J, Balwierz W, Ruud E, Kogner P, Schroeder H, de Lacerda AF, Beck-Popovic M, Bician P, Garami M, Trahair T, Canete A, Ambros PF, Holmes K, Gaze M, Schreier G, Garaventa A, Vassal G, Michon J, Valteau-Couanet D ,Group SEN (2017). Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. Lancet Oncol 18, 500-514.  
  25. Li J, Casteels T, Frogne T, Ingvorsen C, Honore C, Courtney M, Huber KV, Schmitner N, Kimmel RA, Romanov RA, Sturtzel C, Lardeau CH, Klughammer J, Farlik M, Sdelci S, Vieira A, Avolio F, Briand F, Baburin I, Majek P, Pauler FM, Penz T, Stukalov A, Gridling M, Parapatics K, Barbieux C, Berishvili E, Spittler A, Colinge J, Bennett KL, Hering S, Sulpice T, Bock C, Distel M, Harkany T, Meyer D, Superti-Furga G, Collombat P, Hecksher-Sorensen J ,Kubicek S (2017). Artemisinins Target GABAA Receptor Signaling and Impair alpha Cell Identity. Cell 168, 86-100 e115.  
  26. Meier SM, Kreutz D, Winter L, Klose MHM, Cseh K, Weiss T, Bileck A, Alte B, Mader JC, Jana S, Chatterjee A, Bhattacharyya A, Hejl M, Jakupec MA, Heffeter P, Berger W, Hartinger CG, Keppler BK, Wiche G ,Gerner C (2017). An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin. Angew Chem Int Ed Engl 56, 8267-8271.  
  27. Meyer C, Burmeister T, Groger D, Tsaur G, Fechina L, Renneville S, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, Delabesse E, Park TS, Oh SH, Silva MLM, Lund-Aho T, Juvonen V, Moore AS, Heidenreich O, Vormoor J, Zerkalenkova E, Olshanskaya Y, Bueno C, Menendez P, Teigler-Schlegel S, Zur Stadt U, Lentes J, Gohring G, Kustanovich S, Aleinikova O, Schafer BW, Kubetzko S, Madsen HO, Gruhn B, Duarte X, Gameiro P, Lippert E, Bidet S, Cayuela JM, Clappier E, Alonso CN, Zwaan CM, van den Heuvel-Eibrink MM, Izraeli S, Trakhtenbrot L, Archer P, Hancock J, Moricke A, Alten J, Schrappe M, Stanulla M, Strehl S, Attarbaschi A, Dworzak M, Haas OA, Panzer-Grümayer R, Sedek L, Szczepanski T, Caye S, Suarez L, Cave H ,Marschalek R (2017). The MLL recombinome of acute leukemias in 2017. Leukemia.  
  28. Millot F, Dupraz C, Guilhot J, Suttorp M, Brizard F, Leblanc T, Gunes AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A ,Guilhot F (2017). Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents. Cancer 123, 3609-3616.  
  29. Millot F, Guilhot J, Suttorp M, Gunes AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A (2017). Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents. Haematologica 102, 1704-1708.  
  30. Müller H, Jimenez-Heredia R, Krolo A, Hirschmugl T, Dmytrus J, Boztug K ,Bock C (2017). VCF.Filter: interactive prioritization of disease-linked genetic variants from sequencing data. Nucleic Acids Res.  
  31. Mutz CN, Schwentner R, Aryee DNT, Bouchard EDJ, Mejia EM, Hatch GM, Kauer MO, Katschnig AM, Ban J, Garten A, Alonso J, Banerji V ,Kovar H (2017). EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells. Oncotarget 8, 24679-24693.  
  32. Nogueira F, Istel F, Pereira L, Tscherner M ,Kuchler K (2017). Immunological Identification of Fungal Species. Methods Mol Biol 1508, 339-359.  
  33. Obenauer JC, Kavelaars FG, Sanders MA, de Vries ACH, de Haas V, Beverloo HB, De Moerloose B, Lammens T, Dworzak M, Hoogenboezem RM, Valk PJM, Touw IP, van den Heuvel-Eibrink MM (2017). Recurrently affected genes in juvenile myelomonocytic leukaemia. Br J Haematol.  
  34. Ozen A, Comrie WA, Ardy RC, Dominguez Conde C, Dalgic B, Beser OF, Morawski AR, Karakoc-Aydiner E, Tutar E, Baris S, Ozcay F, Serwas NK, Zhang Y, Matthews HF, Pittaluga S, Folio LR, Unlusoy Aksu A, McElwee JJ, Krolo A, Kiykim A, Baris Z, Gulsan M, Ogulur I, Snapper SB, Houwen RHJ, Leavis HL, Ertem D, Kain R, Sari S, Erkan T, Su HC, Boztug K ,Lenardo MJ (2017). CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med 377, 52-61.
  35. Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK ,Valteau-Couanet D (2017). Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 35, 2580-2587.  
  36. Pichler H, Horner K, Engstler G, Poetschger U, Glogova E, Karlhuber S, Martin M, Eibler W, Witt V, Holter W ,Matthes-Martin S (2017). Cost-Effectiveness of Defibrotide in the Prophylaxis of Veno-Occlusive Disease after Pediatric Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 23, 1128-1133.  
  37. Radic-Sarikas B, Tsafou KP, Emdal KB, Papamarkou T, Huber KV, Mutz C, Toretsky JA, Bennett KL, Olsen JV, Brunak S, Kovar H ,Superti-Furga G (2017). Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities. Mol Cancer Ther 16, 88-101.  
  38. Ranft A, Seidel C, Hoffmann C, Paulussen M, Warby AC, van den Berg H, Ladenstein R, Rossig C, Dirksen U, Rosenbaum D ,Juergens H (2017). Quality of Survivorship in a Rare Disease: Clinicofunctional Outcome and Physical Activity in an Observational Cohort Study of 618 Long-Term Survivors of Ewing Sarcoma. J Clin Oncol 35, 1704-1712.  
  39. Rasche M, von Neuhoff C, Dworzak M, Bourquin JP, Bradtke J, Gohring G, Escherich G, Fleischhack G, Graf N, Gruhn B, Haas OA, Klingebiel T, Kremens B, Lehrnbecher T, von Stackelberg A, Tchinda J, Zemanova Z, Thiede C, von Neuhoff N, Zimmermann M, Creutzig U, Reinhardt D (2017). Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004. Leukemia.  
  40. Rifatbegovic F, Frech C, Abbasi MR, Taschner-Mandl S, Weiss T, Schmidt WM, Schmidt I, Ladenstein R, Ambros IM ,Ambros PF (2017). Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression. Int J Cancer.  
  41. Schmah J, Fedders B, Panzer-Grumayer R, Fischer S, Zimmermann M, Dagdan E, Bens S, Schewe D, Moericke A, Alten J, Bleckmann K, Siebert R, Schrappe M, Stanulla M ,Cario G (2017). Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood. Pediatr Blood Cancer 64.  
  42. Schwab C, Nebral K, Chilton L, Leschi C, Waanders E, Boer JM, Žaliová M, Sutton R, Öfverholm II, Ohki K, Yamashita Y, Groeneveld-Krentz S, Froňková E, Bakkus M, Tchinda J, Barbosa TdC, Fazio G, Mlynarski W, Pastorczak A, Cazzaniga G, Pombo-de-Oliveira MS, Trka J, Kirschner-Schwabe R, Imamura T, Barbany G, Stanulla M, Attarbaschi A, Panzer-Grümayer R, Kuiper RP, den Boer ML, Cavé H, Moorman AV, Harrison CJ ,Strehl S (2017). Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia? Blood Advances 1, 1473-1477.  
  43. Sedlyarova N, Rescheneder P, Magan A, Popitsch N, Rziha N, Bilusic I, Epshtein V, Zimmermann B, Lybecker M, Sedlyarov V, Schroeder R ,Nudler E (2017). Natural RNA Polymerase Aptamers Regulate Transcription in E. coli. Mol Cell 67, 30-43 e36.  
  44. Sesti A, Rappersberger K ,Posch C (2017). [Bullous Sweet’s syndrome with pulmonary involvement]. Hautarzt 68, 649-652.   Sheffield NC, Pierron G, Klughammer J, Datlinger P, Schonegger A, Schuster M, Hadler J, Surdez D, Guillemot D, Lapouble E, Freneaux P, Champigneulle J, Bouvier R, Walder D, Ambros IM, Hutter C, Sorz E, Amaral AT, de Alava E, Schallmoser K, Strunk D, Rinner B, Liegl-Atzwanger B, Huppertz B, Leithner A, de Pinieux G, Terrier P, Laurence V, Michon J, Ladenstein R, Holter W, Windhager R, Dirksen U, Ambros PF, Delattre O, Kovar H, Bock C ,Tomazou EM (2017). DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. Nat Med 23, 386-395.  
  45. Smeenk L, Fischer M, Jurado S, Jaritz M, Azaryan A, Werner B, Roth M, Zuber J, Stanulla M, den Boer ML, Mullighan CG, Strehl S ,Busslinger M (2017). Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia. EMBO J 36, 718-735.  
  46. Soukup K, Halfmann A, Dillinger B, Poyer F, Martin K, Blauensteiner B, Kauer M, Kuttke M, Schabbauer G ,Dohnal AM (2017). Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response. Sci Rep 7, 11746.
  47. Sparber-Sauer M, von Kalle T, Seitz G, Dantonello T, Scheer M, Munter M, Fuchs J, Ladenstein R, Bielack SS, Klingebiel T, Koscielniak E ,Cooperative Weichteilsarkom S (2017). The prognostic value of early radiographic response in children and adolescents with embryonal rhabdomyosarcoma stage IV, metastases confined to the lungs: A report from the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr Blood Cancer 64.  
  48. Speckmann C, Sahoo SS, Rizzi M, Hirabayashi S, Karow A, Serwas NK, Hoemberg M, Damatova N, Schindler D, Vannier JB, Boulton SJ, Pannicke U, Gohring G, Thomay K, Verdu-Amoros JJ, Hauch H, Woessmann W, Escherich G, Laack E, Rindle L, Seidl M, Rensing-Ehl A, Lausch E, Jandrasits C, Strahm B, Schwarz K, Ehl SR, Niemeyer C, Boztug K ,Wlodarski MW (2017). Clinical and Molecular Heterogeneity of RTEL1 Deficiency. Front Immunol 8, 449.  
  49. Sturtzel C (2017). Endothelial Cells. Adv Exp Med Biol 1003, 71-91.  
  50. Thannesberger J, Hellinger HJ, Klymiuk I, Kastner MT, Rieder FJJ, Schneider M, Fister S, Lion T, Kosulin K, Laengle J, Bergmann M, Rattei T ,Steininger C (2017). Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples. FASEB J 31, 1987-2000.  
  51. Uffmann M, Rasche M, Zimmermann M, von Neuhoff C, Creutzig U, Dworzak M, Scheffers L, Hasle H, Zwaan CM, Reinhardt D ,Klusmann JH (2017). Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial. Blood 129, 3314-3321.  
  52. van der Lelij P, Lieb S, Jude J, Wutz G, Santos CP, Falkenberg K, Schlattl A, Ban J, Schwentner R, Hoffmann T, Kovar H, Real FX, Waldman T, Pearson MA, Kraut N, Peters JM, Zuber J ,Petronczki M (2017). Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts. Elife 6.  
  53. Worel N, Frank N, Frech C ,Fritsch G (2017). Influence of plerixafor on the mobilization of CD34+ cell subpopulations and lymphocyte subtypes. Transfusion 57, 2206-2215.  
  54. Yanik GA, Parisi MT, Naranjo A, Nadel H, Gelfand MJ, Park JR, Ladenstein RL, Poetschger U, Boubaker A, Valteau-Couanet D, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, Kaminska A, Kreissman SG, Shulkin BL ,Matthay KK (2017). Validation of post-induction Curie scores in high risk neuroblastoma. A Children’s Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1. J Nucl Med.
  1. Araki, A., M. Chocholous, J. Gojo, C. Dorfer, T. Czech, H. Heinzl, K. Dieckmann, I.M. Ambros, P.F. Ambros, I. Slavc, and C. Haberler. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Acta Neuropathol Commun, 2016. 4(1): p. 88.  
  2. Berbegall, A.P., E. Villamon, M. Piqueras, I. Tadeo, A. Djos, P.F. Ambros, T. Martinsson, I.M. Ambros, A. Canete, V. Castel, S. Navarro, and R. Noguera. Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors. Oncogene, 2016. 35(11): p. 1423-32.  
  3. Bileck, A., R.L. Mayer, D. Kreutz, T. Weiss, S. Taschner-Mandl, S.M. Meier, A. Slany, and C. Gerner. Evaluation of inflammation-related signaling events covering phosphorylation and nuclear translocation of proteins based on mass spectrometry data. J Proteomics, 2016. 152: p. 161-171.  
  4. Boer, J.M., A. van der Veer, D. Rizopoulos, M. Fiocco, E. Sonneveld, H.A. de Groot-Kruseman, R.P. Kuiper, P. Hoogerbrugge, M. Horstmann, M. Zaliova, C. Palmi, J. Trka, E. Fronkova, M. Emerenciano, M. do Socorro Pombo-de-Oliveira, W. Mlynarski, T. Szczepanski, K. Nebral, A. Attarbaschi, N. Venn, R. Sutton, C.J. Schwab, A. Enshaei, A. Vora, M. Stanulla, M. Schrappe, G. Cazzaniga, V. Conter, M. Zimmermann, A.V. Moorman, R. Pieters, and M.L. den Boer. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. Leukemia, 2016. 30(1): p. 32-8.  
  5. Bogen, D., C. Brunner, D. Walder, A. Ziegler, R. Abbasi, R.L. Ladenstein, R. Noguera, T. Martinsson, G. Amann, F.H. Schilling, M. Ussowicz, M. Benesch, P.F. Ambros, and I.M. Ambros. The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma. Int J Cancer, 2016. 139(1): p. 153-63.  
  6. Boztug, H., T. Hirschmugl, W. Holter, K. Lakatos, L. Kager, D. Trapin, W. Pickl, E. Förster-Waldl, and K. Boztug. NF-kappaB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation. J Clin Immunol, 2016. 36(6): p. 533-40.  
  7. Boztug, H., N. Mühlegger, U. Pötschger, A. Attarbaschi, C. Peters, G. Mann, and M. Dworzak. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia. Ann Hematol, 2016.  
  8. Brunner, C., B. Brunner-Herglotz, A. Ziegler, C. Frech, G. Amann, R. Ladenstein, I.M. Ambros, and P.F. Ambros. Tumor Touch Imprints as Source for Whole Genome Analysis of Neuroblastoma Tumors. PLoS One, 2016. 11(8): p. e0161369.  
  9. Burchill, S.A., K. Beiske, H. Shimada, P.F. Ambros, R. Seeger, G.A. Tytgat, P.R. Brock, M. Haber, J.R. Park, and F. Berthold. Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma; on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group. Cancer, 2016.  
  10. Byrgazov, K., R. Kastner, M. Gorna, G. Hoermann, M. Koenig, C.B. Lucini, R. Ulreich, M. Benesch, V. Strenger, H. Lackner, W. Schwinger, P. Sovinz, O.A. Haas, M. van den Heuvel-Eibrink, C.M. Niemeyer, O. Hantschel, P. Valent, G. Superti-Furga, C. Urban, M.N. Dworzak, and T. Lion. NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors. Leukemia, 2016.  
  11. Byrgazov, K., C.B. Lucini, B. Berkowitsch, M. Koenig, O.A. Haas, G. Hoermann, P. Valent, and T. Lion. Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors. Oncotarget, 2016.  
  12. Chagtai, T., C. Zill, L. Dainese, J. Wegert, S. Savola, S. Popov, W. Mifsud, G. Vujanic, N. Sebire, Y. Le Bouc, P.F. Ambros, L. Kager, M.J. O’Sullivan, A. Blaise, C. Bergeron, L.H. Mengelbier, D. Gisselsson, M. Kool, G.A. Tytgat, M.M. van den Heuvel-Eibrink, N. Graf, H. van Tinteren, A. Coulomb, M. Gessler, R.D. Williams, and K. Pritchard-Jones. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study. J Clin Oncol, 2016. 34(26): p. 3195-203.  
  13. Colomer-Lahiguera, S. and S. Strehl. Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia. Leuk Lymphoma, 2016. 57(5): p. 1219-22.  
  14. Crazzolara, R., G. Kropshofer, O.A. Haas, S. Matthes-Martin, and L. Kager. Reduced-intensity conditioning and stem cell transplantation in infants with Diamond Blackfan anemia. Haematologica, 2017, Epub 2016 Dec. 102(3): p. e73-e75.  
  15. Creutzig, U., C. Rössig, M. Dworzak, J. Stary, A. von Stackelberg, W. Wössmann, M. Zimmermann, and D. Reinhardt. Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis. Pediatr Blood Cancer, 2016. 63(4): p. 640-5.  
  16. Creutzig, U., M. Zimmermann, D. Reinhardt, M. Rasche, C. von Neuhoff, T. Alpermann, M. Dworzak, K. Perglerova, Z. Zemanova, J. Tchinda, J. Bradtke, C. Thiede, and C. Haferlach. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups. Cancer, 2016.  
  17. Czurda, S. and T. Lion. Broad-Spectrum Molecular Detection of Fungal Nucleic Acids by PCR-Based Amplification Techniques. Methods Mol Biol, 2017, Epub 2016 Nov. 1508: p. 257-266.  
  18. Czurda, S. and T. Lion. Prerequisites for Control of Contamination in Fungal Diagnosis. Methods Mol Biol, 2017, Epub 2016 Nov. 1508: p. 249-255.  
  19. Czurda, S., S. Smelik, S. Preuner-Stix, F. Nogueira, and T. Lion. Occurrence of Fungal DNA Contamination in PCR Reagents: Approaches to Control and Decontamination. J Clin Microbiol, 2016. 54(1): p. 148-52.  
  20. Dittrich, C., M. Kosty, S. Jezdic, D. Pyle, R. Berardi, J. Bergh, N. El Saghir, J.P. Lotz, P. Österlund, N. Pavlidis, G. Purkalne, and E.A.G.C.W. Group. ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016. Ann Oncol, 2016. 27(8): p. 1378-81.  
  21. Dittrich, C., M. Kosty, S. Jezdic, D. Pyle, R. Berardi, J. Bergh, N. El-Saghir, J.P. Lotz, P. Österlund, N. Pavlidis, G. Purkalne, A. Awada, S. Banerjee, S. Bhatia, J. Bogaerts, J. Buckner, F. Cardoso, P. Casali, E. Chu, J.L. Close, B. Coiffier, R. Connolly, S. Coupland, L. De Petris, M. De Santis, E.G. de Vries, D.S. Dizon, J. Duff, L.R. Duska, A. Eniu, M. Ernstoff, E. Felip, M.F. Fey, J. Gilbert, N. Girard, A.W. Glaudemans, P.K. Gopalan, A. Grothey, S.M. Hahn, D. Hanna, C. Herold, J. Herrstedt, K. Homicsko, D.V. Jones, Jr., L. Jost, U. Keilholz, S. Khan, A. Kiss, C.H. Kohne, R. Kunstfeld, H.J. Lenz, S. Lichtman, L. Licitra, T. Lion, S. Litiere, L. Liu, P.J. Loehrer, M.J. Markham, B. Markman, M. Mayerhoefer, J.G. Meran, O. Michielin, E.C. Moser, G. Mountzios, T. Moynihan, T. Nielsen, Y. Ohe, K. Oberg, A. Palumbo, F.A. Peccatori, M. Pfeilstocker, C. Raut, S.C. Remick, M. Robson, P. Rutkowski, R. Salgado, L. Schapira, E. Schernhammer, M. Schlumberger, H.J. Schmoll, L. Schnipper, C. Sessa, C.L. Shapiro, J. Steele, C.N. Sternberg, F. Stiefel, F. Strasser, R. Stupp, R. Sullivan, J. Tabernero, L. Travado, M. Verheij, E. Voest, E. Vokes, J. Von Roenn, J.S. Weber, H. Wildiers, and Y. Yarden. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 2016. 1(5): p. e000097.  
  22. Dmytrus, J., S. Matthes-Martin, H. Pichler, N. Worel, R. Geyeregger, N. Frank, C. Frech, and G. Fritsch. Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources. Bone Marrow Transplant, 2016. 51(8): p. 1093-100.  
  23. Duregger, K., D. Hayn, M. Nitzlnader, M. Kropf, M. Falgenhauer, R. Ladenstein, and G. Schreier. Electronic Patient Reported Outcomes in Paediatric Oncology – Applying Mobile and Near Field Communication Technology. Stud Health Technol Inform, 2016. 223: p. 281-8.  
  24. Ebinger, S., E.Z. Özdemir, C. Ziegenhain, S. Tiedt, C. Castro Alves, M. Grunert, M. Dworzak, C. Lutz, V.A. Turati, T. Enver, H.P. Horny, K. Sotlar, S. Parekh, K. Spiekermann, W. Hiddemann, A. Schepers, B. Polzer, S. Kirsch, M. Hoffmann, B. Knapp, J. Hasenauer, H. Pfeifer, R. Panzer-Grümayer, W. Enard, O. Gires, and I. Jeremias. Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia. Cancer Cell, 2016.  
  25. Ebner, H., D. Hayn, M. Falgenhauer, M. Nitzlnader, G. Schleiermacher, R. Haupt, G. Erminio, R. Defferrari, K. Mazzocco, J. Kohler, G.P. Tonini, R. Ladenstein, and G. Schreier. Piloting the European Unified Patient Identity Management (EUPID) Concept to Facilitate Secondary Use of Neuroblastoma Data from Clinical Trials and Biobanking. Stud Health Technol Inform, 2016. 223: p. 31-8.  
  26. Eder, J., M. Kammerstatter, F. Erhart, D. Mairhofer-Muri, and F. Trautinger. Illness Perception in Primary Cutaneous T-cell Lymphomas: What Patients Believe About Their Disease. Acta Derm Venereol, 2016. 96(3): p. 381-5.  
  27. Eder, J., R. Rogojanu, W. Jerney, F. Erhart, A. Dohnal, M. Kitzwögerer, G. Steiner, J. Moser, and F. Trautinger. Mast Cells Are Abundant in Primary Cutaneous T-Cell Lymphomas: Results from a Computer-Aided Quantitative Immunohistological Study. PLoS One, 2016. 11(11): p. e0163661.  
  28. Fritsch, G., N. Frank, J. Dmytrus, C. Frech, H. Pichler, V. Witt, R. Geyeregger, D. Scharner, D. Trbojevic, E. Zipperer, D. Printz, and N. Worel. Relevance of flow cytometric enumeration of post-thaw leucocytes: influence of temperature during cell staining on viable cell recovery. Vox Sang, 2016. 111(2): p. 187-96.  
  29. Grausenburger, R., S. Bastelberger, C. Eckert, M. Kauer, M. Stanulla, C. Frech, E. Bauer, D. Stoiber, A. von Stackelberg, A. Attarbaschi, O.A. Haas, and R. Panzer-Grümayer. Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia. Leuk Lymphoma, 2016. 57(5): p. 1163-73.  
  30. Salzer E, Cagdas D, Hons M, Mace EM, Garncarz W, Petronczki ÖY, Platzer R, Pfajfer L, Bilic I, Ban SA, Willmann KL, Mukherjee M, Supper V, Hsu HT, Banerjee PP, Sinha P, McClanahan F, Zlabinger GJ, Pickl WF, Gribben JG, Stockinger H, Bennett KL, Huppa JB, Dupré L, Sanal Ö, Jäger U, Sixt M, Tezcan I, Orange JS, Boztug K. RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics. Nat Immunol. 2016 Dec;17(12):1352-1360. doi: 10.1038/ni.3575. Epub 2016 Oct 24. PMID: 27776107; PMCID: PMC6400263.
  31. Grevener, K., L.M. Haveman, A. Ranft, H. van den Berg, S. Jung, R. Ladenstein, S. Klco-Brosius, H. Juergens, J.H. Merks, and U. Dirksen. Management and Outcome of Ewing Sarcoma of the Head and Neck. Pediatr Blood Cancer, 2016. 63(4): p. 604-10.  
  32. Hayn, D., M. Falgenhauer, M. Kropf, M. Nitzlnader, S. Welte, H. Ebner, R. Ladenstein, G. Schleiermacher, B. Hero, and G. Schreier. IT Infrastructure for Merging Data from Different Clinical Trials and Across Independent Research Networks. Stud Health Technol Inform, 2016. 228: p. 287-91.  
  33. He, T., D. Surdez, J.K. Rantala, S. Haapa-Paananen, J. Ban, M. Kauer, E. Tomazou, V. Fey, J. Alonso, H. Kovar, O. Delattre, and K. Iljin. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability. Gene, 2017, Epub 2016 Oct 596: p. 137-146.  
  34. Heller, G., T. Topakian, C. Altenberger, S. Cerny-Reiterer, S. Herndlhofer, B. Ziegler, P. Datlinger, K. Byrgazov, C. Bock, C. Mannhalter, G. Hörmann, W.R. Sperr, T. Lion, C.C. Zielinski, P. Valent, and S. Zöchbauer-Müller. Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia. Leukemia, 2016. 30(9): p. 1861-8.  
  35. Hutter, C. and M. Minkov. Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies. Immunotargets Ther, 2016. 5: p. 81-91.  
  36. Kager, L., L.J. Bruce, P. Zeitlhofer, J.F. Flatt, T.M. Maia, M.L. Ribeiro, B. Fahrner, G. Fritsch, K. Boztug, and O.A. Haas. Band 3 nullVIENNA , a novel homozygous SLC4A1 p.Ser477X variant causing severe hemolytic anemia, dyserythropoiesis and complete distal renal tubular acidosis. Pediatr Blood Cancer, 2016.  
  37. Kager, L., M. Minkov, P. Zeitlhofer, B. Fahrner, F. Ratzinger, K. Boztug, A. Dossenbach-Glaninger, and O.A. Haas. Two Novel Missense Mutations and a 5bp Deletion in the Erythroid-Specific Promoter of the PKLR Gene in Two Unrelated Patients With Pyruvate Kinase Deficient Transfusion-Dependent Chronic Nonspherocytic Hemolytic Anemia. Pediatr Blood Cancer, 2016. 63(5): p. 914-6.  
  38. Kager, L., J. Whelan, U. Dirksen, B. Hassan, J. Anninga, L. Bennister, J.V. Bovee, B. Brennan, J.M. Broto, L. Brugieres, A.M. Cleton-Jansen, C. Copland, A. Dutour, F. Fagioli, S. Ferrari, M. Fiocco, E. Fleuren, N. Gaspar, H. Gelderblom, C. Gerrand, J. Gerss, O. Gonzato, W. van der Graaf, S. Hecker-Nolting, D. Herrero-Martin, S. Klco-Brosius, H. Kovar, R. Ladenstein, C. Lancia, M.C. LeDeley, M.G. McCabe, M. Metzler, O. Myklebost, M. Nathrath, P. Picci, J. Potratz, F. Redini, G.H. Richter, D. Reinke, P. Rutkowski, K. Scotlandi, S. Strauss, D. Thomas, O.M. Tirado, F. Tirode, G. Vassal, and S.S. Bielack. The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. Clin Sarcoma Res, 2016. 6: p. 3.  
  39. Karim-Kos, H.E., M. Hackl, G. Mann, C. Urban, A. Woehrer, I. Slavc, and R. Ladenstein. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011. Cancer Epidemiol, 2016. 42: p. 72-81  
  40. Kosulin, K., B. Berkowitsch, and T. Lion. Modified pan-adenovirus real-time PCR assay based on genome analysis of seventy HAdV types. J Clin Virol, 2016. 80: p. 60-1.  
  41. Kosulin, K., S. Dworzak, A. Lawitschka, S. Matthes-Leodolter, and T. Lion. Comparison of different approaches to quantitative adenovirus detection in stool specimens of hematopoietic stem cell transplant recipients. J Clin Virol, 2016. 85: p. 31-36.  
  42. Kosulin, K., E. Geiger, A. Vecsei, W.D. Huber, M. Rauch, E. Brenner, F. Wrba, K. Hammer, A. Innerhofer, U. Pötschger, A. Lawitschka, S. Matthes-Leodolter, G. Fritsch, and T. Lion. Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clin Microbiol Infect, 2016. 22(4): p. 381 e1-8.  
  43. Kovar, H., J. Amatruda, E. Brunet, S. Burdach, F. Cidre-Aranaz, E. de Alava, U. Dirksen, W. van der Ent, P. Grohar, T.G. Grünewald, L. Helman, P. Houghton, K. Iljin, E. Korsching, M. Ladanyi, E. Lawlor, S. Lessnick, J. Ludwig, P. Meltzer, M. Metzler, J. Mora, R. Moriggl, T. Nakamura, T. Papamarkou, B. Radic Sarikas, F. Redini, G.H. Richter, C. Rössig, K. Schadler, B.W. Schäfer, K. Scotlandi, N.C. Sheffield, A. Shelat, E. Snaar-Jagalska, P. Sorensen, K. Stegmaier, E. Stewart, A. Sweet-Cordero, K. Szuhai, O.M. Tirado, F. Tirode, J. Toretsky, K. Tsafou, A. Üren, A. Zinovyev, and O. Delattre. The second European interdisciplinary Ewing sarcoma research summit–A joint effort to deconstructing the multiple layers of a complex disease. Oncotarget, 2016. 7(8): p. 8613-24.  
  44. Kowalczyk, J.R., M. Samardakiewicz, K. Pritchard-Jones, R. Ladenstein, S. Essiaf, E. Fitzgerald, G. Petrarulo, and G. Vassal. European Survey on Standards of Care in paediatric oncology centres. Eur J Cancer, 2016. 61: p. 11-9.  
  45. Kromp, F., I.M. Ambros, T. Weiss, D. Bogen, H. Dodig, M. Berneder, T. Gerber, S. Taschner-Mandl, P.F. Ambros, and A. Hanbury. Machine Learning Framework incorporating Expert Knowledge in Tissue Image Annotation. Proceedings of the International Conference on Pattern Recognition, Cancun, 2016.  
  46. Kuttke, M., E. Sahin, J. Pisoni, S. Percig, A. Vogel, D. Kraemmer, L. Hanzl, J.S. Brunner, H. Paar, K. Soukup, A. Halfmann, A.M. Dohnal, C.W. Steiner, S. Blüml, J. Basilio, B. Hochreiter, M. Salzmann, B. Hoesel, G. Lametschwandtner, R. Eferl, J.A. Schmid, and G. Schabbauer. Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition. Oncoimmunology, 2016. 5(7): p. e1164918.  
  47. Lewington, V., B. Lambert, U. Poetschger, Z.B. Sever, F. Giammarile, A.J. McEwan, R. Castellani, T. Lynch, B. Shulkin, M. Drobics, A. Staudenherz, and R. Ladenstein. 123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel. Eur J Nucl Med Mol Imaging, 2016.   Li, J., T. Casteels, T. Frogne, C. Ingvorsen, C. Honore, M. Courtney, K.V. Huber, N. Schmitner, R.A. Kimmel, R.A. Romanov, C. Sturtzel, C.H. Lardeau, J. Klughammer, M. Farlik, S. Sdelci, A. Vieira, F. Avolio, F. Briand, I. Baburin, P. Majek, F.M. Pauler, T. Penz, A. Stukalov, M. Gridling, K. Parapatics, C. Barbieux, E. Berishvili, A. Spittler, J. Colinge, K.L. Bennett, S. Hering, T. Sulpice, C. Bock, M. Distel, T. Harkany, D. Meyer, G. Superti-Furga, P. Collombat, J. Hecksher-Sorensen, and S. Kubicek. Artemisinins Target GABAA Receptor Signaling and Impair alpha Cell Identity. Cell, 2017, Epub 2016 Dec. 168(1-2): p. 86-100.  
  48. Lopes, S.S., M. Distel, C. Linker, R. Fior, R. Monteiro, I.H. Bianco, R. Portugues, U. Strahle, and L. Saude. Report of the 4th European Zebrafish Principal Investigator Meeting. Zebrafish, 2016.  
  49. Mann, G. and W. Holter. [Treatment of low-risk pediatric lymphocyte-predominant Hodgkin lymphoma]. Strahlenther Onkol, 2016. 192(11): p. 827-829.  
  50. Minas, T.Z., D. Surdez, T. Javaheri, M. Tanaka, M. Howarth, H.J. Kang, J. Han, Z.Y. Han, B. Sax, B.E. Kream, S.H. Hong, H. Celik, F. Tirode, J. Tuckermann, J.A. Toretsky, L. Kenner, H. Kovar, S. Lee, E.A. Sweet-Cordero, T. Nakamura, R. Moriggl, O. Delattre, and A. Üren. Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model. Oncotarget, 2016.  
  51. Mutz, C.N., R. Schwentner, M.O. Kauer, A.M. Katschnig, F. Kromp, D.N. Aryee, S. Erhardt, M. Goiny, J. Alonso, D. Fuchs, and H. Kovar. EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway. FEBS Lett, 2016. 590(14): p. 2063-75.  
  52. Nitzlnader, M., A. Canete Nieto, A.J. Ribelles, B. Brunmair, R. Ladenstein, and G. Schreier. Interoperability Architecture for a Paediatric Oncology European Reference Network. Stud Health Technol Inform, 2016. 223: p. 39-45.  
  53. Perwein, T., S. Strehl, M. König, H. Lackner, R. Panzer-Grümayer, G. Mann, A. Attarbaschi, E.C. Urban, and O.A. Haas. Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia. Haematologica, 2016. 101(8): p. e332-5.  
  54. Pichler, H., G. Fritsch, M. König, H. Daxberger, E. Glogova, U. Pötschger, S. Breuer, A. Lawitschka, E.D. Guclu, S. Karlhuber, W. Holter, O.A. Haas, T. Lion, and S. Matthes-Martin. Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter? Br J Haematol, 2016. 173(6): p. 905-17.  
  55. Posch, C., H. Moslehi, M. Sanlorenzo, G. Green, I. Vujic, R. Panzer-Grümayer, K. Rappersberger, and S. Ortiz-Urda. Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo. Oncotarget, 2016.  
  56. Posch, C., M. Sanlorenzo, I. Vujic, J.A. Oses-Prieto, B.D. Cholewa, S.T. Kim, J. Ma, K. Lai, M. Zekhtser, R. Esteve-Puig, G. Green, S. Chand, A.L. Burlingame, R. Panzer-Grümayer, K. Rappersberger, and S. Ortiz-Urda. Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2alpha Kinase Levels in NRAS(Q61) Mutant Cells. J Invest Dermatol, 2016. 136(10): p. 2041-8.  
  57. Preuner, S., A. Barna, F. Frommlet, S. Czurda, B. Konstantin, M. Alikian, K. Machova Polakova, T. Sacha, J. Richter, T. Lion, and C. Gabriel. Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches. Int J Mol Sci, 2016. 17(5).  
  58. Preuner, S., C. Peters, U. Pötschger, H. Daxberger, G. Fritsch, R. Geyeregger, A. Schrauder, A. von Stackelberg, M. Schrappe, P. Bader, W. Ebell, C. Eckert, P. Lang, K.W. Sykora, J. Schrum, B. Kremens, K. Ehlert, M.H. Albert, R. Meisel, A. Lawitschka, G. Mann, R. Panzer-Grümayer, T. Güngör, W. Holter, B. Strahm, B. Gruhn, A. Schulz, W. Woessmann, and T. Lion. Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia. Haematologica, 2016. 101(6): p. 741-6.  
  59. Proff, J., C. Walterskirchen, C. Brey, R. Geyeregger, F. Full, A. Ensser, M. Lehner, and W. Holter. Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner. Front Microbiol, 2016. 7: p. 844.  
  60. Radic-Sarikas, B., K.P. Tsafou, K.B. Emdal, T. Papamarkou, K.V.M. Huber, C. Mutz, J.A. Toretsky, K.L. Bennett, J.V. Olsen, S. Brunak, H. Kovar, and G. Superti-Furga. Combinatorial drug screening identifies Ewing sarcoma-specific sensitivities. Molecular Cancer Therapeutics, 2016.  
  61. Reismüller, B., M. Steiner, H. Pichler, M. Dworzak, C. Urban, B. Meister, K. Schmitt, U. Pötschger, M. König, G. Mann, O.A. Haas, A. Attarbaschi, and A.L.L.B.F.M.S.G. Austrian. High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Munster) Study Group. Pediatr Blood Cancer, 2016.  
  62. Reiter, M., P. Rota, F. Kleber, M. Diem, S. Groeneveld-Krentz, and M. Dworzak. Clustering of cell populations in flow cytometry data using a combination of Gaussian mixtures. Pattern Recognition, 2016. 60: p. 1029-1040.  
  63. Rieder, F.J., C. Gröschel, M.T. Kastner, K. Kosulin, J. Laengle, R. Zadnikar, R. Marculescu, M. Schneider, T. Lion, M. Bergmann, E. Kallay, and C. Steininger. Human cytomegalovirus infection downregulates vitamin-D receptor in mammalian cells. J Steroid Biochem Mol Biol, 2016.  
  64. Ruiz-Pinto, S., G. Pita, A. Patino-Garcia, P. Garcia-Miguel, J. Alonso, A. Perez-Martinez, A. Sastre, G. Gomez-Mariano, A. Lissat, K. Scotlandi, M. Serra, R. Ladenstein, E. Lapouble, G. Pierron, U. Kontny, P. Picci, H. Kovar, O. Delattre, and A. Gonzalez-Neira. Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome. Ann Oncol, 2016. 27(9): p. 1788-93.  
  65. Scheer, M., T. Dantonello, E. Hallmen, C. Vokuhl, I. Leuschner, M. Sparber-Sauer, B. Kazanowska, F. Niggli, R. Ladenstein, S.S. Bielack, T. Klingebiel, and E. Koscielniak. Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group. Pediatr Blood Cancer, 2016. 63(7): p. 1198-206.  
  66. Schüller, S., A. Attarbaschi, A. Berger, C. Hutter, K. Klebermass-Schrehof, and M. Steiner. Hemophagocytic lymphohistiocytosis triggered by Gaucher disease in a preterm neonate. Pediatric Hematology and Oncology, 2016: p. 1-6.  
  67. Schwentner, R., D. Herrero-Martin, M.O. Kauer, C.N. Mutz, A.M. Katschnig, G. Sienski, J. Alonso, D.N. Aryee, and H. Kovar. The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma. Oncotarget, 2016.  
  68. Seidel, M.G., K. Boztug, and O.A. Haas. Immune Dysregulation Syndromes (IPEX, CD27 Deficiency, and Others): Always Doomed from the Start? J Clin Immunol, 2016. 36(1): p. 6-7.  
  69. Siebert, N., C. Eger, D. Seidel, M. Juttner, M. Zumpe, D. Wegner, S. Kietz, K. Ehlert, G.J. Veal, W. Siegmund, M. Weiss, H. Loibner, R. Ladenstein, and H.N. Lode. Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2. MAbs, 2016. 8(3): p. 604-16.  
  70. Smidak, R., J. Aradska, S. Kirchberger, M. Distel, F.J. Sialana, J. Wackerlig, D. Mechtcheriakova, and G. Lubec. A detailed proteomic profiling of plasma membrane from zebrafish brain. Proteomics Clin Appl, 2016.   Stegmaier, S., I. Leuschner, C. Poremba, R. Ladenstein, B. Kazanowska, G. Ljungman, M. Scheer, B. Blank, S. Bielack, T. Klingebiel, and E. Koscielniak. The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials. Pediatr Blood Cancer, 2017,
  71. Epub 2016 Sep. 64(1): p. 89-95.  
  72. Taschner-Mandl, S., M. Schwarz, J. Blaha, M. Kauer, F. Kromp, N. Frank, F. Rifatbegovic, T. Weiss, R. Ladenstein, M. Hohenegger, I.M. Ambros, and P.F. Ambros. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence. Oncotarget, 2016. 7(3): p. 3571-86.  
  73. Thompson, D., K.T. Vo, W.B. London, M. Fischer, P.F. Ambros, A. Nakagawara, G.M. Brodeur, K.K. Matthay, and S.G. DuBois. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer, 2016. 122(6): p. 935-45.  
  74. Tischer, S., R. Geyeregger, J. Kwoczek, A. Heim, C. Figueiredo, R. Blasczyk, B. Maecker-Kolhoff, and B. Eiz-Vesper. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection. J Transl Med, 2016. 14(1): p. 286.  
  75. Valent, P., B. Groner, U. Schumacher, G. Superti-Furga, M. Busslinger, R. Kralovics, C. Zielinski, J.M. Penninger, D. Kerjaschki, G. Stingl, J.S. Smolen, R. Valenta, H. Lassmann, H. Kovar, U. Jäger, G. Kornek, M. Müller, and F. Sörgel. Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine. J Innate Immun, 2016. 8(2): p. 111-20.  
  76. Ventura, S., D.N. Aryee, F. Felicetti, A. De Feo, C. Mancarella, M.C. Manara, P. Picci, M.P. Colombo, H. Kovar, A. Care, and K. Scotlandi. CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-kappaB signaling. Oncogene, 2016. 35(30): p. 3944-54.  
  77. Vesely, C., C. Frech, C. Eckert, G. Cario, A. Mecklenbrauker, U. zur Stadt, K. Nebral, F. Kraler, S. Fischer, A. Attarbaschi, M. Schuster, C. Bock, H. Cave, A. von Stackelberg, M. Schrappe, M.A. Horstmann, G. Mann, O.A. Haas, and R. Panzer-Grümayer. Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia. Leukemia, 2016.  
  78. Weilner, S., E. Schraml, M. Wieser, P. Messner, K. Schneider, K. Wassermann, L. Micutkova, K. Fortschegger, A.B. Maier, R. Westendorp, H. Resch, S. Wolbank, H. Redl, P. Jansen-Durr, P. Pietschmann, R. Grillari-Voglauer, and J. Grillari. Secreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells. Aging Cell, 2016. 15(4): p. 744-54.  
  79. Weiss, T., S. Taschner-Mandl, A. Bileck, A. Slany, F. Kromp, F. Rifatbegovic, C. Frech, R. Windhager, H. Kitzinger, C.H. Tzou, P.F. Ambros, C. Gerner, and I.M. Ambros. Proteomics and transcriptomics of peripheral nerve tissue and cells unravel new aspects of the human Schwann cell repair phenotype. Glia, 2016. 64(12): p. 2133-2153.  
  80. Witt, V., H. Pichler, G. Fritsch, and C. Peters. Multiple small versus few large amount aspirations for bone marrow harvesting in autologous and allogeneic bone marrow transplantation. Transfus Apher Sci, 2016. 55(2): p. 221-224.  
  81. Wlodarski, M.W., S. Hirabayashi, V. Pastor, J. Stary, H. Hasle, R. Masetti, M. Dworzak, M. Schmugge, M. van den Heuvel-Eibrink, M. Ussowicz, B. De Moerloose, A. Catala, O.P. Smith, P. Sedlacek, A.C. Lankester, M. Zecca, V. Bordon, S. Matthes-Martin, J. Abrahamsson, J.S. Kühl, K.W. Sykora, M.H. Albert, B. Przychodzien, J.P. Maciejewski, S. Schwarz, G. Göhring, B. Schlegelberger, A. Cseh, P. Noellke, A. Yoshimi, F. Locatelli, I. Baumann, B. Strahm, C.M. Niemeyer, and M.D.S. Ewog. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood, 2016. 127(11): p. 1387-97; quiz 1518.  
  82. Worel, N., G. Fritsch, H. Agis, A. Bohm, G. Engelich, G.C. Leitner, K. Geissler, K. Gleixner, P. Kalhs, V. Buxhofer-Ausch, F. Keil, G. Kopetzky, V. Mayr, W. Rabitsch, R. Reisner, K. Rosskopf, R. Ruckser, C. Zoghlami, N. Zojer, and H.T. Greinix. Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure. J Clin Apher, 2016.  
  83. Zaliova, M., A.V. Moorman, G. Cazzaniga, M. Stanulla, R.C. Harvey, K.G. Roberts, S.L. Heatley, M.L. Loh, M. Konopleva, I.M. Chen, O. Zimmermannova, C. Schwab, O. Smith, M.J. Mozziconacci, C. Chabannon, M. Kim, J.H. Frederik Falkenburg, A. Norton, K. Marshall, O.A. Haas, J. Starkova, J. Stuchly, S.P. Hunger, D. White, C.G. Mullighan, C.L. Willman, J. Stary, J. Trka, and J. Zuna. Characterization of leukemias with ETV6-ABL1 fusion. Haematologica, 2016. 101(9): p. 1082-93.  
  84. Zuna, J., A. Moericke, M. Arens, R. Koehler, R. Panzer-Grümayer, C.R. Bartram, S. Fischer, E. Fronkova, M. Zaliova, A. Schrauder, M. Stanulla, M. Zimmermann, J. Trka, J. Stary, A. Attarbaschi, G. Mann, M. Schrappe, and G. Cario. Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemia. Br J Haematol, 2016. 173(5): p. 742-8.
  1. Anderl S, König M, Attarbaschi A, Strehl S. PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia. Mol Cytogenet. 2015 Jul 8;8:48. doi: 10.1186/s13039-015-0138-3. eCollection 2015.  
  2. Bellutti F, Kauer M, Kneidinger D, Lion T, Klein R. Identification of RISC-Associated Adenoviral MicroRNAs, a Subset of Their Direct Targets, and Global Changes in the Targetome upon Lytic Adenovirus 5 Infection. J Virol. 2015 Feb 1;89(3):1608-27. doi: 10.1128/JVI.02336-14.  
  3. Bogen D, Wei JS, Azorsa DO, Ormanoglu P, Buehler E, Guha R, Keller JM, Mathews Griner LA, Ferrer M, Song YK, Liao H, Mendoza A, Gryder BE, Sindri S, He J, Wen X, Zhang S, Shern JF, Yohe ME, Taschner-Mandl S, Shohet JM, Thomas CJ, Martin SE, Ambros PF, Khan J. Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma. Oncotarget. 2015 Nov 3;6(34):35247-62. doi: 10.18632/oncotarget.6208.  
  4. Cross NC, White H, Colomer D, Ehrencrona H, Foroni L, Gottardi E, Lange T, Lion T, Polakova KM, Dulucq S, Martinelli G, Leibundgut EO, Pallisgaard N, Barbany G, Sacha T, Talmaci R, Izzo B, Saglio G, Pane F, Müller MC, Hochhaus A, “Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia”, Leukemia. 2015 Feb 5. doi: 10.1038/leu.2015.29.  
  5. Freimüller C, Stemberger J, Artwohl M, Germeroth L, Witt V, Fischer G, Tischer S, Eiz-Vesper B, Knippertz I, Dörrie J, Schaft N, Lion T, Fritsch G, Geyeregger R. Selection of adenovirus-specific and Epstein-Barr virus-specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)-compliant conditions. Cytotherapy. 2015 Apr 9. pii: S1465-3249(15)00697-0. doi: 10.1016/j.jcyt.2015.03.613. [Epub ahead of print] PMID: 25866178  
  6. Grausenburger R, Bastelberger S, Eckert C, Kauer M, Stanulla M, Frech C, Bauer E, Stoiber D, von Stackelberg A, Attarbaschi A, Haas OA, Panzer-Grümayer R. Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia. Leuk Lymphoma. 2015 Sep 1:1-24. [Epub ahead of print]  
  7. Heitzeneder S, Zeitlhofer P, Pötschger U, Nowak E, Seidel MG, Hölzl M, Lawitschka A, Förster-Waldl E, Matthes-Martin S, Heja D, Haas OA, Heitger A. Mannan-binding lectin deficiency attenuates acute GvHD in pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant. 2015 Aug;50(8):1127-9. doi: 10.1038/bmt.2015.81. Epub 2015 May 11.  
  8. Kosulin K, Zimmerhackl A, Hainfellner JA, Haberler C, Amann G, Lang S, and Lion T. Screening for the Polyomaviruses BKV, JCV and SV40 in Pediatric Malignancies. Int J Cancer Clin Res 2015, 2:019   Kovar H. SLFN11: Achilles’ Heel or Troublemaker. Clin Cancer Res. 2015 Sep 15;21(18):4033-4. pii: clincanres.0883.2015. [Epub ahead of print] PMID: 26034126  
  9. Malinowska-Ozdowy K, Frech C, Schönegger A, Eckert C, Cazzaniga G, Stanulla M, zur Stadt U, Mecklenbräuker A, Schuster M, Kneidinger D, von Stackelberg A, Locatelli F, Schrappe M, Horstmann MA, Attarbaschi A, Bock C, Mann G, Haas OA, Panzer-Grümayer R. KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia. Leukemia. 2015 Aug;29(8):1656-67. doi: 10.1038/leu.2015.107. Epub 2015 Apr 28.  
  10. Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Catala A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C, Yoshimi A. Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. Haematologica. 2015 Jan;100(1):17-22. doi: 10.3324/haematol.2014.109892.  
  11. Rifatbegovic F, Abbasi MR, Taschner-Mandl S, Kauer M, Weinhäusel A, Handgretinger R, Ambros PF. Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study. PLoS One. 2015 Sep 11;10(9):e0137995. doi: 10.1371/journal.pone.0137995. eCollection 2015.  
  12. Schinnerl D, Fortschegger K, Kauer M, Marchante JR, Kofler R, Den Boer ML, Strehl S. The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia. Blood. 2015 Feb 19;125(8):1282-91. doi: 10.1182/blood-2014-04-570960. Epub 2014 Dec 16.  
  13. Raphaela Schwentner, Theodore Papamarkou, Maximilian O. Kauer, Vassilios Stathopoulos, Fan Yang, Sven Bilke, Paul S. Meltzer, Mark Girolami and Heinrich Kovar, EWS-FLI1 employs an E2F switch to drive target gene expression, Nucleic Acids Research, Mar 11;43(5):2780-9. 2015 doi: 10.1093/nar/gkv123  
  14. Soukup K, Halfmann A, Le Bras M, Sahin E, Vittori S, Poyer F, Schuh C, Luger R, Niederreiter B, Haider T, Stoiber D, Blüml S, Schabbauer G, Kotlyarov A, Gaestel M, Felzmann T, Dohnal AM. The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis. J Immunol. 2015 Jul 15;195(2):541-52. doi: 10.4049/jimmunol.1401663. Epub 2015 Jun 15. PMID: 26078274.  
  15. Tamamyan G, Dominkus M, Lang S, Diakos C, Mittheisz E, Horcher E, Holter W, Zoubek A, Bielack S, Kager L. Multiple relapses in high-grade osteosarcoma: When to stop aggressive therapy? Pediatr Blood Cancer. 2015 Mar;62(3):529-30. doi: 10.1002/pbc.25360. Epub 2014 Dec 8.  
  16. Sabine Taschner-Mandl, Magdalena Schwarz, Johanna Blaha, Maximilian Kauer, Florian Kromp, Nelli Frank, Fikret Rifatbegovic, Tamara Weiss, Ruth Ladenstein, Martin Hohenegger, Inge M. Ambros, Peter F. Ambros. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence. DOI: 10.18632/oncotarget.6527 Dec. 2015  
  17. Tomazou EM, Nathan C. Sheffield, Christian Schmidl, Michael Schuster, Andreas Schönegger, Paul Datlinger, Stefan Kubicek, Christoph Bock, Heinrich Kovar (2015). Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1. Cell Reports, 2015 Feb 24;10(7):1082-95.10:1-14. (Feb 27; online publication Feb 19)  
  18. Woutsas S, Aytekin C, Salzer E, Conde CD, Apaydin S, Pichler H, Memaran-Dadgar N, Hosnut FO, Förster-Waldl E, Matthes S, Huber WD, Lion T, Holter W, Bilic I, Boztug K. Hypomorphic mutation in TTC7A causes combined immunodeficiency with mild structural intestinal defects. Blood. 2015 Mar 5;125(10):1674-6. doi: 10.1182/blood-2014-08-595397.
  1. A. M. Aalbers, M. M. van den Heuvel-Eibrink, I. Baumann, H. B. Beverloo, G. J. Driessen, M. Dworzak, A. Fischer, G. Gohring, H. Hasle, F. Locatelli, B. De Moerloose, P. Noellke, M. Schmugge, J. Stary, A. Yoshimi, M. Zecca, C. M. Zwaan, J. J. van Dongen, R. Pieters, C. M. Niemeyer, V. H. van der Velden, and A. W. Langerak, ‘T-Cell Receptor Vbeta Skewing Frequently Occurs in Refractory Cytopenia of Childhood and Is Associated with an Expansion of Effector Cytotoxic T Cells: A Prospective Study by Ewog-Mds’, Blood Cancer J, 4 (2014), e209.  
  2. A. M. Aalbers, V. H. van der Velden, A. Yoshimi, A. Fischer, P. Noellke, C. M. Zwaan, I. Baumann, H. B. Beverloo, M. Dworzak, H. Hasle, F. Locatelli, B. De Moerloose, G. Gohring, M. Schmugge, J. Stary, M. Zecca, A. W. Langerak, J. J. van Dongen, R. Pieters, C. M. Niemeyer, and M. M. van den Heuvel-Eibrink, ‘The Clinical Relevance of Minor Paroxysmal Nocturnal Hemoglobinuria Clones in Refractory Cytopenia of Childhood: A Prospective Study by Ewog-Mds’, Leukemia, 28 (2014), 189-92.  
  3. M.R. Abbasi, F. Rifatbegovic, C. Brunner, R. Ladenstein, I.M. Ambros, P.F. Ambros, ‘Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses’, Molecular Oncology Mol Oncol. 2014 Oct 28. pii: S1574-7891(14)00249-X. doi: 10.1016/j.molonc.2014.10.010. [Epub ahead of print] (2014) 1e1 0.  
  4. A. Agaimy, K. D. Stachel, J. Jungert, T. Radkow, R. Carbon, M. Metzler, and W. Holter, ‘Malignant Epithelioid Peripheral Nerve Sheath Tumor with Prominent Reticular/Microcystic Pattern in a Child: A Low-Grade Neoplasm with 18-Years Follow-Up’, Appl Immunohistochem Mol Morphol, 22 (2014), 627-33.  
  5. S.M. Ahmadi, M.A. Hölzl, E. Mayer, T. Wekerle, A. Heitger, ‘CTLA4-Ig Preserves Thymus-Derived T Regulatory Cells’, Transplantation. 2014 Sep 29. [Epub ahead of print] PMID: 25269023.  
  6. I. M. Ambros, C. Brunner, R. Abbasi, C. Frech, and P. F. Ambros, ‘Ultra-High Density Snparray in Neuroblastoma Molecular Diagnostics’, Front Oncol, 4 (2014), 202.   A. Attarbaschi, R. Panzer-Grumayer, G. Mann, A. Moricke, M. Konig, A. Mecklenbrauker, A. Teigler-Schlegel, J. Bradtke, J. Harbott, G. Gohring, M. Stanulla, M. Schrappe, M. Zimmermann, O. A. Haas, Austrian on behalf of the, and A. L. L. B. F. M. Study Group German, ‘Minimal Residual Disease-Based Treatment Is Adequate for Relapse-Prone Childhood Acute Lymphoblastic Leukemia with an Intrachromosomal Amplification of Chromosome 21: The Experience of the All-Bfm 2000 Trial’, Klin Padiatr, 226 (2014), 338-43.  
  7. J. Ban, D. Aryee, A. Fourtouna, W. van der Ent, M. Kauer, S. Niedan, I. Machado, C. Rodriguez-Galindo, O.M. Tirado, R. Schwentner, P. Picci, A.M. Flanagan, V. Berg, S.J. Strauss, K. Scotlandi, E.R. Lawlor, E. Snaar-Jagalska, A. Llombart-Bosch, H. Kovar, ‘Suppression of deacetylase SIRT1 mediates tumor suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma’, Cancer Research, (2014) published OnlineFirst October 3; doi: 10.1158/0008-5472.CAN-14-1736  
  8. S. A. Ban, E. Salzer, M. M. Eibl, A. Linder, C. B. Geier, E. Santos-Valente, W. Garncarz, T. Lion, R. Ott, C. Seelbach, K. Boztug, and H. M. Wolf, ‘Combined Immunodeficiency Evolving into Predominant Cd4+ Lymphopenia Caused by Somatic Chimerism in Jak3’, J Clin Immunol (2014).  
  9. H. Boztug, N. Mühlegger, E. Glogova, G. Mann, C. Urban, B. Meister, K. Schmitt, N. Jones, A. Attarbaschi, O. Haas, S. Strehl, T. Lion, U. Pötschger, F.-M. Fink, H. Gadner, M. Dworzak, ‘Development of treatment and clinical results in childhood AML in Austria (1993–2013)’, Magazine of European Oncology, February 2014, Volume 7, Issue 1, pp 63-74.  
  10. J. Buchroithner, J. Pichler, C. Marosi, G. Widhalm, M. Seiz-Rosenhagen, M. Novosielski, S. Oberndorfer, R. Ruckser, K. Rossler, A. Azizi, G. von Campe, K. Bordihn, and T. Felzmann, ‘Vascular Endothelia Growth Factor Targeted Therapy May Improve the Effect of Dendritic Cell-Based Cancer Immune Therapy’, Int J Clin Pharmacol Ther, 52 (2014), 76-7.  
  11. T. D. Buitenkamp, S. Izraeli, M. Zimmermann, E. Forestier, N. A. Heerema, M. M. van den Heuvel-Eibrink, R. Pieters, C. M. Korbijn, L. B. Silverman, K. Schmiegelow, D. C. Liang, K. Horibe, M. Arico, A. Biondi, G. Basso, K. R. Rabin, M. Schrappe, G. Cario, G. Mann, M. Morak, R. Panzer-Grumayer, V. Mondelaers, T. Lammens, H. Cave, B. Stark, I. Ganmore, A. V. Moorman, A. Vora, S. P. Hunger, C. H. Pui, C. G. Mullighan, A. Manabe, G. Escherich, J. R. Kowalczyk, J. A. Whitlock, and C. M. Zwaan, ‘Acute Lymphoblastic Leukemia in Children with Down Syndrome: A Retrospective Analysis from the Ponte Di Legno Study Group’, Blood, 123 (2014), 70-7.  
  12. E. A. Coenen, C. M. Zwaan, J. Stary, A. Baruchel, V. de Haas, R. W. Stam, D. Reinhardt, G. J. Kaspers, S. T. Arentsen-Peters, C. Meyer, R. Marschalek, L. L. Nigro, M. Dworzak, R. Pieters, and M. M. van den Heuvel-Eibrink, ‘Unique Bhlhb3 Overexpression in Pediatric Acute Myeloid Leukemia with T(6;11)(Q27;Q23)’, Leukemia, 28 (2014), 1564-8.   U. Creutzig, M. Zimmermann, M. N. Dworzak, B. Gibson, R. Tamminga, J. Abrahamsson, S. Y. Ha, H. Hasle, A. Maschan, Y. Bertrand, G. Leverger, C. von Neuhoff, B. Razzouk, C. Rizzari, P. Smisek, O. P. Smith, B. Stark, D. Reinhardt, and G. L. Kaspers, ‘The Prognostic Significance of Early Treatment Response in Pediatric Relapsed Acute Myeloid Leukemia: Results of the International Study Relapsed Aml 2001/01’, Haematologica, 99 (2014), 1472-8.  
  13. T. M. Dantonello, M. Stark, B. Timmermann, J. Fuchs, B. Selle, C. Linderkamp, R. Handgretinger, R. Hagen, S. Feuchtgruber, S. Kube, D. Kosztyla, B. Kazanowska, R. Ladenstein, F. Niggli, G. Ljungman, S. S. Bielack, T. Klingebiel, E. Koscielniak, and Studiengruppe Cooperative Weichteilsarkom, ‘Tumour Volume Reduction after Neoadjuvant Chemotherapy Impacts Outcome in Localised Embryonal Rhabdomyosarcoma’, Pediatr Blood Cancer, 62 (2015), 16-23.  
  14. R. Defferrari, K. Mazzocco, I. M. Ambros, P. F. Ambros, C. Bedwell, K. Beiske, J. Benard, A. P. Berbegall, N. Bown, V. Combaret, J. Couturier, G. Erminio, C. Gambini, A. Garaventa, N. Gross, R. Haupt, J. Kohler, M. Jeison, J. Lunec, B. Marques, T. Martinsson, R. Noguera, S. Parodi, G. Schleiermacher, D. A. Tweddle, A. Valent, N. Van Roy, A. Vicha, E. Villamon, and G. P. Tonini, ‘Influence of Segmental Chromosome Abnormalities on Survival in Children over the Age of 12 Months with Unresectable Localised Peripheral Neuroblastic Tumours without Mycn Amplification’, Br J Cancer (2014).  
  15. D. Denk, J. Bradtke, M. Konig, and S. Strehl, ‘Pax5 Fusion Genes in T(7;9)(q11.2;p13) Leukemia: A Case Report and Review of the Literature’, Mol Cytogenet, 7 (2014), 13.  
  16. C. Diakos, Y. Xiao, S. Zheng, L. Kager, M. Dworzak, and J. L. Wiemels, ‘Direct and Indirect Targets of the E2a-Pbx1 Leukemia-Specific Fusion Protein’, PLoS One, 9 (2014), e87602.  
  17. J. Dörrie, C. Krug, C. Hofmann, I. Müller, V. Wellner, I. Knippertz, S. Schierer, S. Thomas, E. Zipperer, D. Printz, G. Fritsch, G. Schuler, N. Schaft, R. Geyeregger, ‘Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation’, PLOS One (2014) Published: October 07, 2014DOI: 10.1371/journal.pone.0109944  
  18. M.N. Dworzak, ‘Cure and care for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries: part II’, Magazine of European Medical Oncology DOI 10.1007/s12254-014-0134-z.  
  19. M. Floderer, M. Prchal-Murphy, C. Vizzardelli, ‘Dendritic Cell-Secreted Lipocalin2 Induces CD8+ T-Cell Apoptosis, Contributes to T-Cell Priming and Leads to a TH1 Phenotype’, PLoS One. 2014 Jul 10;9(7).   K. Fortschegger, S. Anderl, D. Denk, and S. Strehl, ‘Functional Heterogeneity of Pax5 Chimeras Reveals Insight for Leukemia Development’, Mol Cancer Res, 12 (2014), 595-606.  
  20. R. Geyeregger, C. Freimuller, J. Stemberger, M. Artwohl, V. Witt, T. Lion, G. Fischer, A. Lawitschka, J. Ritter, M. Hummel, W. Holter, G. Fritsch, and S. Matthes-Martin, ‘First-in-Man Clinical Results with Good Manufacturing Practice (Gmp)-Compliant Polypeptide-Expanded Adenovirus-Specific T Cells after Haploidentical Hematopoietic Stem Cell Transplantation’, J Immunother, 37 (2014), 245-9.  
  21. R. Geyeregger, C. Freimuller, J. Stemberger, G. Fischer, V. Witt, and G. Fritsch, ‘Human Adv-Specific T Cells: Persisting in Vitro Functionality Despite Lethal Irradiation’, Bone Marrow Transplant, 49 (2014), 934-41.  
  22. L. J. Hajingabo, S. Daakour, M. Martin, R. Grausenburger, R. Panzer-Grumayer, F. Dequiedt, N. Simonis, and J. C. Twizere, ‘Predicting Interactome Network Perturbations in Human Cancer: Application to Gene Fusions in Acute Lymphoblastic Leukemia’, Mol Biol Cell, 25 (2014), 3973  
  23. C. J. Harrison, A. V. Moorman, C. Schwab, A. J. Carroll, E. A. Raetz, M. Devidas, S. Strehl, K. Nebral, J. Harbott, A. Teigler-Schlegel, M. Zimmerman, N. Dastuge, A. Baruchel, J. Soulier, M. F. Auclerc, A. Attarbaschi, G. Mann, B. Stark, G. Cazzaniga, L. Chilton, P. Vandenberghe, E. Forestier, I. Haltrich, S. C. Raimondi, M. Parihar, J. P. Bourquin, J. Tchinda, C. Haferlach, A. Vora, S. P. Hunger, N. A. Heerema, O. A. Haas, and Leukemia Ponte di Legno International Workshop in Childhood Acute Lymphoblastic, ‘An International Study of Intrachromosomal Amplification of Chromosome 21 (Iamp21): Cytogenetic Characterization and Outcome’, Leukemia, 28 (2014), 1015-21.  
  24. O. Hrusak, G. Basso, R. Ratei, G. Gaipa, D. Luria, E. Mejstrikova, L. Karawajew, B. Buldini, E. Rozenthal, J. P. Bourquin, T. Kalina, M. Sartor, M. N. Dworzak, and Aieop-Bfm Flow Network, ‘Flow Diagnostics Essential Code: A Simple and Brief Format for the Summary of Leukemia Phenotyping’, Cytometry B Clin Cytom, 86 (2014), 288-91.  
  25. M. Ilander, P. Koskenvesa, S. Hernesniemi, T. Lion, K. Porkka, and S. Mustjoki, ‘Induction of Sustained Deep Molecular Response in a Patient with Chronic-Phase T315i-Mutated Chronic Myeloid Leukemia with Interferon-Alpha Monotherapy’, Leuk Lymphoma, 55 (2014), 934-7.  
  26. U. Kaindl, M. Morak, C. Portsmouth, A. Mecklenbrauker, M. Kauer, M. Zeginigg, A. Attarbaschi, O. A. Haas, and R. Panzer-Grumayer, ‘Blocking Etv6/Runx1-Induced Mdm2 Overexpression by Nutlin-3 Reactivates P53 Signaling in Childhood Leukemia’, Leukemia, 28 (2014), 600-8.  
  27. R. Kastner, A. Zopf, S. Preuner, J. Proll, N. Niklas, P. Foskett, P. Valent, T. Lion, and C. Gabriel, ‘Rapid Identification of Compound Mutations in Patients with Philadelphia-Positive Leukaemias by Long-Range Next Generation Sequencing’, Eur J Cancer, 50 (2014), 793-800.   M. Koenighofer, T. Lion, A. Bodenteich, E. Prieschl-Grassauer, A. Grassauer, H. Unger, C. A. Mueller, and T. Fazekas, ‘Carrageenan Nasal Spray in Virus Confirmed Common Cold: Individual Patient Data Analysis of Two Randomized Controlled Trials’, Multidiscip Respir Med, 9 (2014), 57.  
  28. K. Kosulin, M. Rauch, P. F. Ambros, U. Potschger, A. Chott, U. Jager, J. Drach, A. Nader, and T. Lion, ‘Screening for Adenoviruses in Haematological Neoplasia: High Prevalence in Mantle Cell Lymphoma’, Eur J Cancer, 50 (2014), 622-7.H.  
  29. Kovar, ‘Blocking the Road, Stopping the Engine or Killing the Driver? Advances in Targeting Ews/Fli-1 Fusion in Ewing Sarcoma as Novel Therapy’, Expert Opin Ther Targets (2014), 1-14.   J. R. Kowalczyk, M. Samardakiewicz, E. Fitzgerald, S. Essiaf, R. Ladenstein, G. Vassal, A. Kienesberger, and K. Pritchard-Jones, ‘Towards Reducing Inequalities: European Standards of Care for Children with Cancer’, Eur J Cancer, 50 (2014), 481-5.  
  30. M. C. Le Deley, M. Paulussen, I. Lewis, B. Brennan, A. Ranft, J. Whelan, G. Le Teuff, J. Michon, R. Ladenstein, P. Marec-Berard, H. van den Berg, L. Hjorth, K. Wheatley, I. Judson, H. Juergens, A. Craft, O. Oberlin, and U. Dirksen, ‘Cyclophosphamide Compared with Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-Ewing99-R1 Trial’, J Clin Oncol, 32 (2014), 2440-8.  
  31. T. Lion, ‘Adenovirus Infections in Immunocompetent and Immunocompromised Patients’, Clin Microbiol Rev, 27 (2014), 441-62.   H. J. Meany, W. B. London, P. F. Ambros, K. K. Matthay, T. Monclair, T. Simon, A. Garaventa, F. Berthold, A. Nakagawara, S. L. Cohn, A. D. Pearson, and J. R. Park, ‘Significance of Clinical and Biologic Features in Stage 3 Neuroblastoma: A Report from the International Neuroblastoma Risk Group Project’, Pediatr Blood Cancer (2014).  
  32. B. Meissner, T. Bartram, C. Eckert, J. Trka, R. Panzer-Grumayer, I. Hermanova, E. Ellinghaus, A. Franke, A. Moricke, A. Schrauder, A. Teigler-Schlegel, P. Dorge, A. von Stackelberg, G. Basso, C. R. Bartram, R. Kirschner-Schwabe, B. Bornhauser, J. P. Bourquin, G. Cazzaniga, J. Hauer, A. Attarbaschi, S. Izraeli, M. Zaliova, G. Cario, M. Zimmermann, S. Avigad, M. Sokalska-Duhme, M. Metzler, M. Schrappe, R. Koehler, G. Te Kronnie, and M. Stanulla, ‘Frequent and Sex-Biased Deletion of Slx4ip by Illegitimate V(D)J-Mediated Recombination in Childhood Acute Lymphoblastic Leukemia’, Hum Mol Genet, 23 (2014), 590-601.  
  33. D. A. Morgenstern, W. B. London, D. Stephens, S. L. Volchenboum, B. Hero, A. Di Cataldo, A. Nakagawara, H. Shimada, P. F. Ambros, K. K. Matthay, S. L. Cohn, A. D. Pearson, and M. S. Irwin, ‘Metastatic Neuroblastoma Confined to Distant Lymph Nodes (Stage 4n) Predicts Outcome in Patients with Stage 4 Disease: A Study from the International Neuroblastoma Risk Group Database’, J Clin Oncol, 32 (2014), 1228-35.   Y. P. Mosse, R. J. Deyell, F. Berthold, A. Nagakawara, P. F. Ambros, T. Monclair, S. L. Cohn, A. D. Pearson, W. B. London, and K. K. Matthay, ‘Neuroblastoma in Older Children, Adolescents and Young Adults: A Report from the International Neuroblastoma Risk Group Project’, Pediatr Blood Cancer, 61 (2014), 627-35.  
  34. S. Niedan, M. Kauer, D. N. Aryee, R. Kofler, R. Schwentner, A. Meier, U. Potschger, U. Kontny, and H. Kovar, ‘Suppression of Foxo1 Is Responsible for a Growth Regulatory Repressive Transcriptional Sub-Signature of Ews-Fli1 in Ewing Sarcoma’, Oncogene, 33 (2014), 3927-38.  
  35. H. Pichler, V. Witt, E. Winter, H. Boztug, E. Glogova, U. Potschger, S. Matthes-Martin, and G. Fritsch, ‘No Impact of Total or Myeloid Cd34+ Cell Numbers on Neutrophil Engraftment and Transplantation-Related Mortality after Allogeneic Pediatric Bone Marrow Transplantation’, Biol Blood Marrow Transplant, 20 (2014), 676-83.  
  36. A. R. Poetsch, D. B. Lipka, T. Witte, R. Claus, P. Nollke, M. Zucknick, C. Olk-Batz, S. Fluhr, M. Dworzak, B. De Moerloose, J. Stary, M. Zecca, H. Hasle, M. Schmugge, M. M. van den Heuvel-Eibrink, F. Locatelli, C. M. Niemeyer, C. Flotho, and C. Plass, ‘Rasa4 Undergoes DNA Hypermethylation in Resistant Juvenile Myelomonocytic Leukemia’, Epigenetics, 9 (2014), 1252-60.  
  37. S. Preuner, M. Danzer, J. Proll, U. Potschger, A. Lawitschka, C. Gabriel, and T. Lion, ‘High-Quality DNA from Fingernails for Genetic Analysis’, J Mol Diagn, 16 (2014), 459-66.   S. Preuner, and T. Lion, ‘Post-Transplant Monitoring of Chimerism by Lineage-Specific Analysis’, Methods Mol Biol, 1109 (2014), 271-91.  
  38. M. Reiter, J. Hoffmann, F. Kleber, A. Schumich, G. Peter, F. Kromp, M. Kampel, M. Dworzak, ‘Towards automation of flow cytometric analysis for quality-assured follow-up assessment to guide curative therapy for acute lymphoblastic leukaemia in children’, Magazine of European Medical Oncology, Epub ahead of print DOI 10.1007/s12254-014-0172-6.  
  39. Reiter M., Kromp F., Ambros P.F., ‘Semi-Automated Segmentation of Neuroblastoma Nuclei Using the Gradient Energy Tensor: A User Driven Approach’, 2014 The 7th International Conference on Machine Vision ICMV 2014, V092 (2014).  
  40. I. Sadovnik, E. Lierman, B. Peter, H. Herrmann, V. Suppan, G. Stefanzl, O. Haas, T. Lion, W. Pickl, J. Cools, P. Vandenberghe, and P. Valent, ‘Identification of Ponatinib as a Potent Inhibitor of Growth, Migration, and Activation of Neoplastic Eosinophils Carrying Fip1l1-Pdgfra’, Exp Hematol, 42 (2014), 282-93 e4.  
  41. E. Sahin, S. Haubenwallner, M. Kuttke, I. Kollmann, A. Halfmann, A. B. Dohnal, L. Chen, P. Cheng, B. Hoesel, E. Einwallner, J. Brunner, J. B. Kral, W. C. Schrottmaier, K. Thell, V. Saferding, S. Bluml, and G. Schabbauer, ‘Macrophage Pten Regulates Expression and Secretion of Arginase I Modulating Innate and Adaptive Immune Responses’, J Immunol, 193 (2014), 1717-27.  
  42. E. Sahin, S. Haubenwallner, M. Kuttke, I. Kollmann, A. Halfmann, A. M. Dohnal, L. Chen, P. Cheng, B. Hoesel, E. Einwallner, J. Brunner, J. B. Kral, W. C. Schrottmaier, K. Thell, V. Saferding, S. Bluml, and G. Schabbauer, ‘Correction: Macrophage Pten Regulates Expression and Secretion of Arginase I Modulating Innate and Adaptive Immune Responses’, J Immunol, 193 (2014), 5350.  
  43. L. Slamova, J. Starkova, E. Fronkova, M. Zaliova, L. Reznickova, F. W. van Delft, E. Vodickova, J. Volejnikova, Z. Zemanova, K. Polgarova, G. Cario, M. Figueroa, T. Kalina, K. Fiser, J. P. Bourquin, B. Bornhauser, M. Dworzak, J. Zuna, J. Trka, J. Stary, O. Hrusak, and E. Mejstrikova, ‘Cd2-Positive B-Cell Precursor Acute Lymphoblastic Leukemia with an Early Switch to the Monocytic Lineage’, Leukemia, 28 (2014), 609-20.  
  44. Svoboda LK, Harris A, Bailey NJ, Schwentner R, Tomazou E, von Levetzow C, Magnuson B, Ljungman M, Kovar H, Lawlor ER. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs. Epigenetics. 2014 Dec 2;9(12):1613-25. doi: 10.4161/15592294.2014.988048.  
  45. P. Valent, I. Sadovnik, Z. Racil, H. Herrmann, K. Blatt, S. Cerny-Reiterer, G. Eisenwort, T. Lion, T. Holyoake, and J. Mayer, ‘Dppiv (Cd26) as a Novel Stem Cell Marker in Ph+ Chronic Myeloid Leukaemia’, Eur J Clin Invest, 44 (2014), 1239-45.  
  46. G. Vassal, E. Fitzgerald, M. Schrappe, F. Arnold, J. Kowalczyk, D. Walker, L. Hjorth, R. Riccardi, A. Kienesberger, K. P. Jones, M. G. Valsecchi, D. Janic, H. Hasle, P. Kearns, G. Petrarulo, F. Florindi, S. Essiaf, and R. Ladenstein, ‘Challenges for Children and Adolescents with Cancer in Europe: The Siop-Europe Agenda’, Pediatr Blood Cancer, 61 (2014), 1551-7.  
  47. E. Vecsei, S. Steinwendner, H. Kogler, A. Innerhofer, K. Hammer, O. A. Haas, G. Amann, A. Chott, H. Vogelsang, R. Schoenlechner, W. Huf, and A. Vecsei, ‘Follow-up of Pediatric Celiac Disease: Value of Antibodies in Predicting Mucosal Healing, a Prospective Cohort Study’, BMC Gastroenterol, 14 (2014), 28.  
  48. V. F. Viprey, W. M. Gregory, M. V. Corrias, A. Tchirkov, K. Swerts, A. Vicha, S. Dallorso, P. Brock, R. Luksch, D. Valteau-Couanet, V. Papadakis, G. Laureys, A. D. Pearson, R. Ladenstein, and S. A. Burchill, ‘Neuroblastoma Mrnas Predict Outcome in Children with Stage 4 Neuroblastoma: A European Hr-Nbl1/Siopen Study’, J Clin Oncol, 32 (2014), 1074-83.  
  49. K. T. Vo, K. K. Matthay, J. Neuhaus, W. B. London, B. Hero, P. F. Ambros, A. Nakagawara, D. Miniati, K. Wheeler, A. D. Pearson, S. L. Cohn, and S. G. DuBois, ‘Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report from the International Neuroblastoma Risk Group Project’, J Clin Oncol. 2014 Oct 1;32(28):3169-76. doi: 10.1200/JCO.2014.56.1621. Epub 2014 Aug 25.  
  50. H. White, L. Deprez, P. Corbisier, V. Hall, F. Lin, S. Mazoua, S. Trapmann, A. Aggerholm, H. Andrikovics, S. Akiki, G. Barbany, N. Boeckx, A. Bench, M. Catherwood, J. M. Cayuela, S. Chudleigh, T. Clench, D. Colomer, F. Daraio, S. Dulucq, J. Farrugia, L. Fletcher, L. Foroni, R. Ganderton, G. Gerrard, E. Gineikiene, S. Hayette, H. El Housni, B. Izzo, M. Jansson, P. Johnels, T. Jurcek, V. Kairisto, A. Kizilors, D. W. Kim, T. Lange, T. Lion, K. M. Polakova, G. Martinelli, S. McCarron, P. A. Merle, B. Milner, G. Mitterbauer-Hohendanner, M. Nagar, G. Nickless, J. Nomdedeu, D. A. Nymoen, E. O. Leibundgut, U. Ozbek, T. Pajic, H. Pfeifer, C. Preudhomme, K. Raudsepp, G. Romeo, T. Sacha, R. Talmaci, T. Touloumenidou, V. H. Van der Velden, P. Waits, L. Wang, E. Wilkinson, G. Wilson, D. Wren, R. Zadro, J. Ziermann, K. Zoi, M. C. Muller, A. Hochhaus, H. Schimmel, N. C. Cross, and H. Emons, ‘A Certified Plasmid Reference Material for the Standardisation of Bcr-Abl1 Mrna Quantification by Real-Time Quantitative Pcr’, Leukemia (2014).  
  51. J. J. Yang, T. S. Park, S. T. Lee, J. Y. Seo, S. H. Oh, E. H. Cho, S. Strehl, N. Muhlegger, M. N. Dworzak, J. Zuna, D. Pospisilova, C. Meyer, R. Marschalek, H. J. Kim, and S. H. Kim, ‘Molecular Characterization and Clinical Impact of T(11;15)(Q23;Q14-15) Mll-Casc5 Rearrangement’, Haematologica, 99 (2014), e11-3.  
  52. A. Yoshimi, M. M. van den Heuvel-Eibrink, I. Baumann, S. Schwarz, I. Simonitsch-Klupp, P. de Paepe, V. Campr, G. B. Kerndrup, M. O’Sullivan, R. Devito, R. Leguit, M. Hernandez, M. Dworzak, B. de Moerloose, J. Stary, H. Hasle, O. P. Smith, M. Zecca, A. Catala, M. Schmugge, F. Locatelli, M. Fuhrer, A. Fischer, A. Guderle, P. Nollke, B. Strahm, and C. M. Niemeyer, ‘Comparison of Horse and Rabbit Antithymocyte Globulin in Immunosuppressive Therapy for Refractory Cytopenia of Childhood’, Haematologica, 99 (2014), 656-63.
  1. A. M. Aalbers, M. M. van den Heuvel-Eibrink, V. de Haas, J. G. Te Marvelde, A. X. de Jong, M. van der Burg, M. Dworzak, H. Hasle, F. Locatelli, B. De Moerloose, M. Schmugge, J. Stary, M. Zecca, C. M. Zwaan, A. A. van de Loosdrecht, J. J. van Dongen, C. M. Niemeyer, and V. H. van der Velden, ‘Applicability of a Reproducible Flow Cytometry Scoring System in the Diagnosis of Refractory Cytopenia of Childhood’, Leukemia, 27 (2013), 1923-5.  
  2. D. N. Aryee, S. Niedan, J. Ban, R. Schwentner, K. Muehlbacher, M. Kauer, R. Kofler, and H. Kovar, ‘Variability in Functional P53 Reactivation by Prima-1(Met)/Apr-246 in Ewing Sarcoma’, Br J Cancer, 109 (2013), 2696-704.  
  3. R. Beier, M. H. Albert, P. Bader, A. Borkhardt, U. Creutzig, M. Eyrich, K. Ehlert, B. Gruhn, J. Greil, R. Handgretinger, W. Holter, T. Klingebiel, B. Kremens, P. Lang, C. Mauz-Korholz, R. Meisel, I. Muller, C. Peters, D. Reinhardt, P. Sedlacek, A. Schulz, F. R. Schuster, A. Schrauder, B. Strahm, K. W. Sykora, W. Wossmann, M. Zimmermann, and M. G. Sauer, ‘Allo-Sct Using Bu, Cy and Melphalan for Children with Aml in Second Cr’, Bone Marrow Transplant, 48 (2013), 651-6.  
  4. R. Beier, A. Schulz, M. Honig, M. Eyrich, P. G. Schlegel, W. Holter, K. D. Stachel, K. Ehlert, J. Greil, W. Nurnberger, W. Wossmann, P. Bader, C. Urban, I. Muller, M. Suttorp, M. Sauer, B. Gruhn, R. Meisel, M. Zimmermann, and K. W. Sykora, ‘Long-Term Follow-up of Children Conditioned with Treosulfan: German and Austrian Experience’, Bone Marrow Transplant, 48 (2013), 491-501.  
  5. S. Bilke, R. Schwentner, F. Yang, M. Kauer, G. Jug, R. L. Walker, S. Davis, Y. J. Zhu, M. Pineda, P. S. Meltzer, and H. Kovar, ‘Oncogenic Ets Fusions Deregulate E2f3 Target Genes in Ewing Sarcoma and Prostate Cancer’, Genome Res, 23 (2013), 1797-809.  
  6. H. Boztug, A. Schumich, U. Potschger, N. Muhlegger, A. Kolenova, K. Reinhardt, and M. Dworzak, ‘Blast Cell Deficiency of Cd11a as a Marker of Acute Megakaryoblastic Leukemia and Transient Myeloproliferative Disease in Children with and without Down Syndrome’, Cytometry B Clin Cytom, 84 (2013), 370-8.  
  7. F. Brackmann, M. Krumbholz, T. Langer, W. Rascher, W. Holter, and M. Metzler, ‘Novel Mll2 Mutation in Kabuki Syndrome with Hypogammaglobulinemia and Severe Chronic Thrombopenia’, J Pediatr Hematol Oncol, 35 (2013), e314-6.  
  8. E. A. Coenen, C. M. Zwaan, D. Reinhardt, C. J. Harrison, O. A. Haas, V. de Haas, V. Mihal, B. De Moerloose, M. Jeison, J. E. Rubnitz, D. Tomizawa, D. Johnston, T. A. Alonzo, H. Hasle, A. Auvrignon, M. Dworzak, A. Pession, V. H. van der Velden, J. Swansbury, K. F. Wong, K. Terui, S. Savasan, M. Winstanley, G. Vaitkeviciene, M. Zimmermann, R. Pieters, and M. M. van den Heuvel-Eibrink, ‘Pediatric Acute Myeloid Leukemia with T(8;16)(P11;P13), a Distinct Clinical and Biological Entity: A Collaborative Study by the International-Berlin-Frankfurt-Munster Aml-Study Group’, Blood, 122 (2013), 2704-13.  
  9. U. Creutzig, M. Zimmermann, J. P. Bourquin, M. N. Dworzak, G. Fleischhack, N. Graf, T. Klingebiel, B. Kremens, T. Lehrnbecher, C. von Neuhoff, J. Ritter, A. Sander, A. Schrauder, A. von Stackelberg, J. Stary, and D. Reinhardt, ‘Randomized Trial Comparing Liposomal Daunorubicin with Idarubicin as Induction for Pediatric Acute Myeloid Leukemia: Results from Study Aml-Bfm 2004’, Blood, 122 (2013), 37-43.  
  10. U. Creutzig, M. Zimmermann, M. N. Dworzak, J. Ritter, G. Schellong, and D. Reinhardt, ‘Development of a Curative Treatment within the Aml-Bfm Studies’, Klin Padiatr, 225 Suppl 1 (2013), S79-86.  
  11. T. M. Dantonello, C. Int-Veen, A. Schuck, G. Seitz, I. Leuschner, M. Nathrath, P. G. Schlegel, U. Kontny, W. Behnisch, I. Veit-Friedrich, S. Kube, E. Hallmen, B. Kazanowska, R. Ladenstein, M. Paulussen, G. Ljungman, S. S. Bielack, T. Klingebiel, E. Koscielniak, and Studiengruppe Cooperative Weichteilsarkom, ‘Survival Following Disease Recurrence of Primary Localized Alveolar Rhabdomyosarcoma’, Pediatr Blood Cancer, 60 (2013), 1267-73.  
  12. C. Eckert, G. Henze, K. Seeger, N. Hagedorn, G. Mann, R. Panzer-Grumayer, C. Peters, T. Klingebiel, A. Borkhardt, M. Schrappe, A. Schrauder, G. Escherich, L. Sramkova, F. Niggli, J. Hitzler, and A. von Stackelberg, ‘Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children with Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group’, J Clin Oncol, 31 (2013), 2736-42.  
  13. M. N. Gaze, T. Boterberg, K. Dieckmann, M. Hormann, J. E. Gains, K. P. Sullivan, and R. Ladenstein, ‘Results of a Quality Assurance Review of External Beam Radiation Therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group’s High-Risk Neuroblastoma Trial: A Siopen Study’, Int J Radiat Oncol Biol Phys, 85 (2013), 170-4.  
  14. R. Geyeregger, C. Freimuller, S. Stevanovic, J. Stemberger, G. Mester, J. Dmytrus, T. Lion, H. G. Rammensee, G. Fischer, B. Eiz-Vesper, A. Lawitschka, S. Matthes, and G. Fritsch, ‘Short-Term in-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application’, PLoS One, 8 (2013), e59592.  
  15. M. Ibrisimovic, D. Kneidinger, T. Lion, and R. Klein, ‘An Adenoviral Vector-Based Expression and Delivery System for the Inhibition of Wild-Type Adenovirus Replication by Artificial Micrornas’, Antiviral Res, 97 (2013), 10-23.  
  16. M. Ibrisimovic, T. Lion, and R. Klein, ‘Combinatorial Targeting of 2 Different Steps in Adenoviral DNA Replication by Herpes Simplex Virus Thymidine Kinase and Artificial Microrna Expression for the Inhibition of Virus Multiplication in the Presence of Ganciclovir’, BMC Biotechnol, 13 (2013), 54.  
  17. G. J. Kaspers, M. Zimmermann, D. Reinhardt, B. E. Gibson, R. Y. Tamminga, O. Aleinikova, H. Armendariz, M. Dworzak, S. Y. Ha, H. Hasle, L. Hovi, A. Maschan, Y. Bertrand, G. G. Leverger, B. I. Razzouk, C. Rizzari, P. Smisek, O. Smith, B. Stark, and U. Creutzig, ‘Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International Bfm Study Group’, J Clin Oncol, 31 (2013), 599-607.  
  18. C. Kirby, P. F. Ambros, D. Billiter, W. B. London, E. Mendonca, T. Monclair, A. D. Pearson, S. L. Cohn, and S. L. Volchenboum, ‘Development of an Open-Source, Flexible Framework for Complex Inter-Institutional Disparate Data Sharing and Collaboration’, AMIA Jt Summits Transl Sci Proc, 2013 (2013), 103.  
  19. R. Ladenstein, S. Weixler, B. Baykan, M. Bleeke, R. Kunert, D. Katinger, I. Pribill, P. Glander, S. Bauer, V. Pistoia, J. Michon, A. Garaventa, and H. N. Lode, ‘Ch14.18 Antibody Produced in Cho Cells in Relapsed or Refractory Stage 4 Neuroblastoma Patients: A Siopen Phase 1 Study’, MAbs, 5 (2013), 801-9.  
  20. T. Lion, G. Webersinke, U. Kastner, C. Seger, G. Mitterbauer-Hohendanner, and G. Gastl, ‘[Current Diagnostic Requirements in Chronic Myeloid Leukemia]’, Wien Med Wochenschr, 163 (2013), 477-94.  
  21. M. Ludwig, E. Enzenhofer, S. Schneider, M. Rauch, A. Bodenteich, K. Neumann, E. Prieschl-Grassauer, A. Grassauer, T. Lion, and C. A. Mueller, ‘Efficacy of a Carrageenan Nasal Spray in Patients with Common Cold: A Randomized Controlled Trial’, Respir Res, 14 (2013), 124.  
  22. R. Luger, S. Valookaran, N. Knapp, C. Vizzardelli, A. M. Dohnal, and T. Felzmann, ‘Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode’, PLoS One, 8 (2013), e54879.  
  23. S. Matthes-Martin, H. Boztug, and T. Lion, ‘Diagnosis and Treatment of Adenovirus Infection in Immunocompromised Patients’, Expert Rev Anti Infect Ther, 11 (2013), 1017-28.  
  24. S. Matthes-Martin, A. Lawitschka, G. Fritsch, T. Lion, B. Grimm, S. Breuer, H. Boztug, S. Karlhuber, W. Holter, C. Peters, and M. Minkov, ‘Stem Cell Transplantation after Reduced-Intensity Conditioning for Sickle Cell Disease’, Eur J Haematol, 90 (2013), 308-12.   E. Mayer, M. Holzl, S. Ahmadi, B. Dillinger, N. Pilat, D. Fuchs, T. Wekerle, and A. Heitger, ‘Ctla4-Ig Immunosuppressive Activity at the Level of Dendritic Cell/T Cell Crosstalk’, Int Immunopharmacol, 15 (2013), 638-45.  
  25. C. Meyer, J. Hofmann, T. Burmeister, D. Groger, T. S. Park, M. Emerenciano, M. Pombo de Oliveira, A. Renneville, P. Villarese, E. Macintyre, H. Cave, E. Clappier, K. Mass-Malo, J. Zuna, J. Trka, E. De Braekeleer, M. De Braekeleer, S. H. Oh, G. Tsaur, L. Fechina, V. H. van der Velden, J. J. van Dongen, E. Delabesse, R. Binato, M. L. Silva, A. Kustanovich, O. Aleinikova, M. H. Harris, T. Lund-Aho, V. Juvonen, O. Heidenreich, J. Vormoor, W. W. Choi, M. Jarosova, A. Kolenova, C. Bueno, P. Menendez, S. Wehner, C. Eckert, P. Talmant, S. Tondeur, E. Lippert, E. Launay, C. Henry, P. Ballerini, H. Lapillone, M. B. Callanan, J. M. Cayuela, C. Herbaux, G. Cazzaniga, P. M. Kakadiya, S. Bohlander, M. Ahlmann, J. R. Choi, P. Gameiro, D. S. Lee, J. Krauter, P. Cornillet-Lefebvre, G. Te Kronnie, B. W. Schafer, S. Kubetzko, C. N. Alonso, U. zur Stadt, R. Sutton, N. C. Venn, S. Izraeli, L. Trakhtenbrot, H. O. Madsen, P. Archer, J. Hancock, N. Cerveira, M. R. Teixeira, L. Lo Nigro, A. Moricke, M. Stanulla, M. Schrappe, L. Sedek, T. Szczepanski, C. M. Zwaan, E. A. Coenen, M. M. van den Heuvel-Eibrink, S. Strehl, M. Dworzak, R. Panzer-Grumayer, T. Dingermann, T. Klingebiel, and R. Marschalek, ‘The Mll Recombinome of Acute Leukemias in 2013’, Leukemia, 27 (2013), 2165-76.  
  26. M. Morak, C. Meyer, R. Marschalek, G. Mann, O. A. Haas, and R. Panzer-Grumayer, ‘Clone-Specific Secondary Aberrations Are Not Detected in Neonatal Blood Spots of Children with Etv6-Runx1-Positive Leukemia’, Haematologica, 98 (2013), e108-10.  
  27. E. Muller, M. G. Seidel, H. Lackner, M. Dworzak, and C. Urban, ‘Acute Promyelocytic Leukemia Complicated by Massive Intracerebral Hemorrhage: Safety and Efficacy of Replacing Conventional Chemotherapy with Arsenic Trioxide in an Adolescent’, Klin Padiatr, 225 (2013), 172-3.  
  28. H. Pichler, B. Reismuller, M. Steiner, M. N. Dworzak, U. Potschger, C. Urban, B. Meister, K. Schmitt, R. Panzer-Grumayer, O. A. Haas, A. Attarbaschi, G. Mann, and A. L. L. B. F. M. Study Group Austrian, ‘The Inferior Prognosis of Adolescents with Acute Lymphoblastic Leukaemia (All) Is Caused by a Higher Rate of Treatment-Related Mortality and Not an Increased Relapse Rate–a Population-Based Analysis of 25 Years of the Austrian All-Bfm (Berlin-Frankfurt-Munster) Study Group’, Br J Haematol, 161 (2013), 556-65.  
  29. S. Preuner, and T. Lion, ‘Species-Specific Identification of a Wide Range of Clinically Relevant Fungal Pathogens by the Luminex((R)) Xmap Technology’, Methods Mol Biol, 968 (2013), 119-39.  
  30. B. Reismuller, C. Peters, M. N. Dworzak, U. Potschger, C. Urban, B. Meister, K. Schmitt, K. Dieckmann, H. Gadner, A. Attarbaschi, G. Mann, and A. L. L. B. F. M. Study Group Austrian, ‘Outcome of Children and Adolescents with a Second or Third Relapse of Acute Lymphoblastic Leukemia (All): A Population-Based Analysis of the Austrian All-Bfm (Berlin-Frankfurt-Munster) Study Group’, J Pediatr Hematol Oncol, 35 (2013), e200-4.   E. Salzer, S. Daschkey, S. Choo, M. Gombert, E. Santos-Valente, S. Ginzel, M. Schwendinger, O. A. Haas, G. Fritsch, W. F. Pickl, E. Forster-Waldl, A. Borkhardt, K. Boztug, K. Bienemann, and M. G. Seidel, ‘Combined Immunodeficiency with Life-Threatening Ebv-Associated Lymphoproliferative Disorder in Patients Lacking Functional Cd27’, Haematologica, 98 (2013), 473-8.  
  31. E. Salzer, E. Santos-Valente, S. Klaver, S. A. Ban, W. Emminger, N. K. Prengemann, W. Garncarz, L. Mullauer, R. Kain, H. Boztug, A. Heitger, K. Arbeiter, F. Eitelberger, M. G. Seidel, W. Holter, A. Pollak, W. F. Pickl, E. Forster-Waldl, and K. Boztug, ‘B-Cell Deficiency and Severe Autoimmunity Caused by Deficiency of Protein Kinase C Delta’, Blood, 121 (2013), 3112-6.  
  32. B. W. Schafer, E. Koscielniak, H. Kovar, and S. Fulda, ‘Esf-Embo Symposium “Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence” Sept 29-Oct 4, Polonia Castle Pultusk, Poland’, Front Oncol, 3 (2013), 142.  
  33. R. K. Schultz, K. S. Baker, J. J. Boelens, C. M. Bollard, R. M. Egeler, M. Cowan, R. Ladenstein, A. Lankester, F. Locatelli, A. Lawitschka, J. E. Levine, M. Loh, E. Nemecek, C. Niemeyer, V. K. Prasad, V. Rocha, S. Shenoy, B. Strahm, P. Veys, D. Wall, P. Bader, S. A. Grupp, M. A. Pulsipher, and C. Peters, ‘Challenges and Opportunities for International Cooperative Studies in Pediatric Hematopoeitic Cell Transplantation: Priorities of the Westhafen Intercontinental Group’, Biol Blood Marrow Transplant, 19 (2013), 1279-87.  
  34. S. Strehl, M. Konig, H. Boztug, B. W. Cooper, K. Suzukawa, S. J. Zhang, H. Y. Chen, A. Attarbaschi, and M. N. Dworzak, ‘All-Trans Retinoic Acid and Arsenic Trioxide Resistance of Acute Promyelocytic Leukemia with the Variant Stat5b-Rara Fusion Gene’, Leukemia, 27 (2013), 1606-10.  
  35. M. M. Strioga, T. Felzmann, D. J. Powell, Jr., V. Ostapenko, N. T. Dobrovolskiene, M. Matuskova, J. Michalek, and V. E. Schijns, ‘Therapeutic Dendritic Cell-Based Cancer Vaccines: The State of the Art’, Crit Rev Immunol, 33 (2013), 489-547.  
  36. R. Sullivan, J. R. Kowalczyk, B. Agarwal, R. Ladenstein, E. Fitzgerald, R. Barr, E. Steliarova-Foucher, I. Magrath, S. C. Howard, M. Kruger, M. G. Valsecchi, A. Biondi, P. Grundy, M. A. Smith, P. Adamson, G. Vassal, and K. Pritchard-Jones, ‘New Policies to Address the Global Burden of Childhood Cancers’, Lancet Oncol, 14 (2013), e125-35.  
  37. I. van der Sluis, A. Moricke, G. Escherich, A. von Stackelberg, W. Holter, T. Klingebiel, C. Flotho, S. Legien, W. Tissing, M. Bierings, C. Guimbal-Schmolck, U. Pichlmeier, H. J. Kuhnel, and R. Pieters, ‘Pediatric Acute Lymphoblastic Leukemia: Efficacy and Safety of Recombinant E. Coli-Asparaginase in Infants (Less Than One Year of Age) with Acute Lymphoblastic Leukemia’, Haematologica, 98 (2013), 1697-701.  
  38. C. M. Zwaan, C. Rizzari, F. Mechinaud, D. L. Lancaster, T. Lehrnbecher, V. H. van der Velden, B. B. Beverloo, M. L. den Boer, R. Pieters, D. Reinhardt, M. Dworzak, J. Rosenberg, G. Manos, S. Agrawal, L. Strauss, A. Baruchel, and P. R. Kearns, ‘Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Results of the Ca180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children with Cancer Consortium’, J Clin Oncol, 31 (2013), 2460-8.
  1. P. Angelini, W. B. London, S. L. Cohn, A. D. Pearson, K. K. Matthay, T. Monclair, P. F. Ambros, H. Shimada, I. Leuschner, M. Peuchmaur, M. S. Irwin, and S. Baruchel, ‘Characteristics and Outcome of Patients with Ganglioneuroblastoma, Nodular Subtype: A Report from the Inrg Project’, Eur J Cancer, 48 (2012), 1185-91.  
  2. A. Attarbaschi, M. Morak, G. Cario, G. Cazzaniga, H. M. Ensor, T. te Kronnie, J. Bradtke, G. Mann, E. Vendramini, C. Palmi, C. Schwab, L. J. Russell, M. Schrappe, V. Conter, C. D. Mitchell, S. Strehl, M. Zimmermann, U. Potschger, C. J. Harrison, M. Stanulla, R. Panzer-Grumayer, O. A. Haas, A. V. Moorman, Group Associazione Italiana di Ematologia ed Oncologia Pediatrica -Berlin-Frankfurt-Munster Study, Cancer National Cancer Research Institute -Children’s, and Group Leukaemia Study, ‘Treatment Outcome of Crlf2-Rearranged Childhood Acute Lymphoblastic Leukaemia: A Comparative Analysis of the Aieop-Bfm and Uk Ncri-Cclg Study Groups’, Br J Haematol, 158 (2012), 772-7.  
  3. I. M. Bennani-Baiti, I. Machado, A. Llombart-Bosch, and H. Kovar, ‘Lysine-Specific Demethylase 1 (Lsd1/Kdm1a/Aof2/Bhc110) Is Expressed and Is an Epigenetic Drug Target in Chondrosarcoma, Ewing’s Sarcoma, Osteosarcoma, and Rhabdomyosarcoma’, Hum Pathol, 43 (2012), 1300-7.  
  4. A. Borgmann-Staudt, R. Rendtorff, S. Reinmuth, C. Hohmann, T. Keil, F. R. Schuster, W. Holter, K. Ehlert, P. Keslova, A. Lawitschka, A. Jarisch, and G. Strauss, ‘Fertility after Allogeneic Haematopoietic Stem Cell Transplantation in Childhood and Adolescence’, Bone Marrow Transplant, 47 (2012), 271-6.  
  5. F. Brackmann, H. G. Dorr, C. R. Bartram, K. Hinderhofer, W. Holter, and T. Langer, ‘Glucocorticoid Withdrawal – Heterozygous Carriers of Congenital Adrenal Hyperplasia at Risk?’, Klin Padiatr, 224 (2012), 392-3.  
  6. I. B. Brecht, A. Agaimy, M. Besendorfer, R. Carbon, F. C. Thiel, O. Rompel, D. Osinski, T. Langer, M. Metzler, and W. Holter, ‘Malignant Peritoneal Mesothelioma in a 16-Year-Old Girl: Presentation of a Rare Disease’, Klin Padiatr, 224 (2012), 170-3.  
  7. S. Breuer, S. Preuner, G. Fritsch, H. Daxberger, M. Koenig, U. Poetschger, A. Lawitschka, C. Peters, G. Mann, T. Lion, and S. Matthes-Martin, ‘Early Recipient Chimerism Testing in the T- and Nk-Cell Lineages for Risk Assessment of Graft Rejection in Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation’, Leukemia, 26 (2012), 509-19.  
  8. S. Breuer, M. Rauch, S. Matthes-Martin, and T. Lion, ‘Molecular Diagnosis and Management of Viral Infections in Hematopoietic Stem Cell Transplant Recipients’, Mol Diagn Ther, 16 (2012), 63-77.  
  9. U. Creutzig, M. M. van den Heuvel-Eibrink, B. Gibson, M. N. Dworzak, S. Adachi, E. de Bont, J. Harbott, H. Hasle, D. Johnston, A. Kinoshita, T. Lehrnbecher, G. Leverger, E. Mejstrikova, S. Meshinchi, A. Pession, S. C. Raimondi, L. Sung, J. Stary, C. M. Zwaan, G. J. Kaspers, D. Reinhardt, and A. M. L. Committee of the International BFM Study Group, ‘Diagnosis and Management of Acute Myeloid Leukemia in Children and Adolescents: Recommendations from an International Expert Panel’, Blood, 120 (2012), 3187-205.  
  10. U. Creutzig, M. Zimmermann, J. P. Bourquin, M. N. Dworzak, B. Kremens, T. Lehrnbecher, C. von Neuhoff, A. Sander, A. von Stackelberg, I. Schmid, J. Stary, D. Steinbach, J. Vormoor, and D. Reinhardt, ‘Favorable Outcome in Infants with Aml after Intensive First- and Second-Line Treatment: An Aml-Bfm Study Group Report’, Leukemia, 26 (2012), 654-61.  
  11. A. Decock, M. Ongenaert, J. Hoebeeck, K. De Preter, G. Van Peer, W. Van Criekinge, R. Ladenstein, J. H. Schulte, R. Noguera, R. L. Stallings, A. Van Damme, G. Laureys, J. Vermeulen, T. Van Maerken, F. Speleman, and J. Vandesompele, ‘Genome-Wide Promoter Methylation Analysis in Neuroblastoma Identifies Prognostic Methylation Biomarkers’, Genome Biol, 13 (2012), R95.  
  12. D. Denk, K. Nebral, J. Bradtke, G. Pass, A. Moricke, A. Attarbaschi, and S. Strehl, ‘Pax5-Auts2: A Recurrent Fusion Gene in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia’, Leuk Res, 36 (2012), e178-81.  
  13. E. Ellinghaus, M. Stanulla, G. Richter, D. Ellinghaus, G. te Kronnie, G. Cario, G. Cazzaniga, M. Horstmann, R. Panzer Grumayer, H. Cave, J. Trka, O. Cinek, A. Teigler-Schlegel, A. ElSharawy, R. Hasler, A. Nebel, B. Meissner, T. Bartram, F. Lescai, C. Franceschi, M. Giordan, P. Nurnberg, B. Heinzow, M. Zimmermann, S. Schreiber, M. Schrappe, and A. Franke, ‘Identification of Germline Susceptibility Loci in Etv6-Runx1-Rearranged Childhood Acute Lymphoblastic Leukemia’, Leukemia, 26 (2012), 902-9.  
  14. T. Fazekas, P. Eickhoff, N. Pruckner, G. Vollnhofer, G. Fischmeister, C. Diakos, M. Rauch, M. Verdianz, A. Zoubek, H. Gadner, and T. Lion, ‘Lessons Learned from a Double-Blind Randomised Placebo-Controlled Study with a Iota-Carrageenan Nasal Spray as Medical Device in Children with Acute Symptoms of Common Cold’, BMC Complement Altern Med, 12 (2012), 147.  
  15. T. Fazekas, P. Eickhoff, M. Rauch, M. Verdianz, A. Attarbaschi, M. Dworzak, C. Peters, K. Hammer, A. Vecsei, U. Potschger, and T. Lion, ‘Prevalence and Clinical Course of Viral Upper Respiratory Tract Infections in Immunocompromised Pediatric Patients with Malignancies or after Hematopoietic Stem Cell Transplantation’, J Pediatr Hematol Oncol, 34 (2012), 442-9.  
  16. K. Fiser, T. Sieger, A. Schumich, B. Wood, J. Irving, E. Mejstrikova, and M. N. Dworzak, ‘Detection and Monitoring of Normal and Leukemic Cell Populations with Hierarchical Clustering of Flow Cytometry Data’, Cytometry A, 81 (2012), 25-34.  
  17. G. Fritsch, V. Witt, H. P. Spengler, J. Pichler, D. Scharner, E. Zipperer, D. Trbojevic, J. Stemberger, R. Geyeregger, M. K. Tea, and D. Printz, ‘Robust Multi-Parameter Single-Platform Quantification of Myeloid and B-Lymphoid Cd34 Progenitor Cells in All Clinical Cd34 Cell Sources and in Thawed Pbsc’, Pediatr Hematol Oncol, 29 (2012), 595-610.  
  18. G. Fuka, H. P. Kantner, R. Grausenburger, A. Inthal, E. Bauer, G. Krapf, U. Kaindl, M. Kauer, M. N. Dworzak, D. Stoiber, O. A. Haas, and R. Panzer-Grumayer, ‘Silencing of Etv6/Runx1 Abrogates Pi3k/Akt/Mtor Signaling and Impairs Reconstitution of Leukemia in Xenografts’, Leukemia, 26 (2012), 927-33.  
  19. G. Gaipa, G. Cazzaniga, M. G. Valsecchi, R. Panzer-Grumayer, B. Buldini, D. Silvestri, L. Karawajew, O. Maglia, R. Ratei, A. Benetello, S. Sala, A. Schumich, A. Schrauder, T. Villa, M. Veltroni, W. D. Ludwig, V. Conter, M. Schrappe, A. Biondi, M. N. Dworzak, and G. Basso, ‘Time Point-Dependent Concordance of Flow Cytometry and Real-Time Quantitative Polymerase Chain Reaction for Minimal Residual Disease Detection in Childhood Acute Lymphoblastic Leukemia’, Haematologica, 97 (2012), 1582-93.  
  20. S. Heitzeneder, M. Seidel, E. Forster-Waldl, and A. Heitger, ‘Mannan-Binding Lectin Deficiency – Good News, Bad News, Doesn’t Matter?’, Clin Immunol, 143 (2012), 22-38.  
  21. S. Hirabayashi, C. Flotho, J. Moetter, M. Heuser, H. Hasle, B. Gruhn, T. Klingebiel, F. Thol, B. Schlegelberger, I. Baumann, B. Strahm, J. Stary, F. Locatelli, M. Zecca, E. Bergstraesser, M. Dworzak, M. M. van den Heuvel-Eibrink, B. De Moerloose, S. Ogawa, C. M. Niemeyer, M. W. Wlodarski, and M. D. S. in Childhood European Working Group of, ‘Spliceosomal Gene Aberrations Are Rare, Coexist with Oncogenic Mutations, and Are Unlikely to Exert a Driver Effect in Childhood Mds and Jmml’, Blood, 119 (2012), e96-9.  
  22. Z. Husak, and M. N. Dworzak, ‘Cd99 Ligation Upregulates Hsp70 on Acute Lymphoblastic Leukemia Cells and Concomitantly Increases Nk Cytotoxicity’, Cell Death Dis, 3 (2012), e425.  
  23. C. Hutter, M. Kauer, I. Simonitsch-Klupp, G. Jug, R. Schwentner, J. Leitner, P. Bock, P. Steinberger, W. Bauer, N. Carlesso, M. Minkov, H. Gadner, G. Stingl, H. Kovar, and E. Kriehuber, ‘Notch Is Active in Langerhans Cell Histiocytosis and Confers Pathognomonic Features on Dendritic Cells’, Blood, 120 (2012), 5199-208.  
  24. M. Ibrisimovic, U. Nagl, D. Kneidinger, M. Rauch, T. Lion, and R. Klein, ‘Targeted Expression of Herpes Simplex Virus Thymidine Kinase in Adenovirus-Infected Cells Reduces Virus Titers Upon Treatment with Ganciclovir in Vitro’, J Gene Med, 14 (2012), 3-19.  
  25. A. Inthal, P. Zeitlhofer, M. Zeginigg, M. Morak, R. Grausenburger, E. Fronkova, B. Fahrner, G. Mann, O. A. Haas, and R. Panzer-Grumayer, ‘Crebbp Hat Domain Mutations Prevail in Relapse Cases of High Hyperdiploid Childhood Acute Lymphoblastic Leukemia’, Leukemia, 26 (2012), 1797-803.  
  26. J. H. Klusmann, D. Reinhardt, M. Zimmermann, B. Kremens, J. Vormoor, M. Dworzak, U. Creutzig, and T. Klingebiel, ‘The Role of Matched Sibling Donor Allogeneic Stem Cell Transplantation in Pediatric High-Risk Acute Myeloid Leukemia: Results from the Aml-Bfm 98 Study’, Haematologica, 97 (2012), 21-9.  
  27. D. Kneidinger, M. Ibrisimovic, T. Lion, and R. Klein, ‘Inhibition of Adenovirus Multiplication by Short Interfering Rnas Directly or Indirectly Targeting the Viral DNA Replication Machinery’, Antiviral Res, 94 (2012), 195-207.   H. Kovar, J. Alonso, P. Aman, D. N. Aryee, J. Ban, S. A. Burchill, S. Burdach, E. De Alava, O. Delattre, U. Dirksen, A. Fourtouna, S. Fulda, L. J. Helman, D. Herrero-Martin, P. C. Hogendoorn, U. Kontny, E. R. Lawlor, S. L. Lessnick, A. Llombart-Bosch, M. Metzler, R. Moriggl, S. Niedan, J. Potratz, F. Redini, G. H. Richter, L. T. Riedmann, C. Rossig, B. W. Schafer, R. Schwentner, K. Scotlandi, P. H. Sorensen, M. S. Staege, F. Tirode, J. Toretsky, S. Ventura, A. Eggert, and R. Ladenstein, ‘The First European Interdisciplinary Ewing Sarcoma Research Summit’, Front Oncol, 2 (2012), 54.  
  28. M. Lanzinger, B. Jurgens, U. Hainz, B. Dillinger, J. Raberger, D. Fuchs, and A. Heitger, ‘Ambivalent Effects of Dendritic Cells Displaying Prostaglandin E2-Induced Indoleamine 2,3-Dioxygenase’, Eur J Immunol, 42 (2012), 1117-28.  
  29. M. Lehner, G. Gotz, J. Proff, N. Schaft, J. Dorrie, F. Full, A. Ensser, Y. A. Muller, A. Cerwenka, H. Abken, O. Parolini, P. F. Ambros, H. Kovar, and W. Holter, ‘Redirecting T Cells to Ewing’s Sarcoma Family of Tumors by a Chimeric Nkg2d Receptor Expressed by Lentiviral Transduction or Mrna Transfection’, PLoS One, 7 (2012), e31210.  
  30. M. Lehner, B. Kellert, J. Proff, M. A. Schmid, P. Diessenbacher, A. Ensser, J. Dorrie, N. Schaft, M. Leverkus, E. Kampgen, and W. Holter, ‘Autocrine Tnf Is Critical for the Survival of Human Dendritic Cells by Regulating Bak, Bcl-2, and Flipl’, J Immunol, 188 (2012), 4810-8.  
  31. T. W. Lion, and R. J. Allen, ‘Computing the Local Pressure in Molecular Dynamics Simulations’, J Phys Condens Matter, 24 (2012), 284133.  
  32. T. Lion, F. Watzinger, S. Preuner, H. Kreyenberg, M. Tilanus, R. de Weger, J. van Loon, L. de Vries, H. Cave, C. Acquaviva, M. Lawler, M. Crampe, A. Serra, B. Saglio, F. Colnaghi, A. Biondi, J. J. van Dongen, M. van der Burg, M. Gonzalez, M. Alcoceba, G. Barbany, M. Hermanson, E. Roosnek, C. Steward, J. Harvey, F. Frommlet, and P. Bader, ‘The Eurochimerism Concept for a Standardized Approach to Chimerism Analysis after Allogeneic Stem Cell Transplantation’, Leukemia, 26 (2012), 1821-8.  
  33. M. Morak, A. Attarbaschi, S. Fischer, C. Nassimbeni, R. Grausenburger, S. Bastelberger, S. Krentz, G. Cario, D. Kasper, K. Schmitt, L. J. Russell, U. Potschger, M. Stanulla, C. Eckert, G. Mann, O. A. Haas, and R. Panzer-Grumayer, ‘Small Sizes and Indolent Evolutionary Dynamics Challenge the Potential Role of P2ry8-Crlf2-Harboring Clones as Main Relapse-Driving Force in Childhood All’, Blood, 120 (2012), 5134-42.  
  34. N. Naumann-Bartsch, R. Carbon, P. Klein, A. Agaimy, W. Holter, and J. Jungert, ‘An Unusual Thyroid Mass in a 5-Year-Old Girl’, J Pediatr, 161 (2012), 565.  
  35. H. Pichler, P. Zeitlhofer, M. N. Dworzak, C. Diakos, O. A. Haas, and L. Kager, ‘Thiamine-Responsive Megaloblastic Anemia (Trma) in an Austrian Boy with Compound Heterozygous Slc19a2 Mutations’, Eur J Pediatr, 171 (2012), 1711-5.  
  36. S. Postel-Vinay, A. S. Veron, F. Tirode, G. Pierron, S. Reynaud, H. Kovar, O. Oberlin, E. Lapouble, S. Ballet, C. Lucchesi, U. Kontny, A. Gonzalez-Neira, P. Picci, J. Alonso, A. Patino-Garcia, B. B. de Paillerets, K. Laud, C. Dina, P. Froguel, F. Clavel-Chapelon, F. Doz, J. Michon, S. J. Chanock, G. Thomas, D. G. Cox, and O. Delattre, ‘Common Variants near Tardbp and Egr2 Are Associated with Susceptibility to Ewing Sarcoma’, Nat Genet, 44 (2012), 323-7.  
  37. S. Preuner, G. Mitterbauer, C. Mannhalter, S. Herndlhofer, W. R. Sperr, P. Valent, and T. Lion, ‘Quantitative Monitoring of Bcr/Abl1 Mutants for Surveillance of Subclone-Evolution, -Expansion, and -Depletion in Chronic Myeloid Leukaemia’, Eur J Cancer, 48 (2012), 233-6.  
  38. W. Pulverer, M. Wielscher, R. Panzer-Grumayer, T. Plessl, A. Kriegner, K. Vierlinger, and A. Weinhausel, ‘The Stem Cell Signature of Chh/Chg Methylation Is Not Present in 271 Cancer Associated 5’utr Gene Regions’, Biochimie, 94 (2012), 2345-52.  
  39. M. G. Seidel, B. Rami, C. Item, E. Schober, P. Zeitlhofer, W. D. Huber, A. Heitger, O. A. Bodamer, and O. A. Haas, ‘Concurrent Foxp3- and Ctla4-Associated Genetic Predisposition and Skewed X Chromosome Inactivation in an Autoimmune Disease-Prone Family’, Eur J Endocrinol, 167 (2012), 131-4.  
  40. M. Steiner, D. Hochreiter, D. C. Kasper, R. Kornmuller, H. Pichler, O. A. Haas, U. Potschger, C. Hutter, M. N. Dworzak, G. Mann, and A. Attarbaschi, ‘Asparagine and Aspartic Acid Concentrations in Bone Marrow Versus Peripheral Blood During Berlin-Frankfurt-Munster-Based Induction Therapy for Childhood Acute Lymphoblastic Leukemia’, Leuk Lymphoma, 53 (2012), 1682-7.  
  41. P. Valent, G. Gastl, K. Geissler, R. Greil, O. Hantschel, A. Lang, W. Linkesch, T. Lion, A. L. Petzer, E. Pittermann, L. Pleyer, J. Thaler, and D. Wolf, ‘Nilotinib as Frontline and Second-Line Therapy in Chronic Myeloid Leukemia: Open Questions’, Crit Rev Oncol Hematol, 82 (2012), 370-7.  
  42. G. J. Veal, L. Nguyen, A. Paci, M. Riggi, M. Amiel, D. Valteau-Couanet, P. Brock, R. Ladenstein, and G. Vassal, ‘Busulfan Pharmacokinetics Following Intravenous and Oral Dosing Regimens in Children Receiving High-Dose Myeloablative Chemotherapy for High-Risk Neuroblastoma as Part of the Hr-Nbl-1/Siopen Trial’, Eur J Cancer, 48 (2012), 3063-72.
  1. I. M. Ambros, B. Brunner, G. Aigner, C. Bedwell, K. Beiske, J. Benard, N. Bown, V. Combaret, J. Couturier, R. Defferrari, N. Gross, M. Jeison, J. Lunec, B. Marques, T. Martinsson, K. Mazzocco, R. Noguera, G. Schleiermacher, F. Speleman, R. Stallings, G. P. Tonini, D. A. Tweddle, A. Valent, A. Vicha, N. V. Roy, E. Villamon, A. Ziegler, S. Preuner, M. Drobics, R. Ladenstein, G. Amann, R. J. Schuit, U. Potschger, and P. F. Ambros, ‘A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma’, Clin Cancer Res, 17 (2011), 792-804.  
  2. J. Ban, G. Jug, P. Mestdagh, R. Schwentner, M. Kauer, D. N. Aryee, K. L. Schaefer, F. Nakatani, K. Scotlandi, M. Reiter, D. Strunk, F. Speleman, J. Vandesompele, and H. Kovar, ‘Hsa-Mir-145 Is the Top Ews-Fli1-Repressed Microrna Involved in a Positive Feedback Loop in Ewing’s Sarcoma’, Oncogene, 30 (2011), 2173-80.  
  3. I. M. Bennani-Baiti, D. N. Aryee, J. Ban, I. Machado, M. Kauer, K. Muhlbacher, G. Amann, A. Llombart-Bosch, and H. Kovar, ‘Notch Signalling Is Off and Is Uncoupled from Hes1 Expression in Ewing’s Sarcoma’, J Pathol, 225 (2011), 353-63.  
  4. E. A. Coenen, S. C. Raimondi, J. Harbott, M. Zimmermann, T. A. Alonzo, A. Auvrignon, H. B. Beverloo, M. Chang, U. Creutzig, M. N. Dworzak, E. Forestier, B. Gibson, H. Hasle, C. J. Harrison, N. A. Heerema, G. J. Kaspers, A. Leszl, N. Litvinko, L. Lo Nigro, A. Morimoto, C. Perot, D. Reinhardt, J. E. Rubnitz, F. O. Smith, J. Stary, I. Stasevich, S. Strehl, T. Taga, D. Tomizawa, D. Webb, Z. Zemanova, R. Pieters, C. M. Zwaan, and M. M. van den Heuvel-Eibrink, ‘Prognostic Significance of Additional Cytogenetic Aberrations in 733 De Novo Pediatric 11q23/Mll-Rearranged Aml Patients: Results of an International Study’, Blood, 117 (2011), 7102-11.  
  5. U. Creutzig, M. Zimmermann, J. P. Bourquin, M. N. Dworzak, G. Fleischhack, C. von Neuhoff, A. Sander, A. Schrauder, A. von Stackelberg, J. Ritter, J. Stary, and D. Reinhardt, ‘Cns Irradiation in Pediatric Acute Myleoid Leukemia: Equal Results by 12 or 18 Gy in Studies Aml-Bfm98 and 2004’, Pediatr Blood Cancer, 57 (2011), 986-92.  
  6. U. Creutzig, M. Zimmermann, J. P. Bourquin, M. N. Dworzak, C. von Neuhoff, A. Sander, A. Schrauder, A. Teigler-Schlegel, J. Stary, S. Corbacioglu, and D. Reinhardt, ‘Second Induction with High-Dose Cytarabine and Mitoxantrone: Different Impact on Pediatric Aml Patients with T(8;21) and with Inv(16)’, Blood, 118 (2011), 5409-15.  
  7. G. Fuka, M. Kauer, R. Kofler, O. A. Haas, and R. Panzer-Grumayer, ‘The Leukemia-Specific Fusion Gene Etv6/Runx1 Perturbs Distinct Key Biological Functions Primarily by Gene Repression’, PLoS One, 6 (2011), e26348.   A. Heitger, ‘Regulation of Expression and Function of Ido in Human Dendritic Cells’, Curr Med Chem, 18 (2011), 2222-33.  
  8. H. Kovar, ‘Dr. Jekyll and Mr. Hyde: The Two Faces of the Fus/Ews/Taf15 Protein Family’, Sarcoma, 2011 (2011), 837474.  
  9. L. Kuster, R. Grausenburger, G. Fuka, U. Kaindl, G. Krapf, A. Inthal, G. Mann, M. Kauer, J. Rainer, R. Kofler, A. Hall, M. Metzler, L. H. Meyer, C. Meyer, J. Harbott, R. Marschalek, S. Strehl, O. A. Haas, and R. Panzer-Grumayer, ‘Etv6/Runx1-Positive Relapses Evolve from an Ancestral Clone and Frequently Acquire Deletions of Genes Implicated in Glucocorticoid Signaling’, Blood, 117 (2011), 2658-67.  
  10. R. Ladenstein, U. Potschger, D. Siabalis, A. Garaventa, C. Bergeron, I. J. Lewis, J. Stein, J. Kohler, P. J. Shaw, W. Holter, V. Pistoia, and J. Michon, ‘Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma after Megatherapy and Autologous Stem-Cell Reinfusion’, J Clin Oncol, 29 (2011), 441-8.  
  11. A. Lawitschka, C. Peters, M. G. Seidel, A. Havranek, A. Heitger, T. Fazekas, E. D. Gueclue, H. Gadner, and S. Matthes-Martin, ‘Long-Term Remission in Pediatric Wegener Granulomatosis Following Allo-Sct after Reduced-Intensity Conditioning’, Bone Marrow Transplant, 46 (2011), 462-3.  
  12. S. L. Lessnick, H. Kovar, and P. Houghton, ‘The Molecular Basis of Sarcoma’, Sarcoma, 2011 (2011), 864130.  
  13. W. B. London, V. Castel, T. Monclair, P. F. Ambros, A. D. Pearson, S. L. Cohn, F. Berthold, A. Nakagawara, R. L. Ladenstein, T. Iehara, and K. K. Matthay, ‘Clinical and Biologic Features Predictive of Survival after Relapse of Neuroblastoma: A Report from the International Neuroblastoma Risk Group Project’, J Clin Oncol, 29 (2011), 3286-92.  
  14. V. Moroz, D. Machin, A. Faldum, B. Hero, T. Iehara, V. Mosseri, R. Ladenstein, B. De Bernardi, H. Rubie, F. Berthold, K. K. Matthay, T. Monclair, P. F. Ambros, A. D. Pearson, S. L. Cohn, and W. B. London, ‘Changes over Three Decades in Outcome and the Prognostic Influence of Age-at-Diagnosis in Young Patients with Neuroblastoma: A Report from the International Neuroblastoma Risk Group Project’, Eur J Cancer, 47 (2011), 561-71.  
  15. K. Nebral, D. Krehan, and S. Strehl, ‘Expression of Pax5 Splice Variants: A Phenomenon of Stress-Induced, Illegitimate Splicing?’, Br J Haematol, 155 (2011), 277-80.  
  16. K. Pritchard-Jones, G. Lewison, S. Camporesi, G. Vassal, R. Ladenstein, Y. Benoit, J. S. Predojevic, J. Sterba, J. Stary, T. Eckschlager, H. Schroeder, F. Doz, U. Creutzig, T. Klingebiel, H. V. Kosmidis, M. Garami, R. Pieters, A. O’Meara, G. Dini, R. Riccardi, J. Rascon, L. Rageliene, V. Calvagna, P. Czauderna, J. Kowalczyk, M. J. Gil-da-Costa, L. Norton, F. Pereira, D. Janic, J. Puskacova, J. Jazbec, A. Canete, L. Hjorth, G. Ljungman, T. Kutluk, B. Morland, M. Stevens, D. Walker, and R. Sullivan, ‘The State of Research into Children with Cancer across Europe: New Policies for a New Decade’, Ecancermedicalscience, 5 (2011), 210.  
  17. H. Rubie, B. De Bernardi, M. Gerrard, A. Canete, R. Ladenstein, J. Couturier, P. Ambros, C. Munzer, A. D. Pearson, A. Garaventa, P. Brock, V. Castel, D. Valteau-Couanet, K. Holmes, A. Di Cataldo, B. Brichard, V. Mosseri, C. Marquez, D. Plantaz, L. Boni, and J. Michon, ‘Excellent Outcome with Reduced Treatment in Infants with Nonmetastatic and Unresectable Neuroblastoma without Mycn Amplification: Results of the Prospective Ines 99.1’, J Clin Oncol, 29 (2011), 449-55.  
  18. G. Schleiermacher, J. Michon, A. Ribeiro, G. Pierron, V. Mosseri, H. Rubie, C. Munzer, J. Benard, N. Auger, V. Combaret, I. Janoueix-Lerosey, A. Pearson, D. A. Tweddle, N. Bown, M. Gerrard, K. Wheeler, R. Noguera, E. Villamon, A. Canete, V. Castel, B. Marques, A. de Lacerda, G. P. Tonini, K. Mazzocco, R. Defferrari, B. de Bernardi, A. di Cataldo, N. van Roy, B. Brichard, R. Ladenstein, I. Ambros, P. Ambros, K. Beiske, O. Delattre, and J. Couturier, ‘Segmental Chromosomal Alterations Lead to a Higher Risk of Relapse in Infants with Mycn-Non-Amplified Localised Unresectable/Disseminated Neuroblastoma (a Siopen Collaborative Study)’, Br J Cancer, 105 (2011), 1940-8.  
  19. W. M. Schmidt, M. H. Uddin, S. Dysek, K. Moser-Thier, C. Pirker, H. Hoger, I. M. Ambros, P. F. Ambros, W. Berger, and R. E. Bittner, ‘DNA Damage, Somatic Aneuploidy, and Malignant Sarcoma Susceptibility in Muscular Dystrophies’, PLoS Genet, 7 (2011), e1002042.  
  20. M. Schrappe, M. G. Valsecchi, C. R. Bartram, A. Schrauder, R. Panzer-Grumayer, A. Moricke, R. Parasole, M. Zimmermann, M. Dworzak, B. Buldini, A. Reiter, G. Basso, T. Klingebiel, C. Messina, R. Ratei, G. Cazzaniga, R. Koehler, F. Locatelli, B. W. Schafer, M. Arico, K. Welte, J. J. van Dongen, H. Gadner, A. Biondi, and V. Conter, ‘Late Mrd Response Determines Relapse Risk Overall and in Subsets of Childhood T-Cell All: Results of the Aieop-Bfm-All 2000 Study’, Blood, 118 (2011), 2077-84.  
  21. T. Szczepanski, V. H. van der Velden, E. Waanders, R. P. Kuiper, P. Van Vlierberghe, B. Gruhn, C. Eckert, R. Panzer-Grumayer, G. Basso, H. Cave, U. Z. Stadt, D. Campana, A. Schrauder, R. Sutton, E. van Wering, J. P. Meijerink, and J. J. van Dongen, ‘Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition’, J Clin Oncol, 29 (2011), 1643-9.  
  22. D. R. Taggart, W. B. London, M. L. Schmidt, S. G. DuBois, T. F. Monclair, A. Nakagawara, B. De Bernardi, P. F. Ambros, A. D. Pearson, S. L. Cohn, and K. K. Matthay, ‘Prognostic Value of the Stage 4s Metastatic Pattern and Tumor Biology in Patients with Metastatic Neuroblastoma Diagnosed between Birth and 18 Months of Age’, J Clin Oncol, 29 (2011), 4358-64.  
  23. U. Thiel, A. Wawer, P. Wolf, M. Badoglio, A. Santucci, T. Klingebiel, O. Basu, A. Borkhardt, H. J. Laws, Y. Kodera, A. Yoshimi, C. Peters, R. Ladenstein, A. Pession, A. Prete, E. C. Urban, W. Schwinger, P. Bordigoni, A. Salmon, M. A. Diaz, B. Afanasyev, I. Lisukov, E. Morozova, A. Toren, B. Bielorai, J. Korsakas, F. Fagioli, D. Caselli, G. Ehninger, B. Gruhn, U. Dirksen, F. Abdel-Rahman, M. Aglietta, E. Mastrodicasa, M. Torrent, P. Corradini, F. Demeocq, G. Dini, P. Dreger, M. Eyrich, J. Gozdzik, F. Guilhot, E. Holler, E. Koscielniak, C. Messina, D. Nachbaur, R. Sabbatini, E. Oldani, H. Ottinger, H. Ozsahin, R. Schots, S. Siena, J. Stein, S. Sufliarska, A. Unal, M. Ussowicz, P. Schneider, W. Woessmann, H. Jurgens, M. Bregni, S. Burdach, Party Solid Tumor Working, Blood the Pediatric DiseaseWorking Party of the European Group for, Transplantation Marrow, Blood Asia Pacific, Transplantation Marrow, Transplantations Pediatric Registry for Stem Cell, and Eicess Study Group Meta, ‘No Improvement of Survival with Reduced- Versus High-Intensity Conditioning for Allogeneic Stem Cell Transplants in Ewing Tumor Patients’, Ann Oncol, 22 (2011), 1614-21.  
  24. M. van der Burg, H. Kreyenberg, A. Willasch, B. H. Barendregt, S. Preuner, F. Watzinger, T. Lion, E. Roosnek, J. Harvey, M. Alcoceba, M. G. Diaz, P. Bader, J. J. van Dongen, and E. U-supported EuroChimerism Consortium project QLRT, ‘Standardization of DNA Isolation from Low Cell Numbers for Chimerism Analysis by Pcr of Short Tandem Repeats’, Leukemia, 25 (2011), 1467-70.   W. Warsch, K. Kollmann, E. Eckelhart, S. Fajmann, S. Cerny-Reiterer, A. Holbl, K. V. Gleixner, M. Dworzak, M. Mayerhofer, G. Hoermann, H. Herrmann, C. Sillaber, G. Egger, P. Valent, R. Moriggl, and V. Sexl, ‘High Stat5 Levels Mediate Imatinib Resistance and Indicate Disease Progression in Chronic Myeloid Leukemia’, Blood, 117 (2011), 3409-20.  
  25. G. E. Winter, U. Rix, A. Lissat, A. Stukalov, M. K. Mullner, K. L. Bennett, J. Colinge, S. M. Nijman, S. Kubicek, H. Kovar, U. Kontny, and G. Superti-Furga, ‘An Integrated Chemical Biology Approach Identifies Specific Vulnerability of Ewing’s Sarcoma to Combined Inhibition of Aurora Kinases a and B’, Mol Cancer Ther, 10 (2011), 1846-56.  
  26. V. Witt, E. Beiglbock, and G. Fritsch, ‘Bone Marrow Processing with the Amicus Separator System’, J Clin Apher, 26 (2011), 195-9.  
  27. M. W. Wlodarski, J. Motter, T. A. Gorr, C. Olk-Batz, H. Hasle, M. Dworzak, C. M. Niemeyer, and C. Flotho, ‘Abnormal Promoter DNA Methylation in Juvenile Myelomonocytic Leukemia Is Not Caused by Mutation in Dnmt3a’, Blood, 118 (2011), 4490-1.
  1. D. N. Aryee, S. Niedan, M. Kauer, R. Schwentner, I. M. Bennani-Baiti, J. Ban, K. Muehlbacher, M. Kreppel, R. L. Walker, P. Meltzer, C. Poremba, R. Kofler, and H. Kovar, ‘Hypoxia Modulates Ews-Fli1 Transcriptional Signature and Enhances the Malignant Properties of Ewing’s Sarcoma Cells in Vitro’, Cancer Res, 70 (2010), 4015-23.  
  2. A. Attarbaschi, M. Pisecker, A. Inthal, G. Mann, D. Janousek, M. Dworzak, U. Potschger, R. Ullmann, M. Schrappe, H. Gadner, O. A. Haas, R. Panzer-Grumayer, S. Strehl, and Group Austrian Berlin-Frankfurt-Munster Study, ‘Prognostic Relevance of Tlx3 (Hox11l2) Expression in Childhood T-Cell Acute Lymphoblastic Leukaemia Treated with Berlin-Frankfurt-Munster (Bfm) Protocols Containing Early and Late Re-Intensification Elements’, Br J Haematol, 148 (2010), 293-300.  
  3. I. M. Bennani-Baiti, A. Cooper, E. R. Lawlor, M. Kauer, J. Ban, D. N. Aryee, and H. Kovar, ‘Intercohort Gene Expression Co-Analysis Reveals Chemokine Receptors as Prognostic Indicators in Ewing’s Sarcoma’, Clin Cancer Res, 16 (2010), 3769-78.  
  4. M. Bruggemann, A. Schrauder, T. Raff, H. Pfeifer, M. Dworzak, O. G. Ottmann, V. Asnafi, A. Baruchel, R. Bassan, Y. Benoit, A. Biondi, H. Cave, H. Dombret, A. K. Fielding, R. Foa, N. Gokbuget, A. H. Goldstone, N. Goulden, G. Henze, D. Hoelzer, G. E. Janka-Schaub, E. A. Macintyre, R. Pieters, A. Rambaldi, J. M. Ribera, K. Schmiegelow, O. Spinelli, J. Stary, A. von Stackelberg, M. Kneba, M. Schrappe, J. J. van Dongen, Leukemia European Working Group for Adult Acute Lymphoblastic, and Group International Berlin-Frankfurt-Munster Study, ‘Standardized Mrd Quantification in European All Trials: Proceedings of the Second International Symposium on Mrd Assessment in Kiel, Germany, 18-20 September 2008’, Leukemia, 24 (2010), 521-35.  
  5. M. Carlet, K. Janjetovic, J. Rainer, S. Schmidt, R. Panzer-Grumayer, G. Mann, M. Prelog, B. Meister, C. Ploner, and R. Kofler, ‘Expression, Regulation and Function of Phosphofructo-Kinase/Fructose-Biphosphatases (Pfkfbs) in Glucocorticoid-Induced Apoptosis of Acute Lymphoblastic Leukemia Cells’, BMC Cancer, 10 (2010), 638.   V. Conter, C. R. Bartram, M. G. Valsecchi, A. Schrauder, R. Panzer-Grumayer, A. Moricke, M. Arico, M. Zimmermann, G. Mann, G. De Rossi, M. Stanulla, F. Locatelli, G. Basso, F. Niggli, E. Barisone, G. Henze, W. D. Ludwig, O. A. Haas, G. Cazzaniga, R. Koehler, D. Silvestri, J. Bradtke, R. Parasole, R. Beier, J. J. van Dongen, A. Biondi, and M. Schrappe, ‘Molecular Response to Treatment Redefines All Prognostic Factors in Children and Adolescents with B-Cell Precursor Acute Lymphoblastic Leukemia: Results in 3184 Patients of the Aieop-Bfm All 2000 Study’, Blood, 115 (2010), 3206-14.  
  6. U. Creutzig, M. Zimmermann, M. Dworzak, C. Urban, G. Henze, B. Kremens, M. Lakomek, J. P. Bourquin, J. Stary, and D. Reinhardt, ‘Favourable Outcome of Patients with Childhood Acute Promyelocytic Leukaemia after Treatment with Reduced Cumulative Anthracycline Doses’, Br J Haematol, 149 (2010), 399-409.  
  7. C. Diakos, S. Zhong, Y. Xiao, M. Zhou, G. M. Vasconcelos, G. Krapf, R. F. Yeh, S. Zheng, M. Kang, J. K. Wiencke, M. S. Pombo-de-Oliveira, R. Panzer-Grumayer, and J. L. Wiemels, ‘Tel-Aml1 Regulation of Survivin and Apoptosis Via Mirna-494 and Mirna-320a’, Blood, 116 (2010), 4885-93.  
  8. M. N. Dworzak, G. Gaipa, A. Schumich, O. Maglia, R. Ratei, M. Veltroni, Z. Husak, G. Basso, L. Karawajew, H. Gadner, and A. Biondi, ‘Modulation of Antigen Expression in B-Cell Precursor Acute Lymphoblastic Leukemia During Induction Therapy Is Partly Transient: Evidence for a Drug-Induced Regulatory Phenomenon. Results of the Aieop-Bfm-All-Flow-Mrd-Study Group’, Cytometry B Clin Cytom, 78 (2010), 147-53.  
  9. S. Ehlers, C. Herbst, M. Zimmermann, N. Scharn, M. Germeshausen, N. von Neuhoff, C. M. Zwaan, K. Reinhardt, I. H. Hollink, J. H. Klusmann, T. Lehrnbecher, S. Roettgers, J. Stary, M. Dworzak, K. Welte, U. Creutzig, and D. Reinhardt, ‘Granulocyte Colony-Stimulating Factor (G-Csf) Treatment of Childhood Acute Myeloid Leukemias That Overexpress the Differentiation-Defective G-Csf Receptor Isoform Iv Is Associated with a Higher Incidence of Relapse’, J Clin Oncol, 28 (2010), 2591-7.  
  10. M. N. Gaze, T. Boterberg, K. Dieckmann, J. L. Habrand, S. Helfre, N. Peylan-Ramu, E. K. Chrzanowska, G. Schreier, and R. Ladenstein, ‘Development of an Electronic Database for Quality Assurance of Radiotherapy in the International Society of Paediatric Oncology (Europe) High Risk Neuroblastoma Study’, Radiother Oncol, 97 (2010), 593-5.  
  11. H. Gerr, M. Zimmermann, M. Schrappe, M. Dworzak, W. D. Ludwig, J. Bradtke, A. Moericke, R. Schabath, U. Creutzig, and D. Reinhardt, ‘Acute Leukaemias of Ambiguous Lineage in Children: Characterization, Prognosis and Therapy Recommendations’, Br J Haematol, 149 (2010), 84-92.  
  12. A. Handisurya, C. Schellenbacher, B. Reininger, F. Koszik, P. Vyhnanek, A. Heitger, R. Kirnbauer, and E. Forster-Waldl, ‘A Quadrivalent Hpv Vaccine Induces Humoral and Cellular Immune Responses in Whim Immunodeficiency Syndrome’, Vaccine, 28 (2010), 4837-41.  
  13. L. Hertzberg, E. Vendramini, I. Ganmore, G. Cazzaniga, M. Schmitz, J. Chalker, R. Shiloh, I. Iacobucci, C. Shochat, S. Zeligson, G. Cario, M. Stanulla, S. Strehl, L. J. Russell, C. J. Harrison, B. Bornhauser, A. Yoda, G. Rechavi, D. Bercovich, A. Borkhardt, H. Kempski, G. te Kronnie, J. P. Bourquin, E. Domany, and S. Izraeli, ‘Down Syndrome Acute Lymphoblastic Leukemia, a Highly Heterogeneous Disease in Which Aberrant Expression of Crlf2 Is Associated with Mutated Jak2: A Report from the International Bfm Study Group’, Blood, 115 (2010), 1006-17.  
  14. Z. Husak, D. Printz, A. Schumich, U. Potschger, and M. N. Dworzak, ‘Death Induction by Cd99 Ligation in Tel/Aml1-Positive Acute Lymphoblastic Leukemia and Normal B Cell Precursors’, J Leukoc Biol, 88 (2010), 405-12.  
  15. C. Hutter, A. Attarbaschi, S. Fischer, C. Meyer, M. Dworzak, M. Konig, R. Marschalek, G. Mann, O. A. Haas, and E. R. Panzer-Grumayer, ‘Acute Monocytic Leukaemia Originating from Mll-Mllt3-Positive Pre-B Cells’, Br J Haematol, 150 (2010), 621-3.  
  16. X. Jiang, Y. Gwye, D. Russell, C. Cao, D. Douglas, L. Hung, H. Kovar, T. J. Triche, and E. R. Lawlor, ‘Cd133 Expression in Chemo-Resistant Ewing Sarcoma Cells’, BMC Cancer, 10 (2010), 116.   B. Jurgens, D. Fuchs, J. Reichenbach, and A. Heitger, ‘Intact Indoleamine 2,3-Dioxygenase Activity in Human Chronic Granulomatous Disease’, Clin Immunol, 137 (2010), 1-4.  
  17. B. Jurgens, J. Raberger, D. Fuchs, and A. Heitger, ‘Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation’, Int J Tryptophan Res, 3 (2010), 77-90.  
  18. H. Kovar, ‘Aurka Inhibitors: Right in Time’, Pediatr Blood Cancer, 55 (2010), 3-4.   H. Kovar, ‘Downstream Ews/Fli1 – Upstream Ewing’s Sarcoma’, Genome Med, 2 (2010), 8.  
  19. A. Kowalska, E. Bozsaky, and P. F. Ambros, ‘Sequence-Based High Resolution Chromosomal Comparative Genomic Hybridization (Cgh)’, Methods Mol Biol, 659 (2010), 299-312.  
  20. R. Ladenstein, U. Potschger, M. C. Le Deley, J. Whelan, M. Paulussen, O. Oberlin, H. van den Berg, U. Dirksen, L. Hjorth, J. Michon, I. Lewis, A. Craft, and H. Jurgens, ‘Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-Ewing 99 Trial’, J Clin Oncol, 28 (2010), 3284-91.  
  21. R. Ladenstein, D. Valteau-Couanet, P. Brock, I. Yaniv, V. Castel, G. Laureys, J. Malis, V. Papadakis, A. Lacerda, E. Ruud, P. Kogner, M. Garami, W. Balwierz, H. Schroeder, M. Beck-Popovic, G. Schreier, D. Machin, U. Potschger, and A. Pearson, ‘Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid Cojec Induction in Pediatric Patients with High-Risk Neuroblastoma: The European Hr-Nbl1/Siopen Study’, J Clin Oncol, 28 (2010), 3516-24.  
  22. C. Landlinger, S. Preuner, L. Baskova, M. van Grotel, N. G. Hartwig, M. Dworzak, G. Mann, A. Attarbaschi, L. Kager, C. Peters, S. Matthes-Martin, A. Lawitschka, M. M. van den Heuvel-Eibrink, and T. Lion, ‘Diagnosis of Invasive Fungal Infections by a Real-Time Panfungal Pcr Assay in Immunocompromised Pediatric Patients’, Leukemia, 24 (2010), 2032-8.  
  23. M. C. Le Deley, O. Delattre, K. L. Schaefer, S. A. Burchill, G. Koehler, P. C. Hogendoorn, T. Lion, C. Poremba, J. Marandet, S. Ballet, G. Pierron, S. C. Brownhill, M. Nesslbock, A. Ranft, U. Dirksen, O. Oberlin, I. J. Lewis, A. W. Craft, H. Jurgens, and H. Kovar, ‘Impact of Ews-Ets Fusion Type on Disease Progression in Ewing’s Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results from the Cooperative Euro-E.W.I.N.G. 99 Trial’, J Clin Oncol, 28 (2010), 1982-8.  
  24. T. Lion, K. Kosulin, C. Landlinger, M. Rauch, S. Preuner, D. Jugovic, U. Potschger, A. Lawitschka, C. Peters, G. Fritsch, and S. Matthes-Martin, ‘Monitoring of Adenovirus Load in Stool by Real-Time Pcr Permits Early Detection of Impending Invasive Infection in Patients after Allogeneic Stem Cell Transplantation’, Leukemia, 24 (2010), 706-14.   K. K. Matthay, B. Shulkin, R. Ladenstein, J. Michon, F. Giammarile, V. Lewington, A. D. Pearson, and S. L. Cohn, ‘Criteria for Evaluation of Disease Extent by (123)I-Metaiodobenzylguanidine Scans in Neuroblastoma: A Report for the International Neuroblastoma Risk Group (Inrg) Task Force’, Br J Cancer, 102 (2010), 1319-26.  
  25. A. L. Petzer, D. Wolf, D. Fong, T. Lion, I. Dyagil, Z. Masliak, A. Bogdanovic, L. Griskevicius, S. Lejniece, S. Goranov, L. Gercheva, A. Stojanovic, D. Peytchev, N. Tzvetkov, R. Griniute, R. Oucheva, H. Ulmer, M. Kwakkelstein, F. Rancati, and G. Gastl, ‘High-Dose Imatinib Improves Cytogenetic and Molecular Remissions in Patients with Pretreated Philadelphia-Positive, Bcr-Abl-Positive Chronic Phase Chronic Myeloid Leukemia: First Results from the Randomized Celsg Phase Iii Cml 11 “Istahit” Study’, Haematologica, 95 (2010), 908-13.  
  26. H. Pichler, A. Moricke, G. Mann, A. Teigler-Schlegel, F. Niggli, K. Nebral, M. Konig, A. Inthal, D. Krehan, M. N. Dworzak, D. Janousek, J. Harbott, M. Schrappe, H. Gadner, S. Strehl, O. A. Haas, R. Panzer-Grumayer, A. Attarbaschi, and Group Berlin-Frankfurt-Munster Study, ‘Prognostic Relevance of Dic(9;20)(P11;Q13) in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia Treated with Berlin-Frankfurt-Munster (Bfm) Protocols Containing an Intensive Induction and Post-Induction Consolidation Therapy’, Br J Haematol, 149 (2010), 93-100.  
  27. P. Rhein, R. Mitlohner, G. Basso, G. Gaipa, M. N. Dworzak, R. Kirschner-Schwabe, C. Hagemeier, M. Stanulla, M. Schrappe, W. D. Ludwig, L. Karawajew, and R. Ratei, ‘Cd11b Is a Therapy Resistance- and Minimal Residual Disease-Specific Marker in Precursor B-Cell Acute Lymphoblastic Leukemia’, Blood, 115 (2010), 3763-71.  
  28. A. Sander, M. Zimmermann, M. Dworzak, G. Fleischhack, C. von Neuhoff, D. Reinhardt, G. J. Kaspers, and U. Creutzig, ‘Consequent and Intensified Relapse Therapy Improved Survival in Pediatric Aml: Results of Relapse Treatment in 379 Patients of Three Consecutive Aml-Bfm Trials’, Leukemia, 24 (2010), 1422-8.  
  29. J. Santos, N. Cerveira, S. Bizarro, F. R. Ribeiro, C. Correia, L. Torres, S. Lisboa, J. Vieira, J. M. Mariz, L. Norton, S. Snijder, C. H. Mellink, A. Buijs, L. Y. Shih, S. Strehl, F. Micci, S. Heim, and M. R. Teixeira, ‘Expression Pattern of the Septin Gene Family in Acute Myeloid Leukemias with and without Mll-Sept Fusion Genes’, Leuk Res, 34 (2010), 615-21.  
  30. M. G. Seidel, E. Grohmann, K. Sadeghi, A. Pollak, A. Heitger, and E. Forster-Waldl, ‘Vaccination against Tick-Borne Encephalitis Virus Tests Specific Igg Production Ability in Patients under Immunoglobulin Substitution Therapy’, Vaccine, 28 (2010), 6621-6.  
  31. E. Sieczkowski, C. Lehner, P. F. Ambros, and M. Hohenegger, ‘Double Impact on P-Glycoprotein by Statins Enhances Doxorubicin Cytotoxicity in Human Neuroblastoma Cells’, Int J Cancer, 126 (2010), 2025-35.   M. Steiner, A. Attarbaschi, M. Dworzak, H. Strobl, W. Pickl, R. Kornmuller, O. Haas, H. Gadner, G. Mann, and Group Austrian Berlin-Frankfurt-Munster Study, ‘Cytochemically Myeloperoxidase Positive Childhood Acute Leukemia with Lymphoblastic Morphology Treated as Lymphoblastic Leukemia’, J Pediatr Hematol Oncol, 32 (2010), e4-7.  
  32. J. Stemberger, V. Witt, D. Printz, R. Geyeregger, and G. Fritsch, ‘Novel Single-Platform Multiparameter Fcm Analysis of Apoptosis: Significant Differences between Wash and No-Wash Procedure’, Cytometry A, 77 (2010), 1075-81.  
  33. C. T. Storlazzi, A. Lonoce, M. C. Guastadisegni, D. Trombetta, P. D’Addabbo, G. Daniele, A. L’Abbate, G. Macchia, C. Surace, K. Kok, R. Ullmann, S. Purgato, O. Palumbo, M. Carella, P. F. Ambros, and M. Rocchi, ‘Gene Amplification as Double Minutes or Homogeneously Staining Regions in Solid Tumors: Origin and Structure’, Genome Res, 20 (2010), 1198-206.  
  34. M. W. Traxlmayr, D. Wesch, A. M. Dohnal, P. Funovics, M. B. Fischer, D. Kabelitz, and T. Felzmann, ‘Immune Suppression by Gammadelta T-Cells as a Potential Regulatory Mechanism after Cancer Vaccination with Il-12 Secreting Dendritic Cells’, J Immunother, 33 (2010), 40-52.  
  35. P. Van Vlierberghe, T. Palomero, H. Khiabanian, J. Van der Meulen, M. Castillo, N. Van Roy, B. De Moerloose, J. Philippe, S. Gonzalez-Garcia, M. L. Toribio, T. Taghon, L. Zuurbier, B. Cauwelier, C. J. Harrison, C. Schwab, M. Pisecker, S. Strehl, A. W. Langerak, J. Gecz, E. Sonneveld, R. Pieters, E. Paietta, J. M. Rowe, P. H. Wiernik, Y. Benoit, J. Soulier, B. Poppe, X. Yao, C. Cordon-Cardo, J. Meijerink, R. Rabadan, F. Speleman, and A. Ferrando, ‘Phf6 Mutations in T-Cell Acute Lymphoblastic Leukemia’, Nat Genet, 42 (2010), 338-42.  
  36. C. von Neuhoff, D. Reinhardt, A. Sander, M. Zimmermann, J. Bradtke, D. R. Betts, Z. Zemanova, J. Stary, J. P. Bourquin, O. A. Haas, M. N. Dworzak, and U. Creutzig, ‘Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients with Acute Myeloid Leukemia Treated Uniformly According to Trial Aml-Bfm 98’, J Clin Oncol, 28 (2010), 2682-9.  
  37. C. M. Zwaan, D. Reinhardt, M. Zimmerman, H. Hasle, J. Stary, B. Stark, M. Dworzak, U. Creutzig, G. J. Kaspers, and B. F. M. Study Group on Paediatric A. M. L. International, ‘Salvage Treatment for Children with Refractory First or Second Relapse of Acute Myeloid Leukaemia with Gemtuzumab Ozogamicin: Results of a Phase Ii Study’, Br J Haematol, 148 (2010), 768-76.